WO2018178014A1 - 4-cyclopropyl-2-oxopyrrolidine-3-carboxamide derivatives and related compounds as herbicidal plant protection agents - Google Patents

4-cyclopropyl-2-oxopyrrolidine-3-carboxamide derivatives and related compounds as herbicidal plant protection agents Download PDF

Info

Publication number
WO2018178014A1
WO2018178014A1 PCT/EP2018/057643 EP2018057643W WO2018178014A1 WO 2018178014 A1 WO2018178014 A1 WO 2018178014A1 EP 2018057643 W EP2018057643 W EP 2018057643W WO 2018178014 A1 WO2018178014 A1 WO 2018178014A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
cycloalkyl
alkoxy
compounds
cio
Prior art date
Application number
PCT/EP2018/057643
Other languages
German (de)
French (fr)
Inventor
Thomas Müller
Hendrik Helmke
Olaf Peters
Michael Charles MCLEOD
Uwe Döller
Stefan Lehr
Hansjörg Dietrich
Anu Bheemaiah MACHETTIRA
Christopher Hugh Rosinger
Dirk Schmutzler
Elmar Gatzweiler
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of WO2018178014A1 publication Critical patent/WO2018178014A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones

Definitions

  • the invention relates to the technical field of crop protection agents, in particular that of herbicides for the selective control of weeds and grass weeds in crops. Specifically, this invention relates to substituted cycloalkylpyrrolidinones and their salts, processes for their preparation and their use as herbicides.
  • the present invention thus provides substituted Cycloalkylpyrrolidmone the general formula (I) or salts thereof
  • Q is optionally substituted (C3-Cio) -cycloalkyl, (C3-Cio) -halocycloalkyl, (C3-C10) -cyanocycloalkyl, (Ci-Cio) -alkyl - (C3-Cio) -cycloalkyl, (Ci-Cio) - Alkoxy- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -haloalkoxy- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -alkylthio (C 3 -C 10) -cycloalkyl, aryl- (C 3 -) Cio) - cycloalkyl, heteroaryl- (C3-Cio) -cycloalkyl, (Ci-Cio) -alkoxycarbonyl - (C3-Cio) -cycloalky
  • Y is -C (R 7 ) (R 8 ) -, oxygen, or NR 1 ,
  • W 1 and W 2 are independently oxygen or sulfur; for hydrogen, amino, hydroxy, cyano, formyl, (Ci-Cg) alkyl, (Ci-Cg) -haloalkyl, (Ci-Cg) - cyanoalkyl, (Ci-Cg) -Hydroxyalkyl, (Ci-Cg) -alkoxy - (Ci-Cg) -alkyl, aryl (Ci-Cg) -alkyl, heteroaryl (Ci-Cg) -alkyl, heterocyclyl (Ci-Cg) -alkyl, (C 3 -Cio) -cycloalkyl, (C 3- Cio) -cycloalkyl- (Ci-Cg) -alkyl, (C 3 -Cg) -halocycloalkyl, (C 3 -Cg) -halocycloalkyl- (Ci-Cg) -alky
  • R 7 and R 8 are independently hydrogen, hydroxy, halogen, (Ci-Cs) alkyl, (Ci-C 8) - haloalkyl, (C 2 -C 8) alkenyl, (C 2 -C 8) alkynyl , (Ci-C 8) alkoxy (Ci-C 8) alkyl (Ci-C 8) - haloalkoxy (Ci-C 8) alkyl, (Ci-C 8) -AlkyltWo- (Ci-C 8 ) -alkyL (C 1 -C 8 ) -alkylsulfinyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylsulfonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylcarbonyl, (Ci -C 8) haloalkylcarbonyl
  • the compounds of general formula (I) can be prepared by addition of a suitable organic compound.
  • inorganic or organic acid such as mineral acids such as HCl, HBr, H2SO4, H3PO4 or HNO3, or organic acids, e.g. Carboxylic acids, such as formic acid, acetic acid, propionic acid, oxalic acid, lactic acid or salicylic acid, or sulfonic acids, such as p-toluenesulfonic acid, to a basic group, e.g. Amino, alkylamino, dialkylamino, piperidino, morpholino or pyridino, salts. These salts then contain the conjugate base of the acid as an anion. Suitable substituents which are in deprotonated form, e.g. Sulfonic acids, certain
  • Sulfonklareamide or carboxylic acids may form internal salts with their turn protonatable groups, such as amino groups. Salt formation can also be due to the action of a base
  • Suitable bases are, for example, organic amines, such as trialkylamines, morpholine, piperidine and pyridine and ammonium, alkali or
  • Potassium hydroxide, sodium and potassium carbonate and sodium and potassium bicarbonate are compounds in which the azide hydrogen is replaced by a cation suitable for agriculture, for example metal salts, in particular alkali metal salts or Alkaline earth metal salts, in particular sodium and potassium salts, or else ammonium salts, salts with organic amines or quaternary ammonium salts, for example with cations of the formula
  • R a to R d are each independently an organic radical, in particular alkyl, aryl, arylalkyl or alkylaryl. Also suitable are alkylsulfonium and
  • Alkylsulfoxoniumsalze such as (Ci-C4) -trialkylsulfonium and (Ci-C4) -Trialkylsulfoxoniumsalze.
  • the substituted cycloalkylpyrrolidinones of the general formula (I) according to the invention may be present in various tautomeric structures, all of which are intended to be encompassed by the general formula (I).
  • Preferred subject of the invention are compounds of the general formula (I) wherein
  • Q is optionally substituted (C3-Cio) -cycloalkyl, (C3-Cio) -halocycloalkyl, (C3-C10) -
  • Cyanocycloalkyl (C 1 -C 10) -alkyl- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -alkoxy- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -haloalkoxy- (C 3 -C 10) -cycloalkyl , (C 1 -C 10) -alkylthio (C 3 -C 10) -cycloalkyl, aryl- (C 3 -C 10) -cycloalkyl, heteroaryl- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -alkoxycarbonyl - (C 3 -C 4) -cycloalkyl, Cio) -cycloalkyl, hydroxcarbonyl- (C3-Cio) -cycloalkyl, (C3-Cio) -cycloalkyl
  • Y is -C (R 7 ) (R 8 ) -, oxygen, or NR 1 ,
  • W 1 and W 2 are independently oxygen or sulfur
  • R 1 is hydrogen, amino, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -hydroxyalkyl, (C 1 -C 6 ) -
  • R 7 and R 8 independently of one another are hydrogen, hydroxyl, halogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, (C 2 -C 6 ) -alkenyl, (C 2 -C 6 ) -alkynyl, (C 1 -C 6 ) -alkoxyalkyl, (C 1 -C 6 ) -haloalkoxyalkyl,
  • Q is optionally substituted (C3-C9) -cycloalkyl, (C3-C9) halocycloalkyl, (C3-C9) - Cyanocycloalkyl, (Ci-C9) alkyl - (C 3 -C 9) cycloalkyl, (Ci- C 9 ) -alkoxy- (C 3 -C 9 ) -cycloalkyl,
  • C 9 haloalkoxy (C 3 -C 9) cycloalkyl, (Ci-C 9) -alkylthio- (C 3 -C 9) cycloalkyl, aryl (C 3 -C 9) - cycloalkyl, heteroaryl (C 3 -C 9) cycloalkyl, (Ci-C9) alkoxycarbonyl - (C 3 -C 9) cycloalkyl, Hydroxcarbonyl- (C 3 -C 9) cycloalkyl, (C 3 -Cio) - Cycloalkyl- (C 3 -C 9 ) -cycloalkyl,
  • W 1 and W 2 are independently oxygen or sulfur
  • R 1 represents hydrogen, amino, (Ci-C 6) -alkyl, (Ci-C 6) -haloalkyl, (Ci-C 6) hydroxyalkyl, (Ci-C6) - alkoxy- (Ci-C 6) - alkyl, aryl- (C 1 -C 6 ) -alkyl, heteroaryl- (C 1 -C 6 ) -alkyl, heterocyclyl- (C 1 -C 6 ) -alkyl,
  • R 2 is hydrogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -hydroxyalkyl, (C 1 -C 6 ) -alkoxy- (C 1 -C 6 ) -alkyl .
  • each ring or each ring system may optionally be substituted by up to 5 substituents from the group R 6 , for hydrogen, (C 1 -C 6 ) -alkyl, ( Ci-C 6 ) -haloalkyl, (C 2 -C 6 ) -alkenyl, (C 3 -C 6 ) -alkynyl, (Ci-C 6 ) - alkoxy (Ci-C 6 ) -alkyl, (Ci-C 6 ) -haloalkoxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 )
  • R 7 and R 8 independently of one another represent hydrogen, hydroxyl, halogen, (C 1 -C 6) -alkyl, (C 1 -C 6) -
  • Haloalkyl (C 2 -C 6) -alkenyl, (C 3 -C 6) alkynyl, (Ci-C 6) alkoxyalkyl, (Ci-C 6) -Haloalkoxyalkyl, (Ci-C 6) alkylthio ( Ci-C 6 ) -alkyl.
  • Very particularly preferred subject of the invention are compounds of the general formula (I) wherein
  • Q is optionally substituted (C 3 -C 8 ) -cycloalkyl, (C 3 -C 8 ) -halocycloalkyl, (C 3 -C 8 ) -
  • W 1 and W 2 are independently oxygen or sulfur; preferably oxygen are;
  • R 1 is hydrogen, amino, (C 1 -C 4 ) -alkyl, (C 1 -C 4 ) -alkoxy- (C 1 -C 4 ) -alkyl, aryl- (C 1 -C 4 ) -alkyl,
  • R 2 is hydrogen, (Ci-C 4) alkyl, (Ci-C 4) -haloalkyl, (Ci-C 4) hydroxyalkyl, (Ci-C 4) alkoxy (Ci-C 4) -alkyl , is hydrogen, fluorine, chlorine, (C 1 -C 4 ) -alkyl,
  • R is an optionally substituted aryl and heteroaryl, where each ring or each ring system may optionally be substituted with up to 5 substituents from the group R 6 ,
  • R 5 represents hydrogen, (Ci-C 6) -alkyl, (Ci-C 6) -haloalkyl, (C 2 -C 6) -alkenyl, (C 3 -C 6) alkynyl, (Ci-C 6) - Alkoxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkoxy- (C 1 -C 6 ) -alkyl,
  • R 6 represents hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen, (C 1 -C 4) -alkyl,
  • R 7 is hydrogen, hydroxy, halogen, (Ci-C 3) alkyl, (Ci-C 3) -haloalkyl, (C 2 -C 3) alkenyl, (C3-C3) - alkynyl, (Ci-C 3 ) Alkoxy- (C 1 -C 3 ) -alkyl, (C 1 -C 3 ) -haloalkoxy- (C 1 -C 3 ) -alkyl, (C 1 -C 3 ) -alkylthio (C 1 -C 3 ) -alkyl.
  • Q is optionally substituted (C3-C7) -cycloalkyl, (C3-C 7) halocycloalkyl, (C3-C7) -
  • Y is -CH 2 -
  • W 1 and W 2 are independently oxygen or sulfur; preferably oxygen are;
  • R 1 represents hydrogen, amino, (Ci-C 3) alkyl, aryl (Ci-C 3) alkyl, heteroaryl (Ci-C 3) alkyl, (C 3 -C 6) - cycloalkyl, (C3 -C 5) cycloalkyl (Ci-C 3) alkyl, (Ci-C 6) alkylcarbonyl, (Ci-C 6) -alkoxycarbonyl, (C 2 -C 6) alkenyl, (C 2 -C 6 ) -Alkynyl,
  • R 2 is hydrogen
  • R 3 is hydrogen, fluorine or chlorine.
  • R 4 is an optionally substituted aryl and heteroaryl, wherein each ring or each ring system may optionally be substituted with up to 5 substituents from the group R 6 ,
  • R 5 represents hydrogen, (Ci-C 6) -alkyl, (Ci-C 6) -haloalkyl, (C 2 -C 6) -alkenyl, (C 3 -C 6) alkynyl, (Ci-C 6) - Alkoxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkoxy- (C 1 -C 6 ) -alkyl, R 6 is hydrogen, nitro,
  • Y is -CH 2 -, W 1 and W 2 are oxygen;
  • R 1 is hydrogen, amino, methyl, cyclopropyl, benzyl, p-methoxy-benzyl, allyl, propargyl, R stands for hydrogen, and
  • R 3 is hydrogen, fluorine or chlorine.
  • Q stands for one of the groupings Q-1 .1 to Q-1 .40 mentioned specifically in the table above.
  • Z represents the groups Z-1 .1 to Z-4.3.
  • Y is -CH 2 -, W 1 and W 2 are oxygen;
  • R 1 is hydrogen, methyl, cyclopropyl, benzyl, p-methoxy-benzyl, allyl, propargyl
  • R 2 is hydrogen
  • R 3 is hydrogen.
  • alkylsulfonyl alone or as part of a chemical group - is straight-chain or branched alkylsulfonyl, preferably with 1 to 8, or with 1 to 6
  • Carbon atoms e.g. (but not limited to) (C 1 -C 6) alkylsulfonyl such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methyl-propylsulfonyl, 1, 1-dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 1, 1-dimethylpropylsulfonyl, 1, 2-dimethylpropylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, hexylsulfonyl, 1-methylpentyl
  • heteroarylsulfonyl is optionally substituted pyridylsulfonyl
  • Heteroarylsulfonyl here in particular optionally substituted quinolinylsulfonyl, for example substituted by fluorine, chlorine, bromine, iodine, cyano, nitro, alkyl, haloalkyl, haloalkoxy, amino, alkylamino, alkylcarbonylamino, dialkylamino or alkoxy groups.
  • alkylthio alone or as part of a chemical group - is straight-chain or branched S-alkyl, preferably with 1 to 8, or with 1 to 6
  • Carbon atoms such as (C 1 -C 10) -, (C 1 -C 6) - or (C 1 -C 4) -alkylthio, for example (but not limited to) (C 1 -C 6) -alkylthio, such as methylthio, ethylthio, propylthio, 1-methylethylthio, Butylthio, 1-methylpropylthio, 2-methylpropylthio, 1, 1-dimethylethylthio, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3 Methylbutylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 2,2-dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio
  • Cycloalkylthio means according to the invention a bonded via a sulfur atom
  • Alkoxy means an alkyl radical bonded through an oxygen atom, for example (but not limited to) (C 1 -C 6) alkoxy, such as methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1 , 1-dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1, 2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy , 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy , 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethylbut
  • Alkenyloxy means an alkenyl radical bonded through an oxygen atom, alkynyloxy a bonded via an oxygen atom alkynyl group such as (C 2 -C 1 0) -, (C 2 -C 6) - or (C 2 -C 4) alkenoxy, and (C3-C10) -, (C 3 -C 6 ) - or (C 3 -C 4 ) -alkoxy.
  • Cycloalkyloxy means a cycloalkyl group bonded via an oxygen atom.
  • the number of C atoms refers to the alkyl radical in the
  • the number of carbon atoms refers to the alkyl radical in the alkoxycarbonyl group.
  • Alkynyloxycarbonyl refers to the alkenyl or alkynyl radical in the alkene or alkynyloxycarbonyl group.
  • the number of carbon atoms refers to the alkyl radical in the alkylcarbonyloxy group.
  • aryl means an optionally substituted mono-, bi- or polycyclic aromatic system having preferably 6 to 14, in particular 6 to 10 ring C atoms, for example phenyl, naphthyl, anthryl, phenanthrenyl and the like, preferably phenyl
  • optionally substituted aryl are also Vectorcyclische systems, such as
  • Preferred aryl substituents here are, for example, hydrogen, halogen, alkyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, halocycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, alkoxyalkyl, alkylthio, haloalkylthio, haloalkyl, alkoxy, haloalkoxy, Cycloalkoxy, cycloalkylalkoxy, aryloxy, heteroaryloxy, alkoxyalkoxy, alkynylalkoxy, alkenyloxy, bis-alkylaminoalkoxy, tris [alkyl] silyl, bis [alkyl] arylsilyl, bis [alkyl] alkylsilyl, tris [alkyl] silylalkyny
  • heterocyclic radical contains at least one heterocyclic ring
  • heterocyclic ring in which at least one C atom is replaced by a heteroatom, preferably by a heteroatom from the group N, O, S, P
  • N, O, S, P saturated, unsaturated, partially saturated or heteroaromatic and may be unsubstituted or substituted, wherein the binding site is located on a ring atom.
  • heterocyclyl or heterocyclic ring is optionally substituted, it may be fused with other carbocyclic or heterocyclic rings.
  • polycyclic systems are also included, for example 8-azabicyclo [3.2.1] octanyl, 8-azabicyclo [2.2.2] octanyl or 1-azabicyclo [2.2.1] heptyl.
  • optionally substituted heterocyclyl also become
  • the heterocyclic ring preferably contains 3 to 9 ring atoms, in particular 3 to 6 ring atoms, and one or more, preferably 1 to 4, in particular 1, 2 or 3 heteroatoms in the heterocyclic ring, preferably from the group N, O, and S, but not two
  • Oxygen atoms are to be directly adjacent, such as with a heteroatom from the group N, O and S 1- or 2- or 3-pyrrolidinyl, 3,4-dihydro-2H-pyrrol-2 or 3-yl, 2,3- dihydro-lH-pyrrole
  • 3-membered ring and 4-membered ring heterocycles are, for example, 1- or 2-aziridinyl, oxiranyl, thiiranyl, 1- or 2- or 3-azetidinyl,
  • heterocyclyl are a partially or fully hydrogenated heterocyclic radical having two heteroatoms from the group N, O and S, such as 1- or 2- or 3- or 4-pyrazolidinyl; 4,5-dihydro-3H-pyrazole-3 or 4 or 5-yl; 4,5-dihydro-1H-pyrazole-1 - or 3 or 4 or 5-yl; 2,3-dihydro-1H-pyrazole-1 - or 2- or 3- or 4- or 5-yl; 1- or 2- or 3- or 4-imidazolidinyl; 2,3-dihydro-1H-imidazole-I or 2- or
  • 6-yl 1,4,5,6-tetrahydropyridazine-1- or 3- or 4- or 5- or 6-yl; 3,4,5,6-tetrahydropyridazine-3- or 4- or 5-yl; 4,5-dihydropyridazine-3 or 4-yl; 3,4-dihydropyridazine-3- or 4- or 5- or 6-yl;
  • 6- or 7-yl 2,5-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 2,7-dihydro-1,3-oxazepine 2- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; l, 3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 1,4-oxazepan-2- or 3- or 5- or 6- or 7-yl; 2,3,4,5-tetrahydro-1,4-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-l,
  • heterocyclyl are a partially or fully hydrogenated heterocyclic radical having 3 heteroatoms from the group N, O and S, such as, for example, l, 4,2-dioxazolidin-2 or 3 or 5-yl; l, 4,2-dioxazol-3 or 5-yl; 1,2,2-dioxazinane-2- or -3- or 5- or 6-yl; 5,6-dihydro-l, 4,2-dioxazine-3 or 5 or 6-yl; l, 4,2-dioxazine-3- or 5- or 6-yl; l, 4,2-dioxazepan-2 or 3 or 5 or 6 or 7-yl; 6,7-dihydro-5H-l, 4,2-dioxazepine-3 or 5 or 6 or 7-yl; 2,3-dihydro-7H-l, 4,2-dioxazepin-2 or 3 or 5 or 6 or 7-yl; 2,3-dihydro-5H-1,
  • heterocycles listed above are preferably, for example, hydrogen, halogen, alkyl, haloalkyl, hydroxy, alkoxy, cycloalkoxy, aryloxy, alkoxyalkyl, alkoxyalkoxy, cycloalkyl,
  • Alkylaminocarbonyl bis-alkylaminocarbonyl, cycloalkylaminocarbonyl,
  • Suitable substituents for a substituted heterocyclic radical are the substituents mentioned below, in addition to oxo and thioxo.
  • the oxo group as a substituent on a ring C atom then means, for example, a carbonyl group in the heterocyclic ring.
  • lactones and lactams are preferably also included.
  • the oxo may also be attached to the hetero ring atoms, which may exist in different oxidation states, e.g. For example, at N and S, the divalent groups N (O), S (O) (also SO for short) and S (O) 2 (also SO2 for short) occur and form in the heterocyclic ring. In the case of -N (O) and -S (0) groups, both enantiomers are included.
  • heteroaryl stands for heteroaromatic compounds, ie.
  • heteroaryls are, for example, 1H-pyrrol-1-yl; lH-pyrrol-2-yl; lH-pyrrole
  • quinolines e.g., quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl
  • Isoquinolines e.g., isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl, isoquinolin-8-yl
  • quinoxaline quinazoline
  • cinnoline 1,5-naphthyridine; 1,6-naphthyridine; 1,7-naphthyridine; 1,8-naphthyridine;
  • heteroaryl are also 5- or 6-membered benzo-fused rings from the group 1H-indol-1-yl, 1H-indol-2-yl, 1H-indol-3-yl, 1H-indol-4-yl, 1H- Indol-5-yl, 1H-indol-6-yl, 1H-indol-7-yl, 1-benzofuran-2-yl, 1-benzofuran-3-yl, 1-benzofuran-4-yl, 1-benzofuran 5-yl, 1-benzofuran-6-yl, 1-benzofuran-7-yl, 1-benzothiophene-2-yl, 1-benzothiophen-3-yl, 1-benzothiophene-4-yl, 1-benzothiophene-5 yl, 1-benzothiophene-6-yl, 1-benzothiophene-7-yl, 1H-indazo
  • halogen means, for example, fluorine, chlorine, bromine or iodine.
  • halogen means, for example, a fluorine, chlorine, bromine or iodine atom.
  • alkyl means a straight-chain or branched, open-chain, saturated hydrocarbon radical which is optionally monosubstituted or polysubstituted and is referred to in the latter case as “substituted alkyl".
  • Preferred substituents are halogen atoms, alkoxy, haloalkoxy, cyano, alkylthio, haloalkylthio, amino or nitro groups, particularly preferred are methoxy, methyl, fluoroalkyl, cyano, nitro, fluorine, chlorine, bromine or iodine.
  • the prefix "bis” also includes the combination of different alkyl radicals, for example, methyl (ethyl) or ethyl (methyl).
  • Haloalkyl means by the same or different halogen atoms, partially or fully substituted alkyl, alkenyl and alkynyl, for example monohaloalkyl
  • ( Monohaloalkyl) such. CH 2 CH 2 Cl, CH 2 CH 2 Br, CHClCH 3 , CH 2 Cl, CH 2 F; Perhaloalkyl such. B. CCl 3, CC1F 2, CFC1 2 CF 2 CC1F 2, CF 2 CC1FCF 3; Polyhaloalkyl such. CH 2 CHFC1, CF 2 CC1FH, CF 2 CBrFH, CH 2 CF 3; The term perhaloalkyl also encompasses the term perfluoroalkyl.
  • Partially fluorinated alkyl means a straight-chain or branched, saturated hydrocarbon which is monosubstituted or polysubstituted by fluorine, it being possible for the corresponding fluorine atoms to be present as substituents on one or more different carbon atoms of the straight-chain or branched hydrocarbon chain, for example CHFCH3, CH2CH2F, CH2CH2CF3, CHF 2, CH 2 F, CHFCF2CF3
  • Partially fluorinated haloalkyl means a straight-chain or branched, saturated one
  • Hydrocarbon which is substituted by various halogen atoms having at least one fluorine atom, wherein all other optional halogen atoms are selected from the group fluorine, chlorine or bromine, iodine.
  • the corresponding halogen atoms may be present as substituents on one or more different carbon atoms of the straight-chain or branched hydrocarbon chain.
  • Partially fluorinated haloalkyl also includes the complete substitution of halogen with the participation of at least one fluorine atom of the straight-chain or branched chain.
  • Haloalkoxy is, for example OCF 3, OCHF 2, OCH 2 F, OCF2CF3, OCH2CF3 and OCH2CH2CI;.
  • haloalkenyl and other halogen-substituted radicals of the exemplarily mentioned term "(Ci-C4) -alkyl” is an abbreviated notation for straight-chain or branched alkyl having one to 4 carbon atoms corresponding to
  • Range indication for C atoms, d. H. includes the radicals methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methylpropyl or tert-butyl.
  • General alkyl radicals having a larger specified range of carbon atoms eg. As "(Ci-C6) alkyl", accordingly also include straight-chain or branched alkyl radicals having a larger number of C atoms, d. H. according to example, the alkyl radicals with 5 and 6 carbon atoms.
  • hydrocarbon radicals such as alkyl, alkenyl and alkynyl radicals, even in assembled radicals, are the lower carbon skeletons, e.g. with 1 to 6 C atoms or with unsaturated groups having 2 to 6 C atoms, preferred.
  • Alkenyl and alkynyl radicals have the meaning of the possible unsaturated radicals corresponding to the alkyl radicals, wherein at least one double bond or triple bond is contained. Preference is given to radicals having a double bond or
  • alkenyl in particular also includes straight-chain or branched open-chain
  • Hydrocarbon radicals having more than one double bond such as 1,3-butadienyl and 1,4-pentadienyl, but also allenyl or cumulenyl radicals having one or more cumulated double bonds, such as allenyl (1,2-propadienyl), 1, 2-butadienyl and 1,2,3-pentatrienyl.
  • Alkenyl is, for example, vinyl, which may optionally be substituted by further alkyl radicals, for example (but not limited to) (C 2 -C 6) -alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3 Pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl 2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl
  • alkynyl in particular also includes straight-chain or branched open-chain
  • C 2 -C 6) -alkynyl is, for example, ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3 Pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1, 1-dimethyl-2-propynyl, 1 Ethyl 2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl,
  • cycloalkyl means a carbocyclic saturated ring system preferably having 3-8
  • Ring C atoms for example cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, which is optionally further substituted, preferably by hydrogen, alkyl, alkoxy, cyano, nitro, alkylthio, haloalkylthio, Halogen, alkenyl, alkynyl, haloalkyl, amino, alkylamino, bisalkylamino, alkocycarbonyl,
  • Cycloalkylaminocarbonyl In the case of optionally substituted cycloalkyl cyclic systems are included with substituents, wherein substituents having a double bond on
  • polycyclic aliphatic systems are also included, such as, for example, bicyclo [1,1.0] butan-1-yl, bicyclo [1,1-0] butan-2-yl, bicyclo [2.1.0] pentan-1-yl , Bicyclo [1,11] pentan-1-yl, bicyclo [2.1.0] pentan-2-yl, bicyclo [2.1.0] pentan-5-yl, bicyclo [2.1.1] hexyl, bicyclo [2.2.1 ] hept-2-yl, bicyclo [2.2.2] octan-2-yl, bicyclo [3.2.1] octan-2-yl, bicyclo [3.2.2] nonan-2-yl, adamantane-1-yl and adamantane -2-yl, but also systems such.
  • spirocyclic aliphatic systems are also included, such as spiro [2.2] pent-1-yl, spiro [2.3] hex-1-yl, spiro [2.3] hex-4-yl, 3-spiro [2.3] hex-5-yl, spiro [3.3] hept-1-yl, spiro [3.3] hept-2-yl.
  • Cycloalkenyl means a carbocyclic, non-aromatic, partially unsaturated ring system preferably having 4-8 C atoms, eg 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1-cyclohexenyl, 2- Cyclohexenyl, 3-cyclohexenyl, 1, 3-cyclohexadienyl or 1, 4-cyclohexadienyl, wherein substituents having a double bond on the cycloalkenyl radical, for example an alkylidene group such as methylidene, are also included in the case of optionally substituted cycloalkenyl the explanations for substituted
  • alkylidene e.g.
  • B. in the form of (Ci-Cio) alkylidene means the radical of a straight-chain or branched open-chain hydrocarbon radical which is bonded via a double bond.
  • Cycloalkylidene means a
  • Alkoxyalkyl means an alkoxy group attached via an alkyl group
  • alkoxyalkoxy means an alkoxyalkyl group bonded via an oxygen atom, e.g. (but not limited to) methoxymethoxy, methoxyethoxy, ethoxyethoxy, methoxy-n-propyloxy.
  • Alkylthioalkyl means an alkylthio radical bonded via an alkyl group
  • Alkylthioalkylthio means an alkylthioalkyl radical bonded via an oxygen atom.
  • Arylalkoxyalkyl means an aryloxy group bonded through an alkyl group, and “heteroaryloxyalkyl” means a heteroaryloxy group bonded via an alkyl group.
  • Heteroaryloxyalkyl means a heteroaryloxy group bonded via an alkyl group.
  • Haloalkoxyalkyl means a haloalkoxy radical attached and "haloalkylthioalkyl” means a haloalkylthio radical attached via an alkyl group.
  • Arylalkyl means an aryl group attached via an alkyl group
  • heteroarylalkyl means a heteroaryl group bonded via an alkyl group
  • heterocyclylalkyl means a heterocyclyl group bonded through an alkyl group.
  • Cycloalkylalkyl means a cycloalkyl radical attached via an alkyl group, for example (but not limited to) cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclopropyleth-1-yl, 2-cyclopropyleth-1-yl, 1-cyclopropylpropyl l -yl, 3-cyclopropylprop-1-yl.
  • haloalkylthio alone or as part of a chemical group - represents straight-chain or branched S-haloalkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as (C 1 -C 5) -, (C 1 -C 5) - or (C 1 -C 4) -haloalkylthio, for example (but not limited to) trifluoromethylthio, pentafluoroethylthio, difluoromethyl, 2,2-difluoroeth-1-ylthio, 2,2,2-difluoroeth-1-ylthio, 3,3,3-prop-1-ylthio.
  • Halocycloalkyl and “Halocycloalkenyl” mean by the same or different halogen atoms, such as. B. F, Cl and Br, or by haloalkyl, such as. Trifluoromethyl or difluoromethyl, partially or fully substituted cycloalkyl or cycloalkenyl, e.g. 1-fluorocycloprop-1-yl, 2-fluorocycloprop-1-yl, 2,2-difluorocycloprop-1-yl, 1-fluorocyclobutyl, 1-trifluoromethylcycloprop-1-yl, 2
  • Trifluoromethylcycloprop-1-yl 1-chlorocycloprop-1-yl, 2-chlorocycloprop-1-yl, 2,2-dichlorocycloprop-1-yl, 3,3-difluorocyclobutyl,
  • trialkylsilyl alone or as part of a chemical group - is straight-chain or branched Si-alkyl, preferably with 1 to 8, or with 1 to 6
  • Carbon atoms such as tri - [(Ci-Cg) -, (Ci-Ce) - or (Ci-C4) -alkyl] silyl, e.g. (but not limited to) trimethylsilyl, triethylsilyl, tri (n-propyl) silyl, tri (iso-propyl) silyl, tri (n-butyl) silyl, tri (1-methylprop-1-yl) silyl, Tri- (2-methylprop-1-yl) silyl, tri (1,1-dimethyleth-1-yl) silyl, tri (2,2-dimethyl-1-yl) silyl.
  • the compounds of the general formula (I) can exist as stereoisomers.
  • the possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers, Z and E isomers, are all encompassed by the general formula (I). If, for example, one or more alkenyl groups are present, diastereomers (Z and E isomers) can occur. For example, if one or more asymmetric carbon atoms are present, enantiomers and diastereomers may occur.
  • Stereoisomers can be distinguished from those in the
  • stereoisomers can be selectively prepared by using stereoselective reactions using optically active sources and / or adjuvants.
  • the invention thus also relates to all stereoisomers which comprises the general formula (I) but are not specified with their specific stereoform, and mixtures thereof. If the compounds are obtained as solids, the purification can also by
  • the substituted pyrrolidinones of the general formula (I) can be prepared starting from known processes.
  • the synthetic routes used and investigated are based on commercially available or easily prepared amines, on appropriately substituted aldehydes and on commercially available chemicals such as malonic acid derivatives and nitromethane.
  • the groupings Q, Y, W 1 , W 2 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 of the general formula (I) have the meanings defined above in the following schemes unless definitions are given by way of example but not by way of limitation.
  • the synthesis of the compounds of general formula (Ia) according to the invention is carried out via a
  • Polymer-bound reagents such as polymer-bound dicyclohexylcarbodiimide are also suitable for this coupling reaction.
  • the reaction preferably takes place in the temperature range between 0 ° C and 80 ° C, in an adequate solvent such as dichloromethane, acetonitrile, N, N-dimethylformamide or ethyl acetate and in the presence of a base such as triethylamine, N, N-diisopropylethylamine or l, 8-diazabicyclo [5.4.0] undec-7-cene (see Scheme 1).
  • an adequate solvent such as dichloromethane, acetonitrile, N, N-dimethylformamide or ethyl acetate
  • a base such as triethylamine, N, N-diisopropylethylamine or l, 8-diazabicyclo [5.4.0] undec-7-cene (see Scheme 1).
  • the synthesis of the acid of the general formula (II) can be prepared by saponification of the compound of the general formula (IV) according to or analogously to methods known to those skilled in the art.
  • the saponification can be carried out in the presence of a base or a Lewis acid.
  • the base may be a hydroxide salt of an alkali metal (such as lithium, sodium or potassium), and the saponification reaction preferably takes place in the temperature range between room temperature and ° C.
  • the Lewis acid may be boron tribromide, and the reaction may be carried out in a temperature range between -20 ° C and 100 ° C, preferably -5 ° C and 50 ° C.
  • R ' (C 1 -C 4 ) -alkyl.
  • the synthesis of the compound of the general formula (IV) can be prepared by reduction of the compound of the general formula (V) and subsequent in situ cyclization of the resulting amine intermediate according to or analogously to methods known in the art (see Scheme 3).
  • the literature describes the reduction of aliphatic nitro groups by catalytic hydrogenolysis in the presence of palladium on carbon or Raney nickel, iron or zinc in an acidic medium (see, for example, reports of the Deutsche Chemischen Deutschen 1961 1904, 37, 3520-3525), and lithium alanate , The reduction can also be carried out with samarium (II) iodide in the presence of a proton source such as methanol (see, for example, Tetrahedron Letters 1991, 32 (14), 1699-1702).
  • a proton source such as methanol
  • R ' (C 1 -C 4 ) -alkyl.
  • R ' (C 1 -C 4 ) -alkyl.
  • the compounds of general formula (VI) can be prepared by Knoevenagel condensation of an aldehyde of general formula (VIII) and malonic esters of general formula (IX) (see Scheme 5, G. Jones, Organic Reactions Volume 15, John Wiley and Sons, 1967 ).
  • the base may be an alkanolate salt or hydroxide of an alkali metal (such as sodium methylate or sodium ethylate), in an adequate solvent such as methanol or ethanol, or bases such as lithium hexamethyldisilazane,
  • the compounds of general formula (X) can be prepared by condensation of an aldehyde of general formula (VIII) and compounds of general formula (XI) in the presence of a base such as sodium hydride in an adequate solvent such as tetrahydrofuran (see Scheme 7) ).
  • the compounds of the general formula (Ia) can be prepared by reduction of the compound of the general formula (XII) and subsequent in situ cyclization of the resulting amine intermediate according to methods known to those skilled in the art (see Scheme 8).
  • the literature describes the reduction of aliphatic nitro groups by catalytic hydrogenolysis in the presence of palladium on carbon or RaneyNickel.
  • Nickel (II) chloride
  • R ' (C 1 -C 4 ) -alkyl.
  • Scheme 9 describes the synthesis of the compound of general formula (XII) by reaction of a malonic ester of general formula (XIII) with a nitro olefin of general formula (X) in the presence of a base.
  • the base may be an alkanolate salt or hydroxide of an alkali metal (such as sodium methylate or sodium ethylate) in an adequate solvent such as methanol or ethanol.
  • an alkanolate salt or hydroxide of an alkali metal such as sodium methylate or sodium ethylate
  • an adequate solvent such as methanol or ethanol.
  • R ' (C 1 -C 4 ) -alkyl.
  • Monomalonic acid chlorides of the general formula (XIV) with an amine of the general formula (XV) in the presence of a base see Scheme 10).
  • the base can be triethylamine or
  • Diisopropylethylamine and the reaction can be carried out in an adequate solvent such as dichloromethane or tetrahydrofuran.
  • Preferred compounds of the formula (L I) are the compounds 1.1-1 to 1.1-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.1-1 to 1.1-40 of Table LI are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.2 Preferred compounds of the formula (1.2) are the compounds 1.2-1 to 1.2-40, wherein Q has the meanings given in Table 1 of each Table.
  • the compounds 1.2-1 to 1.2- 40 of Table 1.2 are thus by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.3 Preferred compounds of the formula (1.3) are the compounds 1.3-1 to 1.3-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.3-1 to 1.3-40 of Table 1.3 are thus determined by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.4 Preferred compounds of the formula (1.4) are the compounds 1.4-1 to 1.4-40, wherein Q has the meanings of Table 1 given in the respective line.
  • the compounds 1.4-1 to 1.4-40 of Table 1.4 are thus by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.5 Preferred compounds of the formula (1.5) are the compounds 1.5-1 to 1.5-40, wherein Q has the meanings indicated in the respective line of Table 1.
  • the compounds 1.5-1 to 1.5-346 of Table 1.5 are thus by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.6 Preferred compounds of the formula (1.6) are the compounds 1.6-1 to 1.6-40, in which Q has the meanings indicated in the respective line of Table 1.
  • the compounds 1.6-1 to 1.6-40 of Table 1.6 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.7 Preferred compounds of the formula (1.7) are the compounds 1.7-1 to 1.7-40, wherein Q has the meanings given in Table 1 of each Table.
  • the compounds 1.7-1 to 1.7-40 of Table 1.7 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.8 Preferred compounds of the formula (1.8) are the compounds 1.8-1 to 1.8-40, in which Q has the meanings indicated in the respective line of Table 1.
  • the compounds 1.8-1 to 1.8-40 of Table 1.8 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.9 Preferred compounds of the formula (1.9) are the compounds 1.9-1 to 1.9-40, wherein Q has the meanings indicated in the respective line of Table 1.
  • the compounds 1.9-1 to 1.9- 40 of Table 1.9 are thus by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.10 Preferred compounds of the formula (1.10) are the compounds 1.10-1 to 1.10-40, wherein Q has the meanings given in Table 1 of each Table.
  • the connections 1.10-1 to 1.10-40 of Table 1.10 are therefore distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.11 Preferred compounds of the formula (1.11) are the compounds 1.11-1 to 1.11-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds L I 1-1 to L I 1-40 of the table LI 1 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.12 Preferred compounds of the formula (1.12) are the compounds 1.12-1 to 1.12-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.12-1 to 1.12-40 of Table 1.12 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.13 Preferred compounds of the formula (1.13) are the compounds 1.13-1 to 1.13-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.13-1 to 1.13-40 of Table 1.13 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.14 Preferred compounds of the formula (1.14) are the compounds 1.14-1 to 1.14-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.14-1 to 1.14-40 of Table 1.14 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.15 Preferred compounds of the formula (1.15) are the compounds 1.15-1 to 1.15-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.15-1 to 1.15-40 of Table 1.15 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.16 Preferred compounds of the formula (1.16) are the compounds 1.16-1 to 1.16-40, wherein Q has the meanings given in Table 1 of each Table.
  • the compounds 1.16-1 to 1.16-40 of Table 1.16 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.17 Preferred compounds of the formula (1.17) are the compounds 1.17-1 to 1.17-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.17-1 to 1.17-40 of Table 1.17 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.18 Preferred compounds of the formula (1.18) are the compounds 1.18-1 to 1.18-40, in which Q has the meanings of Table 1 given in the respective line.
  • the compounds 1.18-1 to 1.18-40 of Table 1.18 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.19 Preferred compounds of the formula (1.19) are the compounds 1.19-1 to 1.19-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.19-1 to 1.19-40 of Table 1.19 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.20 Preferred compounds of the formula (1.20) are the compounds 1.20-1 to 1.20-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.20-1 to 1.20-40 of Table 1.20 are thus determined by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.21 Preferred compounds of the formula (1.21) are the compounds 1.21-1 to 1.21-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.21-1 to 1.21-40 of Table 1.21 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.22 Preferred compounds of the formula (1.22) are the compounds 1.22-1 to 1.22-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.22-1 to 1.22-40 of Table 1.22 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.23 Preferred compounds of the formula (1.23) are the compounds 1.23-1 to 1.23-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.23-1 to 1.23-40 of Table 1.23 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.24 Preferred compounds of the formula (1.24) are the compounds 1.24-1 to 1.24-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.24-1 to 1.24-40 of Table 1.24 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.25 Preferred compounds of the formula (1.25) are the compounds 1.25-1 to 1.25-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.25-1 to 1.25-40 of Table 1.25 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.26 Preferred compounds of the formula (1.26) are the compounds 1.26-1 to 1.26-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.26-1 to 1.26-40 of Table 1.26 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.27 Preferred compounds of the formula (1.27) are the compounds 1.27-1 to 1.27-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.27-1 to 1.27-40 of Table 1.27 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.28 Preferred compounds of the formula (1.28) are the compounds 1.28-1 to 1.28-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the connections 1.28-1 to 1.28-40 of Table 1.28 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.29 Preferred compounds of the formula (1.29) are the compounds 1.29-1 to 1.29-40, in which Q has the meanings of Table 1 given in the respective line.
  • the compounds 1.29-1 to 1.29-40 of Table 1.29 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.30 Preferred compounds of the formula (1.30) are the compounds 1.30-1 to 1.30-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.30-1 to 1.30-40 of Table 1.30 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.31 Preferred compounds of the formula (1.31) are the compounds 1.31-1 to 1.31-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.31-1 to 1.31-40 of Table 1.31 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.32 Preferred compounds of the formula (1.32) are the compounds 1.32-1 to 1.32-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.32-1 to 1.32-40 of Table 1.32 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.33 Preferred compounds of the formula (1.33) are the compounds 1.33-1 to 1.33-40, in which Q has the meanings given in Table 1 of each Table.
  • the compounds 1.33-1 to 1.33-40 of Table 1.33 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.34 Preferred compounds of the formula (1.34) are the compounds 1.34-1 to 1.34-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.34-1 to 1.34-40 of Table 1.34 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.35 Preferred compounds of the formula (1.35) are the compounds 1.35-1 to 1.35-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.35-1 to 1.35-40 of Table 1.35 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.36 Preferred compounds of the formula (1.36) are the compounds 1.36-1 to 1.36-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the connections 1.36-1 to 1.36-40 of Table 1.36 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.37 Preferred compounds of the formula (1.37) are the compounds 1.37-1 to 1.37-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.37-1 to 1.37-40 of Table 1.37 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.38 Preferred compounds of the formula (1.38) are the compounds 1.38-1 to 1.38-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.38-1 to 1.38-40 of Table 1.38 are thus affected by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.39 Preferred compounds of the formula (1.39) are the compounds 1.39-1 to 1.39-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.39-1 to 1.39-40 of Table 1.39 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.40 Preferred compounds of the formula (1.40) are the compounds 1.40-1 to 1.40-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.40-1 to 1.40-40 of Table 1.40 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.41 Preferred compounds of the formula (1.41) are the compounds 1.41-1 to 1.41-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.41-1 to 1.41-40 of Table 1.41 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.42 Preferred compounds of the formula (1.42) are the compounds 1.42-1 to 1.42-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.42-1 to 1.42-40 of Table 1.42 are therefore distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.43 Preferred compounds of the formula (1.43) are the compounds 1.43-1 to 1.43-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.43-1 to 1.43-40 of Table 1.43 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.44 Preferred compounds of the formula (1.44) are the compounds 1.44-1 to 1.44-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the connections 1.44-1 to 1.44-40 of Table 1.44 are therefore distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.45 Preferred compounds of the formula (1.45) are the compounds 1.45-1 to 1.45-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.45-1 to 1.45-40 of Table 1.45 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.46 Preferred compounds of the formula (1.46) are the compounds 1.46-1 to 1.46-40, wherein Q has the meanings given in Table 1 of each Table.
  • the compounds 1.46-1 to 1.46-40 of Table 1.46 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.47 Preferred compounds of the formula (1.47) are the compounds 1.47-1 to 1.47-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.47-1 to 1.47-40 of Table 1.47 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.48 Preferred compounds of the formula (1.48) are the compounds 1.48-1 to 1.48-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.48-1 to 1.48-40 of Table 1.48 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
  • Table 1.49 Preferred compounds of the formula (1.49) are the compounds 1.49-1 to 1.49-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.49-1 to 1.49-40 of Table 1.49 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • Table 1.50 Preferred compounds of the formula (1.50) are the compounds 1.50-1 to 1.50-40, in which Q has the meanings of Table 1 indicated in the respective line.
  • the compounds 1.50-1 to 1.50-40 of Table 1.50 are thus affected by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
  • n-Bu unbranched butyl
  • n-Pr unbranched propyl
  • i-Pr branched propyl
  • c-Pr cyclopropyl
  • c-hex cyclohexyl.
  • the 1H NMR data of selected examples are noted in terms of 1H NMR peak lists. For each signal peak, first the ⁇ value in ppm and then the signal intensity in round brackets are listed. The ⁇ -value signal intensity number pairs of different signal peaks are listed separated by semicolons.
  • the peak list of an example therefore has the form: ⁇ (intensity ⁇ ; 82 (intensity 2);; ⁇ ; (intensity ⁇ ;; ⁇ ⁇ (intensity n )
  • the intensity of sharp signals correlates with the height of the signals in a printed example of an NMR spectrum in cm and shows the true ratios of the signal intensities. For broad signals, multiple peaks or the center of the signal and their relative intensity can be shown compared to the most intense signal in the spectrum.
  • stereoisomers and / or impurities may be typical of each
  • ⁇ 8.5107 (1.4); 8.3077 (0.8); 8.2947 (1.5); 8.2895 (1.6); 8.2753 (2.6); 8.2553 (1.6); 8.2512 (1.4); 7.5191 (0.9); 7.2607 (173.5); 7.2557 (2.6); 7.2533 (1.3); 7.2524 (1.2); 7.2517 (1.2); 7.2501 (0.9); 7.2484 (0.7); 7.2477 (0.7); 7.2461 (0.6); 7.2381 (0.5); 7.1646 (0.9); 7.1581 (1.5); 7.1511 (1.5); 7.1437 (2.4); 7.1297 (3.1); 7.1228 (3.7); 7.1197 (3.6); 7.1178 (3.6); 7.1139 (2.6); 7.1101 (4.2); 7.1083 (4.4); 7.1060 (4.7); 7.0940 (6.3); 7.0905 (4.8); 7.0793 (2.2); 7.0753 (1.8); 7.0686 (1.8); 7.0640 (1.9); 7.0586 (1.4); 7.0516 (1.4); 7.0476 (1.4); 7.0340 (0.9); 6.9970 (1.1); 5.3002 (16.0);
  • the present invention furthermore relates to the use of one or more
  • the present invention furthermore relates to a method for controlling harmful plants and / or for regulating the growth of plants, characterized in that an effective amount of one or more compounds of the general formula (I) and / or their salts, as defined above, is preferably present in one of the marked as preferred or particularly preferred
  • Embodiment in particular one or more compounds of the formulas (LI) to (1.50) and / or salts thereof, each as defined above, or - an agent according to the invention, as defined below, on the (harmful) plants, (harmful) plant seeds, the Soil in which or on which the (harmful) plants grow, or the cultivated area is applied.
  • the present invention also provides a process for controlling undesirable plants, preferably in crops, characterized in that an effective amount of one or more compounds of the general formula (I) and / or salts thereof, as defined above, preferably in one of preferred or particularly preferred marked
  • Embodiment in particular one or more compounds of the formulas (LI) to (1.50) and / or salts thereof, each as defined above, or an agent according to the invention, as defined below, on undesirable plants (eg harmful plants such as mono- or dicotyledonous weeds or unwanted Crops), the seed of the undesirable plants (ie plant seeds, eg grains, seeds or vegetative propagules such as tubers or sprouts with buds), the soil in which or on which the undesirable plants grow (eg the soil of cultivated land or non-cultivated land ) or the area under cultivation (ie area on which the unwanted plants will grow) is applied.
  • the present invention is also a method for controlling
  • Plants preferably of useful plants, characterized in that an effective amount of one or more compounds of general formula (I) and / or their salts, as defined above, preferably in one of the preferred or particularly preferred Embodiment, in particular one or more compounds of the general formulas (LI) to (1.50) and / or salts thereof, each as defined above, or an agent according to the invention, as defined below, the plant, the seed of the plant (ie plant seeds, eg grains , Seeds or vegetative
  • Propagating organs such as tubers or sprouts with buds
  • the soil in which or on which the plants grow e.g., the soil of cultivated land or non-cultivated land
  • the cultivated area i.e., area on which the plants will grow
  • the compounds according to the invention or the agents according to the invention may e.g. in Vorsaat- (possibly also by incorporation into the soil), pre-emergence and / or
  • one or more compounds of the general formula (I) and / or their salts are employed for controlling harmful plants or regulating growth in crops of crops or ornamental plants, the crops or ornamentals in a preferred embodiment are transgenic plants.
  • the compounds of the general formula (I) according to the invention and / or salts thereof are suitable for controlling the following genera of monocotyledonous and dicotyledonous harmful plants:
  • the compounds according to the invention are applied to the surface of the earth (weeds and / or weeds) prior to germination (pre-emergence method), either the emergence of the weed seedlings or weed seedlings is completely prevented or they grow up to the cotyledon stage, but then grow and eventually die off after three to four weeks.
  • the compounds of the invention have excellent herbicidal activity against mono- and dicotyledonous weeds, crops of economically important crops, e.g. dicotyledonous cultures of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Miscanthus, Nicotiana, Phaseolus, Pisum, Solanum, Vicia, or monocotyledonous cultures of the genera Allium, Pineapple , Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Seeale, Sorghum, Triticale, Triticum, Zea, depending on the structure of the respective compound of the invention and their application rate only insignificantly or not at all damaged.
  • the present compounds are very well suited for the selective control of undesired plant growth in crops such as
  • the compounds according to the invention (depending on their respective structure and the applied application rate) have excellent growth-regulatory properties
  • the active compounds can also be used to control harmful plants in crops of genetically engineered or conventional mutagenized plants.
  • the transgenic plants are usually characterized by particular advantageous properties, for example by resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens of plant diseases such as certain insects or microorganisms such as fungi, bacteria or viruses.
  • Other special properties concern, for example, the crop in terms of quantity, quality, shelf life, composition and special ingredients. So are transgenic plants with increased starch content or altered quality of starch or those with others
  • transgenic cultures is the use of the compounds of the invention and / or their salts in economically important transgenic crops of useful and ornamental plants, e.g. of cereals such as wheat, barley, rye, oats, millet, rice and maize or also crops of sugar beet, cotton, soya, rapeseed, potato, tomato, pea and other vegetables.
  • cereals such as wheat, barley, rye, oats, millet, rice and maize or also crops of sugar beet, cotton, soya, rapeseed, potato, tomato, pea and other vegetables.
  • the compounds of the invention may also be used as herbicides in
  • Crop plants are used, which are resistant to the phytotoxic effects of herbicides or have been made genetically resistant.
  • the active compounds can also be used for controlling harmful plants in crops of known or yet to be developed genetically modified plants.
  • the transgenic plants are usually characterized by particular advantageous properties, for example by resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens of plant diseases such as certain insects or microorganisms such as fungi, bacteria or viruses.
  • Other special properties concern e.g. the crop in terms of quantity, quality, shelf life, composition and special ingredients. So are transgenic plants with increased starch content or altered quality of starch or those with others
  • Other particular properties may include tolerance or resistance to abiotic stressors, e.g. Heat, cold, drought, salt and ultraviolet radiation are present.
  • cereals such as wheat, barley, rye, oats, triticale, millet, rice, manioc and maize or also crops of sugar beet, cotton, soya, rapeseed, potato, tomato, pea and other vegetables.
  • Crop plants are used, which are resistant to the phytotoxic effects of herbicides or have been made genetically resistant.
  • Conventional ways of producing new plants which have modified properties in comparison with previously occurring plants consist, for example, in classical methods
  • nucleic acid molecules can be introduced into plasmids that allow mutagenesis or sequence alteration by recombination of DNA sequences.
  • Base exchanges are made, partial sequences removed or natural or synthetic sequences added.
  • For the connection of the DNA fragments with one another adapters or linkers can be attached to the fragments.
  • the production of plant cells having a reduced activity of a gene product can be achieved, for example, by the expression of at least one corresponding antisense RNA, a sense RNA to obtain a cosuppression effect, or the expression of at least one appropriately engineered ribozyme which specifically cleaves transcripts of the above gene product.
  • DNA molecules can be used which comprise the entire coding sequence of a gene product including any flanking sequences, as well as DNA molecules which comprise only parts of the coding sequence, which parts have to be long enough to be present in the cells to cause an antisense effect. It is also possible to use DNA sequences which have a high degree of homology to the coding sequences of a gene product, but are not completely identical.
  • the synthesized protein may be located in any compartment of the plant cell.
  • the coding region is linked to DNA sequences which ensure localization in a particular compartment.
  • sequences are known to the person skilled in the art (see, for example, Braun et al., EMBO J. 11 (1992), 3219-3227).
  • the expression of the nucleic acid molecules can also take place in the organelles of the plant cells.
  • the transgenic plant cells can be regenerated to whole plants by known techniques.
  • the transgenic plants can in principle be plants of any one
  • the compounds (I) according to the invention can be used in transgenic cultures which are resistant to growth factors, such as e.g. Dicamba or against herbicides, the essential
  • Plant enzymes e.g. Acetylactate synthases (ALS), EPSP synthases, glutamine synthases (GS) or hydroxyphenylpyruvate dioxygenases (HPPD), respectively, which are resistant to herbicides from the group of sulfonylureas, glyphosate, glufosinate or benzoylisoxazole and analogues.
  • ALS Acetylactate synthases
  • EPSP synthases glutamine synthases
  • HPPD hydroxyphenylpyruvate dioxygenases
  • the invention therefore also relates to the use of the compounds of the general formula (I) according to the invention and / or salts thereof as herbicides for controlling harmful plants in crops of useful or ornamental plants, optionally in transgenic crop plants.
  • Preferred is the use in cereals, preferably corn, wheat, barley, rye, oats, millet, or rice, in the pre- or post-emergence.
  • Preference is also the use in soy in the pre or postemergence.
  • Growth regulation of plants also includes the case where the active ingredient of general formula (I) or its salt is formed from a precursor substance ("prodrug”) only after plant, plant or soil application.
  • the invention also provides the use of one or more compounds of the general formula (I) or salts thereof or an agent according to the invention (as defined below) (in a process) for controlling harmful plants or regulating the growth of plants, characterized in that an effective amount of one or more compounds of the general formula (I) or their salts on the plants (harmful plants, optionally together with the crops) plant seeds, the soil in which or on which the plants grow, or applied to the acreage.
  • the invention also provides a herbicidal and / or plant growth-regulating agent, characterized in that the agent
  • Embodiment in particular one or more compounds of the formulas (LI) to (1.50) and / or salts thereof, in each case as defined above,
  • one or more further agrochemically active substances preferably selected from the group consisting of insecticides, acaricides, nematicides, further herbicides (ie those which do not correspond to the general formula (I) defined above), fungicides, safeners, fertilizers and / or or other growth regulators,
  • the other agrochemically active substances of constituent (i) of an agent according to the invention are preferably selected from the group of substances described in "The Pesticide Manual", 16th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2012 are mentioned.
  • a herbicidal or plant growth-regulating agent according to the invention preferably comprises one, two, three or more plant protection formulation auxiliaries (ii) selected from the group consisting of surfactants, emulsifiers, dispersants, film formers, thickeners, inorganic salts, dusts, at 25 ° C and 1013 mbar solid carriers, preferably adsorptive, granulated inert materials, wetting agents, antioxidants, stabilizers, buffer substances, anti-foaming agents, water, organic solvents, preferably at 25 ° C and 1013 mbar with water in any ratio miscible organic solvents.
  • auxiliaries selected from the group consisting of surfactants, emulsifiers, dispersants, film formers, thickeners, inorganic salts, dusts, at 25 ° C and 1013 mbar solid carriers, preferably adsorptive, granulated inert materials, wetting agents, antioxidants, stabilizers, buffer substances, anti-foaming agents, water
  • the compounds of the general formula (I) according to the invention can be used in the form of wettable powders, emulsifiable concentrates, sprayable solutions, dusts or granules in the customary formulations.
  • the invention therefore also herbicidal and Plant growth regulating agents containing compounds of general formula (I) and / or their salts.
  • the compounds of the general formula (I) and / or their salts can be formulated in various ways, depending on which biological and / or chemical-physical parameters are predetermined. Possible formulation options are, for example: wettable powder (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as oil-in-water and water-in-oil emulsions, sprayable solutions .
  • WP wettable powder
  • SP water-soluble powders
  • EC emulsifiable concentrates
  • EW emulsions
  • sprayable solutions such as oil-in-water and water-in-oil emulsions, sprayable solutions .
  • SC Suspension concentrates
  • granules in the form of micro, spray, elevator and adsorption granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations,
  • Microcapsules and waxes are known to those skilled in the art and are described, for example, in Watkins, Handbook of Insecticides Dust Diluents and Carriers, 2nd ed., Darland Books, Caldwell N.J., H.v. Olphen, "Introduction to Clay Colloid Chemistry”; 2nd Ed., J. Wiley & Sons, N.Y .; C. Marsden, “Solvents Guide”; 2nd Ed., Interscience, N.Y. 1963; McCutcheon's "Detergents and Emulsifiers Annual", MC Publ. Corp., Ridgewood N.J .; Sisley and Wood, “Encyclopedia of Surface Active Agents", Chem. Publ. Co. Inc., N.Y. 1964; Schönfeldt, "Grenz somnluxe
  • Spray powders are preparations which are uniformly dispersible in water and which, in addition to the active substance, have a dilution or inert or ionic and / or nonionic surfactants (wetting agents,
  • Dispersants for example polyoxyethylated alkylphenols, polyoxethylated fatty alcohols, polyoxethylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenesulfonates, sodium lignosulfonate, sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, dibutylnaphthalene-sodium sulfonate or sodium oleoylmethyltaurine.
  • Dispersants for example polyoxyethylated alkylphenols, polyoxethylated fatty alcohols, polyoxethylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenesulfonates, sodium lignosulfonate, sodium 2,2'-dinaphthylme
  • the herbicidal active compounds are finely ground, for example, in customary apparatus such as hammer mills, blower mills and air-jet mills and mixed simultaneously or subsequently with the formulation auxiliaries.
  • Emulsifiable concentrates are prepared by dissolving the active ingredient in an organic solvent such as butanol, cyclohexanone, dimethylformamide, xylene or higher-boiling aromatics or hydrocarbons or mixtures of organic solvents with the addition of one or several surfactants of ionic and / or nonionic type (emulsifiers).
  • emulsifiers can be used for example: Alkylarylsulfonsaure calcium salts such as
  • Ca-dodecylbenzenesulfonate or nonionic emulsifiers such as fatty acid polyglycol ester
  • Alkylaryl polyglycol ethers fatty alcohol polyglycol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers, sorbitan esters such as e.g. Sorbitan fatty acid esters or
  • Polyoxethylenesorbitanester such. Polyoxyethylene.
  • Dusts are obtained by milling the active ingredient with finely divided solids, e.g.
  • Talc natural clays such as kaolin, bentonite and pyrophyllite, or diatomaceous earth.
  • Suspension concentrates may be water or oil based. They can be prepared, for example, by wet grinding using commercially available bead mills and, if appropriate, addition of surfactants, as described, for example, in US Pat. are already listed above for the other formulation types.
  • Emulsions e.g. Oil-in-water emulsions (EW), for example, by means of stirrers,
  • Granules can either by spraying the active ingredient on adsorptive, granulated
  • Water-dispersible granules are generally prepared by the usual methods such as spray drying, fluidized bed granulation, plate granulation, mixing with high-speed mixers and extrusion without solid inert material.
  • the agrochemical preparations preferably herbicidal or plant growth-regulating agents of the present invention, preferably contain a total amount of from 0.1 to 99% by weight, preferably 0.5 to 95% by weight, more preferably 1 to 90% by weight, more preferably 2 to 80 wt .-%, of active compounds of the general formula (I) and their salts.
  • the drug concentration is e.g. about 10 to 90 wt .-%, the balance to 100 wt .-% consists of conventional formulation ingredients.
  • the balance to 100 wt .-% consists of conventional formulation ingredients.
  • Active ingredient concentration about 1 to 90, preferably 5 to 80 wt .-% amount.
  • Formulations contain 1 to 30 wt .-% of active ingredient, preferably usually 5 to 20 wt .-% of
  • Active ingredient, sprayable solutions contain about 0.05 to 80, preferably 2 to 50 wt .-% of active ingredient.
  • the active ingredient content depends, in part, on whether the active compound is liquid or solid and which granulating aids, fillers, etc. are used.
  • the content of active ingredient is, for example, between 1 and 95% by weight, preferably between 10 and 80% by weight.
  • the active substance formulations mentioned optionally contain the customary adhesion, wetting, dispersing, emulsifying, penetrating, preserving, antifreezing and solvent, fillers, carriers and dyes, antifoams, evaporation inhibitors and the pH and the Viscosity-influencing agent.
  • formulation auxiliaries are described inter alia in "Chemistry and Technology of Agrochemical Formulations", ed. D.A. Knowles, Kluwer Academic Publishers (1998).
  • the compounds of general formula (I) or their salts may be used as such or in the form of their formulations (formulations) with other pesticidally active substances, e.g. Insecticides, acaricides, nematicides, herbicides, fungicides, safeners, fertilizers and / or
  • Growth regulators can be used in combination, e.g. as finished formulation or as
  • the combination formulations can be based on the above
  • Formulations are prepared, taking into account the physical properties and stabilities of the active ingredients to be combined.
  • combination partners for the compounds of general formula (I) according to the invention in mixture formulations or in tank mix are known active compounds which are based on inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate-3-phosphate Synthase, glutamine synthetase, p-hydroxyphenylpyruvate Dioxygenase, phytoene desaturase, photosystem I, photosystem II, protoporphyrinogen oxidase, can be used, as described, for example, in Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 16th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2012 and the literature cited therein.
  • Compounds (I) of particular interest which contain the compounds of general formula (I) or their combinations with other herbicides or pesticides and safeners.
  • the safeners which are used in an antidote effective content, reduce the phytotoxic side effects of the herbicides / pesticides used, e.g. in economically important crops such as cereals (wheat, barley, rye, corn, rice, millet), sugar beet, sugar cane, oilseed rape, cotton and soybeans, preferably cereals.
  • the weight ratios of herbicide (mixture) to safener generally depends on the
  • herbicide and the effectiveness of each safener may vary within wide limits, for example in the range of 200: 1 to 1: 200, preferably 100: 1 to 1: 100, especially 20: 1 to 1: 20.
  • the safeners can be formulated analogously to the compounds of the general formula (I) or mixtures thereof with further herbicides / pesticides and as
  • Ready-made formulation or tank mix with the herbicides are provided and used.
  • the herbicidal or herbicidal safener formulations present in commercial form are optionally diluted in a customary manner, e.g. for wettable powders, emulsifiable concentrates, dispersions and water-dispersible granules by means of water. Dust-like preparations, ground or scattered granules and sprayable solutions are usually no longer diluted with other inert substances before use.
  • the total amount of compounds of general formula (I) and their salts is preferably in the range of 0.001 to 10.0 kg / ha, preferably in the range of 0.005 to 5 kg / ha, more preferably in Range of 0.01 to 1.5 kg / ha, particularly preferably in the range of 0.05 to 1 kg / ha. This applies both to pre-emergence or post-emergence applications.
  • compounds of general formula (I) and / or their salts as
  • Plant growth regulator for example as Halmverkürzer in crops, as mentioned above, preferably in cereal plants such as wheat, barley, rye, triticale, millet, rice or corn, the total application rate is preferably in the range of 0.001 to 2 kg / ha, preferably in the range of 0.005 to 1 kg / ha, in particular in the range of 10 to 500 g / ha, most preferably in the range of 20 to 250 g / ha. This applies to both the application in the
  • Halmverkürzer Pre-emergence or postemergence.
  • the application as Halmverkürzer can be done in various stages of growth of the plants. For example, the application is preferred after placement at the beginning of
  • seed treatment when used as a plant growth regulator, seed treatment may be considered, including the different seed dressing and coating techniques.
  • the application rate depends on the individual techniques and can be determined in preliminary tests.
  • active substances are those which are based on inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvyl shikimate 3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II or
  • Protoporphyrinogen oxidase can be used, as e.g. from Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 16th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2012 and cited therein.
  • ISO International Organization for Standardization
  • herbicidal mixture partners examples include:
  • flucarbazone flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazine, fluometuron, flurenol, flurenol-butyl, - dimethylammonium and -methyl, fluoroglycofen, fluoroglycofen-ethyl, flupropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone, fluroxypyr, fluroxypyr-meptyl, flurtamone, fluthiacet, fluthiacet-methyl, fomesafen, fomesafen-sodium, foramsulfuron, fosamine, glufosinate, glufosinate-ammonium, glufosinate-p-s
  • methabenzothiazuron metam, metamifop, metamitron, metazachlor, metazosulfuron,
  • met.zthiazuron methiopyrsulfuron, methiozoline, methyl isothiocyanate, metobromuron, metolachlor, S-metolachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinate, monolinuron, monosulfuron, monosulfuron ester, MT-5950, ie N- [3-chloro -4- (1-methylethyl) phenyl] -2-methylpentanamide, NGGC-011, napropamide, NC-310, ie 4- (2,4-dichlorobenzoyl) -l-methyl-5-benzyloxypyrazole, neburon, nicosulfuron, nonanoic acid (pelargonic acid), norflurazon, oleic acid (fatty acids), orbencarb, orthosulfamuron, oryzalin, oxadiar
  • plant growth regulators as possible mixing partners are:
  • S1 compounds from the group of heterocyclic carboxylic acid derivatives:
  • S 1 a compounds of the type dichlorophenylpyrazoline-3-carboxylic acid (S 1 a ), preferably
  • Fenchlorazole ethyl ester
  • ethyl ester i. 1- (2,4-dichlorophenyl) -5-trichloromethyl- (1H) -l, 2,4-triazole-3-carboxylic acid ethyl ester (SI-7), and related compounds as described in EP-A-174562 and EP-A- A-346620;
  • Sl e compounds of the type of 5-benzyl- or 5-phenyl-2-isoxazoline-3-carboxylic acid, or of 5,5-diphenyl-2-isoxazoline-3-carboxylic acid (Sl e ), preferably compounds such as
  • S2 a compounds of the 8-quinolinoxyacetic acid type (S2 a ), preferably
  • Benoxacor (4-dichloroacetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazine) (S3-4),
  • PPG-1292 N-allyl-N - [(1,3-dioxolan-2-yl) -methyl] -dichloroacetamide
  • TI-35 (1-dichloroacetyl-azepane) from TRI-Chemical RT (S3-8),
  • RA 1 (C 1 -C 6) alkyl, (C 3 -C 6) cycloalkyl, where the 2 last-mentioned radicals are represented by VA
  • RA 2 halogen (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, CF 3; mA 1 or 2;
  • VA is 0, 1, 2 or 3;
  • RB 1 , RB 2 independently of one another are hydrogen, (C 1 -C 6) -alkyl, (C 3 -C 6) -cycloalkyl, (C 3 -C 6) -alkyl,
  • RB 1 cyclopropyl
  • RB 1 ethyl
  • RB 1 isopropyl
  • R B 2 hydrogen
  • (RB 3 ) 5-Cl-2-OMe is (S4-4) and
  • RB 1 isopropyl
  • R B 2 hydrogen
  • (RB 3 ) 2-OMe (S4-5);
  • Rc 1 , Rc 2 are each independently hydrogen, (Ci-Cg) alkyl, (C3-Cg) cycloalkyl, (C3-
  • R c 3 is halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, CF 3 and mc are 1 or 2; for example
  • RD 4 is halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, CF 3; mD 1 or 2; RD 5 is hydrogen, (C 1 -C 6 ) alkyl, (C 3 -C 6 ) cycloalkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 5 -C 6 ) cycloalkenyl.
  • Carboxylic acid derivatives (S5) e.g.
  • RD 1 is halogen, (Ci-C 4) alkyl, (Ci-C 4) haloalkyl, (Ci-C 4) alkoxy, (Ci-C 4) haloalkoxy, RD 2 is hydrogen or (Ci-C 4) alkyl,
  • RD 3 is hydrogen, (Ci-Cg) alkyl, (C 2 -C 4 ) alkenyl, (C 2 -C 4 ) alkynyl, or aryl, wherein each of the aforementioned C-containing radicals unsubstituted or by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy substituted; or their salts, is an integer from 0 to 2.
  • Oxabetrinil ((Z) -l, 3-dioxolan-2-ylmethoxyimino (phenyl) acetonitrile) (Sl 1-1), which is known as a seed dressing safener for millet against damage by metolachlor,
  • Fluorofenim (1- (4-chlorophenyl) -2,2,2-trifluoro-1-ethanone-0- (1,3-dioxolan-2-ylmethyl) -oxime) (S1-2) used as seed dressing -Safener for millet is known against damage from metolachlor, and
  • Cyometrinil or “CGA-43089” ((Z) -cyanomethoxyimino (phenyl) acetonitrile) (Sl l-3), which is known as a seed dressing safener for millet against damage from metolachlor.
  • Naphthalene anhydride (1,8-naphthalenedicarboxylic anhydride) (S13-1), which is known as a seed safener for corn against damage by thiocarbamate herbicides.
  • Cyanamide which is known as safener for maize against damage of imidazolinones
  • MG 191 (CAS Reg. No. 96420-72-3) (2-dichloromethyl-2-methyl-1,3-dioxolane) (S13-5) from Nitrokemia, which is known as safener for corn,
  • Active substances which, in addition to having a herbicidal action against harmful plants, also have safener action on cultivated plants such as rice, such as, for example, rice.
  • RH 4 are independently hydrogen, (Ci-Ci6) alkyl, (C2-Ci6) alkenyl or
  • (C 2 -C 6) alkynyl each of the last-mentioned 3 unsubstituted or by one or more radicals from the group halogen, hydroxy, cyano, (Ci-C i) alkoxy, (Ci-C i) haloalkoxy, (Ci-C 4 ) alkylthio, (C 1 -C 4 ) alkylamino, di [(C 1 -C 4 ) alkyl] amino, [(C 1 -C 4 ) alkoxy] carbonyl, [(C 1 -C 4 ) haloalkoxy] carbonyl, ( C3-C6) cycloalkyl which is unsubstituted or substituted, phenyl which is unsubstituted or substituted, and heterocyclyl which is unsubstituted or substituted, is substituted, or (C3-C6) cycloalkyl, (C 4 -C 6) cycloalkenyl, (
  • RH 3 is (C 1 -C 4 ) -alkoxy, (C 2 -C 4 ) -alkenyloxy, (C 2 -C 6) -alkinyloxy or (C 2 -C 4 ) -haloalkoxy and RH 4 is hydrogen or (C 1 -C 4 ) -alkyl or
  • RH 3 and RH 4 together with the directly attached N atom form a four- to eight-membered one
  • heterocyclic ring which, in addition to the N atom, may also contain further hetero ring atoms, preferably up to two further hetero ring atoms from the group consisting of N, O and S, and which may be unsubstituted or substituted by one or more radicals from the group consisting of halogen, cyano, nitro, C 4 ) alkyl, (Ci-C 4 ) haloalkyl, (Ci-C 4 ) alkoxy, (Ci-C 4 ) haloalkoxy and (Ci-C 4 ) alkylthio is substituted, means.
  • Preferred safeners in combination with the compounds of the formula (I) according to the invention and / or their salts, in particular with the compounds of the formulas (LI) to (1.50) and / or salts thereof are: cloquintocet-mexyl, cyprosulfamide, fenchlorazole ethyl ester, isoxadifen and particularly preferred safeners are: cloquintocetmexyl, cyprosulfamide, isoxadifen-ethyl and mefenpyr-diethyl.
  • A Seeds of monocotyledonous or dicotyledonous weed or crop plants are placed in sandy loam soil in plastic or wood fiber pots, covered with soil and grown in the greenhouse under controlled growth conditions. 2 to 3 weeks after sowing, the test plants are treated in the single leaf stage.
  • the compounds according to the invention formulated as wettable powders (WP) or as emulsion concentrates (EC) are then sprayed onto the green plant parts as an aqueous suspension or emulsion with the addition of 0.5% of additive at a rate of 600 l / ha. After about 3 weeks of service life of
  • Seeds of monocotyledonous or dicotyledonous weed plants are laid out in 96-well microtiter plates in quartz sand and grown in the climatic chamber under controlled growth conditions. 5 to 7
  • test plants Days after sowing, the test plants are treated at the cotyledon stage.
  • the compounds of the invention formulated in the form of emulsion concentrates (EC) are applied at a rate of 2200 liters per hectare.
  • EC emulsion concentrates
  • Tables B1 to B2 the effects of selected compounds of the general formula (I) according to Tables LI to 1.50 on various harmful plants and an application rate corresponding to 1900 g / ha, which were obtained according to the aforementioned test protocol are shown.
  • compounds of the formula (I) according to the invention have a good herbicidal activity against harmful plants during postemergence treatment.
  • Tables Bl to B2 compounds postemergence a very good herbicidal action (80% to 100% herbicidal activity) against harmful plants such as Diplotaxis tenuifolia (DIPTE) and Matricaria chamomilla (MATCH) at an application rate of 1900 g of active ingredient per hectare.
  • DIPTE Diplotaxis tenuifolia
  • MATCH Matricaria chamomilla
  • Seeds of monocotyledonous or dicotyledonous weeds and crops are in plastic or
  • Wood fiber pots designed and covered with soil.
  • the compounds according to the invention formulated in the form of wettable powders (WP) or as emulsion concentrates (EC) are then in the form of an aqueous suspension or emulsion with the addition of 0.5% of an additive with a water application rate of converted 600 1 / ha applied to the surface of the cover soil.
  • WP wettable powders
  • EC emulsion concentrates
  • the pots are placed in the greenhouse and kept under good growth conditions for the test plants.

Abstract

Described are substituted pyrrolidinones of general formula (I) and the use thereof as herbicides, in particular for controlling weeds and/or weed grasses in crops of useful plants and/or as plant growth regulators for influencing the growth of crops of useful plants. The invention further relates to herbicidal and/or plant growth-regulating agents comprising one or more of the compounds of general formula (I).

Description

4-CYCLOPROPYL-2-OXOPYRROLIDIN-3-CARBOXAMID-DERIVATE UND  4-CYCLOPROPYL-2-OXOPYRROLIDIN-3-CARBOXAMIDE DERIVATIVES AND
VERWANDTE VERBINDUNGEN ALS HERBIZIDE PFLANZENSCHUTZMITTEL  RELATED COMPOUNDS AS HERBICIDE PLANT PROTECTION AGENTS
Beschreibung description
Die Erfindung betrifft das technische Gebiet der Pflanzenschutzmittel, insbesondere das der Herbizide zur selektiven Bekämpfung von Unkräutern und Ungräsern in Nutzpflanzenkulturen. Speziell betrifft diese Erfindung substituierte Cycloalkylpyrrolidinone sowie deren Salze, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide. The invention relates to the technical field of crop protection agents, in particular that of herbicides for the selective control of weeds and grass weeds in crops. Specifically, this invention relates to substituted cycloalkylpyrrolidinones and their salts, processes for their preparation and their use as herbicides.
Bisher bekannte Pflanzenschutzmittel zur selektiven Bekämpfung von Schadpflanzen in Previously known crop protection agents for the selective control of harmful plants in
Nutzpflanzenkulturen oder Wirkstoffe zur Bekämpfung von unerwünschtem Pflanzenwuchs weisen bei ihrer Anwendung teilweise Nachteile auf, sei es, dass sie (a) keine oder aber eine unzureichende herbizide Wirkung gegen bestimmte Schadpflanzen, (b) ein zu geringes Spektrum der Schadpflanzen, das mit einem Wirkstoff bekämpft werden kann, (c) zu geringe Selektivität in Nutzpflanzenkulturen und/oder (d) ein toxikologisch ungünstiges Profil besitzen. Weiterhin führen manche Wirkstoffe, die als Pflanzenwachstumsregulatoren bei einigen Nutzpflanzen eingesetzt werden können, bei anderen Nutzpflanzen zu unerwünscht verminderten Ernteerträgen oder sind mit der Kulturpflanze nicht oder nur in einem engen Aufwandmengenbereich verträglich. Einige der bekannten Wirkstoffe lassen sich wegen schwer zugänglicher Vorprodukte und Reagenzien im industriellen Maßstab nicht wirtschaftlich herstellen oder besitzen nur unzureichende chemische Stabilitäten. Bei anderen Wirkstoffen hängt die Wirkung zu stark von Umweltbedingungen, wie Wetter- und Bodenverhältnissen ab. Commercial crops or active substances for combating undesirable plant growth have some drawbacks in their application, be it that they (a) no or insufficient herbicidal activity against certain harmful plants, (b) a too low a range of harmful plants, which fights with an active ingredient (c) have too low selectivity in crops and / or (d) have a toxicologically unfavorable profile. Furthermore, some active ingredients that can be used as plant growth regulators in some crops, in other crops to undesirably reduced crop yields or are not compatible with the crop or only in a narrow application rate range. Some of the known active compounds can not be produced economically on the industrial scale because of difficultly accessible precursors and reagents or have only insufficient chemical stabilities. For other active ingredients the effect depends too much on environmental conditions, such as weather and soil conditions.
Die herbizide Wirkung dieser bekannten Verbindungen, insbesondere bei niedrigen Aufwandmengen, bzw. deren Verträglichkeit gegenüber Kulturpflanzen bleiben verbesserungswürdig. The herbicidal action of these known compounds, in particular at low application rates, or their compatibility with crop plants, should be improved.
Verschiedene Schriften beschreiben substituierte Pyrrolidinone mit herbiziden Eigenschaften. Aus WO2015084796, WO2016164201, WO2016196019, WO2016196593, US4874422, EP2336104, WO2004037787 und IP.com Journal (2015), 15(6B), 1-293 sind substituierte Pyrrolidinone bekannt, die an der Amid-Bindung substituierte Aryle bzw. substituierte Heteroaryle tragen. Der Prozess zur Synthese von substituierten Pyrrolidinonen ist in WO2016094117 beschrieben. Außerdem werden in WO2016182780 substituierte Bicyclen mit herbiziden Eigenschaften beschrieben, die an der Amid- Bindung substituierte Aryle bzw. substituierte Heteroaryle tragen. Es ist weiterhin bekannt, dass sich bestimmte substituierte Pyrrolidinone enantioselektiv herstellen lassen können (vgl. Chemmical Communications, 2012, 48(61), 7571-7573; Advanced Synthesis & Catalysis 2012, 354(11-12),2151-2156, S2151/1-S2151/99). Die Verwendung substituierter Cycloalkylpyrrolidmone oder deren Salze als herbizide Wirkstoffe, die an der Amid-Bindung einen substituierten Phenylrest tragen ist dagegen noch nicht beschrieben. Various documents describe substituted Pyrrolidinone with herbicidal properties. WO2015084796, WO2016164201, WO2016196019, WO2016196593, US4874422, EP2336104, WO2004037787 and IP.com Journal (2015), 15 (6B), 1-293 disclose substituted pyrrolidinones carrying aryl or substituted heteroaryl substituted at the amide linkage. The process for the synthesis of substituted pyrrolidinones is described in WO2016094117. In addition, WO2016182780 describes substituted bicyclic compounds having herbicidal properties which carry aryls or substituted heteroaryls substituted on the amide bond. It is further known that certain substituted pyrrolidinones can be prepared enantioselectively (see Chemmical Communications, 2012, 48 (61), 7571-7573; Advanced Synthesis & Catalysis 2012, 354 (11-12), 2151-2156, S2151 / 1-S2151 / 99). The use of substituted Cycloalkylpyrrolidmone or their salts as herbicidal active ingredients which carry a substituted phenyl radical on the amide bond, however, is not yet described.
Überraschenderweise wurde nun gefunden, daß substituierte Cycloalkylpyrrolidmone oder deren Salze als herbizide Wirkstoffe, die an der Amid-Bindung einen substituierten Cycloalkylalkylrest tragen, als Herbizide besonders gut geeignet sind. Surprisingly, it has now been found that substituted Cycloalkylpyrrolidmone or salts thereof as herbicidal active ingredients which carry a substituted cycloalkylalkyl radical on the amide bond, are particularly suitable as herbicides.
Gegenstand der vorliegenden Erfindung sind damit substituierte Cycloalkylpyrrolidmone der allgemeinen Formel (I) oder deren Salze The present invention thus provides substituted Cycloalkylpyrrolidmone the general formula (I) or salts thereof
Figure imgf000003_0001
Figure imgf000003_0001
worin wherein
Q für gegebenenfalls substituiertes (C3-Cio)-Cycloalkyl, (C3-Cio)-Halocycloalkyl, (C3-C10)- Cyanocycloalkyl, (Ci-Cio)-Alkyl -(C3-Cio)-cycloalkyl, (Ci-Cio)-Alkoxy-(C3-Cio)-cycloalkyl, (Ci-Cio)-Haloalkoxy-(C3-Cio)-cycloalkyl, (Ci-Cio)-Alkylthio-(C3-Cio)-cycloalkyl, Aryl-(C3-Cio)- cycloalkyl, Heteroaryl-(C3-Cio)-cycloalkyl, (Ci-Cio)-Alkoxycarbonyl -(C3-Cio)-cycloalkyl, Hydroxcarbonyl- (C3-Cio)-cycloalkyl, (C3-Cio)-Cycloalkyl-(C3-Cio)-cycloalkyl steht, Q is optionally substituted (C3-Cio) -cycloalkyl, (C3-Cio) -halocycloalkyl, (C3-C10) -cyanocycloalkyl, (Ci-Cio) -alkyl - (C3-Cio) -cycloalkyl, (Ci-Cio) - Alkoxy- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -haloalkoxy- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -alkylthio (C 3 -C 10) -cycloalkyl, aryl- (C 3 -) Cio) - cycloalkyl, heteroaryl- (C3-Cio) -cycloalkyl, (Ci-Cio) -alkoxycarbonyl - (C3-Cio) -cycloalkyl, hydroxcarbonyl- (C3-Cio) -cycloalkyl, (C3-Cio) -cycloalkyl- (C3-Cio) -cycloalkyl- C 3 -C 10) -cycloalkyl,
Z für die Gruppe
Figure imgf000003_0002
steht, Z for the group
Figure imgf000003_0002
stands,
Y für -C(R7)(R8)-, Sauerstoff, oder NR1 steht, Y is -C (R 7 ) (R 8 ) -, oxygen, or NR 1 ,
W1 und W2 unabhängig voneinander für Sauerstoff oder Schwefel stehen; für Wasserstoff, Amino, Hydroxy, Cyano, Formyl, (Ci-Cg)-Alkyl, (Ci-Cg)-Haloalkyl, (Ci-Cg)- Cyanoalkyl, (Ci-Cg)-Hydroxyalkyl, (Ci-Cg)-Alkoxy-(Ci-Cg)-alkyl, Aryl-(Ci-Cg)-alkyl, Heteroaryl-(Ci-Cg)-alkyl, Heterocyclyl-(Ci-Cg)-alkyl, (C3-Cio)-Cycloalkyl, (C3-Cio)-Cycloalkyl- (Ci-Cg)-alkyl, (C3-Cg)-Halocycloalkyl, (C3-Cg)-Halocycloalkyl-(Ci-Cg)-alkyl, (Ci-Cg)- Alkylcarbonyl, (Ci-Cg)-Alkoxycarbonyl, (C2-Cg)-Alkenyl, (C2-Cg)-Alkynyl, Tris-[(Ci-Cg)- alkyl]silyl-(C2-Cg)-alkynyl, Tris-[(Ci-Cg)-alkyl]silyl steht, für Wasserstoff, Halogen, Hydroxy, (Ci-Cg)-Alkyl, (Ci-Cg)-Haloalkyl, (Ci-Cg)-Hydroxyalkyl, (Ci-Cg)-Alkoxy-(Ci-Cg)-alkyl steht, für Wasserstoff, Halogen, Hydroxy, (Ci-Cg)-Alkyl, (Ci-Cg)-Haloalkyl, (Ci-Cg)-Hydroxyalkyl, (Ci-Cg)-Alkoxy, (Ci-Cg)-Alkoxy-(Ci-Cg)-alkyl steht, für ein gegebenenfalls substituiertes Aryl und Heteroaryl steht, wobei jeder Ring oder jedes Ringsystem optional mit bis zu 5 Substituenten aus der Gruppe R6 substituiert sein kann, für Wasserstoff, Hydroxy, Amino, (Ci-Cg)-Alkyl, (Ci-Cg)-Haloalkyl, (C2-Cg)-Alkenyl, (C3-Cg)- Alkynyl, (Ci-Cg)-Alkoxy-(Ci-Cg)-alkyl, (Ci-Cg)-Haloalkoxy-(Ci-Cg)-alkyl, (Ci-Cg)-Alkylthio- (Ci-Cg)-alkyl, (Ci-Cg)-Alkylsulfmyl-(Ci-Cg)-alkyl, (Ci-Cg)-Alkylsulfonyl-(Ci-Cg)-alkyl, (Ci-Cg)-Alkylcarbonyl, (Ci-Cg)-Haloalkylcarbonyl, (C3-Cg)-Cycloalkylcarbonyl, (Ci-Cg)- Alkoxycarbonyl, (C2-Cg)- Haloalkoxycarbonyl, (C4-Cg)-Cycloalkoxycarbonyl, (C2-Cg)- Alkylaminocarbonyl, (C3-Cio)-Dialkylaminocarbonyl, (C3-Cio)-Cycloalkylaminocarbonyl, (Ci-Cg)-Alkoxy, (Ci-Cg)-Alkylthio, (Ci-Cg)-Haloalkylthio, (C3-Cg)-Cycloalkylthio, (Ci-Cg)- Alkylsulfmyl, (Ci-Cg)-Haloalkylsulfmyl, (C3-Cg)-Cycloalkylsulfmyl, (Ci-Cg)-Alkylsulfonyl, (Ci-Cg)-Haloalkylsulfonyl, (C3-Cg)-cycloalkylsulfonyl, (Ci-Cg)-Alkylaminosulfonyl, (C2-Cg)- Dialkylaminosulfonyl oder (C3-Cg)-Trialkylsilyl steht, für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (Ci-Cg)-Alkyl, (C3-Cg)-Cycloalkyl, (C2-Cg)-Alkenyl, (C2-Cg)-Alkynyl, Aryl, Aryl-(Ci-Cg)-alkyl, Aryl-(C2-Cg)- alkenyl, Aryl-(C2-Cg)-alkinyl, Aryl-(Ci-Cg)-alkoxy, Heteroaryl, (Ci-Cg)-Alkoxy-(Ci-Cg)-alkyl, (Ci-Cg)-Hydroxyalkyl, (Ci-Cg)-Haloalkyl, (C3-Cg)-Halocycloalkyl, (Ci-Cg)-Alkoxy, (Ci-Cg)- Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-Cg)-Cycloalkyloxy, Hydroxy, (C3-Cg)-Cycloalkyl- (Ci-Cg)-alkoxy, (Ci-Cg)-Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (Ci-Cg)- Alkylaminocarbonyl, (C3-Cg)-Cycloalkylaminocarbonyl, (Ci-Cg)-Cyanoalkylaminocarbonyl, (C2-Cg)-Alkenylaminocarbonyl, (C2-Cg)-Alkynylaminocarbonyl, (Ci-Cg)-Alkylamino, (Ci-Cg)- Alkylthio, (Ci-Cg)-Haloalkylthio, Hydrothio, (Ci-Cg)-Bisalkylamino, (C3-Cg)-Cycloalkylamino, (Ci-Cg)-Alkylcarbonylamino, (C3-Cg)-Cycloalkylcarbonylamino, Formylamino, (Ci-Cg)- Haloalkylcarbonylamino, (Ci-C8)-Alkoxycarbonylamino, (Ci-C8)-Alkylaminocarbonylamino, (Ci-C8)-Dialkyl-aminocarbonylamino, (Ci-C8)-Alkylsulfonylamino, (C3-C8)- Cycloalkylsulfonylamino, Arylsulfonylamino, Heteroarylsulfonylamino, Aminosulfonyl, (Ci-C8)-Aminohaloalkylsulfonyl, (Ci-C8)-Alkylaminosulfonyl, (Ci-C8)-Bisalkylaminosulfonyl, (C3-C8)-Cycloalkylaminosulfonyl, (Ci-C8)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl-W 1 and W 2 are independently oxygen or sulfur; for hydrogen, amino, hydroxy, cyano, formyl, (Ci-Cg) alkyl, (Ci-Cg) -haloalkyl, (Ci-Cg) - cyanoalkyl, (Ci-Cg) -Hydroxyalkyl, (Ci-Cg) -alkoxy - (Ci-Cg) -alkyl, aryl (Ci-Cg) -alkyl, heteroaryl (Ci-Cg) -alkyl, heterocyclyl (Ci-Cg) -alkyl, (C 3 -Cio) -cycloalkyl, (C 3- Cio) -cycloalkyl- (Ci-Cg) -alkyl, (C 3 -Cg) -halocycloalkyl, (C 3 -Cg) -halocycloalkyl- (Ci-Cg) -alkyl, (Ci-Cg) -alkylcarbonyl, ( Ci-Cg) -alkoxycarbonyl, (C 2 -Cg) -alkenyl, (C 2 -Cg) -alkynyl, tris - [(Ci-Cg) -alkyl] silyl- (C 2 -Cg) -alkynyl, tris- (Ci-Cg) -alkyl] silyl, represents hydrogen, halogen, hydroxy, (Ci-Cg) -alkyl, (Ci-Cg) -haloalkyl, (Ci-Cg) -Hydroxyalkyl, (Ci-Cg) -alkoxy (Ci-Cg) -alkyl, represents hydrogen, halogen, hydroxy, (Ci-Cg) -alkyl, (Ci-Cg) -haloalkyl, (Ci-Cg) -Hydroxyalkyl, (Ci-Cg) -alkoxy, (Ci -Cg) -alkoxy- (Ci-Cg) -alkyl, represents an optionally substituted aryl and heteroaryl, wherein each ring or each ring system may optionally be substituted with up to 5 substituents from the group R 6 , for hydrogen, Hydr oxy, amino, (Ci-Cg) -alkyl, (Ci-Cg) -haloalkyl, (C 2 -Cg) -alkenyl, (C 3 -Cg) -alkynyl, (Ci-Cg) -alkoxy- (Ci-Cg ) -alkyl, (Ci-Cg) -haloalkoxy- (Ci-Cg) -alkyl, (Ci-Cg) -alkylthio (Ci-Cg) -alkyl, (Ci-Cg) -alkylsulfmyl- (Ci-Cg) - alkyl, (Ci-Cg) -alkylsulfonyl- (Ci-Cg) -alkyl, (Ci-Cg) -alkylcarbonyl, (Ci-Cg) -haloalkylcarbonyl, (C 3 -Cg) -cycloalkylcarbonyl, (Ci-Cg) - alkoxycarbonyl , (C 2 -Cg) - haloalkoxycarbonyl, (C 4 -C 9) -cycloalkoxycarbonyl, (C 2 -Cg) -alkylaminocarbonyl, (C 3 -C 10) -dialkylaminocarbonyl, (C 3 -C 10) -cycloalkylaminocarbonyl, (Ci-Cg) Alkoxy, (Ci-Cg) -alkylthio, (Ci-Cg) -haloalkylthio, (C 3 -Cg) -cycloalkylthio, (Ci-Cg) -alkylsulfmyl, (Ci-Cg) -haloalkylsulfmyl, (C 3 -Cg) Cycloalkylsulfmyl, (Ci-Cg) -alkylsulfonyl, (Ci-Cg) -haloalkylsulfonyl, (C 3 -Cg) -cycloalkylsulfonyl, (Ci-Cg) -alkylaminosulfonyl, (C 2 -Cg) - dialkylaminosulfonyl or (C 3 -Cg ) -Trialkylsilyl, represents hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen, (Ci-Cg) alkyl, (C 3 -Cg) -cycloalkyl, (C 2 -Cg) -alkenyl, (C 2 - cg ) -Alkynyl, aryl, aryl- (Ci-Cg) -alkyl, aryl- (C 2 -Cg) -alkenyl, aryl- (C 2 -Cg) -alkynyl, aryl- (Ci-Cg) -alkoxy, heteroaryl, (Ci-Cg) -alkoxy (Ci-Cg) -alkyl, (Ci-Cg) -Hydroxyalkyl, (Ci-Cg) -Haloalkyl, (C 3 -Cg) -Halocycloalkyl, (Ci-Cg) -alkoxy, ( Ci-Cg) - haloalkoxy, aryloxy, heteroaryloxy, (C 3 -Cg) -cycloalkyloxy, hydroxy, (C 3 -Cg) -cycloalkyl- (Ci-Cg) -alkoxy, (Ci-Cg) -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl , (Ci-Cg) - alkylaminocarbonyl, (C 3 -Cg) -cycloalkylaminocarbonyl, (Ci-Cg) -cyanoalkylaminocarbonyl, (C 2 -Cg) -alkenylaminocarbonyl, (C 2 -Cg) -alkynylaminocarbonyl, (Ci-Cg) - Alkylamino, (Ci-Cg) - alkylthio, (Ci-Cg) haloalkylthio, hydrothio, (Ci-Cg) -bisalkylamino, (C 3 -Cg) -cycloalkylamino, (Ci-Cg) -alkylcarbonylamino, (C 3 -Cg ) -Cycloalkylcarbonylamino, formylamino, (Ci-Cg) - Haloalkylcarbonylamino, (C 1 -C 8 ) -alkoxycarbonylamino, (C 1 -C 8 ) -alkylaminocarbonylamino, (C 1 -C 8 ) -dialkylaminocarbonylamino, (C 1 -C 8 ) -alkylsulfonylamino, (C 3 -C 8 ) -cycloalkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, aminosulfonyl , (C 1 -C 8) -Aminohaloalkylsulfonyl, (C 1 -C 8) -alkylaminosulfonyl, (C 1 -C 8) -bisalkylaminosulfonyl, (C 3 -C 8) -cycloalkylaminosulfonyl, (C 1 -C 8) -haloalkylaminosulfonyl, arylaminosulfonyl, aryl
(Ci-C8)-alkylaminosulfonyl, (Ci-C8)-Alkylsulfonyl, (C3-C8)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C8)-Alkylsulfmyl, (C3-C8)-Cycloalkylsulfinyl, Arylsulfmyl, N,S-(Ci-C8)- Dialkylsulfonimidoyl, S-(Ci-C8)-Alkylsulfonimidoyl, (Ci-C8)-Alkylsulfonylaminocarbonyl, (C3-C8)-Cycloalkylsulfonylaminocarbonyl, (C3-C8)-Cycloalkylaminosulfonyl, Aryl-(Ci-C8)- alkylcarbonylamino, (C3-C8)-Cycloalkyl-(C i-C8)-alkylcarbonylamino, (C 1 -C 8 ) -alkylaminosulfonyl, (C 1 -C 8 ) -alkylsulfonyl, (C 3 -C 8 ) -cycloalkylsulfonyl, arylsulfonyl, (C 1 -C 8 ) -alkylsulfmyl, (C 3 -C 8 ) -cycloalkylsulfinyl, arylsulfmyl, N, S- ( C 1 -C 8 ) - dialkylsulfonimidoyl, S- (C 1 -C 8 ) -alkylsulfonimidoyl, (C 1 -C 8 ) -alkylsulfonylaminocarbonyl, (C 3 -C 8) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 8) -cycloalkylaminosulfonyl, aryl- (C 1 -C 8) - alkylcarbonylamino, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) -alkylcarbonylamino,
Heteroarylcarbonylamino, (Ci-C8)-Alkoxy-(Ci-C8)-alkylcarbonylamino, (Ci-C8)- Hydroxyalkylcarbonylamino, (Ci-C8)-Trialkylsilyl steht; Heteroarylcarbonylamino, (Ci-C8) alkoxy- (Ci-C8) alkylcarbonylamino, (Ci-C 8) - Hydroxyalkylcarbonylamino, (Ci-C 8) trialkylsilyl group;
R7 und R8 unabhängig voneinander für Wasserstoff, Hydroxy, Halogen, (Ci-Cs)-Alkyl, (Ci-C8)- Haloalkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkynyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyL (Ci-C8)- Haloalkoxy-(Ci-C8)-alkyl, (Ci-C8)-AlkyltWo-(Ci-C8)-alkyL (Ci-C8)-Alkylsulfinyl-(Ci-C8)-alkyl, (Ci-C8)-Alkylsulfonyl-(Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, (Ci-C8)-Haloalkylcarbonyl, (C3-C8)-Cycloalkylcarbonyl, (Ci-C8)-Alkoxycarbonyl, (C2-C8)- Haloalkoxycarbonyl, (C3-C8)- Cycloalkoxycarbonyl, (Ci-C8)-Alkylaminocarbonyl, (Ci-Cio)-Dialkylaminocarbonyl, (C3-C10)- Cycloalkylaminocarbonyl, (Ci-C8)-Alkoxy, (Ci-C8)-Alkylthio, (Ci-C8)-Haloalkylthio, (C3-C8)- Cycloalkylthio steht. R 7 and R 8 are independently hydrogen, hydroxy, halogen, (Ci-Cs) alkyl, (Ci-C 8) - haloalkyl, (C 2 -C 8) alkenyl, (C 2 -C 8) alkynyl , (Ci-C 8) alkoxy (Ci-C 8) alkyl (Ci-C 8) - haloalkoxy (Ci-C 8) alkyl, (Ci-C 8) -AlkyltWo- (Ci-C 8 ) -alkyL (C 1 -C 8 ) -alkylsulfinyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylsulfonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylcarbonyl, (Ci -C 8) haloalkylcarbonyl, (C3-C8) cycloalkylcarbonyl, (Ci-C8) alkoxycarbonyl, (C2-C8) - haloalkoxycarbonyl, (C3-C8) - cycloalkoxycarbonyl, (Ci-C8) alkylaminocarbonyl, (Ci-Cio) dialkylaminocarbonyl, (C3-C10) - cycloalkylaminocarbonyl, (Ci-C 8) alkoxy, (Ci-C8) alkylthio, (Ci-C8) haloalkylthio, (C 3 -C 8) - Cycloalkylthio stands.
Die Verbindungen der allgemeinen Formel (I) können durch Anlagerung einer geeigneten The compounds of general formula (I) can be prepared by addition of a suitable
anorganischen oder organischen Säure, wie beispielsweise Mineralsäuren, wie beispielsweise HCl, HBr, H2SO4, H3PO4 oder HNO3, oder organische Säuren, z. B. Carbonsäuren, wie Ameisensäure, Essigsäure, Propionsäure, Oxalsäure, Milchsäure oder Salicylsäure oder Sulfonsäuren, wie zum Beispiel p- Toluolsulfonsäure, an eine basische Gruppe, wie z.B. Amino, Alkylamino, Dialkylamino, Piperidino, Morpholino oder Pyridino, Salze bilden. Diese Salze enthalten dann die konjugierte Base der Säure als Anion. Geeignete Substituenten, die in deprotonierter Form, wie z.B. Sulfonsäuren, bestimmte inorganic or organic acid, such as mineral acids such as HCl, HBr, H2SO4, H3PO4 or HNO3, or organic acids, e.g. Carboxylic acids, such as formic acid, acetic acid, propionic acid, oxalic acid, lactic acid or salicylic acid, or sulfonic acids, such as p-toluenesulfonic acid, to a basic group, e.g. Amino, alkylamino, dialkylamino, piperidino, morpholino or pyridino, salts. These salts then contain the conjugate base of the acid as an anion. Suitable substituents which are in deprotonated form, e.g. Sulfonic acids, certain
Sulfonsäureamide oder Carbonsäuren, vorliegen, können innere Salze mit ihrerseits protonierbaren Gruppen, wie Aminogruppen bilden. Salzbildung kann auch durch Einwirkung einer Base auf Sulfonsäureamide or carboxylic acids, may form internal salts with their turn protonatable groups, such as amino groups. Salt formation can also be due to the action of a base
Verbindungen der allgemeinen Formel (I) erfolgen. Geeignete Basen sind beispielsweise organische Amine, wie Trialkylamine, Morpholin, Piperidin und Pyridin sowie Ammonium-, Alkali- oder Compounds of the general formula (I) take place. Suitable bases are, for example, organic amines, such as trialkylamines, morpholine, piperidine and pyridine and ammonium, alkali or
Erdalkalimetallhydroxide, -carbonate und -hydrogencarbonate, insbesondere Natrium- und Alkaline earth metal hydroxides, carbonates and bicarbonates, in particular sodium and
Kaliumhydroxid, Natrium- und Kaliumcarbonat und Natrium- und Kaliumhydrogencarbonat. Diese Salze sind Verbindungen, in denen der azide Wasserstoff durch ein für die Landwirtschaft geeignetes Kation ersetzt wird, beispielsweise Metallsalze, insbesondere Alkalimetallsalze oder Erdalkalimetallsalze, insbesondere Natrium- und Kaliumsalze, oder auch Ammoniumsalze, Salze mit organischen Aminen oder quartäre Ammoniumsalze, zum Beispiel mit Kationen der Formel Potassium hydroxide, sodium and potassium carbonate and sodium and potassium bicarbonate. These salts are compounds in which the azide hydrogen is replaced by a cation suitable for agriculture, for example metal salts, in particular alkali metal salts or Alkaline earth metal salts, in particular sodium and potassium salts, or else ammonium salts, salts with organic amines or quaternary ammonium salts, for example with cations of the formula
[NRaRbRcRd]+ worin Ra bis Rd jeweils unabhängig voneinander einen organischen Rest, insbesondere Alkyl, Aryl, Arylalkyl oder Alkylaryl darstellen. Infrage kommen auch Alkylsulfonium- und [NR a R b R c R d ] + wherein R a to R d are each independently an organic radical, in particular alkyl, aryl, arylalkyl or alkylaryl. Also suitable are alkylsulfonium and
Alkylsulfoxoniumsalze, wie (Ci-C4)-Trialkylsulfonium- und (Ci-C4)-Trialkylsulfoxoniumsalze. Alkylsulfoxoniumsalze, such as (Ci-C4) -trialkylsulfonium and (Ci-C4) -Trialkylsulfoxoniumsalze.
Die erfindungsgemäßen substituierten Cycloalkylpyrrolidinone der allgemeinen Formel (I) können in Abhängigkeit von äußeren Bedingungen, wie pH- Wert, Lösungsmittel und Temperatur in verschiedenen tautomeren Strukturen vorliegen, die alle von der allgemeinen Formel (I) umfasst sein sollen. Depending on external conditions, such as pH, solvent and temperature, the substituted cycloalkylpyrrolidinones of the general formula (I) according to the invention may be present in various tautomeric structures, all of which are intended to be encompassed by the general formula (I).
Im Folgenden werden die erfindungsgemäß verwendeten Verbindungen der Formel (I) und ihre Salze "Verbindungen der allgemeinen Formel (I)" bezeichnet. The compounds of the formula (I) used according to the invention and their salts are referred to below as "compounds of the general formula (I)".
Bevorzugter Erfindungsgegenstand sind Verbindungen der allgemeinen Formel (I), worin Preferred subject of the invention are compounds of the general formula (I) wherein
Q für gegebenenfalls substituiertes (C3-Cio)-Cycloalkyl, (C3-Cio)-Halocycloalkyl, (C3-C10)-Q is optionally substituted (C3-Cio) -cycloalkyl, (C3-Cio) -halocycloalkyl, (C3-C10) -
Cyanocycloalkyl, (Ci-Cio)-Alkyl -(C3-Cio)-cycloalkyl, (Ci-Cio)-Alkoxy-(C3-Cio)-cycloalkyl, (Ci-Cio)-Haloalkoxy-(C3-Cio)-cycloalkyl, (Ci-Cio)-Alkylthio-(C3-Cio)-cycloalkyl, Aryl-(C3-Cio)- cycloalkyl, Heteroaryl-(C3-Cio)-cycloalkyl, (Ci-Cio)-Alkoxycarbonyl -(C3-Cio)-cycloalkyl, Hydroxcarbonyl- (C3-Cio)-cycloalkyl, (C3-Cio)-Cycloalkyl-(C3-Cio)-cycloalkyl, steht, Cyanocycloalkyl, (C 1 -C 10) -alkyl- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -alkoxy- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -haloalkoxy- (C 3 -C 10) -cycloalkyl , (C 1 -C 10) -alkylthio (C 3 -C 10) -cycloalkyl, aryl- (C 3 -C 10) -cycloalkyl, heteroaryl- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -alkoxycarbonyl - (C 3 -C 4) -cycloalkyl, Cio) -cycloalkyl, hydroxcarbonyl- (C3-Cio) -cycloalkyl, (C3-Cio) -cycloalkyl- (C3-Cio) -cycloalkyl,
Z für die Gruppe Z for the group
*■ steht, * ■ stands,
Y für -C(R7)(R8)-, Sauerstoff, oder NR1 steht, Y is -C (R 7 ) (R 8 ) -, oxygen, or NR 1 ,
W1 und W2 unabhängig voneinander für Sauerstoff oder Schwefel stehen; W 1 and W 2 are independently oxygen or sulfur;
R1 für Wasserstoff, Amino, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (Ci-C6)-Hydroxyalkyl, (Ci-C6)-R 1 is hydrogen, amino, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -hydroxyalkyl, (C 1 -C 6 ) -
Alkoxy-(Ci-C6)-alkyl, Aryl-(Ci-C6)-alkyl, Heteroaryl-(Ci-C6)-alkyl, Heterocyclyl-(Ci-C6)-alkyl, (C3-C6)-Cycloalkyl, (C3-C6)-Cycloalkyl-(Ci-C6)-alkyl, (C3-C6)-Halocycloalkyl, (C3-C6)- Halocycloalkyl-(Ci-C6)-alkyl, (Ci-C6)-Alkylcarbonyl, (Ci-C6)-Alkoxycarbonyl, (d-Ce)- Alkenyl, (C2-C6)-Alkinyl, Tris-[(Ci-C6)-alkyl]silyl-(C2-C6)-alkmyl, Tris-[(Ci-C6)-alkyl]silyl steht, für Wasserstoff, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (Ci-C6)-Hydroxyalkyl, (Ci-C6)-Alkoxy- (Ci-C6)-alkyl steht, für Wasserstoff, Fluor, Chlor, Brom, Iod, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (Ci-C6)- Hydroxyalkyl, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl steht, für ein gegebenenfalls substituiertes Aryl und Heteroaryl steht, wobei jeder Ring oder jedes Ringsystem optional mit bis zu 5 Substituenten aus der Gruppe R6 substituiert sein kann, für Wasserstoff, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (C2-C6)-Alkenyl, (C3-C6)-Alkynyl, (Ci-C6)- Alkoxy-(Ci-C6)-alkyl, (Ci-C6)-Haloalkoxy-(Ci-C6)-alkyl, (Ci-C6)-Alkylthio-(Ci-C6)-alkyl, (Ci-C6)-Alkylsulfmyl-(Ci-C6)-alkyl, (Ci-C6)-Alkylsulfonyl-(Ci-C6)-alkyl, (C2-C6)- Dialkylaminosulfonyl oder (C3-C8)-Trialkylsilyl, steht, für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (Ci-C7)-Alkyl, (C3-C7)-Cycloalkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkynyl, Aryl, Aryl-(Ci-C7)-alkyl, Aryl-(C2-C7)- alkenyl, Aryl-(C2-C7)-alkinyl, Aryl-(Ci-C7)-alkoxy, Heteroaryl, (Ci-C7)-Alkoxy-(Ci-C7)-alkyl, (Ci-C7)-Hydroxyalkyl, (Ci-C7)-Haloalkyl, (C3-C7)-Halocycloalkyl, (Ci-C7)-Alkoxy, (C1-C7)- Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C7)-Cycloalkyloxy, Hydroxy, (C3-C7)-Cycloalkyl- (Ci-C7)-alkoxy, (Ci-C7)-Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (C1-C7)- Alkylaminocarbonyl, (C3-C7)-Cycloalkylaminocarbonyl, (Ci-C7)-Cyanoalkylaminocarbonyl, (C2-C7)-Alkenylaminocarbonyl, (C2-C7)-Alkynylaminocarbonyl, (Ci-C7)-Alkylamino, (C1-C7)- Alkylthio, (Ci-C7)-Haloalkylthio, Hydrothio, (Ci-C7)-Bisalkylamino, (C3-C7)-Cycloalkylamino, (Ci-C7)-Alkylcarbonylamino, (C3-C7)-Cycloalkylcarbonylamino, Formylamino, (C1-C7)- Haloalkylcarbonylamino, (Ci-C7)-Alkoxycarbonylamino, (Ci-C7)-Alkylaminocarbonylamino, (Ci-C7)-Dialkyl-aminocarbonylamino, (Ci-C7)-Alkylsulfonylamino, (C3-C7)- Cycloalkylsulfonylamino, Arylsulfonylamino, Heteroarylsulfonylamino, Aminosulfonyl, (Ci-C7)-Aminoalkylsulfonyl, (Ci-C7)-Alkylaminosulfonyl, (Ci-C7)-Bisalkylaminosulfonyl, (C3-C7)-Cycloalkylaminosulfonyl, (Ci-C7)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl- (Ci-C7)-alkylaminosulfonyl, (Ci-C7)-Alkylsulfonyl, (C3-C7)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C7)-Alkylsulfmyl, (C3-C7)-Cycloalkylsulfinyl, Arylsulfmyl, N,S-(Ci-C7)- Dialkylsulfonimidoyl, S-(Ci-C7)-Alkylsulfonimidoyl, (Ci-C7)-Alkylsulfonylaminocarbonyl, (C3-C7)-Cycloalkylsulfonylaminocarbonyl, (C3-C7)-Cycloalkylaminosulfonyl, Aryl-(Ci-C7)- alkylcarbonylamino, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-C7)-Alkoxy-(Ci-C7)-alkylcarbonylamino, (C1-C7)- Hydroxyalkylcarbonylamino, (Ci-Cv)-Trialkylsilyl steht; Alkoxy (Ci-C 6) alkyl, aryl (Ci-C 6) alkyl, heteroaryl (Ci-C 6) alkyl, heterocyclyl (Ci-C 6) alkyl, (C 3 -C 6 ) -cycloalkyl, (C3-C6) cycloalkyl (Ci-C 6) alkyl, (C 3 -C 6) halocycloalkyl, (C 3 -C 6) - Halocycloalkyl- (Ci-C6) alkyl, (C 1 -C 6) -alkylcarbonyl, (C 1 -C 6) -alkoxycarbonyl, (d-Ce) - Alkenyl, (C 2 -C 6) alkynyl, tris - [(Ci-C6) alkyl] silyl (C 2 -C 6) -alkmyl, tris - [(Ci-C6) alkyl] silyl, is hydrogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -hydroxyalkyl, (C 1 -C 6 ) -alkoxy- (C 1 -C 6 ) -alkyl, Hydrogen, fluorine, chlorine, bromine, iodine, (Ci-C 6 ) -alkyl, (Ci-C 6 ) -haloalkyl, (Ci-C 6 ) - hydroxyalkyl, (Ci-C 6 ) -alkoxy- (Ci-C 6 ) -alkyl, represents an optionally substituted aryl and heteroaryl, where each ring or each ring system may optionally be substituted with up to 5 substituents from the group R 6 , for hydrogen, (Ci-C 6 ) alkyl, (Ci -C 6) -haloalkyl, (C 2 -C 6) -alkenyl, (C 3 -C 6) alkynyl, (Ci-C6) - alkoxy- (Ci-C 6) alkyl, (Ci-C 6 ) Haloalkoxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkylthio (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkylsulfmyl (C 1 -C 6 ) -alkyl, (Ci -C 6) alkylsulfonyl (Ci-C 6) alkyl, (C 2 -C 6) - dialkylaminosulphonyl or (C3-C8) trialkylsilyl, represents hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen , (Ci-C 7) alkyl, (C 3 -C 7) cycloalkyl, (C 2 -C 7) alkenyl, (C 2 -C 7) alkynyl, aryl, aryl (Ci-C7) alkyl, aryl (C 2 -C 7) - alkenyl, aryl- (C 2 -C 7) alkynyl, aryl (Ci-C7) alkoxy, heteroaryl, (Ci-C7) alkoxy (Ci-C 7) alkyl, (Ci-C7) hydroxyalkyl, (Ci-C7) haloalkyl, (C 3 -C 7) halocycloalkyl, (Ci-C7) alkoxy, (C1-C7) - haloalkoxy, aryloxy, Heteroaryloxy, (C 3 -C 7 ) -cycloalkyloxy, hydroxy, (C 3 -C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, (C 1 -C 7 ) - alkylaminocarbonyl, (C3-C 7) cycloalkylaminocarbonyl, (Ci-C 7) -Cyanoalkylaminocarbonyl, (C 2 -C 7) -Alkenylaminocarbonyl, (C 2 -C 7) -Alkynylaminocarbonyl, (Ci-C7) alkylamino, ( C1-C7) - alkylthio, (Ci-C 7) haloalkylthio, Hydrothio, (Ci-C 7) -Bisalkylamino, (C3-C7) cycloalkylamino, (Ci-C7) alkylcarbonylamino, (C3-C 7 ) -Cycloalkylcarbonylamino, formylamino, (C 1 -C 7 ) -haloalkylcarbonylamino, (C 1 -C 7 ) -alkoxycarbonylamino, (C 1 -C 7 ) -alkylaminocarbonylamino, (C 1 -C 7 ) -dialkylaminocarbony lamino, (C 1 -C 7 ) -alkylsulfonylamino, (C 3 -C 7 ) -cycloalkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, aminosulfonyl, (C 1 -C 7 ) -aminomethylsulfonyl, (C 1 -C 7 ) -alkylaminosulfonyl, (C 1 -C 7 ) - Bisalkylaminosulfonyl, (C 3 -C 7 ) -cycloalkylaminosulfonyl, (C 1 -C 7 ) -haloalkylaminosulfonyl, arylaminosulfonyl, aryl- (C 1 -C 7 ) -alkylaminosulfonyl, (C 1 -C 7 ) -alkylsulfonyl, (C 3 -C 7 ) -cycloalkylsulfonyl , arylsulfonyl, (Ci-C 7) -Alkylsulfmyl, (C 3 -C 7) cycloalkylsulfinyl, Arylsulfmyl, N, S- (Ci-C7) - Dialkylsulfonimidoyl, S- (Ci-C7) -Alkylsulfonimidoyl, (C -C 7) -Alkylsulfonylaminocarbonyl, (C3-C 7) -Cycloalkylsulfonylaminocarbonyl, (C3-C 7) -Cycloalkylaminosulfonyl, aryl (Ci-C7) - alkylcarbonylamino, (C3-C7) -cycloalkyl- (Ci-C 7 ) alkylcarbonylamino, Heteroarylcarbonylamino, (C 1 -C 7) alkoxy- (C 1 -C 7) -alkylcarbonylamino, (C 1 -C 7) -hydroxyalkylcarbonylamino, (C 1 -C 4) -trialkylsilyl;
R7 und R8 unabhängig voneinander für Wasserstoff, Hydroxy, Halogen, (Ci-C6)-Alkyl, (CI-CÖ)- Haloalkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkynyl, (Ci-C6)-Alkoxyalkyl, (Ci-C6)-Haloalkoxyalkyl,R 7 and R 8 independently of one another are hydrogen, hydroxyl, halogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, (C 2 -C 6 ) -alkenyl, (C 2 -C 6 ) -alkynyl, (C 1 -C 6 ) -alkoxyalkyl, (C 1 -C 6 ) -haloalkoxyalkyl,
(Ci-C6)-Alkylthio-(Ci-C6)-alkyl steht. (C 1 -C 6 ) -alkylthio (C 1 -C 6 ) -alkyl.
Besonders bevorzugter Erfindungsgegenstand sind Verbindungen der allgemeinen Formel (I), worin Particularly preferred subject of the invention are compounds of general formula (I), wherein
Q für gegebenenfalls substituiertes (C3-C9)-Cycloalkyl, (C3-C9)-Halocycloalkyl, (C3-C9)- Cyanocycloalkyl, (Ci-C9)-Alkyl -(C3-C9)-cycloalkyl, (Ci-C9)-Alkoxy-(C3-C9)-cycloalkyl,Q is optionally substituted (C3-C9) -cycloalkyl, (C3-C9) halocycloalkyl, (C3-C9) - Cyanocycloalkyl, (Ci-C9) alkyl - (C 3 -C 9) cycloalkyl, (Ci- C 9 ) -alkoxy- (C 3 -C 9 ) -cycloalkyl,
(Ci-C9)-Haloalkoxy-(C3-C9)-cycloalkyl, (Ci-C9)-Alkylthio-(C3-C9)-cycloalkyl, Aryl-(C3-C9)- cycloalkyl, Heteroaryl-(C3-C9)-cycloalkyl, (Ci-C9)-Alkoxycarbonyl -(C3-C9)-cycloalkyl, Hydroxcarbonyl- (C3-C9)-cycloalkyl, (C3-Cio)-Cycloalkyl-(C3-C9)-cycloalkyl, steht, (C 9), haloalkoxy (C 3 -C 9) cycloalkyl, (Ci-C 9) -alkylthio- (C 3 -C 9) cycloalkyl, aryl (C 3 -C 9) - cycloalkyl, heteroaryl (C 3 -C 9) cycloalkyl, (Ci-C9) alkoxycarbonyl - (C 3 -C 9) cycloalkyl, Hydroxcarbonyl- (C 3 -C 9) cycloalkyl, (C 3 -Cio) - Cycloalkyl- (C 3 -C 9 ) -cycloalkyl,
Z für die Gruppe Z for the group
*■ steht, Y für - C(R7)(R8)- steht, * ■ , Y stands for - C (R 7 ) (R 8 ) -,
W1 und W2 unabhängig voneinander für Sauerstoff oder Schwefel stehen; W 1 and W 2 are independently oxygen or sulfur;
R1 für Wasserstoff, Amino, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (Ci-C6)-Hydroxyalkyl, (Ci-C6)- Alkoxy-(Ci-C6)-alkyl, Aryl-(Ci-C6)-alkyl, Heteroaryl-(Ci-C6)-alkyl, Heterocyclyl-(Ci-C6)-alkyl,R 1 represents hydrogen, amino, (Ci-C 6) -alkyl, (Ci-C 6) -haloalkyl, (Ci-C 6) hydroxyalkyl, (Ci-C6) - alkoxy- (Ci-C 6) - alkyl, aryl- (C 1 -C 6 ) -alkyl, heteroaryl- (C 1 -C 6 ) -alkyl, heterocyclyl- (C 1 -C 6 ) -alkyl,
(C3-C6)-Cycloalkyl, (C3-C6)-Cycloalkyl-(Ci-C6)-alkyl, (C3-C6)-Halocycloalkyl, (C3-C6)- Halocycloalkyl-(Ci-C6)-alkyl, (Ci-C6)-Alkylcarbonyl, (Ci-C6)-Alkoxycarbonyl, (d-Ce)- Alkenyl, (C2-C6)-Alkynyl, Tris-[(Ci-C6)-alkyl]silyl-(C2-C6)-alkynyl, Tris-[(Ci-C6)-alkyl]silyl steht, (Halocycloalkyl- - (C 3 -C 6) -cycloalkyl, (C 3 -C 6) -cycloalkyl- (Ci-C 6) alkyl, (C 3 -C 6) halocycloalkyl, (C 3 -C 6) C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkylcarbonyl, (C 1 -C 6 ) -alkoxycarbonyl, (C 1 -C 6 ) -alkenyl, (C 2 -C 6 ) -alkynyl, tris - [(C 1 -C 6 ) - alkyl] silyl (C 2 -C 6) alkynyl, tris - is [(Ci-C6) alkyl] silyl,
R2 für Wasserstoff, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (Ci-C6)-Hydroxyalkyl, (Ci-C6)-Alkoxy- (Ci-C6)-alkyl steht, für Wasserstoff, Fluor, Chlor, Brom, Iod, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (Ci-C6)- Hydroxyalkyl, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl steht, für ein gegebenenfalls substituiertes Aryl und Heteroaryl steht, wobei jeder Ring oder jedes Ringsystem optional mit bis zu 5 Substituenten aus der Gruppe R6 substituiert sein kann, für Wasserstoff, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (C2-C6)-Alkenyl, (C3-C6)-Alkynyl, (Ci-C6)- Alkoxy-(Ci-C6)-alkyl, (Ci-C6)-Haloalkoxy-(Ci-C6)-alkyl, (Ci-C6)-Alkylthio-(Ci-C6)-alkyl, (Ci-C6)-Alkylsulfmyl-(Ci-C6)-alkyl, (Ci-C6)-Alkylsulfonyl-(Ci-C6)-alkyl, (C2-C6)- Dialkylaminosulfonyl oder (C3-C8)-Trialkylsilyl steht, für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (Ci-C6)-Alkyl, (C3-C6)-Cycloalkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkynyl, Aryl, Aryl-(Ci-C6)-alkyl, Aryl-(C2-C6)- alkenyl, Aryl-(C2-C6)-alkinyl, Aryl-(Ci-C6)-alkoxy, Heteroaryl, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl, (Ci-C6)-Hydroxyalkyl, (Ci-C6)-Haloalkyl, (C3-C6)-Halocycloalkyl, (Ci-C6)-Alkoxy, (Ci-C6)- Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C6)-Cycloalkyloxy, Hydroxy, (C3-C6)-Cycloalkyl- (Ci-C6)-alkoxy, (Ci-C6)-Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (CI-CÖ)- Alkylaminocarbonyl, (C3-C6)-Cycloalkylaminocarbonyl, (Ci-C6)-Cyanoalkylaminocarbonyl, (C2-C6)-Alkenylaminocarbonyl, (C2-C6)-Alkynylaminocarbonyl, (Ci-C6)-Alkylamino, (CI-CÖ)- Alkylthio, (Ci-C6)-Haloalkylthio, Hydrothio, (Ci-C6)-Bisalkylamino, (C3-C6)-Cycloalkylamino, (Ci-C6)-Alkylcarbonylamino, (C3-C6)-Cycloalkylcarbonylamino, Formylamino, (CI-CÖ)- Haloalkylcarbonylamino, (Ci-C6)-Alkoxycarbonylamino, (Ci-C6)-Alkylaminocarbonylamino, (Ci-C6)-Dialkyl-aminocarbonylamino, (Ci-C6)-Alkylsulfonylamino, (C3-C6)- Cycloalkylsulfonylamino, Arylsulfonylamino, Heteroarylsulfonylamino, Aminosulfonyl, (Ci-C6)-Aminoalkylsulfonyl, (Ci-C6)-Alkylaminosulfonyl, (Ci-C6)-Bisalkylaminosulfonyl, (C3-C6)-Cycloalkylaminosulfonyl, (Ci-C6)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl- (Ci-C6)-alkylaminosulfonyl, (Ci-C6)-Alkylsulfonyl, (C3-C6)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C6)-Alkylsulfmyl, (C3-C6)-Cycloalkylsulfmyl, Arylsulfmyl, N,S-(Ci-C6)- Dialkylsulfonimidoyl, S-(Ci-C6)-Alkylsulfonimidoyl, (Ci-C6)-Alkylsulfonylaminocarbonyl, (C3-C6)-Cycloalkylsulfonylaminocarbonyl, (C3-C6)-Cycloalkylaminosulfonyl, Aryl-(Ci-C6)- alkylcarbonylamino, (C3-C6)-Cycloalkyl-(Ci-C6)-alkylcarbonylamino, R 2 is hydrogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -hydroxyalkyl, (C 1 -C 6 ) -alkoxy- (C 1 -C 6 ) -alkyl . represents hydrogen, fluorine, chlorine, bromine, iodine, (Ci-C 6) -alkyl, (Ci-C 6) -haloalkyl, (Ci-C 6) - (hydroxyalkyl, (Ci-C 6) alkoxy- Ci- C 6 ) -alkyl, represents an optionally substituted aryl and heteroaryl, where each ring or each ring system may optionally be substituted by up to 5 substituents from the group R 6 , for hydrogen, (C 1 -C 6 ) -alkyl, ( Ci-C 6 ) -haloalkyl, (C 2 -C 6 ) -alkenyl, (C 3 -C 6 ) -alkynyl, (Ci-C 6 ) - alkoxy (Ci-C 6 ) -alkyl, (Ci-C 6 ) -haloalkoxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkylthio (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -alkylsulfmyl (C 1 -C 6 ) -alkyl, ( Ci-C 6) alkylsulfonyl (Ci-C 6) alkyl, (C 2 -C 6) - dialkylaminosulphonyl or (C3-C8) trialkylsilyl, represents hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen , (C 1 -C 6 ) -alkyl, (C 3 -C 6 ) -cycloalkyl, (C 2 -C 6 ) -alkenyl, (C 2 -C 6 ) -alkynyl, aryl, aryl- (C 1 -C 6 ) - alkyl, aryl (C 2 -C 6) - alkenyl, aryl- (C 2 -C 6) alkynyl, aryl (Ci-C6) alkoxy, heteroaryl, (Ci-C6) alkoxy (Ci-C6) -alkyl, (Ci-C 6 ) -hydro xyalkyl, (Ci-C 6) -haloalkyl, (C 3 -C 6) halocycloalkyl, (Ci-C 6) alkoxy, (Ci-C6) - haloalkoxy, aryloxy, heteroaryloxy, (C3-C6) cycloalkyloxy , Hydroxy, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkoxy, (C 1 -C 6) -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, (C 1 -C 6) -alkylaminocarbonyl, (C 3 -C 6) -cycloalkylaminocarbonyl, C6) -cyanoalkylaminocarbonyl, (C 2 -C 6) -alkenylaminocarbonyl, (C 2 -C 6) -alkynylaminocarbonyl, (C 1 -C 6) -alkylamino, (C 1 -C 6) -alkylthio, (C 1 -C 6) -haloalkylthio, hydrothio, ( C 1 -C 6) -alkylamino, (C 3 -C 6) -cycloalkylamino, (C 1 -C 6) -alkylcarbonylamino, (C 3 -C 6) -cycloalkylcarbonylamino, formylamino, (C 1 -C 6) -haloalkylcarbonylamino, (C 1 -C 6) -alkoxycarbonylamino, ( C 1 -C 6) -alkylaminocarbonylamino, (C 1 -C 6) -dialkylaminocarbonylamino, (C 1 -C 6) -alkylsulfonylamino, (C 3 -C 6) -cycloalkylsulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, aminosulfonyl, (C 1 -C 6) -aminoalkylsulfonyl, C6) -alkylaminosulfonyl, (C 1 -C 6) -bisalkylaminosulfonyl, (C 3 -C 6) -cycloalkylaminosulfonyl, (C 1 -C 6) -haloalkylaminos ulfonyl, arylaminosulfonyl, aryl- (C 1 -C 6 ) -alkylaminosulfonyl, (C 1 -C 6 ) -alkylsulfonyl, (C 3 -C 6 ) -cycloalkylsulfonyl, arylsulfonyl, (C 1 -C 6 ) -alkylsulfmyl, (C 3 -C 6 ) -cycloalkylsulfmyl, Arylsulfmyl, N, S- (C 1 -C 6 ) -dialkylsulfonimidoyl, S- (C 1 -C 6 ) -alkylsulfonimidoyl, (C 1 -C 6) -alkylsulfonylaminocarbonyl, (C 3 -C 6) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 6) -cycloalkylaminosulfonyl, aryl (C 1 -C 6) -alkylcarbonylamino, (C 3 -C 6) -cycloalkyl- (C 1 -C 6) -alkylcarbonylamino,
Heteroarylcarbonylamino, (Ci-C6)-Alkoxy-(Ci-C6)-alkylcarbonylamino, (CI-CÖ)- Hydroxyalkylcarbonylamino, (Ci-C6)-Trialkylsilyl steht; R7 und R8 unabhängig voneinander für Wasserstoff, Hydroxy, Halogen, (Ci-C6)-Alkyl, (CI-CÖ)-Heteroarylcarbonylamino, (Ci-C6) -alkoxy- (Ci-C6) -alkylcarbonylamino, (CI-CÖ) - hydroxyalkylcarbonylamino, (Ci-C6) -trialkylsilyl; R 7 and R 8 independently of one another represent hydrogen, hydroxyl, halogen, (C 1 -C 6) -alkyl, (C 1 -C 6) -
Haloalkyl, (C2-C6)-Alkenyl, (C3-C6)-Alkynyl, (Ci-C6)-Alkoxyalkyl, (Ci-C6)-Haloalkoxyalkyl, (Ci-C6)-Alkylthio-(Ci-C6)-alkyl steht. Ganz besonders bevorzugter Erfindungsgegenstand sind Verbindungen der allgemeinen Formel (I), worin Haloalkyl, (C 2 -C 6) -alkenyl, (C 3 -C 6) alkynyl, (Ci-C 6) alkoxyalkyl, (Ci-C 6) -Haloalkoxyalkyl, (Ci-C 6) alkylthio ( Ci-C 6 ) -alkyl. Very particularly preferred subject of the invention are compounds of the general formula (I) wherein
Q für gegebenenfalls substituiertes (C3-C8)-Cycloalkyl, (C3-C8)-Halocycloalkyl, (C3-C8)-Q is optionally substituted (C 3 -C 8 ) -cycloalkyl, (C 3 -C 8 ) -halocycloalkyl, (C 3 -C 8 ) -
Cyanocycloalkyl, (Ci-C8)-Alkyl -(C3-C8)-cycloalkyl, (Ci-C8)-Alkoxy-(C3-C8)-cycloalkyl, (Ci-C8)-Haloalkoxy-(C3-C8)-cycloalkyl, (Ci-C8)-Alkylthio-(C3-C8)-cycloalkyl, Aryl-(C3-C8)- cycloalkyl, Heteroaryl-(C3-C8)-cycloalkyl, (Ci-C8)-Alkoxycarbonyl -(C3-C8)-cycloalkyl, Hydroxcarbonyl- (C3-C8)-cycloalkyl, (C3-C8)-Cycloalkyl-(C3-C8)-cycloalkyl steht, Cyanocycloalkyl, (Ci-C8) alkyl - (C 3 -C 8) cycloalkyl, (Ci-C8) alkoxy- (C3-C8) cycloalkyl, (Ci-C8) haloalkoxy (C 3 -C 8) cycloalkyl, (Ci-C8) alkylthio (C 3 -C 8) cycloalkyl, aryl (C 3 -C 8) - cycloalkyl, heteroaryl (C 3 -C 8) cycloalkyl , (C 1 -C 8 ) -alkoxycarbonyl - (C 3 -C 8 ) -cycloalkyl, hydroxcarbonyl- (C 3 -C 8 ) -cycloalkyl, (C 3 -C 8 ) -cycloalkyl- (C 3 -C 8 ) - is cycloalkyl,
Z für die Gruppe Z for the group
R5 steht, R 5 stands,
Y für - CH(R7)- steht, Y stands for - CH (R 7 ) -
W1 und W2 unabhängig voneinander für Sauerstoff oder Schwefel; bevorzugt Sauerstoff stehen; W 1 and W 2 are independently oxygen or sulfur; preferably oxygen are;
R1 für Wasserstoff, Amino, (Ci-C4)-Alkyl, (Ci-C4)-Alkoxy-(Ci-C4)-alkyl, Aryl-(Ci-C4)-alkyl,R 1 is hydrogen, amino, (C 1 -C 4 ) -alkyl, (C 1 -C 4 ) -alkoxy- (C 1 -C 4 ) -alkyl, aryl- (C 1 -C 4 ) -alkyl,
Heteroaryl-(Ci-C4)-alkyl, Heterocyclyl-(Ci-C4)-alkyl, (C3-C6)-Cycloalkyl, (C3-C6)-Cycloalkyl- (Ci-C6)-alkyl, (C3-C6)-Halocyclo-(Ci-C4)-alkyl, (Ci-C6)-Alkylcarbonyl, (Ci-C6)-Heteroaryl- (C 1 -C 4 ) -alkyl, heterocyclyl- (C 1 -C 4 ) -alkyl, (C 3 -C 6 ) -cycloalkyl, (C 3 -C 6 ) -cycloalkyl- (C 1 -C 6 ) -alkyl , (C 3 -C 6) -Halocyclo- (Ci-C 4) alkyl, (Ci-C 6) alkylcarbonyl, (Ci-C 6) -
Alkoxycarbonyl, (C2-C6)-Alkenyl, (C2-C6)-Alkynyl, Tris-[(Ci-C6)-alkyl]silyl-(C2-C6)-alkynyl, Tris-[(Ci-C6)-alkyl]silyl steht, Alkoxycarbonyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, tris - [(C 1 -C 6 ) alkyl] silyl (C 2 -C 6 ) alkynyl, tris - [(Ci -C 6 ) -alkyl] silyl,
R2 für Wasserstoff, (Ci-C4)-Alkyl, (Ci-C4)-Haloalkyl, (Ci-C4)-Hydroxyalkyl, (Ci-C4)-Alkoxy- (Ci-C4)-alkyl steht, für Wasserstoff, Fluor, Chlor, (Ci-C4)-Alkyl steht, R 2 is hydrogen, (Ci-C 4) alkyl, (Ci-C 4) -haloalkyl, (Ci-C 4) hydroxyalkyl, (Ci-C 4) alkoxy (Ci-C 4) -alkyl , is hydrogen, fluorine, chlorine, (C 1 -C 4 ) -alkyl,
R für ein gegebenenfalls substituiertes Aryl und Heteroaryl steht, wobei jeder Ring oder jedes Ringsystem optional mit bis zu 5 Substituenten aus der Gruppe R6 substituiert sein kann, R5 für Wasserstoff, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (C2-C6)-Alkenyl, (C3-C6)-Alkynyl, (Ci-C6)- Alkoxy-(Ci-C6)-alkyl, (Ci-C6)-Haloalkoxy-(Ci-C6)-alkyl steht, R is an optionally substituted aryl and heteroaryl, where each ring or each ring system may optionally be substituted with up to 5 substituents from the group R 6 , R 5 represents hydrogen, (Ci-C 6) -alkyl, (Ci-C 6) -haloalkyl, (C 2 -C 6) -alkenyl, (C 3 -C 6) alkynyl, (Ci-C 6) - Alkoxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkoxy- (C 1 -C 6 ) -alkyl,
R6 für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (Ci-C4)-Alkyl,R 6 represents hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen, (C 1 -C 4) -alkyl,
(C3-C5)-Cycloalkyl, (C2-C4)-Alkenyl, (C2-C4)-Alkynyl, Aryl, Aryl-(Ci-C4)-alkyl, Aryl-(C2-C3)- alkenyl, Aryl-(C2-C3)-alkinyl, Aryl-(Ci-C4)-alkoxy, Heteroaryl, (Ci-C4)-Alkoxy-(Ci-C4)-alkyl, (Ci-C4)-Hydroxyalkyl, (Ci-C4)-Haloalkyl, (C3-C5)-Halocycloalkyl, (Ci-C4)-Alkoxy, (Ci-C4)- Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-Cs)-Cycloalkyloxy, Hydroxy, (C3-Cs)-Cycloalkyl- (Ci-C4)-alkoxy, (Ci-C4)-Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (C1-C4)- Alkylaminocarbonyl, (C3-C5)-Cycloalkylaminocarbonyl, (Ci-C4)-Cyanoalkylaminocarbonyl, (C2-C4)-Alkenylaminocarbonyl, (C2-C4)-Alkynylaminocarbonyl, (Ci-C4)-Alkylamino, (C1-C4)- Alkylthio, (Ci-C4)-Haloalkylthio, Hydrothio, (Ci-C4)-Bisalkylamino, (C3-C5)-Cycloalkylamino, (Ci-C4)-Alkylcarbonylamino, (C3-C5)-Cycloalkylcarbonylamino, Formylamino, (C1-C4)- Haloalkylcarbonylamino, (Ci-C4)-Alkoxycarbonylamino, (Ci-C4)-Alkylaminocarbonylamino, (Ci-C4)-Dialkylaminocabonylamino, (Ci-C4)-Alkylsulfonylamino, (C3-C5)- Cycloalkylsulfonylamino, Arylsulfonylamino, Heteroarylsulfonylamino, Aminosulfonyl, (Ci-C4)-Aminoalkylsulfonyl, (Ci-C4)-Alkylaminosulfonyl, (Ci-C4)-Bisalkylaminosulfonyl, (C3-C5)-Cycloalkylaminosulfonyl, (Ci-C4)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl- (Ci-C4)-alkylaminosulfonyl, (Ci-C4)-Alkylsulfonyl, (C3-C5)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C4)-Alkylsulfmyl, (C3-C5)-Cycloalkylsulfinyl, Arylsulfmyl, N,S-(Ci-C4)- Dialkylsulfonimidoyl, S-(Ci-C4)-Alkylsulfonimidoyl, (Ci-C4)-Alkylsulfonylaminocarbonyl, (C3-C5)-Cycloalkylsulfonylaminocarbonyl, (C3-C5)-Cycloalkylaminosulfonyl, Aryl-(Ci-C4)- alkylcarbonylamino, (C3-C5)-Cycloalkyl-(Ci-C4)-alkylcarbonylamino, (C 3 -C 5) cycloalkyl, (C 2 -C 4) alkenyl, (C 2 -C 4) alkynyl, aryl, aryl (Ci-C 4) alkyl, aryl (C 2 -C 3 ) -alkenyl, aryl- (C 2 -C 3 ) -alkynyl, aryl- (C 1 -C 4) -alkoxy, heteroaryl, (C 1 -C 4) -alkoxy- (C 1 -C 4) -alkyl, (C 1 -C 4 ) hydroxyalkyl, (Ci-C 4) -haloalkyl, (C 3 -C 5) halocycloalkyl, (Ci-C 4) alkoxy, (Ci-C4) - haloalkoxy, aryloxy, heteroaryloxy, (C3-Cs) - Cycloalkyloxy, hydroxy, (C 3 -C 5) -cycloalkyl- (C 1 -C 4) -alkoxy, (C 1 -C 4) -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, (C 1 -C 4) -alkylaminocarbonyl, (C 3 -C 5) -cycloalkylaminocarbonyl, (Ci -C4) -cyanoalkylaminocarbonyl, (C 2 -C 4) -alkenylaminocarbonyl, (C 2 -C 4) -alkynylaminocarbonyl, (C 1 -C 4) -alkylamino, (C 1 -C 4) -alkylthio, (C 1 -C 4) -haloalkylthio, hydrothio, (C 1 -C 4) -alkylamino, (C 3 -C 5) -cycloalkylamino, (C 1 -C 4) -alkylcarbonylamino, (C 3 -C 5) -cycloalkylcarbonylamino, formylamino, (C 1 -C 4) -haloalkylcarbonylamino, (C 1 -C 4) -alkoxycarbonylamino, (C 1 -C 4) -alkylaminocarbonylamino, (C 1 -C 4) -dialkylaminocabonylamino, (C 1 -C 4) -alkylsulfonylamino, (C 3 -C 5) -cycloalkyl isulfonylamino, arylsulfonylamino, heteroarylsulfonylamino, aminosulfonyl, (C 1 -C 4) -aminoalkylsulfonyl, (C 1 -C 4) -alkylaminosulfonyl, (C 1 -C 4) -bisalkylaminosulfonyl, (C 3 -C 5) -cycloalkylaminosulfonyl, (C 1 -C 4) -haloalkylaminosulfonyl, arylaminosulfonyl, Aryl- (C 1 -C 4 ) -alkylaminosulfonyl, (C 1 -C 4 ) -alkylsulfonyl, (C 3 -C 5 ) -cycloalkylsulfonyl, arylsulfonyl, (C 1 -C 4 ) -alkylsulfmyl, (C 3 -C 5 ) -cycloalkylsulfinyl, arylsulfmyl, N , S- (C 1 -C 4 ) -dialkylsulfonimidoyl, S- (C 1 -C 4 ) -alkylsulfonimidoyl, (C 1 -C 4) -alkylsulfonylaminocarbonyl, (C 3 -C 5) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 5) -cycloalkylaminosulfonyl, aryl- (Ci -C 4) - alkylcarbonylamino, (C 3 -C 5) -cycloalkyl- (C 1 -C 4) -alkylcarbonylamino,
Heteroarylcarbonylamino, (Ci-C4)-Alkoxy-(Ci-C4)-alkylcarbonylamino, (C1-C4)- Hydroxyalkylcarbonylamino, (Ci-C4)-Trialkylsilyl steht;  Heteroarylcarbonylamino, (C 1 -C 4) -alkoxy- (C 1 -C 4) -alkylcarbonylamino, (C 1 -C 4) -hydroxyalkylcarbonylamino, (C 1 -C 4) -trialkylsilyl;
R7 für Wasserstoff, Hydroxy, Halogen, (Ci-C3)-Alkyl, (Ci-C3)-Haloalkyl, (C2-C3)-Alkenyl, (C3-C3)- Alkynyl, (Ci-C3)-Alkoxy-(Ci-C3)-alkyl, (Ci-C3)-Haloalkoxy-(Ci-C3)-alkyl, (Ci-C3)-Alkylthio- (Ci-C3)-alkyl steht. R 7 is hydrogen, hydroxy, halogen, (Ci-C 3) alkyl, (Ci-C 3) -haloalkyl, (C 2 -C 3) alkenyl, (C3-C3) - alkynyl, (Ci-C 3 ) Alkoxy- (C 1 -C 3 ) -alkyl, (C 1 -C 3 ) -haloalkoxy- (C 1 -C 3 ) -alkyl, (C 1 -C 3 ) -alkylthio (C 1 -C 3 ) -alkyl.
Im Speziellen bevorzugter Erfindungsgegenstand sind Verbindungen der allgemeinen Formel (I), worin In particular preferred subject of the invention are compounds of general formula (I) wherein
Q für gegebenenfalls substituiertes (C3-C7)-Cycloalkyl, (C3-C7)-Halocycloalkyl, (C3-C7)-Q is optionally substituted (C3-C7) -cycloalkyl, (C3-C 7) halocycloalkyl, (C3-C7) -
Cyanocycloalkyl, (Ci-Cv)-Alkyl -(C3-C7)-cycloalkyl, (Ci-C7)-Alkoxy-(C3-C7)-cycloalkyl, (Ci-C7)-Haloalkoxy-(C3-Cio)-cycloalkyl, (Ci-C7)-Alkylthio-(C3-C7)-cycloalkyl, Aryl-(C3-C7)- cycloalkyl, Heteroaryl-(C3-Cv)-cycloalkyl, (Ci-Cv)-Alkoxycarbonyl -(C3-Cv)-cycloalkyl, Hydroxcarbonyl- (C3-Cv)-cycloalkyl, (C3-C7)-Cycloalkyl-(C3-Cv)-cycloalkyl, steht, Cyanocycloalkyl, (Ci-Cv) alkyl - (C 3 -C 7) cycloalkyl, (Ci-C7) alkoxy (C3-C7) cycloalkyl, (Ci-C7) haloalkoxy (C 3 -C) cycloalkyl, (C 1 -C 7 ) -alkylthio (C 3 -C 7 ) -cycloalkyl, aryl- (C 3 -C 7 ) - cycloalkyl, heteroaryl- (C3-Cv) -cycloalkyl, (Ci-Cv) -alkoxycarbonyl - (C3-Cv) -cycloalkyl, hydroxcarbonyl- (C3-Cv) -cycloalkyl, (C3-C7) -cycloalkyl- (C3-Cv ) cycloalkyl,
Z für die Gruppe
Figure imgf000012_0001
steht, Z for the group
Figure imgf000012_0001
stands,
Y für -CH2- steht, Y is -CH 2 -,
W1 und W2 unabhängig voneinander für Sauerstoff oder Schwefel; bevorzugt Sauerstoff stehen; W 1 and W 2 are independently oxygen or sulfur; preferably oxygen are;
R1 für Wasserstoff, Amino, (Ci-C3)-Alkyl, Aryl-(Ci-C3)-alkyl, Heteroaryl-(Ci-C3)-alkyl, (C3-C6)- Cycloalkyl, (C3-C5)-Cycloalkyl-(Ci-C3)-alkyl, (Ci-C6)-Alkylcarbonyl, (Ci-C6)-Alkoxycarbonyl, (C2-C6)-Alkenyl, (C2-C6)-Alkynyl steht, R 1 represents hydrogen, amino, (Ci-C 3) alkyl, aryl (Ci-C 3) alkyl, heteroaryl (Ci-C 3) alkyl, (C 3 -C 6) - cycloalkyl, (C3 -C 5) cycloalkyl (Ci-C 3) alkyl, (Ci-C 6) alkylcarbonyl, (Ci-C 6) -alkoxycarbonyl, (C 2 -C 6) alkenyl, (C 2 -C 6 ) -Alkynyl,
R2 für Wasserstoff steht, R 2 is hydrogen,
R3 für Wasserstoff, Fluor oder Chlor steht. R 3 is hydrogen, fluorine or chlorine.
R4 für ein gegebenenfalls substituiertes Aryl und Heteroaryl steht, wobei jeder Ring oder jedes Ringsystem optional mit bis zu 5 Substituenten aus der Gruppe R6 substituiert sein kann, R 4 is an optionally substituted aryl and heteroaryl, wherein each ring or each ring system may optionally be substituted with up to 5 substituents from the group R 6 ,
R5 für Wasserstoff, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (C2-C6)-Alkenyl, (C3-C6)-Alkynyl, (Ci-C6)- Alkoxy-(Ci-C6)-alkyl, (Ci-C6)-Haloalkoxy-(Ci-C6)-alkyl, steht,R6 für Wasserstoff, Nitro,R 5 represents hydrogen, (Ci-C 6) -alkyl, (Ci-C 6) -haloalkyl, (C 2 -C 6) -alkenyl, (C 3 -C 6) alkynyl, (Ci-C 6) - Alkoxy- (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkoxy- (C 1 -C 6 ) -alkyl, R 6 is hydrogen, nitro,
Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (Ci-C i)-Alkyl, (C3-Cs)-Cycloalkyl, (C2-C4)-Alkenyl, (C2-C4)-Alkynyl, Aryl, Aryl-(Ci-C4)-alkyl, Aryl-(C2-C3)-alkenyl, Aryl-(C2-C3)- alkinyl, Aryl-(Ci-C4)-alkoxy, Heteroaryl, (Ci-C4)-Alkoxy-(Ci-C4)-alkyl, (Ci-C4)-Hydroxyalkyl, (Ci-C4)-Haloalkyl, (C3-C5)-Halocycloalkyl, (Ci-C4)-Alkoxy, (Ci-C4)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-Cs)-Cycloalkyloxy, Hydroxy, (C3-C5)-Cycloalkyl-(Ci-C4)-alkoxy, (C1-C4)-Amino, cyano, thiocyanato, isothiocyanato, halogen, (Ci-C i) -alkyl, (C3-Cs) -cycloalkyl, (C 2 -C 4 ) -alkenyl, (C 2 -C 4 ) -alkynyl, aryl, aryl - (Ci-C 4) alkyl, aryl (C 2 -C 3) alkenyl, aryl (C 2 -C 3) - alkynyl, aryl (Ci-C 4) alkoxy, heteroaryl, (Ci- C 4) alkoxy (Ci-C 4) alkyl, (Ci-C 4) hydroxyalkyl, (Ci-C 4) -haloalkyl, (C 3 -C 5) halocycloalkyl, (Ci-C 4) - Alkoxy, (C 1 -C 4 ) -haloalkoxy, aryloxy, heteroaryloxy, (C 3 -C 5) -cycloalkyloxy, hydroxy, (C 3 -C 5) -cycloalkyl- (C 1 -C 4 ) -alkoxy, (C 1 -C 4 ) -
Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (Ci-C4)-Alkylaminocarbonyl, (C3-C5)- Cycloalkylaminocarbonyl, (Ci-C4)-Cyanoalkylaminocarbonyl, (C2-C4)-Alkenylaminocarbonyl, (C2-C4)-Alkynylaminocarbonyl, (Ci-C4)-Alkylamino, (Ci-C4)-Alkylthio, (Ci-C4)-Haloalkylthio, Hydrothio, (Ci-C4)-Bisalkylamino, (C3-C5)-Cycloalkylamino, (Ci-C4)-Alkylcarbonylamino, (C3-C5)-Cycloalkylcarbonylamino, Formylamino, (Ci-C4)-Haloalkylcarbonylamino, (C1-C4)- Alkoxycarbonylamino, (Ci-C4)-Alkylaminocarbonylamino, (Ci-C4)-Dialkylaminocabonylamino, (Ci-C4)-Alkylsulfonylamino, (C3-C5)-Cycloalkylsulfonylamino, Arylsulfonylamino, Alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, (Ci-C4) alkylaminocarbonyl, (C3-C5) - cycloalkylaminocarbonyl, (Ci-C 4) -Cyanoalkylaminocarbonyl, (C 2 -C 4) -Alkenylaminocarbonyl, (C 2 -C 4) -Alkynylaminocarbonyl , (C 1 -C 4) -alkylamino, (C 1 -C 4) -alkylthio, (C 1 -C 4) -haloalkylthio, hydrothio, (C 1 -C 4) -alkylamino, (C 3 -C 5) -cycloalkylamino, (C 1 -C 4) -alkylcarbonylamino , (C 3 -C 5) -cycloalkylcarbonylamino, formylamino, (C 1 -C 4) -haloalkylcarbonylamino, (C 1 -C 4) - Alkoxycarbonylamino, (C 1 -C 4) -alkylaminocarbonylamino, (C 1 -C 4) -dialkylaminocabonylamino, (C 1 -C 4) -alkylsulfonylamino, (C 3 -C 5) -cycloalkylsulfonylamino, arylsulfonylamino,
Heteroarylsulfonylamino, Aminosulfonyl, (Ci-C4)-Aminoalkylsulfonyl, (C1-C4)- Alkylaminosulfonyl, (Ci-C4)-Bisalkylaminosulfonyl, (C3-C5)-Cycloalkylaminosulfonyl, (C1-C4)- Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl-(Ci-C4)-alkylaminosulfonyl, (C1-C4)- Alkylsulfonyl, (C3-C5)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C4)-Alkylsulfmyl, (C3-C5)- Cycloalkylsulfmyl, Arylsulfmyl, N,S-(Ci-C4)-Dialkylsulfonimidoyl, S-(Ci-C4)- Alkylsulfonimidoyl, (Ci-C4)-Alkylsulfonylaminocarbonyl, (C3-C5)- Cycloalkylsulfonylaminocarbonyl, (C3-C5)-Cycloalkylaminosulfonyl, Aryl-(Ci-C4)- alkylcarbonylamino, (C3-C5)-Cycloalkyl-(Ci-C4)-alkylcarbonylamino, Heteroarylsulfonylamino, aminosulfonyl, (C 1 -C 4) -aminoalkylsulfonyl, (C 1 -C 4) -alkylaminosulfonyl, (C 1 -C 4) -bisalkylaminosulfonyl, (C 3 -C 5) -cycloalkylaminosulfonyl, (C 1 -C 4) -haloalkylaminosulfonyl, arylaminosulfonyl, aryl- C 1 -C 4) -alkylaminosulfonyl, (C 1 -C 4 ) -alkylsulfonyl, (C 3 -C 5 ) -cycloalkylsulfonyl, arylsulfonyl, (C 1 -C 4 ) -alkylsulfmyl, (C 3 -C 5 ) -cycloalkylsulfmyl, arylsulfmyl, N, S - (Ci-C 4) -Dialkylsulfonimidoyl, S- (Ci-C4) - Alkylsulfonimidoyl, (Ci-C4) -Alkylsulfonylaminocarbonyl, (C3-C5) - Cycloalkylsulfonylaminocarbonyl, (C3-C5) -Cycloalkylaminosulfonyl, aryl (Ci- C 4) alkylcarbonylamino, (C 3 -C 5) -cycloalkyl- (C 1 -C 4) -alkylcarbonylamino,
Heteroarylcarbonylamino, (Ci-C4)-Alkoxy-(Ci-C4)-alkylcarbonylamino, (C1-C4)- Hydroxyalkylcarbonylamino, (Ci-C4)-Trialkylsilyl steht.  Heteroarylcarbonylamino, (C 1 -C 4) -alkoxy- (C 1 -C 4) -alkylcarbonylamino, (C 1 -C 4) -hydroxyalkylcarbonylamino, (C 1 -C 4) -trialkylsilyl.
Im ganz Speziellen bevorzugter Erfindungsgegenstand sind Verbindungen der allgemeinen Formel (I), worin in Tabelle A, Q für die Gruppen Q-l . l bis Q-1.42 In a very particularly preferred subject of the invention are compounds of general formula (I), wherein in Table A, Q for the groups Q-l. l to Q-1.42
Figure imgf000013_0001
Figure imgf000014_0001
Figure imgf000013_0001
Figure imgf000014_0001
steht,  stands,
in Tabelle B, Z für die Gruppen Z-1.1 bis Z-4.3  in Table B, Z for the groups Z-1.1 to Z-4.3
Z-1.1 Z-1.2 Z-1.3 Z-1.4 Z-1.5
Figure imgf000015_0001
Figure imgf000016_0001
Z-1.1 Z-1.2 Z-1.3 Z-1.4 Z-1.5
Figure imgf000015_0001
Figure imgf000016_0001
steht,  stands,
Y für -CH2- steht, W1 und W2 für Sauerstoff stehen; Y is -CH 2 -, W 1 and W 2 are oxygen;
R1 für Wasserstoff, Amino, Methyl, Cyclopropyl, Benzyl, p-Methoxy-Benzyl, Allyl, Propargyl steht, R für Wasserstoff, steht, und R 1 is hydrogen, amino, methyl, cyclopropyl, benzyl, p-methoxy-benzyl, allyl, propargyl, R stands for hydrogen, and
R3 für Wasserstoff, Fluor oder Chlor steht. R 3 is hydrogen, fluorine or chlorine.
Im äußerst besonders Speziellen bevorzugter Erfindungsgegenstand sind Verbindungen der allgemeinen Formel (I), worin In a particularly particularly preferred subject of the invention are compounds of general formula (I) wherein
Q für eine der in der oben stehenden Tabelle spezifisch genannten Gruppierungen Q-l .1 bis Q-l .40 steht. Q stands for one of the groupings Q-1 .1 to Q-1 .40 mentioned specifically in the table above.
Z für die Gruppen Z-l .1 bis Z-4.3 steht. Z represents the groups Z-1 .1 to Z-4.3.
Y für -CH2- , steht, W1 und W2 für Sauerstoff stehen; Y is -CH 2 -, W 1 and W 2 are oxygen;
R1 für Wasserstoff, Methyl, Cyclopropyl, Benzyl, p-Methoxy-Benzyl, Allyl, Propargyl steht, R2 für Wasserstoff steht, und R 1 is hydrogen, methyl, cyclopropyl, benzyl, p-methoxy-benzyl, allyl, propargyl, R 2 is hydrogen, and
R3 für Wasserstoff steht. Die oben aufgeführten allgemeinen oder in Vorzugsbereichen aufgeführten Restedefinitionen gelten sowohl für die Endprodukte der allgemeinen Formel (I) als auch entsprechend für die jeweils zur Herstellung benötigten Ausgangs- oder Zwischenprodukte. Diese Restedefinitionen können R 3 is hydrogen. The general or preferred radical definitions given above apply both to the end products of the general formula (I) and correspondingly to the starting materials or intermediates required in each case for the preparation. These remainder definitions can
untereinander, also auch zwischen den angegebenen bevorzugten Bereichen beliebig kombiniert werden. Vor allem aus den Gründen der höheren herbiziden Wirkung, besseren Selektivität und/oder besseren Herstellbarkeit sind erfindungsgemäße Verbindungen der genannten allgemeinen Formel (I) oder deren Salze bzw. deren erfindungsgemäße Verwendung von besonderem Interesse, worin einzelne Reste eine der bereits genannten oder im folgenden genannten bevorzugten Bedeutungen haben, oder insbesondere solche, worin eine oder mehrere der bereits genannten oder im Folgenden genannten bevorzugten Bedeutungen kombiniert auftreten. Im Hinblick auf die erfindungsgemäßen Verbindungen werden die vorstehend und weiter unten verwendeten Bezeichnungen erläutert. Diese sind dem Fachmann geläufig und haben insbesondere die im Folgenden erläuterten Bedeutungen: among each other, so also between the specified preferred ranges are arbitrarily combined. Especially for the reasons of higher herbicidal activity, better selectivity and / or better manufacturability, compounds of the invention of said general formula (I) or their salts or their use according to the invention are of particular interest, in which individual radicals have a have the preferred meanings already mentioned or mentioned below, or in particular those in which one or more of the preferred meanings already mentioned or mentioned below occur in combination. With regard to the compounds according to the invention, the terms used above and below are explained. These are familiar to the person skilled in the art and in particular have the meanings explained below:
Sofern nicht anders definiert, gilt generell für die Bezeichnung von chemischen Gruppen, dass die Anbindung an das Gerüst bzw. den Rest des Moleküls über das zuletzt genannte Strukturelement der betreffenden chemischen Gruppe erfolgt, d.h. beispielsweise im Falle von (C2-Cg)-Alkenyloxy über das Sauerstoffatom, und im Falle von Heterocyclyl-(Ci-Cg)-alkyl oder R120(0)C-(Ci-Cg)-Alkyl jeweils über das C-Atom der Alkylgruppe. Erfindungsgemäß steht "Alkylsulfonyl" - in Alleinstellung oder als Bestandteil einer chemischen Gruppe - für geradkettiges oder verzweigtes Alkylsulfonyl, vorzugsweise mit 1 bis 8, oder mit 1 bis 6 Unless otherwise defined, generally applies to the designation of chemical groups that the attachment to the skeleton or the rest of the molecule via the last-mentioned structural element of the chemical group in question, ie, for example, in the case of (C2-Cg) alkenyloxy over the oxygen atom, and in the case of heterocyclyl (Ci-Cg) alkyl or R 12 0 (0) C (Ci-Cg) alkyl in each case via the C atom of the alkyl group. According to the invention "alkylsulfonyl" - alone or as part of a chemical group - is straight-chain or branched alkylsulfonyl, preferably with 1 to 8, or with 1 to 6
Kohlenstoffatomen, z.B. (aber nicht beschränkt auf) (Ci-C6)-Alkylsulfonyl wie Methylsulfonyl, Ethyl- sulfonyl, Propylsulfonyl, 1 -Methylethylsulfonyl, Butylsulfonyl, 1 -Methylpropylsulfonyl, 2-Methyl- propylsulfonyl, 1 ,1 -Dimethylethylsulfonyl, Pentylsulfonyl, 1 -Methylbutylsulfonyl, 2-Methylbutyl- sulfonyl, 3 -Methylbutylsulfonyl, 1 ,1 -Dimethylpropylsulfonyl, 1 ,2-Dimethylpropylsulfonyl, 2,2-Di- methylpropylsulfonyl, 1 -Ethylpropylsulfonyl, Hexylsulfonyl, 1 -Methylpentylsulfonyl, 2-Methyl- pentylsulfonyl, 3 -Methylpentylsulfonyl, 4-Methylpentylsulfonyl, 1 ,1 -Dimethylbutylsulfonyl, 1 ,2-Di- methylbutylsulfonyl, 1 ,3-Dimethylbutylsulfonyl, 2,2-Dimethylbutylsulfonyl, 2,3-Dimethylbutylsulfonyl, 3 ,3 -Dimethylbutylsulfonyl, 1 -Ethylbutylsulfonyl, 2-Ethylbutylsulfonyl, 1 , 1 ,2-Trimethylpropylsulfonyl, 1 ,2,2-Trimethylpropylsulfonyl, 1 -Ethyl- 1 -methylpropylsulfonyl und 1 -Ethyl-2-methylpropylsulfonyl. Carbon atoms, e.g. (but not limited to) (C 1 -C 6) alkylsulfonyl such as methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methyl-propylsulfonyl, 1, 1-dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 1, 1-dimethylpropylsulfonyl, 1, 2-dimethylpropylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2-methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1, 1-dimethylbutylsulfonyl, 1, 2-dimethylbutylsulfonyl, 1, 3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1, 1, 2-trimethylpropylsulfonyl, 1, 2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl and 1-ethyl-2-methylpropylsulfonyl.
Erfindungsgemäß steht "Heteroarylsulfonyl" für gegebenenfalls substituiertes Pyridylsulfonyl, According to the invention "heteroarylsulfonyl" is optionally substituted pyridylsulfonyl,
Pyrimidinylsulfonyl, Pyrazinylsulfonyl oder gegebenenfalls substituiertes polycyclisches Pyrimidinylsulfonyl, pyrazinylsulfonyl or optionally substituted polycyclic
Heteroarylsulfonyl, hier insbesondere gegebenenfalls substituiertes Chinolinylsulfonyl, beispielsweise substituiert durch Fluor, Chlor, Brom, Iod, Cyano, Nitro, Alkyl-, Haloalkyl-, Haloalkoxy-, Amino-, Alkylamino-, Alkylcarbonylamino-, Dialkylamino- oder Alkoxygruppen. Heteroarylsulfonyl, here in particular optionally substituted quinolinylsulfonyl, for example substituted by fluorine, chlorine, bromine, iodine, cyano, nitro, alkyl, haloalkyl, haloalkoxy, amino, alkylamino, alkylcarbonylamino, dialkylamino or alkoxy groups.
Erfindungsgemäß steht "Alkylthio" - in Alleinstellung oder als Bestandteil einer chemischen Gruppe - für geradkettiges oder verzweigtes S-Alkyl, vorzugsweise mit 1 bis 8, oder mit 1 bis 6 According to the invention "alkylthio" - alone or as part of a chemical group - is straight-chain or branched S-alkyl, preferably with 1 to 8, or with 1 to 6
Kohlenstoffatomen, wie (Ci-Cio)-, (CI-CÖ)- oder (Ci-C4)-Alkylthio, z.B. (aber nicht beschränkt auf) (Ci- Ce)-Alkylthio wie Methylthio, Ethylthio, Propylthio, 1 -Methylethylthio, Butylthio, 1 -Methylpropylthio, 2-Methylpropylthio, 1 ,1 -Dimethylethylthio, Pentylthio, 1 -Methylbutylthio, 2-Methylbutylthio, 3- Methylbutylthio, 1,1-Dimethylpropylthio, 1 ,2-Dimethylpropylthio, 2,2-Dimethylpropylthio, 1- Ethylpropylthio, Hexylthio, 1 -Methylpentylthio, 2-Methylpentylthio, 3-Methylpentylthio, 4-Methyl- pentylthio, 1,1-Dimethylbutylthio, 1 ,2-Dimethylbutylthio, 1,3-Dimethylbutylthio, 2,2-Dimethylbutyl- thio, 2,3-Dimethylbutylthio, 3,3-Dimethylbutylthio, 1 -Ethylbutylthio, 2-Ethylbutylthio, 1,1,2-Tri- methylpropylthio, 1 ,2,2-Trimethylpropylthio, 1-Ethyl-l -methylpropylthio und 1 -Ethyl-2-methyl- propylthio. Carbon atoms, such as (C 1 -C 10) -, (C 1 -C 6) - or (C 1 -C 4) -alkylthio, for example (but not limited to) (C 1 -C 6) -alkylthio, such as methylthio, ethylthio, propylthio, 1-methylethylthio, Butylthio, 1-methylpropylthio, 2-methylpropylthio, 1, 1-dimethylethylthio, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3 Methylbutylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 2,2-dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio, 1, 2-dimethylbutylthio, 1,3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio, 2-ethylbutylthio, 1,1,2-trimethylpropylthio, 1, 2,2-trimethylpropylthio, 1-ethyl-1-methylpropylthio and 1-ethyl-2-methylpropylthio.
„Cycloalkylthio" bedeutet bedeutet erfindungsgemäßt ein über ein Schwefelatom gebundenen "Cycloalkylthio" means according to the invention a bonded via a sulfur atom
Cycloalkylrest. Cycloalkyl.
„Alkylsulfinyl (Alkyl-S(=0)-)", soweit nicht an anderer Stelle anders definiert steht erfindungsgemäß für Alkylreste, die über -S(=0)- an das Gerüst gebunden sind, wie (Ci-Cio)-, (CI-CÖ)- oder (C1-C4)- Alkylsulfinyl, z. B. (aber nicht beschränkt auf) (Ci-C6)-Alkylsulfinyl wie Methylsulfinyl, Ethylsulfinyl, Propylsulfinyl, 1 -Methylethylsulfinyl, Butylsulfinyl, 1 -Methylpropylsulfinyl, 2-Methylpropylsulfinyl, 1,1 -Dimethylethylsulfmyl, Pentylsulfmyl, 1 -Methylbutylsulfmyl, 2-Methylbutylsulfmyl, 3 - Methylbutylsulfinyl, 1,1-Dimethylpropylsulfinyl, 1 ,2-Dimethylpropylsulfinyl, 2,2-Di- methylpropylsulfinyl, 1 -Ethylpropylsulfinyl, Hexylsulfinyl, 1 -Methylpentylsulfinyl, 2-Methylpentyl- sulfinyl, 3 -Methylpentylsulfinyl, 4-Methylpentylsulfinyl, 1,1 -Dimethylbutylsulfinyl, 1 ,2-Dimethyl- butylsulfinyl, 1,3 -Dimethylbutylsulfinyl, 2,2-Dimethylbutylsulfinyl, 2,3 -Dimethylbutylsulfinyl, 3,3- Dimethylbutylsulfinyl, 1 -Ethylbutylsulfinyl, 2-Ethylbutylsulfinyl, 1,1,2-Trimethylpropylsulfinyl, 1,2,2- Trimethylpropylsulfinyl, 1-Ethyl-l -methylpropylsulfinyl und 1 -Ethyl-2-methylpropylsulfinyl. "Alkylsulfinyl (alkyl-S (= 0) -)", unless otherwise defined elsewhere, according to the invention for alkyl radicals which are bonded to the skeleton via -S (= O) -, such as (C 1 -C 10) -, ( CI-CÖ) - or (C 1 -C 4 ) -alkylsulfinyl, for example (but not limited to) (C 1 -C 6 ) -alkylsulfinyl, such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl, butylsulfinyl, 1-methylpropylsulfinyl, 2 Methylpropylsulfinyl, 1,1-dimethylethylsulfmyl, pentylsulfmyl, 1-methylbutylsulfmyl, 2-methylbutylsulfmyl, 3-methylbutylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, hexylsulfinyl, 1 Methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1, 2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3 , 3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulf inyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl and 1-ethyl-2-methylpropylsulfinyl.
„Alkoxy" bedeutet ein über ein Sauerstoffatom gebundenen Alkylrest, z. B. (aber nicht beschränkt auf) (Ci-Ce)-Alkoxy wie Methoxy, Ethoxy, Propoxy, 1 -Methylethoxy, Butoxy, 1 -Methylpropoxy, 2- Methylpropoxy, 1,1-Dimethylethoxy, Pentoxy, 1 -Methylbutoxy, 2-Methylbutoxy, 3-Methylbutoxy, 1,1- Dimethylpropoxy, 1 ,2-Dimethylpropoxy, 2,2-Dimethylpropoxy, 1 -Ethylpropoxy, Hexoxy, 1 - Methylpentoxy, 2-Methylpentoxy, 3-Methylpentoxy, 4-Methylpentoxy, 1,1-Dimethylbutoxy, 1,2-Di- methylbutoxy, 1,3-Dimethylbutoxy, 2,2-Dimethylbutoxy, 2,3-Dimethylbutoxy, 3,3-Dimethylbutoxy, 1- Ethylbutoxy, 2-Ethylbutoxy, 1,1,2-Trimethylpropoxy, 1 ,2,2-Trimethylpropoxy, 1-Ethyl-l-methyl- propoxy und 1 -Ethyl-2-methylpropoxy. Alkenyloxy bedeutet ein über ein Sauerstoffatom gebundenen Alkenylrest, Alkinyloxy bedeutet ein über ein Sauerstoffatom gebundenen Alkinylrest wie (C2-C10)-, (C2-C6)- oder (C2-C4)-Alkenoxy bzw. (C3-C10)-, (C3-C6)- oder (C3-C4)-Alkmoxy. "Alkoxy" means an alkyl radical bonded through an oxygen atom, for example (but not limited to) (C 1 -C 6) alkoxy, such as methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1 , 1-dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1, 2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy , 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy , 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy and 1-ethyl-2-methylpropoxy. Alkenyloxy means an alkenyl radical bonded through an oxygen atom, alkynyloxy a bonded via an oxygen atom alkynyl group such as (C 2 -C 1 0) -, (C 2 -C 6) - or (C 2 -C 4) alkenoxy, and (C3-C10) -, (C 3 -C 6 ) - or (C 3 -C 4 ) -alkoxy.
„Cycloalkyloxy" bedeutet ein über ein Sauerstoffatom gebundenen Cycloalkylrest. "Cycloalkyloxy" means a cycloalkyl group bonded via an oxygen atom.
„Alkylcarbonyl" (Alkyl-C(=0)-), soweit nicht an anderer Stelle anders definiert, steht erfindungsgemäß für Alkylreste, die über -C(=0)- an das Gerüst gebunden sind, wie (C1-C10)-, (CI-CÖ)- oder (C1-C4)- Alkylcarbonyl. Die Anzahl der C-Atome bezieht sich dabei auf den Alkylrest in der "Alkylcarbonyl" (alkyl-C (= O) -), unless otherwise defined elsewhere, is according to the invention alkyl radicals which are bonded to the skeleton via -C (= O) -, such as (C 1 -C 10) -, (CI-CÖ) - or (C1-C4) - Alkylcarbonyl. The number of C atoms refers to the alkyl radical in the
Alkylcarbonylgruppe. Alkylcarbonyl.
„Alkoxycarbonyl (Alkyl-0-C(=0)-)", soweit nicht an anderer Stelle anders definiert: Alkylreste, die über -0-C(=0)- an das Gerüst gebunden sind, wie (Ci-Cio)-, (CI-CÖ)- oder (Ci-C i)-Alkoxycarbonyl. Die Anzahl der C-Atome bezieht sich dabei auf den Alkylrest in der Alkoxycarbonylgruppe. Analog stehen „Alkenyloxycarbonyl" und„Alkinyloxycarbonyl", soweit nicht an anderer Stelle anders definiert, erfindungsgemäß für Alkenyl- bzw. Alkinylreste, die über -0-C(=0)- an das Gerüst gebunden sind, wie (C2-C10)-, (C2-C6)- oder (C2-C4)-Alkenyloxycarbonyl bzw. (C3-C10)-, (C3-C6)- oder (C3-C4)-"Alkoxycarbonyl (alkyl-0-C (= 0) -)", unless otherwise defined elsewhere: alkyl radicals attached to the skeleton via -0-C (= 0) - such as (Ci-Cio) - , (CI-CÖ) - or (Ci-C i) -alkoxycarbonyl.The number of carbon atoms refers to the alkyl radical in the alkoxycarbonyl group. Analogously, "alkenyloxycarbonyl" and "alkynyloxycarbonyl", unless otherwise defined elsewhere , according to the invention for alkenyl or alkynyl radicals which are bonded to the skeleton via -O-C (= O) -, such as (C 2 -C 10) -, (C 2 -C 6 ) - or (C 2 -C 4 ) alkenyloxycarbonyl or (C3-C10) -, (C 3 -C 6) - or (C3-C4) -
Alkinyloxycarbonyl. Die Anzahl der C-Atome bezieht sich dabei auf den Alkenyl- bzw. Alkinylrest in der Alken- bzw. Alkinyloxycarbonylgruppe. Alkynyloxycarbonyl. The number of C atoms refers to the alkenyl or alkynyl radical in the alkene or alkynyloxycarbonyl group.
Der Begriff„Alkylcarbonyloxy" (Alkyl-C(=0)-0-) steht erfindungsgemäß, soweit nicht an anderer Stelle anders definiert, für Alkylreste, die über eine Carbonyloxygruppe (-C(=0)-0-) mit dem Sauerstoff an das Gerüst gebunden sind, wie (C1-C10)-, (CI-CÖ)- oder (Ci-C i)-Alkylcarbonyloxy. Die Anzahl der C- Atome bezieht sich dabei auf den Alkylrest in der Alkylcarbonyloxygruppe. The term "alkylcarbonyloxy" (alkyl-C (= 0) -O-) is according to the invention, unless otherwise defined elsewhere, for alkyl radicals which have a carbonyloxy group (-C (= O) -O-) with the oxygen the skeleton are bonded, such as (C1-C10) -, (CI-CÖ) - or (Ci-C i) -Alkylcarbonyloxy.The number of carbon atoms refers to the alkyl radical in the alkylcarbonyloxy group.
Der Begriff„Aryl" bedeutet ein gegebenenfalls substituiertes mono-, bi- oder polycyclisches aromatisches System mit vorzugsweise 6 bis 14, insbesondere 6 bis 10 Ring-C- Atomen, beispielsweise Phenyl, Naphthyl, Anthryl, Phenanthrenyl, und ähnliches, vorzugsweise Phenyl. Vom Begriff„gegebenenfalls substituiertes Aryl" sind auch mehrcyclische Systeme, wie The term "aryl" means an optionally substituted mono-, bi- or polycyclic aromatic system having preferably 6 to 14, in particular 6 to 10 ring C atoms, for example phenyl, naphthyl, anthryl, phenanthrenyl and the like, preferably phenyl The term "optionally substituted aryl" are also mehrcyclische systems, such as
Tetrahydronaphtyl, Indenyl, Indanyl, Fluorenyl, Biphenylyl, umfasst, wobei die Bindungsstelle am aromatischen System ist. Von der Systematik her ist„Aryl" in der Regel auch von dem Begriff „gegebenenfalls substituiertes Phenyl" umfasst. Bevorzugte Aryl-Substituenten sind hier zum Beispiel Wasserstoff, Halogen, Alkyl, Cycloalkyl, Cycloalkylalkyl, Cycloalkenyl, Halocycloalkyl, Alkenyl, Alkinyl, Aryl, Arylalkyl, Heteroaryl, Heteroarylalkyl, Heterocyclyl, Heterocyclylalkyl, Alkoxyalkyl, Alkylthio, Haloalkylthio, Haloalkyl, Alkoxy, Haloalkoxy, Cycloalkoxy, Cycloalkylalkoxy, Aryloxy, Heteroraryloxy, Alkoxyalkoxy, Alkinylalkoxy, Alkenyloxy, Bis-alkylaminoalkoxy, Tris- [alkyl] silyl, Bis- [alkyl] arylsilyl, Bis- [alkyl] alkylsilyl, Tris- [alkyl] silylalkinyl, Alkylalkinyl, Cycloalkylalkinyl, Haloalkylalkinyl, Heterocyclyl-N-alkoxy, Nitro, Cyano, Amino, Alkylamino, Bis-alkylamino,  Tetrahydronaphthyl, indenyl, indanyl, fluorenyl, biphenylyl, wherein the binding site is on the aromatic system. As a rule, "aryl" is also encompassed by the term "optionally substituted phenyl". Preferred aryl substituents here are, for example, hydrogen, halogen, alkyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, halocycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, alkoxyalkyl, alkylthio, haloalkylthio, haloalkyl, alkoxy, haloalkoxy, Cycloalkoxy, cycloalkylalkoxy, aryloxy, heteroaryloxy, alkoxyalkoxy, alkynylalkoxy, alkenyloxy, bis-alkylaminoalkoxy, tris [alkyl] silyl, bis [alkyl] arylsilyl, bis [alkyl] alkylsilyl, tris [alkyl] silylalkynyl, alkylalkynyl, cycloalkylalkynyl, Haloalkylalkynyl, heterocyclyl-N-alkoxy, nitro, cyano, amino, alkylamino, bis-alkylamino,
Alkylcarbonylamino, Cycloalkylcarbonylamino, Arylcarbonylamino, Alkoxycarbonylamino, Alkylcarbonylamino, cycloalkylcarbonylamino, arylcarbonylamino, alkoxycarbonylamino,
Alkoxycarbonylalkylamino, Arylalkoxycarbonylalkylamino, Hydroxycarbonyl, Alkoxycarbonyl, Aminocarbonyl, Alkylaminocarbonyl, Cycloalkylaminocarbonyl, Bis-Alkylaminocarbonyl, Alkoxycarbonylalkylamino, arylalkoxycarbonylalkylamino, hydroxycarbonyl, alkoxycarbonyl, Aminocarbonyl, alkylaminocarbonyl, cycloalkylaminocarbonyl, bis-alkylaminocarbonyl,
Heteroarylalkoxy, Arylalkoxy Heteroarylalkoxy, arylalkoxy
Ein heterocyclischer Rest (Heterocyclyl) enthält mindestens einen heterocyclischen Ring A heterocyclic radical (heterocyclyl) contains at least one heterocyclic ring
(=carbocyclischer Ring, in dem mindestens ein C-Atom durch ein Heteroatom ersetzt ist, vorzugsweise durch ein Heteroatom aus der Gruppe N, O, S, P) der gesättigt, ungesättigt, teilgesättigt oder heteroaromatisch ist und dabei unsubstituiert oder substituiert sein kann, wobei die Bindungsstelle an einem Ringatom lokalisiert ist. Ist der Heterocyclylrest oder der heterocyclische Ring gegebenenfalls substituiert, kann er mit anderen carbocyclischen oder heterocyclischen Ringen annelliert sein. Im Falle von gegebenenfalls substituiertem Heterocyclyl werden auch mehrcyclische Systeme umfasst, wie beispielsweise 8-Aza-bicyclo[3.2.1]octanyl, 8-Aza-bicyclo[2.2.2]octanyl oder 1-Aza- bicyclo[2.2.1]heptyl. Im Falle von gegebenenfalls substituiertem Heterocyclyl werden auch (= carbocyclic ring in which at least one C atom is replaced by a heteroatom, preferably by a heteroatom from the group N, O, S, P) which is saturated, unsaturated, partially saturated or heteroaromatic and may be unsubstituted or substituted, wherein the binding site is located on a ring atom. When the heterocyclyl or heterocyclic ring is optionally substituted, it may be fused with other carbocyclic or heterocyclic rings. In the case of optionally substituted heterocyclyl, polycyclic systems are also included, for example 8-azabicyclo [3.2.1] octanyl, 8-azabicyclo [2.2.2] octanyl or 1-azabicyclo [2.2.1] heptyl. In the case of optionally substituted heterocyclyl also become
spirocyclische Systeme umfasst, wie beispielsweise l-Oxa-5-aza-spiro[2.3]hexyl. Wenn nicht anders definiert, enthält der heterocyclische Ring vorzugsweise 3 bis 9 Ringatome, insbesondere 3 bis 6 Ringatome, und ein oder mehrere, vorzugsweise 1 bis 4, insbesondere 1 , 2 oder 3 Heteroatome im heterocyclischen Ring, vorzugsweise aus der Gruppe N, O, und S, wobei jedoch nicht zwei spiro-cyclic systems such as 1-oxa-5-aza-spiro [2.3] hexyl. Unless defined otherwise, the heterocyclic ring preferably contains 3 to 9 ring atoms, in particular 3 to 6 ring atoms, and one or more, preferably 1 to 4, in particular 1, 2 or 3 heteroatoms in the heterocyclic ring, preferably from the group N, O, and S, but not two
Sauerstoffatome direkt benachbart sein sollen, wie beispielsweise mit einem Heteroatom aus der Gruppe N, O und S 1- oder 2- oder 3-Pyrrolidinyl, 3,4-Dihydro-2H-pyrrol-2- oder 3-yl, 2,3-Dihydro-lH-pyrrol-Oxygen atoms are to be directly adjacent, such as with a heteroatom from the group N, O and S 1- or 2- or 3-pyrrolidinyl, 3,4-dihydro-2H-pyrrol-2 or 3-yl, 2,3- dihydro-lH-pyrrole
1- oder 2- oder 3- oder 4- oder 5-yl; 2,5-Dihydro-lH-pyrrol-l - oder 2- oder 3-yl, 1- oder 2- oder 3- oder 4-Piperidinyl; 2,3,4,5-Tetrahydropyridin-2- oder 3- oder 4- oder 5-yl oder 6-yl; 1,2,3,6-1- or 2- or 3- or 4- or 5-yl; 2,5-dihydro-1H-pyrrol-1 - or 2- or 3-yl, 1- or 2- or 3- or 4-piperidinyl; 2,3,4,5-tetrahydropyridine-2- or 3- or 4- or 5-yl or 6-yl; 1,2,3,6
Tetrahydropyridin-1- oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1,2,3,4-Tetrahydropyridin-l- oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1,4-Dihydropyridin-l - oder 2- oder 3- oder 4-yl; 2,3-Dihydropyridin-Tetrahydropyridine-1 or 2 or 3 or 4 or 5 or 6-yl; 1,2,3,4-tetrahydropyridine-1- or 2- or 3- or 4- or 5- or 6-yl; 1,4-dihydropyridine-I - or 2- or 3- or 4-yl; 2,3-dihydropyridine
2- oder 3- oder 4- oder 5- oder 6-yl; 2,5-Dihydropyridin-2- oder 3- oder 4- oder 5- oder 6-yl, 1- oder 2- oder 3- oder 4-Azepanyl; 2,3,4,5-Tetrahydro-lH-azepin-l- oder 2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,7-Tetrahydro-lH-azepin-l- oder 2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,6,7-2- or 3- or 4- or 5- or 6-yl; 2,5-dihydropyridine-2- or 3- or 4- or 5- or 6-yl, 1- or 2- or 3- or 4-azepanyl; 2,3,4,5-tetrahydro-1H-azepine-1 or 2 or 3 or 4 or 5 or 6 or 7-yl; 2,3,4,7-tetrahydro-1H-azepine-1 or 2 or 3 or 4 or 5 or 6 or 7-yl; 2,3,6,7
Tetrahydro-lH-azepin-1- oder 2- oder 3- oder 4-yl; 3,4,5,6-Tetrahydro-2H-azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-lH-azepin-l- oder 2- oder 3- oder 4-yl; 2,5-Dihydro-lH-azepin-Tetrahydro-1H-azepine-1 or 2- or 3- or 4-yl; 3,4,5,6-tetrahydro-2H-azepine-2 or 3 or 4 or 5 or 6 or 7-yl; 4,5-dihydro-1H-azepine-1 or 2 or 3 or 4-yl; 2,5-dihydro-lH-azepin-
1- oder -2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,7-Dihydro-lH-azepin-l- oder -2- oder 3- oder 4- yl; 2,3-Dihydro-lH-azepin-l - oder -2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 3,4-Dihydro-2H-azepin- 2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 3,6-Dihydro-2H-azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 5,6-Dihydro-2H-azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-3H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,7-dihydro-1H-azepine-1 or -2 or 3 or 4 yl; 2,3-dihydro-1H-azepine-1 or -2 or 3 or 4 or 5 or 6 or 7-yl; 3,4-dihydro-2H-azepine 2- or 3- or 4- or 5- or 6- or 7-yl; 3,6-dihydro-2H-azepine-2 or 3 or 4 or 5 or 6 or 7-yl; 5,6-dihydro-2H-azepine-2 or 3 or 4 or 5 or 6 or 7-yl; 4,5-dihydro-3H-azepine
2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 1H-Azepin-1- oder -2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2H-Azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 3H-Azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4H-Azepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl, 2- oder 3-Oxolanyl (= 2- oder 3- Tetrahydrofuranyl); 2,3-Dihydrofuran-2- oder 3- oder 4- oder 5-yl; 2,5-Dihydrofuran-2- oder 3-yl, 2- oder 3- oder 4-Oxanyl (= 2- oder 3- oder 4-Tetrahydropyranyl); 3,4-Dihydro-2H-pyran-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro-2H-pyran-2- oder 3-oder 4- oder 5- oder 6-yl; 2H-Pyran-2- oder 3- oder 4- oder 5- oder 6-yl; 4H-Pyran-2- oder 3- oder 4-yl, 2- oder 3- oder 4-Oxepanyl; 2,3,4,5- Tetrahydrooxepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,7-Tetrahydrooxepin-2- oder 3- oder2- or 3- or 4- or 5- or 6- or 7-yl; 1H-azepine-1 or -2 or 3 or 4 or 5 or 6 or 7-yl; 2H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl; 3H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl; 4H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl, 2- or 3-oxolanyl (= 2- or 3-tetrahydrofuranyl); 2,3-dihydrofuran-2- or 3- or 4- or 5-yl; 2,5-dihydrofuran-2- or 3-yl, 2- or 3- or 4-oxanyl (= 2- or 3- or 4-tetrahydropyranyl); 3,4-dihydro-2H-pyran-2 or 3 or 4 or 5 or 6-yl; 3,6-dihydro-2H-pyran-2 or 3 or 4 or 5 or 6-yl; 2H-pyran-2 or 3 or 4- or 5- or 6-yl; 4H-pyran-2- or 3- or 4-yl, 2- or 3- or 4-oxepanyl; 2,3,4,5-tetrahydrooxepin-2 or 3 or 4 or 5 or 6 or 7-yl; 2,3,4,7-tetrahydrooxepin-2 or 3 or
4- oder 5- oder 6- oder 7-yl; 2,3,6,7-Tetrahydrooxepin-2- oder 3- oder 4-yl; 2,3-Dihydrooxepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydrooxepin-2- oder 3- oder 4-yl; 2,5-Dihydrooxepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; Oxepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2- oder 3-4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydrooxepin-2 or 3 or 4-yl; 2,3-dihydrooxepin-2 or 3 or 4 or 5 or 6 or 7-yl; 4,5-dihydrooxepin-2 or 3 or 4-yl; 2,5-dihydrooxepin-2 or 3 or 4 or 5 or 6 or 7-yl; Oxepin-2 or 3 or 4 or 5 or 6 or 7-yl; 2- or 3-
Tetrahydrothiophenyl; 2,3-Dihydrothiophen-2- oder 3- oder 4- oder 5-yl; 2,5-Dihydrothiophen-2- oder 3-yl; Tetrahydro-2H-thiopyran-2- oder 3- oder 4-yl; 3,4-Dihydro-2H-thiopyran-2- oder 3- oder 4- odertetrahydrothiophenyl; 2,3-dihydrothiophene-2 or 3 or 4 or 5-yl; 2,5-dihydrothiophene-2 or 3-yl; Tetrahydro-2H-thiopyran-2- or 3- or 4-yl; 3,4-dihydro-2H-thiopyran-2 or 3 or 4 or
5- oder 6-yl; 3,6-Dihydro-2H-thiopyran-2- oder 3- oder 4- oder 5- oder 6-yl; 2H-Thiopyran-2- oder 3- oder 4- oder 5- oder 6-yl; 4H-Thiopyran-2- oder 3- oder 4-yl. Bevorzugte 3-Ring und 4-Ring- Heterocyclen sind beispielsweise 1- oder 2-Aziridinyl, Oxiranyl, Thiiranyl, 1- oder 2- oder 3-Azetidinyl,5- or 6-yl; 3,6-dihydro-2H-thiopyran-2 or 3 or 4 or 5 or 6-yl; 2H-thiopyran-2 or 3 or 4 or 5 or 6-yl; 4H-thiopyran-2- or 3- or 4-yl. Preferred 3-membered ring and 4-membered ring heterocycles are, for example, 1- or 2-aziridinyl, oxiranyl, thiiranyl, 1- or 2- or 3-azetidinyl,
2- oder 3-Oxetanyl, 2- oder 3-Thietanyl, l,3-Dioxetan-2-yl. Weitere Beispiele für "Heterocyclyl" sind ein partiell oder vollständig hydrierter heterocyclischer Rest mit zwei Heteroatomen aus der Gruppe N, O und S, wie beispielsweise 1- oder 2- oder 3- oder 4-Pyrazolidinyl; 4,5-Dihydro-3H-pyrazol- 3- oder 4- oder 5-yl; 4,5-Dihydro-lH-pyrazol-l - oder 3- oder 4- oder 5-yl; 2,3-Dihydro-lH-pyrazol-l - oder 2- oder 3- oder 4- oder 5-yl; 1- oder 2- oder 3- oder 4- Imidazolidinyl; 2,3-Dihydro-lH-imidazol-l- oder 2- oder2- or 3-oxetanyl, 2- or 3-thietanyl, 1,3-dioxetan-2-yl. Further examples of "heterocyclyl" are a partially or fully hydrogenated heterocyclic radical having two heteroatoms from the group N, O and S, such as 1- or 2- or 3- or 4-pyrazolidinyl; 4,5-dihydro-3H-pyrazole-3 or 4 or 5-yl; 4,5-dihydro-1H-pyrazole-1 - or 3 or 4 or 5-yl; 2,3-dihydro-1H-pyrazole-1 - or 2- or 3- or 4- or 5-yl; 1- or 2- or 3- or 4-imidazolidinyl; 2,3-dihydro-1H-imidazole-I or 2- or
3- oder 4-yl; 2,5-Dihydro-lH-imidazol-l- oder 2- oder 4- oder 5-yl; 4,5-Dihydro-lH-imidazol-l- oder 2- oder 4- oder 5-yl; Hexahydropyridazin-1- oder 2- oder 3- oder 4-yl; 1,2,3,4-Tetrahydropyridazin-l- oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1,2,3, 6-Tetrahydropyridazin-l- oder 2- oder 3- oder 4- oder 5- oder3- or 4-yl; 2,5-dihydro-1H-imidazole-1- or 2- or 4- or 5-yl; 4,5-dihydro-1H-imidazole-1- or 2- or 4- or 5-yl; Hexahydropyridazine-1 or 2- or 3- or 4-yl; 1,2,3,4-tetrahydropyridazine-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2,3,6-tetrahydropyridazine-l- or 2- or 3- or 4- or 5- or
6- yl; 1,4,5, 6-Tetrahydropyridazin-l- oder 3- oder 4- oder 5- oder 6-yl; 3,4,5, 6-Tetrahydropyridazin-3- oder 4- oder 5-yl; 4,5-Dihydropyridazin-3- oder 4-yl; 3,4-Dihydropyridazin-3- oder 4- oder 5- oder 6-yl;6-yl; 1,4,5,6-tetrahydropyridazine-1- or 3- or 4- or 5- or 6-yl; 3,4,5,6-tetrahydropyridazine-3- or 4- or 5-yl; 4,5-dihydropyridazine-3 or 4-yl; 3,4-dihydropyridazine-3- or 4- or 5- or 6-yl;
3,6-Dihydropyridazin-3- oder 4-yl; 1,6-Dihydropyriazin-l- oder 3- oder 4- oder 5- oder 6-yl; 3,6-dihydropyridazine-3 or 4-yl; 1,6-dihydropyriazine-1- or 3- or 4- or 5- or 6-yl;
Hexahydropyrimidin-1- oder 2- oder 3- oder 4-yl; 1,4,5,6-Tetrahydropyrimidin-l- oder 2- oder 4- oder 5- oder 6-yl; 1,2,5,6-Tetrahydropyrimidin-l - oder 2- oder 4- oder 5- oder 6-yl; 1,2,3,4- Tetrahydropyrimidin-1- oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1,6-Dihydropyrimidin-l- oder 2- oder 4- oder 5- oder 6-yl; 1,2-Dihydropyrimidin-l - oder 2- oder 4- oder 5- oder 6-yl; 2,5-Dihydropyrimidin- 2- oder 4- oder 5-yl; 4,5-Dihydropyrimidin- 4- oder 5- oder 6-yl; 1,4-Dihydropyrimidin-l- oder 2- oderHexahydropyrimidine-1 or 2 or 3 or 4-yl; 1,4,5,6-tetrahydropyrimidine-1- or 2- or 4- or 5- or 6-yl; 1,2,5,6-tetrahydropyrimidine-1 - or 2- or 4- or 5- or 6-yl; 1,2,3,4-tetrahydropyrimidine-1 or 2 or 3 or 4 or 5 or 6-yl; 1,6-dihydropyrimidine-1- or 2- or 4- or 5- or 6-yl; 1,2-dihydropyrimidine-1 - or 2- or 4- or 5- or 6-yl; 2,5-dihydropyrimidine-2- or 4- or 5-yl; 4,5-dihydropyrimidine-4- or 5- or 6-yl; 1,4-dihydropyrimidine-I or 2- or
4- oder 5- oder 6-yl; 1- oder 2- oder 3-Piperazinyl; 1,2,3,6-Tetrahydropyrazin-l- oder 2- oder 3- oder 5- oder 6-yl; 1,2,3,4-Tetrahydropyrazin-l - oder 2- oder 3- oder 4- oder 5- oder 6-yl; 1,2-Dihydropyrazin-l- oder 2- oder 3- oder 5- oder 6-yl; 1,4-Dihydropyrazin-l - oder 2- oder 3-yl; 2,3-Dihydropyrazin-2- oder 3- oder 5- oder 6-yl; 2,5-Dihydropyrazin-2- oder 3-yl; l,3-Dioxolan-2- oder 4- oder 5-yl; l,3-Dioxol-2- oder 4-yl; l,3-Dioxan-2- oder 4- oder 5-yl; 4H-l,3-Dioxin-2- oder 4- oder 5- oder 6-yl; l,4-Dioxan-2- oder 3- oder 5- oder 6-yl; 2,3-Dihydro-l,4-dioxin-2- oder 3- oder 5- oder 6-yl; l,4-Dioxin-2- oder 3-yl; l,2-Dithiolan-3- oder 4-yl; 3H-l,2-Dithiol-3- oder 4- oder 5-yl; l,3-Dithiolan-2- oder 4-yl; 1,3-Dithiol- 2- oder 4-yl; l,2-Dithian-3- oder 4-yl; 3,4-Dihydro-l,2-dithiin-3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro- l,2-dithiin-3- oder 4-yl; l,2-Dithiin-3- oder 4-yl; l,3-Dithian-2- oder 4- oder 5-yl; 4H-l,3-Dithiin-2- oder 4- oder 5- oder 6-yl; Isoxazolidin-2- oder 3- oder 4- oder 5-yl; 2,3-Dihydroisoxazol-2- oder 3- oder 4- oder 5-yl; 2,5-Dihydroisoxazol-2- oder 3- oder 4- oder 5-yl; 4,5-Dihydroisoxazol-3- oder 4- oder 5-yl; l,3-Oxazolidin-2- oder 3- oder 4- oder 5-yl; 2,3-Dihydro-l,3-oxazol-2- oder 3- oder 4- oder 5-yl; 2,5- Dihydro-l,3-oxazol-2- oder 4- oder 5-yl; 4,5-Dihydro-l,3-oxazol-2- oder 4- oder 5-yl; l,2-Oxazinan-2- oder 3- oder 4- oder 5- oder 6-yl; 3,4-Dihydro-2H-l,2-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6- Dihydro-2H-l,2-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-2H-l,2-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-4H-l,2-oxazin-3- oder 4- oder 5- oder 6-yl; 2H-l,2-Oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 6H-l,2-Oxazin-3- oder 4- oder 5- oder 6-yl; 4H-l,2-Oxazin-3- oder 4- oder 5- oder 6-yl; l,3-Oxazinan-2- oder 3- oder 4- oder 5- oder 6-yl; 3,4-Dihydro-2H-l,3-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro-2H-l,3-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-2H- l,3-oxazin-2- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-4H-l,3-oxazin-2- oder 4- oder 5- oder 6-yl; 2H- l,3-Oxazin-2- oder 4- oder 5- oder 6-yl; 6H-l,3-Oxazin-2- oder 4- oder 5- oder 6-yl; 4H-l,3-Oxazin-2- oder 4- oder 5- oder 6-yl; Morpholin-2- oder 3- oder 4-yl; 3,4-Dihydro-2H-l,4-oxazin-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6-Dihydro-2H-l,4-oxazin-2- oder 3- oder 5- oder 6-yl; 2H-l,4-oxazin-2- oder 3- oder 5- oder 6-yl; 4H-l,4-oxazin-2- oder 3-yl; 1 ,2-Oxazepan-2- oder 3- oder 4- oder 5- oder 6- oder 7- yl; 2,3,4,5-Tetrahydro-l,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,7-Tetrahydro-l,2- oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,6,7-Tetrahydro-l,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,5,6,7-Tetrahydro-l,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7- yl; 4,5,6,7-Tetrahydro-l,2-oxazepin-3- oder 4- oder 5- oder 6- oder 7-yl; 2,3-Dihydro-l,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,5-Dihydro-l,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,7-Dihydro-l,2-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-l,2- oxazepin-3- oder 4- oder 5- oder 6- oder 7-yl; 4,7-Dihydro-l,2-oxazepin-3- oder 4- oder 5- oder 6- oder 7-yl; 6,7-Dihydro-l,2-oxazepin-3- oder 4- oder 5- oder 6- oder 7-yl; l,2-Oxazepin-3- oder 4- oder 5- oder 6- oder 7-yl; l,3-Oxazepan-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,5-Tetrahydro-l,3- oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,7-Tetrahydro-l,3-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,6,7-Tetrahydro-l,3-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7- yl; 2,5,6,7-Tetrahydro-l,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 4,5,6,7-Tetrahydro-l,3- oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 2,3-Dihydro-l,3-oxazepin-2- oder 3- oder 4- oder 5- oder4- or 5- or 6-yl; 1- or 2- or 3-piperazinyl; 1,2,3,6-tetrahydropyrazine-1- or 2- or 3- or 5- or 6-yl; 1,2,3,4-tetrahydropyrazine-1 - or 2- or 3- or 4- or 5- or 6-yl; 1,2-dihydropyrazine 1- or 2- or 3- or 5- or 6-yl; 1,4-dihydropyrazine-1 - or 2- or 3-yl; 2,3-dihydropyrazine-2- or 3- or 5- or 6-yl; 2,5-dihydropyrazine-2 or 3-yl; l, 3-dioxolane-2- or 4- or 5-yl; l, 3-dioxol-2 or 4-yl; 1, 3-dioxan-2 or 4 or 5-yl; 4H-l, 3-dioxin-2 or 4 or 5 or 6-yl; 1, 4-dioxane-2 or 3 or 5 or 6-yl; 2,3-dihydro-1,4-dioxin-2- or 3- or 5- or 6-yl; l, 4-dioxin-2 or 3-yl; l, 2-dithiolan-3 or 4-yl; 3H-1,2-dithiol-3- or 4- or 5-yl; l, 3-dithiolan-2 or 4-yl; 1,3-dithiol-2- or 4-yl; 1, 2-dithian-3 or 4-yl; 3,4-dihydro-1,2-dithiin-3 or 4 or 5 or 6-yl; 3,6-dihydro-l, 2-dithiin-3 or 4-yl; l, 2-dithiin-3 or 4-yl; l, 3-dithian-2 or 4 or 5-yl; 4H-l, 3-dithiin-2 or 4 or 5 or 6-yl; Isoxazolidine-2 or 3 or 4 or 5-yl; 2,3-dihydroisoxazole-2 or 3 or 4 or 5-yl; 2,5-dihydroisoxazole-2 or 3 or 4 or 5-yl; 4,5-dihydroisoxazole-3 or 4 or 5-yl; l, 3-oxazolidine-2 or 3 or 4 or 5-yl; 2,3-dihydro-1,3-oxazol-2 or 3 or 4 or 5-yl; 2,5-dihydro-1,3-oxazol-2 or 4 or 5-yl; 4,5-dihydro-1,3-oxazol-2 or 4 or 5-yl; 1, 2-oxazinan-2 or 3 or 4 or 5 or 6-yl; 3,4-dihydro-2H-1,2-oxazine-2 or 3 or 4 or 5 or 6-yl; 3,6-dihydro-2H-1,2-oxazine-2 or 3 or 4 or 5 or 6-yl; 5,6-dihydro-2H-1,2-oxazine-2 or 3 or 4 or 5 or 6-yl; 5,6-dihydro-4H-1,2-oxazine-3 or 4 or 5 or 6-yl; 2H-l, 2-oxazine-2 or 3 or 4 or 5 or 6-yl; 6H-l, 2-oxazine-3 or 4 or 5 or 6-yl; 4H-1, 2-oxazine-3 or 4 or 5 or 6-yl; l, 3-oxazinan-2 or 3 or 4 or 5 or 6-yl; 3,4-dihydro-2H-1,3-oxazine-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1,3-oxazine-2 or 3 or 4 or 5 or 6-yl; 5,6-dihydro-2H-1,3-oxazine-2- or 4- or 5- or 6-yl; 5,6-dihydro-4H-1,3-oxazine-2- or 4- or 5- or 6-yl; 2H-, 3-oxazine-2- or 4- or 5- or 6-yl; 6H-1, 3-oxazine-2 or 4 or 5 or 6-yl; 4H-1, 3-oxazine-2 or 4 or 5 or 6-yl; Morpholine-2- or 3- or 4-yl; 3,4-dihydro-2H-1,4-oxazine-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1,4-oxazine-2- or 3- or 5- or 6-yl; 2H-1,4-oxazine-2- or 3- or 5- or 6-yl; 4H-1,4-oxazine-2 or 3-yl; 1, 2-oxazepan-2 or 3 or 4 or 5 or 6 or 7 yl; 2,3,4,5-tetrahydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-1, 2-oxazepine-2 or 3 or 4 or 5 or 6 or 7-yl; 2,3,6,7-tetrahydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-tetrahydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5,6,7-tetrahydro-1,2-oxazepine-3- or 4- or 5- or 6- or 7-yl; 2,3-dihydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5-dihydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,7-dihydro-1,2-oxazepine-2 or 3 or 4 or 5 or 6 or 7-yl; 4,5-dihydro-1, 2-oxazepine-3 or 4 or 5 or 6 or 7-yl; 4,7-dihydro-1,2-oxazepine-3 or 4 or 5 or 6 or 7-yl; 6,7-dihydro-1,2-oxazepine-3- or 4- or 5- or 6- or 7-yl; 1, 2-oxazepine-3 or 4 or 5 or 6 or 7-yl; l, 3-oxazepan-2 or 3 or 4 or 5 or 6 or 7-yl; 2,3,4,5-tetrahydro-1, 3-oxazepine-2 or 3 or 4 or 5 or 6 or 7-yl; 2,3,4,7-tetrahydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydro-1,3-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-tetrahydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 4,5,6,7-tetrahydro-1, 3-oxazepine-2 or 4 or 5 or 6 or 7-yl; 2,3-dihydro-1,3-oxazepine-2 or 3 or 4 or 5 or
6- oder 7-yl; 2,5-Dihydro-l,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 2,7-Dihydro-l,3-oxazepin- 2- oder 4- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-l,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 4,7- Dihydro-l,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 6,7-Dihydro-l,3-oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; l,3-Oxazepin-2- oder 4- oder 5- oder 6- oder 7-yl; 1 ,4-Oxazepan-2- oder 3- oder 5- oder 6- oder 7-yl; 2,3,4,5-Tetrahydro-l,4-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,4,7- Tetrahydro-l,4-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3,6,7-Tetrahydro-l,4-oxazepin-6- or 7-yl; 2,5-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 2,7-dihydro-1,3-oxazepine 2- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,3-oxazepine-2- or 4- or 5- or 6- or 7-yl; l, 3-oxazepine-2- or 4- or 5- or 6- or 7-yl; 1,4-oxazepan-2- or 3- or 5- or 6- or 7-yl; 2,3,4,5-tetrahydro-1,4-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-l, 4-oxazepine-2 or 3 or 4 or 5 or 6 or 7-yl; 2,3,6,7-tetrahydro-l, 4-oxazepin
2- oder 3- oder 5- oder 6- oder 7-yl; 2,5,6,7-Tetrahydro-l,4-oxazepin-2- oder 3- oder 5- oder 6- oder 7- yl; 4,5,6,7-Tetrahydro-l,4-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7-yl; 2,3-Dihydro-l,4- oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 2,5-Dihydro-l,4-oxazepin-2- oder 3- oder 5- oder 6- oder2- or 3- or 5- or 6- or 7-yl; 2,5,6,7-tetrahydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 4,5,6,7-tetrahydro-l, 4-oxazepine-2 or 3 or 4 or 5 or 6 or 7-yl; 2,3-dihydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 2,5-dihydro-l, 4-oxazepine-2 or 3 or 5 or 6 or
7- yl; 2,7-Dihydro-l,4-oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 4,5-Dihydro-l,4-oxazepin-2- oder7- yl; 2,7-dihydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 4,5-dihydro-1,4-oxazepine-2- or
3- oder 4- oder 5- oder 6- oder 7-yl; 4,7-Dihydro-l,4-oxazepin-2- oder 3- oder 4- oder 5- oder 6- oder 7- yl; 6,7-Dihydro-l,4-oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 1 ,4-Oxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; Isothiazolidin-2- oder 3- oder 4- oder 5-yl; 2,3-Dihydroisothiazol-2- oder 3- oder 4- oder 5- yl; 2,5-Dihydroisothiazol-2- oder 3- oder 4- oder 5-yl; 4,5-Dihydroisothiazol-3- oder 4- oder 5-yl; 1,3- Thiazolidin-2- oder 3- oder 4- oder 5-yl; 2,3-Dihydro-l ,3-thiazol-2- oder 3- oder 4- oder 5-yl; 2,5- Dihydro-l,3-thiazol-2- oder 4- oder 5-yl; 4,5-Dihydro-l,3-thiazol-2- oder 4- oder 5-yl; l,3-Thiazinan-2- oder 3- oder 4- oder 5- oder 6-yl; 3,4-Dihydro-2H-l,3-thiazin-2- oder 3- oder 4- oder 5- oder 6-yl; 3,6- Dihydro-2H-l,3-thiazin-2- oder 3- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-2H-l,3-thiazin-2- oder 4- oder 5- oder 6-yl; 5,6-Dihydro-4H-l,3-thiazin-2- oder 4- oder 5- oder 6-yl; 2H-l,3-Thiazin-2- oder 4- oder 5- oder 6-yl; 6H-l,3-Thiazin-2- oder 4- oder 5- oder 6-yl; 4H-l,3-Thiazin-2- oder 4- oder 5- oder 6-yl. Weitere Beispiele für "Heterocyclyl" sind ein partiell oder vollständig hydrierter heterocyclischer Rest mit 3 Heteroatomen aus der Gruppe N, O und S, wie beispielsweise l,4,2-Dioxazolidin-2- oder 3- oder 5-yl; l,4,2-Dioxazol-3- oder 5-yl; 1 ,4,2-Dioxazinan-2- oder -3- oder 5- oder 6-yl; 5,6-Dihydro-l,4,2- dioxazin-3- oder 5- oder 6-yl; l,4,2-Dioxazin-3- oder 5- oder 6-yl; l,4,2-Dioxazepan-2- oder 3- oder 5- oder 6- oder 7-yl; 6,7-Dihydro-5H-l,4,2-Dioxazepin-3- oder 5- oder 6- oder 7-yl; 2,3-Dihydro-7H-l,4,2- Dioxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 2,3-Dihydro-5H-l,4,2-Dioxazepin-2- oder 3- oder 5- oder 6- oder 7-yl; 5H-l,4,2-Dioxazepin-3- oder 5- oder 6- oder 7-yl; 7H-l,4,2-Dioxazepin-3- oder 5- oder 6- oder 7-yl. Strukturbeispiele für gegebenenfalls weiter substituierte Heterocyclen sind auch im Folgenden aufgeführt: 3- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-l, 4-oxazepine-2 or 3 or 4 or 5 or 6 or 7 yl; 6,7-dihydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; Isothiazolidine-2- or 3- or 4- or 5-yl; 2,3-dihydroisothiazole-2 or 3 or 4 or 5 yl; 2,5-dihydroisothiazole-2 or 3 or 4 or 5-yl; 4,5-dihydroisothiazole-3 or 4 or 5-yl; 1,3-thiazolidine-2- or 3- or 4- or 5-yl; 2,3-dihydro-1,3-thiazole-2 or 3 or 4 or 5-yl; 2,5-dihydro-1,3-thiazol-2 or 4 or 5-yl; 4,5-dihydro-1,3-thiazol-2 or 4 or 5-yl; l, 3-thiazinan-2 or 3 or 4 or 5 or 6-yl; 3,4-dihydro-2H-1, 3-thiazine-2 or 3 or 4 or 5 or 6-yl; 3,6-dihydro-2H-l, 3-thiazine-2 or 3 or 4 or 5 or 6-yl; 5,6-dihydro-2H-1, 3-thiazine-2 or 4 or 5 or 6-yl; 5,6-dihydro-4H-1, 3-thiazine-2 or 4 or 5 or 6-yl; 2H-1, 3-thiazine-2 or 4 or 5 or 6-yl; 6H-l, 3-thiazine-2 or 4 or 5 or 6-yl; 4H-l, 3-thiazine-2 or 4 or 5 or 6-yl. Further examples of "heterocyclyl" are a partially or fully hydrogenated heterocyclic radical having 3 heteroatoms from the group N, O and S, such as, for example, l, 4,2-dioxazolidin-2 or 3 or 5-yl; l, 4,2-dioxazol-3 or 5-yl; 1,2,2-dioxazinane-2- or -3- or 5- or 6-yl; 5,6-dihydro-l, 4,2-dioxazine-3 or 5 or 6-yl; l, 4,2-dioxazine-3- or 5- or 6-yl; l, 4,2-dioxazepan-2 or 3 or 5 or 6 or 7-yl; 6,7-dihydro-5H-l, 4,2-dioxazepine-3 or 5 or 6 or 7-yl; 2,3-dihydro-7H-l, 4,2-dioxazepin-2 or 3 or 5 or 6 or 7-yl; 2,3-dihydro-5H-1, 4,2-dioxazepine-2 or 3 or 5 or 6 or 7-yl; 5H-l, 4,2-dioxazepine-3 or 5 or 6 or 7-yl; 7H-l, 4,2-dioxazepine-3 or 5 or 6 or 7-yl. Structural examples of optionally further substituted heterocycles are also listed below:
Figure imgf000024_0001
Figure imgf000024_0001
Figure imgf000025_0001
Figure imgf000026_0001
Figure imgf000025_0001
Figure imgf000026_0001
Die oben aufgeführten Heterocyclen sind bevorzugt beispielsweise durch Wasserstoff, Halogen, Alkyl, Haloalkyl, Hydroxy, Alkoxy, Cycloalkoxy, Aryloxy, Alkoxyalkyl, Alkoxyalkoxy, Cycloalkyl, The heterocycles listed above are preferably, for example, hydrogen, halogen, alkyl, haloalkyl, hydroxy, alkoxy, cycloalkoxy, aryloxy, alkoxyalkyl, alkoxyalkoxy, cycloalkyl,
Halocycloalkyl, Aryl, Arylalkyl, Heteroaryl, Heterocyclyl, Alkenyl, Alkylcarbonyl, Cycloalkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, Alkoxycarbonyl, Hydroxycarbonyl, Cycloalkoxycarbonyl, Halocycloalkyl, aryl, arylalkyl, heteroaryl, heterocyclyl, alkenyl, alkylcarbonyl, cycloalkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, hydroxycarbonyl, cycloalkoxycarbonyl,
Cycloalkylalkoxycarbonyl, Alkoxycarbonylalkyl, Arylalkoxycarbonyl, Arylalkoxycarbonylalkyl, Alkinyl, Alkinylalkyl, Alkylalkinyl, Tris-alkylsilylalkinyl, Nitro, Amino, Cyano, Haloalkoxy, Cycloalkylalkoxycarbonyl, alkoxycarbonylalkyl, arylalkoxycarbonyl, arylalkoxycarbonylalkyl, alkynyl, alkynylalkyl, alkylalkynyl, trisalkylsilylalkynyl, nitro, amino, cyano, haloalkoxy,
Haloalkylthio, Alkylthio, Hydrothio, Hydroxyalkyl, Oxo, Heteroarylalkoxy, Arylalkoxy, Haloalkylthio, alkylthio, hydrothio, hydroxyalkyl, oxo, heteroarylalkoxy, arylalkoxy,
Heterocyclylalkoxy, Heterocyclylalkylthio, Heterocyclyloxy, Heterocyclylthio, Heteroaryloxy, Bis- alkylamino, Alkylamino, Cycloalkylamino, Hydroxycarbonylalkylamino, Alkoxycarbonylalkylamino, Arylalkoxycarbonylalkylamino, Alkoxycarbonylalkyl(alkyl)amino, Aminocarbonyl, Heterocyclylalkoxy, heterocyclylalkylthio, heterocyclyloxy, heterocyclylthio, heteroaryloxy, bisalkylamino, alkylamino, cycloalkylamino, hydroxycarbonylalkylamino, alkoxycarbonylalkylamino, arylalkoxycarbonylalkylamino, alkoxycarbonylalkyl (alkyl) amino, aminocarbonyl,
Alkylaminocarbonyl, Bis-alkylaminocarbonyl, Cycloalkylaminocarbonyl, Alkylaminocarbonyl, bis-alkylaminocarbonyl, cycloalkylaminocarbonyl,
Hydroxycarbonylalkylaminocarbonyl, Alkoxycarbonylalkylaminocarbonyl, Hydroxycarbonylalkylaminocarbonyl, alkoxycarbonylalkylaminocarbonyl,
Arylalkoxycarbonylalkylaminocarbonyl substituiert. Wenn ein Grandkörper "durch einen oder mehrere Reste" aus einer Aufzählung von Resten (= Gruppe) oder einer generisch definierten Gruppe von Resten substituiert ist, so schließt dies jeweils die gleichzeitige Substitution durch mehrere gleiche und/oder strukturell unterschiedliche Reste ein. Arylalkoxycarbonylalkylaminocarbonyl substituted. If a grandbody is "substituted by one or more radicals" from an enumeration of radicals (= group) or a generically defined group of radicals, this includes the simultaneous substitution by a plurality of identical and / or structurally different radicals.
Handelt es sich es sich um einen teilweise oder vollständig gesättigten Stickstoff-Heterocyclus, so kann dieser sowohl über Kohlenstoff als auch über den Stickstoff mit dem Rest des Moleküls verknüpft sein. If it is a partially or fully saturated nitrogen heterocycle, it may be linked to the rest of the molecule via both carbon and nitrogen.
Als Substituenten für einen substituierten heterocyclischen Rest kommen die weiter unten genannten Substituenten in Frage, zusätzlich auch Oxo und Thioxo. Die Oxograppe als Substituent an einem Ring- C-Atom bedeutet dann beispielsweise eine Carbonylgrappe im heterocyclischen Ring. Dadurch sind vorzugsweise auch Lactone und Lactame umfasst. Die Oxograppe kann auch an den Heteroringatomen, die in verschiedenen Oxidationsstufen existieren können, z.B. bei N und S, auftreten und bilden dann beispielsweise die divalenten Gruppen N(O) , S(O) (auch kurz SO) und S(0)2 (auch kurz SO2) im heterocyclischen Ring. Im Fall von -N(O)- und -S(0)-Gruppen sind jeweils beide Enantiomere umfasst. Suitable substituents for a substituted heterocyclic radical are the substituents mentioned below, in addition to oxo and thioxo. The oxo group as a substituent on a ring C atom then means, for example, a carbonyl group in the heterocyclic ring. As a result, lactones and lactams are preferably also included. The oxo may also be attached to the hetero ring atoms, which may exist in different oxidation states, e.g. For example, at N and S, the divalent groups N (O), S (O) (also SO for short) and S (O) 2 (also SO2 for short) occur and form in the heterocyclic ring. In the case of -N (O) and -S (0) groups, both enantiomers are included.
Erfindungsgemäß steht der Ausdruck„Heteroaryl" für heteroaromatische Verbindungen, d. h. According to the invention, the term "heteroaryl" stands for heteroaromatic compounds, ie.
vollständig ungesättigte aromatische heterocyclische Verbindungen, vorzugsweise für 5- bis 7-gliedrige Ringe mit 1 bis 4, vorzugsweise 1 oder 2 gleichen oder verschiedenen Heteroatomen, vorzugsweise O, S oder N. Erfindungsgemäße Heteroaryle sind beispielsweise lH-Pyrrol-l-yl; lH-Pyrrol-2-yl; lH-Pyrrol-completely unsaturated aromatic heterocyclic compounds, preferably for 5- to 7-membered rings having 1 to 4, preferably 1 or 2 identical or different heteroatoms, preferably O, S or N. Heteroaryls according to the invention are, for example, 1H-pyrrol-1-yl; lH-pyrrol-2-yl; lH-pyrrole
3- yl; Furan-2-yl; Furan-3-yl; Thien-2-yl; Thien-3-yl, lH-Imidazol-l-yl; lH-Imidazol-2-yl; lH-Imidazol-3-yl; Furan-2-yl; Furan-3-yl; Thien-2-yl; Thien-3-yl, 1H-imidazol-1-yl; lH-imidazol-2-yl; lH-imidazole
4- yl; lH-Imidazol-5-yl; lH-Pyrazol-l-yl; lH-Pyrazol-3-yl; lH-Pyrazol-4-yl; lH-Pyrazol-5-yl, 1H-1,2,3- Triazol-l-yl, lH-l,2,3-Triazol-4-yl, lH-l,2,3-Triazol-5-yl, 2H-l,2,3-Triazol-2-yl, 2H-l,2,3-Triazol-4-yl, lH-l,2,4-Triazol-l-yl, lH-l,2,4-Triazol-3-yl, 4H-l,2,4-Triazol-4-yl, l,2,4-Oxadiazol-3-yl, 1,2,4-4-yl; lH-imidazol-5-yl; lH-pyrazol-l-yl; lH-pyrazol-3-yl; lH-pyrazol-4-yl; lH-pyrazol-5-yl, 1H-1,2,3-triazol-1-yl, 1H-l, 2,3-triazol-4-yl, 1H-l, 2,3-triazol-5-yl, 2H-l, 2,3-triazol-2-yl, 2H-l, 2,3-triazol-4-yl, 1H-l, 2,4-triazol-1-yl, 1H-l, 2,4- Triazol-3-yl, 4H-l, 2,4-triazol-4-yl, l, 2,4-oxadiazol-3-yl, 1,2,4-
Oxadiazol-5-yl, l,3,4-Oxadiazol-2-yl, l,2,3-Oxadiazol-4-yl, l,2,3-Oxadiazol-5-yl, l,2,5-Oxadiazol-3-yl, Azepinyl, Pyridin-2-yl, Pyridin-3-yl, Pyridin-4-yl, Pyrazin-2-yl, Pyrazin-3-yl, Pyrimidin-2-yl, Oxadiazol-5-yl, l, 3,4-oxadiazol-2-yl, l, 2,3-oxadiazol-4-yl, l, 2,3-oxadiazol-5-yl, l, 2,5-oxadiazole 3-yl, azepinyl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrazine-2-yl, pyrazine-3-yl, pyrimidin-2-yl,
Pyrimidin-4-yl, Pyrimidin-5-yl, Pyridazin-3-yl, Pyridazin-4-yl, l,3,5-Triazin-2-yl, l,2,4-Triazin-3-yl, l,2,4-Triazin-5-yl, 1 ,2,4-Triazin-6-yl, l,2,3-Triazin-4-yl, l,2,3-Triazin-5-yl, 1,2,4-, 1,3,2-, 1,3,6- und 1,2,6-Oxazinyl, Isoxazol-3-yl, Isoxazol-4-yl, Isoxazol-5-yl, l,3-Oxazol-2-yl, l,3-Oxazol-4-yl, 1,3- Oxazol-5-yl, Isothiazol-3-yl, Isothiazol-4-yl, Isothiazol-5-yl, l,3-Thiazol-2-yl, l,3-Thiazol-4-yl, 1,3- Thiazol-5-yl, Oxepinyl, Thiepinyl, 1 ,2,4-Triazolonyl und 1 ,2,4-Diazepinyl, 2H-l,2,3,4-Tetrazol-5-yl, lH-l,2,3,4-Tetrazol-5-yl, l,2,3,4-Oxatriazol-5-yl, l,2,3,4-Thiatriazol-5-yl, l,2,3,5-Oxatriazol-4-yl, l,2,3,5-Thiatriazol-4-yl. Die erfindungsgemäßen Heteroarylgrappen können ferner mit einem oder mehreren, gleichen oder verschiedenen Resten substituiert sein. Sind zwei benachbarte Pyrimidin-4-yl, pyrimidin-5-yl, pyridazin-3-yl, pyridazin-4-yl, l, 3,5-triazin-2-yl, l, 2,4-triazin-3-yl, 2,4-triazin-5-yl, 1, 2,4-triazin-6-yl, l, 2,3-triazin-4-yl, l, 2,3-triazin-5-yl, 1,2, 4-, 1,3,2-, 1,3,6- and 1,2,6-oxazinyl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, 1,3-oxazole-2 -yl, 1,3-oxazol-4-yl, 1,3-oxazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, l, 3-thiazol-2-yl , 1, 3-Thiazol-4-yl, 1,3-thiazol-5-yl, oxepinyl, thiepinyl, 1, 2,4-triazolonyl and 1, 2,4-diazepinyl, 2H-l, 2,3,4 -Tetrazol-5-yl, 1H-l, 2,3,4-tetrazol-5-yl, l, 2,3,4-oxatriazol-5-yl, l, 2,3,4-thiatriazol-5-yl 1,2,3,5-Oxatriazol-4-yl, 1,2,3,5-thiatriazol-4-yl. The Heteroarylgrappen invention can be further substituted with one or more, identical or different radicals. Are two neighbors
Kohlenstoffatome Bestandteil eines weiteren aromatischen Rings, so handelt es sich um annellierte heteroaromatische Systeme, wie benzokondensierte oder mehrfach annellierte Heteroaromaten. Bevorzugt sind beispielsweise Chinoline (z. B. Chinolin-2-yl, Chinolin-3-yl, Chinolin-4-yl, Chinolin-5- yl, Chinolin-6-yl, Chinolin-7-yl, Chinolin-8-yl); Isochinoline (z. B. Isochinolin-l -yl, Isochinolin-3-yl, Isochinolin-4-yl, Isochinolin-5-yl, Isochinolin-6-yl, Isochinolin-7-yl, Isochinolin-8-yl); Chinoxalin; Chinazolin; Cinnolin; 1,5-Naphthyridin; 1 ,6-Naphthyridin; 1 ,7-Naphthyridin; 1,8-Naphthyridin; 2,6- Naphthyridin; 2,7-Naphthyridin; Phthalazin; Pyridopyrazine; Pyridopyrimidine; Pyridopyridazine;Carbon atoms part of another aromatic ring, they are fused heteroaromatic systems, such as benzo-fused or multiply fused heteroaromatic. Preferred are, for example, quinolines (e.g., quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl ); Isoquinolines (e.g., isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl, isoquinolin-8-yl); quinoxaline; quinazoline; cinnoline; 1,5-naphthyridine; 1,6-naphthyridine; 1,7-naphthyridine; 1,8-naphthyridine; 2,6-naphthyridine; 2,7-naphthyridine; phthalazine; Pyridopyrazine; pyridopyrimidines; Pyridopyridazine;
Pteridine; Pyrimidopyrimidine. Beispiele für Heteroaryl sind auch 5- oder 6-gliedrige benzokondensierte Ringe aus der Gruppe lH-Indol-l-yl, lH-Indol-2-yl, lH-Indol-3-yl, lH-Indol-4-yl, lH-Indol-5-yl, 1H- Indol-6-yl, lH-Indol-7-yl, l-Benzofuran-2-yl, l-Benzofuran-3-yl, l-Benzofuran-4-yl, l-Benzofuran-5- yl, l-Benzofuran-6-yl, l-Benzofuran-7-yl, l-Benzothiophen-2-yl, l-Benzothiophen-3-yl, 1- Benzothiophen-4-yl, l-Benzothiophen-5-yl, l-Benzothiophen-6-yl, l-Benzothiophen-7-yl, lH-Indazol-pteridines; Pyrimidopyrimidine. Examples of heteroaryl are also 5- or 6-membered benzo-fused rings from the group 1H-indol-1-yl, 1H-indol-2-yl, 1H-indol-3-yl, 1H-indol-4-yl, 1H- Indol-5-yl, 1H-indol-6-yl, 1H-indol-7-yl, 1-benzofuran-2-yl, 1-benzofuran-3-yl, 1-benzofuran-4-yl, 1-benzofuran 5-yl, 1-benzofuran-6-yl, 1-benzofuran-7-yl, 1-benzothiophene-2-yl, 1-benzothiophen-3-yl, 1-benzothiophene-4-yl, 1-benzothiophene-5 yl, 1-benzothiophene-6-yl, 1-benzothiophene-7-yl, 1H-indazole
1- yl, lH-Indazol-3-yl, lH-Indazol-4-yl, lH-Indazol-5-yl, lH-Indazol-6-yl, lH-Indazol-7-yl, 2H-Indazol-1-yl, 1H-indazol-3-yl, 1H-indazol-4-yl, 1H-indazol-5-yl, 1H-indazol-6-yl, 1H-indazol-7-yl, 2H-indazole
2- yl, 2H-Indazol-3-yl, 2H-Indazol-4-yl, 2H-Indazol-5-yl, 2H-Indazol-6-yl, 2H-Indazol-7-yl, 2H- Isoindol-2-yl, 2H-Isoindol-l-yl, 2H-Isoindol-3-yl, 2H-Isoindol-4-yl, 2H-Isoindol-5-yl, 2H-Isoindol-6-yl; 2H-Isoindol-7-yl, lH-Benzimidazol-l-yl, lH-Benzimidazol-2-yl, lH-Benzimidazol-4-yl, 1H- Benzimidazol-5-yl, lH-Benzimidazol-6-yl, lH-Benzimidazol-7-yl, l,3-Benzoxazol-2-yl, 1,3-2-yl, 2H-indazol-3-yl, 2H-indazol-4-yl, 2H-indazol-5-yl, 2H-indazol-6-yl, 2H-indazol-7-yl, 2H-isoindole-2 yl, 2H-isoindol-1-yl, 2H-isoindol-3-yl, 2H-isoindol-4-yl, 2H-isoindol-5-yl, 2H-isoindol-6-yl; 2H-isoindol-7-yl, 1H-benzimidazol-1-yl, 1H-benzimidazol-2-yl, 1H-benzimidazol-4-yl, 1H-benzimidazol-5-yl, 1H-benzimidazol-6-yl, 1H- Benzimidazol-7-yl, 1,3-benzoxazol-2-yl, 1,3-
Benzoxazol-4-yl, l,3-Benzoxazol-5-yl, l,3-Benzoxazol-6-yl, l,3-Benzoxazol-7-yl, l,3-Benzthiazol-2-yl, l,3-Benzthiazol-4-yl, l,3-Benzthiazol-5-yl, l,3-Benzthiazol-6-yl, l,3-Benzthiazol-7-yl, 1,2- Benzisoxazol-3-yl, l,2-Benzisoxazol-4-yl, l,2-Benzisoxazol-5-yl, l,2-Benzisoxazol-6-yl, 1,2- Benzisoxazol-7-yl, l,2-Benzisothiazol-3-yl, 1 ,2-Benzisothiazol-4-yl, l,2-Benzisothiazol-5-yl, 1,2- Benzisothiazol-6-yl, l,2-Benzisothiazol-7-yl. Benzoxazol-4-yl, l, 3-benzoxazol-5-yl, l, 3-benzoxazol-6-yl, l, 3-benzoxazol-7-yl, l, 3-benzthiazol-2-yl, l, 3 Benzothiazol-4-yl, 1,3-benzthiazol-5-yl, 1,3-benzthiazol-6-yl, 1,3-benzthiazol-7-yl, 1,2-benzisoxazol-3-yl, 1, 2 Benzisoxazol-4-yl, 1,2-benzisoxazol-5-yl, 1,2-benzisoxazol-6-yl, 1,2-benzisoxazol-7-yl, 1,2-benzisothiazol-3-yl, 1, 2 Benzisothiazol-4-yl, 1,2-benzisothiazol-5-yl, 1,2-benzisothiazol-6-yl, 1,2-benzisothiazol-7-yl.
Die Bezeichnung "Halogen" bedeutet beispielsweise Fluor, Chlor, Brom oder Iod. Wird die The term "halogen" means, for example, fluorine, chlorine, bromine or iodine. Will the
Bezeichnung für einen Rest verwendet, dann bedeutet "Halogen" beispielsweise ein Fluor-, Chlor-, Brom- oder Iodatom. When used to denote a radical, then "halogen" means, for example, a fluorine, chlorine, bromine or iodine atom.
Erfindungsgemäß bedeutet„Alkyl" einen geradkettigen oder verzweigten offenkettigen, gesättigten Kohlenwasserstoffrest, der gegebenenfalls ein- oder mehrfach substituiert ist und im letzteren Falle als „substituiertes Alkyl" bezeichnet wird. Bevorzugte Substituenten sind Halogenatome, Alkoxy-, Haloalkoxy-, Cyano-, Alkylthio, Haloalkylthio-, Amino- oder Nitrogruppen, besonders bevorzugt sind Methoxy, Methyl, Fluoralkyl, Cyano, Nitro, Fluor, Chlor, Brom oder Iod. Die Vorsilbe„Bis" schließt auch die Kombination unterschiedlicher Alkylreste ein, z. B. Methyl(Ethyl) oder Ethyl(Methyl). According to the invention, "alkyl" means a straight-chain or branched, open-chain, saturated hydrocarbon radical which is optionally monosubstituted or polysubstituted and is referred to in the latter case as "substituted alkyl". Preferred substituents are halogen atoms, alkoxy, haloalkoxy, cyano, alkylthio, haloalkylthio, amino or nitro groups, particularly preferred are methoxy, methyl, fluoroalkyl, cyano, nitro, fluorine, chlorine, bromine or iodine. The prefix "bis" also includes the combination of different alkyl radicals, for example, methyl (ethyl) or ethyl (methyl).
„Haloalkyl", ,,-alkenyl" und ,,-alkinyl" bedeuten durch gleiche oder verschiedene Halogenatome, teilweise oder vollständig substituiertes Alkyl, Alkenyl bzw. Alkinyl, z.B. Monohaloalkyl "Haloalkyl", "-alkenyl" and "-alkynyl" mean by the same or different halogen atoms, partially or fully substituted alkyl, alkenyl and alkynyl, for example monohaloalkyl
(= Monohalogenalkyl) wie z. B. CH2CH2C1, CH2CH2Br, CHC1CH3, CH2C1, CH2F; Perhaloalkyl wie z. B. CCI3, CC1F2, CFC12,CF2CC1F2, CF2CC1FCF3; Polyhaloalkyl wie z. B. CH2CHFC1, CF2CC1FH, CF2CBrFH, CH2CF3; Der Begriff Perhaloalkyl umfasst dabei auch den Begriff Perfluoralkyl. „Teilfluoriertes Alkyl" bedeutet einen geradkettigen oder verzweigten, gesättigten Kohlenwasserstoff, der einfach oder mehrfach durch Fluor substituiert ist, wobei sich die entsprechenden Fluoratome als Substituenten an einem oder mehreren verschiedenen Kohlenstoffatomen der geradkettigen oder verzweigten Kohlenwasserstoffkette befinden können, wie z. B. CHFCH3, CH2CH2F, CH2CH2CF3, CHF2, CH2F, CHFCF2CF3 (= Monohaloalkyl) such. CH 2 CH 2 Cl, CH 2 CH 2 Br, CHClCH 3 , CH 2 Cl, CH 2 F; Perhaloalkyl such. B. CCl 3, CC1F 2, CFC1 2 CF 2 CC1F 2, CF 2 CC1FCF 3; Polyhaloalkyl such. CH 2 CHFC1, CF 2 CC1FH, CF 2 CBrFH, CH 2 CF 3; The term perhaloalkyl also encompasses the term perfluoroalkyl. "Partially fluorinated alkyl" means a straight-chain or branched, saturated hydrocarbon which is monosubstituted or polysubstituted by fluorine, it being possible for the corresponding fluorine atoms to be present as substituents on one or more different carbon atoms of the straight-chain or branched hydrocarbon chain, for example CHFCH3, CH2CH2F, CH2CH2CF3, CHF 2, CH 2 F, CHFCF2CF3
„Teilfluoriertes Haloalkyl" bedeutet einen geradkettigen oder verzweigten, gesättigten "Partially fluorinated haloalkyl" means a straight-chain or branched, saturated one
Kohlenwasserstoff, der durch verschiedenene Halogenatomen mit mindestens einem Fluoratom substituiert ist, wobei alle anderen gegebenenfalls vorhandenen Halogenatome ausgewählt sind aus der Gruppe Fluor, Chlor oder Brom, Iod. Die entsprechenden Halogenatome können sich dabei als Substituenten an einem oder mehreren verschiedenen Kohlenstoffatomen der geradkettigen oder verzweigten Kohlenwasserstoffkette befinden. Teilfluoriertes Haloalkyl schließt auch die vollständige Substitution der geradkettigen oder verzweigten Kette durch Halogen unter Beteiligung von mindestens einem Fluoratom ein. Hydrocarbon which is substituted by various halogen atoms having at least one fluorine atom, wherein all other optional halogen atoms are selected from the group fluorine, chlorine or bromine, iodine. The corresponding halogen atoms may be present as substituents on one or more different carbon atoms of the straight-chain or branched hydrocarbon chain. Partially fluorinated haloalkyl also includes the complete substitution of halogen with the participation of at least one fluorine atom of the straight-chain or branched chain.
„Haloalkoxy" ist z.B. OCF3, OCHF2, OCH2F, OCF2CF3, OCH2CF3 und OCH2CH2CI; Entsprechendes gilt für Haloalkenyl und andere durch Halogen substituierten Reste. Der hier beispielhaft genannte Ausdruck "(Ci-C4)-Alkyl" bedeutet eine Kurzschreibweise für geradkettiges oder verzweigtes Alkyl mit einem bis 4 Kohlenstoffatomen entsprechend der "Haloalkoxy" is, for example OCF 3, OCHF 2, OCH 2 F, OCF2CF3, OCH2CF3 and OCH2CH2CI;. The same applies to haloalkenyl and other halogen-substituted radicals of the exemplarily mentioned term "(Ci-C4) -alkyl" is an abbreviated notation for straight-chain or branched alkyl having one to 4 carbon atoms corresponding to
Bereichsangabe für C-Atome, d. h. umfasst die Reste Methyl, Ethyl, 1 -Propyl, 2-Propyl, 1 -Butyl, 2-Butyl, 2-Methylpropyl oder tert-Butyl. Allgemeine Alkylreste mit einem größeren angegebenen Bereich von C-Atomen, z. B. "(Ci-C6)-Alkyl", umfassen entsprechend auch geradkettige oder verzweigte Alkylreste mit einer größeren Zahl von C-Atomen, d. h. gemäß Beispiel auch die Alkylreste mit 5 und 6 C-Atomen. Range indication for C atoms, d. H. includes the radicals methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methylpropyl or tert-butyl. General alkyl radicals having a larger specified range of carbon atoms, eg. As "(Ci-C6) alkyl", accordingly also include straight-chain or branched alkyl radicals having a larger number of C atoms, d. H. according to example, the alkyl radicals with 5 and 6 carbon atoms.
Wenn nicht speziell angegeben, sind bei den Kohlenwasserstoffresten wie Alkyl-, Alkenyl- und Alkinylresten, auch in zusammengesetzten Resten, die niederen Kohlenstoffgerüste, z.B. mit 1 bis 6 C-Atomen bzw. bei ungesättigten Gruppen mit 2 bis 6 C-Atomen, bevorzugt. Alkylreste, auch in den zusammengesetzten Resten wie Alkoxy, Haloalkyl usw., bedeuten z.B. Methyl, Ethyl, n- oder i-Propyl, n-, i-, t- oder 2-Butyl, Pentyle, Hexyle, wie n-Hexyl, i-Hexyl und 1,3-Dimethylbutyl, Heptyle, wie n-Heptyl, 1 -Methylhexyl und 1 ,4-Dimethylpentyl; Alkenyl- und Alkinylreste haben die Bedeutung der den Alkylresten entsprechenden möglichen ungesättigten Reste, wobei mindestens eine Doppelbindung bzw. Dreifachbindung enthalten ist. Bevorzugt sind Reste mit einer Doppelbindung bzw. Unless specifically stated, the hydrocarbon radicals such as alkyl, alkenyl and alkynyl radicals, even in assembled radicals, are the lower carbon skeletons, e.g. with 1 to 6 C atoms or with unsaturated groups having 2 to 6 C atoms, preferred. Alkyl radicals, also in the assembled radicals such as alkoxy, haloalkyl, etc., mean e.g. Methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, i-hexyl and 1,3-dimethylbutyl, heptyls, such as n-heptyl, 1-methylhexyl and 1, 4-dimethylpentyl; Alkenyl and alkynyl radicals have the meaning of the possible unsaturated radicals corresponding to the alkyl radicals, wherein at least one double bond or triple bond is contained. Preference is given to radicals having a double bond or
Dreifachbindung. Der Begriff„Alkenyl" schließt insbesondere auch geradkettige oder verzweigte offenkettige Triple bond. The term "alkenyl" in particular also includes straight-chain or branched open-chain
Kohlenwasserstoffreste mit mehr als einer Doppelbindung ein, wie 1,3-Butadienyl und 1 ,4-Pentadienyl, aber auch Allenyl- oder Kumulenyl-reste mit einer bzw. mehreren kumulierten Doppelbindungen, wie beispielsweise Allenyl (1,2-Propadienyl), 1 ,2-Butadienyl und 1,2,3-Pentatrienyl. Alkenyl bedeutet z.B. Vinyl, welches gegebenenfalls durch weitere Alkylreste substituiert sein kann, z B. (aber nicht beschränkt auf) (C2-Ce)-Alkenyl wie Ethenyl, 1 -Propenyl, 2-Propenyl, 1 -Methylethenyl, 1 -Butenyl, 2- Butenyl, 3-Butenyl, 1 -Methyl- 1 -propenyl, 2-Methyl-l -propenyl, 1 -Methyl-2-propenyl, 2-Methyl-2- propenyl, 1-Pentenyl, 2-Pentenyl, 3-Pentenyl, 4-Pentenyl, 1 -Methyl- 1 -butenyl, 2-Methyl-l -butenyl, 3- Methyl- 1-butenyl, 1 -Methyl-2-butenyl, 2-Methyl-2-butenyl, 3-Methyl-2-butenyl, l-Methyl-3 -butenyl, 2- Methyl-3 -butenyl, 3 -Methyl-3 -butenyl, l,l-Dimethyl-2-propenyl, 1,2-Dimethyl-l -propenyl, 1,2-Hydrocarbon radicals having more than one double bond, such as 1,3-butadienyl and 1,4-pentadienyl, but also allenyl or cumulenyl radicals having one or more cumulated double bonds, such as allenyl (1,2-propadienyl), 1, 2-butadienyl and 1,2,3-pentatrienyl. Alkenyl is, for example, vinyl, which may optionally be substituted by further alkyl radicals, for example (but not limited to) (C 2 -C 6) -alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3 Pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl 2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1, 2
Dimethyl-2-propenyl, 1-Ethyl-l -propenyl, 1 -Ethyl-2-propenyl, 1-Hexenyl, 2-Hexenyl, 3-Hexenyl, 4- Hexenyl, 5-Hexenyl, 1 -Methyl- 1-pentenyl, 2-Methyl-l -pentenyl, 3 -Methyl- 1-pentenyl, 4-Methyl-l- pentenyl, 1 -Methyl-2-pentenyl, 2-Methyl-2-pentenyl, 3-Methyl-2-pentenyl, 4-Methyl-2-pentenyl, 1- Methyl-3 -pentenyl, 2-Methyl-3 -pentenyl, 3 -Methyl-3 -pentenyl, 4-Methyl-3 -pentenyl, l-Methyl-4- pentenyl, 2-Methyl-4-pentenyl, 3-Methyl-4-pentenyl, 4-Methyl-4-pentenyl, 1 , 1 -Dimethyl-2-butenyl,Dimethyl 2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4- Methyl 2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl 4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1, 1-dimethyl-2-butenyl,
1 , 1 -Dimethyl-3 -butenyl, 1,2-Dimethyl-l -butenyl, l,2-Dimethyl-2-butenyl, 1 ,2-Dimethyl-3 -butenyl, 1,3- Dimethyl- 1 -butenyl, l,3-Dimethyl-2-butenyl, l,3-Dimethyl-3-butenyl, 2,2-Dimethyl-3 -butenyl, 2,3- Dimethyl- 1 -butenyl, 2,3-Dimethyl-2-butenyl, 2,3-Dimethyl-3-butenyl, 3,3-Dimethyl-l-butenyl, 3,3- Dimethy 1-2 -butenyl, 1-Ethyl-l -butenyl, 1 -Ethyl-2-butenyl, l-Ethyl-3 -butenyl, 2-Ethyl- 1 -butenyl, 2- Ethyl-2-butenyl, 2-Ethyl-3 -butenyl, l,l,2-Trimethyl-2-propenyl, l-Ethyl-l-methyl-2-propenyl, 1-Ethyl- 2-methyl-l -propenyl und 1 -Ethyl-2-methyl-2-propenyl. 1, 1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1, 2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1, 3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl 1-2 -butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl 3 -butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1, 1, 2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2 -propenyl, 1-ethyl-2-methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl.
Der Begriff„Alkinyl" schließt insbesondere auch geradkettige oder verzweigte offenkettige The term "alkynyl" in particular also includes straight-chain or branched open-chain
Kohlenwasserstoffreste mit mehr als einer Dreifachbindung oder auch mit einer oder mehreren Hydrocarbon radicals with more than one triple bond or with one or more
Dreifachbindungen und einer oder mehreren Doppelbindungen ein, wie beispielsweise 1,3-Butatrienyl bzw. 3-Penten-l -in-l -yl. (C2-C6)-Alkinyl bedeutet z.B. Ethinyl, 1-Propinyl, 2-Propinyl, 1-Butinyl, 2- Butinyl, 3-Butinyl, 1 -Methyl-2-propinyl, 1-Pentinyl, 2-Pentinyl, 3-Pentinyl, 4-Pentinyl, l-Methyl-2- butinyl, 1 -Methyl-3 -butinyl, 2-Methyl-3-butinyl, 3 -Methyl- 1-butinyl, 1 , 1 -Dimethyl-2-propinyl, 1-Ethyl- 2-propinyl, 1-Hexinyl, 2-Hexinyl, 3-Hexinyl, 4-Hexinyl, 5-Hexinyl, 1 -Methyl-2-pentinyl, l-Methyl-3- pentinyl, 1 -Methyl-4-pentinyl, 2-Methyl-3-pentinyl, 2-Methyl-4-pentinyl, 3 -Methyl- 1-pentinyl, 3-Triple bonds and one or more double bonds, such as 1,3-butatrienyl and 3-penten-1-yn-1-yl, respectively. (C 2 -C 6) -alkynyl is, for example, ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3 Pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1, 1-dimethyl-2-propynyl, 1 Ethyl 2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3
Methyl-4-pentinyl, 4-Methyl- 1-pentinyl, 4-Methyl-2-pentinyl, 1 , 1 -Di-methyl-2-butinyl, 1,1 -Dimethyl-3 - butinyl, 1 ,2-Dimethyl-3 -butinyl, 2,2-Dimethyl-3 -butinyl, 3, 3 -Dimethyl- 1-butinyl, 1 -Ethyl-2-butinyl, 1- Ethyl-3 -butinyl, 2-Ethyl-3 -butinyl und l-Ethyl-l-methyl-2-propinyl. Der Begriff„Cycloalkyl" bedeutet ein carbocyclisches, gesättigtes Ringsystem mit vorzugsweise 3-8Methyl 4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-di-methyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl 3 -butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl and ethyl-l-methyl-2-propynyl. The term "cycloalkyl" means a carbocyclic saturated ring system preferably having 3-8
Ring-C- Atomen, z.B. Cyclopropyl, Cyclobutyl, Cyclopentyl oder Cyclohexyl, das gegebenenfalls weiter substituiert ist, bevorzugt durch Wasserstoff, Alkyl, Alkoxy, Cyano, Nitro, Alkylthio, Haloalkylthio, Halogen, Alkenyl, Alkinyl, Haloalkyl, AMino, Alkylamino, Bisalkylamino, Alkocycarbonyl, Ring C atoms, for example cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, which is optionally further substituted, preferably by hydrogen, alkyl, alkoxy, cyano, nitro, alkylthio, haloalkylthio, Halogen, alkenyl, alkynyl, haloalkyl, amino, alkylamino, bisalkylamino, alkocycarbonyl,
Hydroxycarbonyl, Arylalkoxycarbonyl, Aminocarbonyl, Alkylaminocarbonyl, Hydroxycarbonyl, arylalkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl,
Cycloalkylaminocarbonyl. Im Falle von gegebenenfalls substituiertem Cycloalkyl werden cyclische Systeme mit Substituenten umfasst, wobei auch Substituenten mit einer Doppelbindung am Cycloalkylaminocarbonyl, In the case of optionally substituted cycloalkyl cyclic systems are included with substituents, wherein substituents having a double bond on
Cycloalkylrest, z. B. eine Alkylidengruppe wie Methyliden, umfasst sind. Im Falle von gegebenenfalls substituiertem Cycloalkyl werden auch mehrcyclische aliphatische Systeme umfasst, wie beispielsweise Bicyclo[l .1.0]butan-l -yl, Bicyclo[l .1.0]butan-2-yl, Bicyclo[2.1.0]pentan-l -yl, Bicyclo[l .1.1 ]pentan-l - yl, Bicyclo[2.1.0]pentan-2-yl, Bicyclo[2.1.0]pentan-5-yl, Bicyclo[2.1.1 ]hexyl, Bicyclo[2.2.1 ]hept-2-yl, Bicyclo[2.2.2]octan-2-yl, Bicyclo[3.2.1 ]octan-2-yl, Bicyclo[3.2.2]nonan-2-yl, Adamantan-l -yl und Adamantan-2-yl, aber auch Systeme wie z. B. l , l '-Bi(cyclopropyl)-l -yl, l , l '-Bi(cyclopropyl)-2-yl. Der Ausdruck "(C3-C7)-Cycloalkyl" bedeutet eine Kurzschreibweise für Cycloalkyl mit drei bis 7 Cycloalkyl, z. As an alkylidene group such as methylidene, are included. In the case of optionally substituted cycloalkyl, polycyclic aliphatic systems are also included, such as, for example, bicyclo [1,1.0] butan-1-yl, bicyclo [1,1-0] butan-2-yl, bicyclo [2.1.0] pentan-1-yl , Bicyclo [1,11] pentan-1-yl, bicyclo [2.1.0] pentan-2-yl, bicyclo [2.1.0] pentan-5-yl, bicyclo [2.1.1] hexyl, bicyclo [2.2.1 ] hept-2-yl, bicyclo [2.2.2] octan-2-yl, bicyclo [3.2.1] octan-2-yl, bicyclo [3.2.2] nonan-2-yl, adamantane-1-yl and adamantane -2-yl, but also systems such. B. l, l '-Bi (cyclopropyl) -1-yl, l, l' -Bi (cyclopropyl) -2-yl. The term "(C 3 -C 7) -cycloalkyl" means a short notation for cycloalkyl of three to seven
Kohlenstoffatomen entsprechend der Bereichsangabe für C-Atome. Carbon atoms corresponding to the range for C atoms.
Im Falle von substituiertem Cycloalkyl werden auch spirocyclische aliphatische Systeme umfasst, wie beispielsweise Spiro[2.2]pent-l -yl, Spiro[2.3]hex-l -yl, Spiro[2.3]hex-4-yl, 3-Spiro[2.3]hex-5-yl, Spiro[3.3]hept-l -yl, Spiro[3.3]hept-2-yl. In the case of substituted cycloalkyl, spirocyclic aliphatic systems are also included, such as spiro [2.2] pent-1-yl, spiro [2.3] hex-1-yl, spiro [2.3] hex-4-yl, 3-spiro [2.3] hex-5-yl, spiro [3.3] hept-1-yl, spiro [3.3] hept-2-yl.
„Cycloalkenyl" bedeutet ein carbocyclisches, nicht aromatisches, partiell ungesättigtes Ringsystem mit vorzugsweise 4-8 C-Atomen, z.B. 1 -Cyclobutenyl, 2-Cyclobutenyl, 1 -Cyclopentenyl, 2-Cyclopentenyl, 3 -Cyclopentenyl, oder 1 -Cyclohexenyl, 2-Cyclohexenyl, 3-Cyclohexenyl, 1 ,3-Cyclohexadienyl oder 1 ,4-Cyclohexadienyl, wobei auch Substituenten mit einer Doppelbindung am Cycloalkenylrest, z. B. eine Alkylidengruppe wie Methyliden, umfasst sind. Im Falle von gegebenenfalls substituiertem Cycloalkenyl gelten die Erläuterungen für substituiertes Cycloalkyl entsprechend. Der Begriff„Alkyliden", z. B. auch in der Form (Ci-Cio)-Alkyliden, bedeutet den Rest eines geradkettigen oder verzweigten offenkettigen Kohlenwasserstoffrests, der über eine Zweifachbindung gebunden ist. Als Bindungsstelle für Alkyliden kommen naturgemäß nur Positionen am Grundkörper in Frage, an denen zwei H- Atome durch die Doppelbindung ersetzt werden können; Reste sind z. B. =CH2, =CH-CH3, =C(CH3)-CH3, =C(CH3)-C2H5 oder =C(C2H5)-C2H5. Cycloalkyliden bedeutet ein "Cycloalkenyl" means a carbocyclic, non-aromatic, partially unsaturated ring system preferably having 4-8 C atoms, eg 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1-cyclohexenyl, 2- Cyclohexenyl, 3-cyclohexenyl, 1, 3-cyclohexadienyl or 1, 4-cyclohexadienyl, wherein substituents having a double bond on the cycloalkenyl radical, for example an alkylidene group such as methylidene, are also included in the case of optionally substituted cycloalkenyl the explanations for substituted The term "alkylidene", e.g. B. in the form of (Ci-Cio) alkylidene, means the radical of a straight-chain or branched open-chain hydrocarbon radical which is bonded via a double bond. As a binding site for alkylidene naturally only positions on the body in question, in which two H atoms can be replaced by the double bond; Remains are z. B. = CH 2, = CH-CH 3, = C (CH 3) -CH 3, = C (CH 3) -C 2 H 5 or = C (C 2 H 5) C 2 H5. Cycloalkylidene means a
carbocyc lischer Rest, der über eine Zweifachbindung gebunden ist. carbocyclic radical bonded via a double bond.
„Alkoxyalkyl" steht für einen über eine Alkylgruppe gebundenen Alkoxyrest und„Alkoxyalkoxy" bedeutet einen über ein Sauerstoffatom gebundenen Alkoxyalkylrest, z.B. (aber nicht beschränkt auf) Methoxymethoxy, Methoxyethoxy, Ethoxyethoxy, Methoxy-n-propyloxy. "Alkoxyalkyl" means an alkoxy group attached via an alkyl group, and "alkoxyalkoxy" means an alkoxyalkyl group bonded via an oxygen atom, e.g. (but not limited to) methoxymethoxy, methoxyethoxy, ethoxyethoxy, methoxy-n-propyloxy.
„Alkylthioalkyl" steht für einen über eine Alkylgruppe gebundenen Alkylthiorest und "Alkylthioalkyl" means an alkylthio radical bonded via an alkyl group and
„Alkylthioalkylthio" bedeutet einen über ein Sauerstoffatom gebundenen Alkylthioalkylrest. „Arylalkoxyalkyl" steht für einen über eine Alkylgruppe gebundenen Aryloxyrest und „Heteroaryloxyalkyl" bedeutet einen über eine Alkylgruppe gebundenen Heteroaryloxyrest. „Haloalkoxyalkyl" steht für einen gebundenen Haloalkoxyrest und„Haloalkylthioalkyl" bedeutet einen über eine Alkylgruppe gebundenen Haloalkylthiorest. "Alkylthioalkylthio" means an alkylthioalkyl radical bonded via an oxygen atom. "Arylalkoxyalkyl" means an aryloxy group bonded through an alkyl group, and "heteroaryloxyalkyl" means a heteroaryloxy group bonded via an alkyl group. "Haloalkoxyalkyl" means a haloalkoxy radical attached and "haloalkylthioalkyl" means a haloalkylthio radical attached via an alkyl group.
„Arylalkyl" steht für einen über eine Alkylgruppe gebundenen Arylrest,„Heteroarylalkyl" bedeutet einen über eine Alkylgruppe gebundenen Heteroarylrest, und„Heterocyclylalkyl" bedeutet einen über eine Alkylgruppe gebundenen Heterocyclylrest. "Arylalkyl" means an aryl group attached via an alkyl group, "heteroarylalkyl" means a heteroaryl group bonded via an alkyl group, and "heterocyclylalkyl" means a heterocyclyl group bonded through an alkyl group.
„Cycloalkylalkyl" steht für einen über eine Alkylgruppe gebundenen Cycloalkylrest, z. B. (aber nicht beschränkt auf) Cyclopropylmethyl, Cyclobutylmethyl, Cyclopentylmethyl, Cyclohexylmethyl, 1 - Cyclopropyleth-l -yl, 2-Cyclopropyleth-l -yl, 1 -Cyclopropylprop-l -yl, 3-Cyclopropylprop-l -yl. "Cycloalkylalkyl" means a cycloalkyl radical attached via an alkyl group, for example (but not limited to) cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclopropyleth-1-yl, 2-cyclopropyleth-1-yl, 1-cyclopropylpropyl l -yl, 3-cyclopropylprop-1-yl.
Erfindungsgemäß steht "Haloalkylthio" - in Alleinstellung oder als Bestandteil einer chemischen Gruppe - für geradkettiges oder verzweigtes S-Halogenalkyl, vorzugsweise mit 1 bis 8, oder mit 1 bis 6 Kohlenstoffatomen, wie (Ci-Cs)-, (CI-CÖ)- oder (Ci-C4)-Haloalkylthio, z.B. (aber nicht beschränkt auf) Trifluormethylthio, Pentafluorethylthio, Difluormethyl, 2,2-Difluoreth-l -ylthio, 2,2,2-Difluoreth-l - ylthio, 3,3,3-prop-l -ylthio. According to the invention, "haloalkylthio" - alone or as part of a chemical group - represents straight-chain or branched S-haloalkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as (C 1 -C 5) -, (C 1 -C 5) - or (C 1 -C 4) -haloalkylthio, for example (but not limited to) trifluoromethylthio, pentafluoroethylthio, difluoromethyl, 2,2-difluoroeth-1-ylthio, 2,2,2-difluoroeth-1-ylthio, 3,3,3-prop-1-ylthio.
„Halocycloalkyl" und„Halocycloalkenyl" bedeuten durch gleiche oder verschiedene Halogenatome, wie z. B. F, Cl und Br, oder durch Haloalkyl, wie z. B. Trifluormethyl oder Difluormethyl teilweise oder vollständig substituiertes Cycloalkyl oder Cycloalkenyl , z.B. 1 -Fluorcycloprop-l -yl, 2-Fluorcycloprop- 1 -yl, 2,2-Difluorcycloprop-l -yl, 1 -Fluorcyclobut-l -yl, 1 -Trifluormethylcycloprop-l -yl, 2-"Halocycloalkyl" and "Halocycloalkenyl" mean by the same or different halogen atoms, such as. B. F, Cl and Br, or by haloalkyl, such as. Trifluoromethyl or difluoromethyl, partially or fully substituted cycloalkyl or cycloalkenyl, e.g. 1-fluorocycloprop-1-yl, 2-fluorocycloprop-1-yl, 2,2-difluorocycloprop-1-yl, 1-fluorocyclobutyl, 1-trifluoromethylcycloprop-1-yl, 2
Trifluormethylcycloprop- 1 -yl, 1 -Chlor-cycloprop- 1 -yl, 2-Chlorcycloprop- 1 -yl, 2,2-Dichlorcycloprop- 1 - yl, 3,3-Difluorcyclobutyl, Trifluoromethylcycloprop-1-yl, 1-chlorocycloprop-1-yl, 2-chlorocycloprop-1-yl, 2,2-dichlorocycloprop-1-yl, 3,3-difluorocyclobutyl,
Erfindungsgemäß steht "Trialkylsilyl" - in Alleinstellung oder als Bestandteil einer chemischen Gruppe - für geradkettiges oder verzweigtes Si-Alkyl, vorzugsweise mit 1 bis 8, oder mit 1 bis 6 According to the invention "trialkylsilyl" - alone or as part of a chemical group - is straight-chain or branched Si-alkyl, preferably with 1 to 8, or with 1 to 6
Kohlenstoffatomen, wie Tri-[(Ci-Cg)-, (Ci-Ce)- oder (Ci-C4)-alkyl]silyl, z.B. (aber nicht beschränkt auf) Trimethylsilyl, Triethylsilyl, Tri-(n-propyl)silyl, Tri-(iso-propyl)silyl, Tri-(n-butyl)silyl, Tri-(1 - methylprop-l -yl)silyl, Tri-(2-methylprop-l -yl)silyl, Tri(l ,l -Dimethyleth-l -yl)silyl, Tri(2,2- Dimethyleth- 1 -yl)silyl.  Carbon atoms such as tri - [(Ci-Cg) -, (Ci-Ce) - or (Ci-C4) -alkyl] silyl, e.g. (but not limited to) trimethylsilyl, triethylsilyl, tri (n-propyl) silyl, tri (iso-propyl) silyl, tri (n-butyl) silyl, tri (1-methylprop-1-yl) silyl, Tri- (2-methylprop-1-yl) silyl, tri (1,1-dimethyleth-1-yl) silyl, tri (2,2-dimethyl-1-yl) silyl.
Wenn die Verbindungen durch Wasserstoffverschiebung Tautomere bilden können, welche strukturell formal nicht durch die allgemeine Formel (I) erfasst würden, so sind diese Tautomere gleichwohl von der Definition der erfindungsgemäßen Verbindungen der allgemeinen Formel (I) umfasst, sofern nicht ein bestimmtes Tautomer Gegenstand der Betrachtung ist. So können beispielsweise viele If the compounds can form tautomers by hydrogen shift which would not be structurally formally recognized by the general formula (I), these tautomers are nonetheless of the definition of the compounds of general formula (I) according to the invention, unless a particular tautomer is the subject of consideration. For example, many
Carbonylverbindungen sowohl in der Ketoform wie auch in der Enolform vorliegen, wobei beide Formen durch die Definition der Verbindung der allgemeinen Formel (I) umfasst werden. Carbonyl compounds in both the keto form as well as in the enol form, both forms by the definition of the compound of general formula (I) are included.
Die Verbindungen der allgemeinen Formel (I) können je nach Art und Verknüpfung der Substituenten als Stereoisomere vorliegen. Die durch ihre spezifische Raumform definierten möglichen Stereoisomere, wie Enantiomere, Diastereomere, Z- und E-Isomere sind alle von der allgemeinen Formel (I) umfasst. Sind beispielsweise eine oder mehrere Alkenylgruppen vorhanden, so können Diastereomere (Z- und E- Isomere) auftreten. Sind beispielsweise ein oder mehrere asymmetrische Kohlenstoffatome vorhanden, so können Enantiomere und Diastereomere auftreten. Stereoisomere lassen sich aus den bei der Depending on the nature and linkage of the substituents, the compounds of the general formula (I) can exist as stereoisomers. The possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers, Z and E isomers, are all encompassed by the general formula (I). If, for example, one or more alkenyl groups are present, diastereomers (Z and E isomers) can occur. For example, if one or more asymmetric carbon atoms are present, enantiomers and diastereomers may occur. Stereoisomers can be distinguished from those in the
Herstellung anfallenden Gemischen nach üblichen Trennmethoden erhalten. Die chromatographische Trennung kann sowohl im analytischen Maßstab zur Feststellung des Enantiomerenüberschusses bzw. des Diastereomerenüberschusses, wie auch im präparativen Maßstab zur Herstellung von Prüfmustern für die biologische Ausprüfung erfolgen. Ebenso können Stereoisomere durch Einsatz stereoselektiver Reaktionen unter Verwendung optisch aktiver Ausgangs- und/oder Hilfsstoffe selektiv hergestellt werden. Die Erfindung betrifft somit auch alle Stereoisomeren, die von der allgemeinen Formel (I) umfasst, jedoch nicht mit ihrer spezifischen Stereoform angegeben sind, sowie deren Gemische. Sofern die Verbindungen als Feststoffe erhalten werden, kann die Reinigung auch durch Preparation of resulting mixtures obtained by conventional separation methods. The chromatographic separation can be carried out both on an analytical scale to determine the enantiomeric excess or the diastereomeric excess, as well as on a preparative scale for the preparation of test samples for the biological assay. Similarly, stereoisomers can be selectively prepared by using stereoselective reactions using optically active sources and / or adjuvants. The invention thus also relates to all stereoisomers which comprises the general formula (I) but are not specified with their specific stereoform, and mixtures thereof. If the compounds are obtained as solids, the purification can also by
Umkristallisieren oder Digerieren erfolgen. Sofern einzelne Verbindungen (I) nicht auf den nachstehend beschriebenen Wegen zufriedenstellend zugänglich sind, können sie durch Derivatisierung anderer Verbindungen (I) hergestellt werden. Als Isolierungs-, Reinigungs- und Stereoisomerenauftrennungsverfahren von Verbindungen der allgemeinen Formel (I) kommen Methoden in Frage, die dem Fachmann aus analogen Fällen allgemein bekannt sind, z.B. durch physikalische Verfahren wie Kristallisation, Chromatographieverfahren, vor allem Säulenchromatographie und HPLC (Hochdruckflüssigchromatographie), Destillation, gegebenenfalls unter reduziertem Druck, Extraktion und andere Verfahren, können gegebenfalls verbleibende Gemische in der Regel durch chromatographische Trennung, z.B. an chiralen Festphasen, getrennt werden. Für präparative Mengen oder im industriellen Maßstab kommen Verfahren in Frage wie Kristallisation, z.B. diastereomerer Salze, die aus den Diastereomerengemischen mit optisch aktiven Säuren und gegebenenfalls bei vorhandenen sauren Gruppen mit optisch aktiven Basen erhalten werden können.  Recrystallize or digest. Unless individual compounds (I) are satisfactorily accessible by the routes described below, they can be prepared by derivatization of other compounds (I). Suitable isolation, purification and stereoisomer separation methods of compounds of general formula (I) are those which are well known to those skilled in the art from analogous cases, e.g. by physical methods such as crystallization, chromatographic methods, especially column chromatography and HPLC (high performance liquid chromatography), distillation, optionally under reduced pressure, extraction and other methods, residual mixtures may optionally be removed by chromatographic separation, e.g. at chiral solid phases, to be separated. For preparative amounts or on an industrial scale, such processes as crystallization, e.g. diastereomeric salts which can be obtained from the diastereomeric mixtures with optically active acids and optionally in the presence of acidic groups with optically active bases.
Synthese von substituierten Pyrrolidinone der allgemeinen Formel (I). Die erfindungsgemäßen substituierten Pyrrolidinone der allgemeinen Formel (I) können ausgehend von bekannten Verfahren hergestellt werden. Die eingesetzten und untersuchten Syntheserouten gehen dabei von kommerziell erhältlichen oder leicht herstellbaren Aminen, von entsprechend substituierten Aldehyden und von kommerziell erhältlichen Chemikalien wie Malonsäurederivaten und Nitromethan aus. Die Gruppierungen Q, Y, W1, W2, R1, R2, R3, R4, R5, R6, R7 und R8 der allgemeinen Formel (I) haben in den nachfolgenden Schemata die zuvor definierten Bedeutungen, sofern nicht beispielhafte, aber nicht einschränkende, Definitionen erfolgen. Die Synthese der erfindungsgemäßen Verbindungen der allgemeinen Formel (Ia) erfolgt über eineSynthesis of substituted pyrrolidinones of the general formula (I). The substituted pyrrolidinones of the general formula (I) according to the invention can be prepared starting from known processes. The synthetic routes used and investigated are based on commercially available or easily prepared amines, on appropriately substituted aldehydes and on commercially available chemicals such as malonic acid derivatives and nitromethane. The groupings Q, Y, W 1 , W 2 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 of the general formula (I) have the meanings defined above in the following schemes unless definitions are given by way of example but not by way of limitation. The synthesis of the compounds of general formula (Ia) according to the invention is carried out via a
Amidkupplung von einer Säure der allgemeinen Formel (II) mit einem Amin der allgemeinen Formel (III) in Gegenwart eines Amidkupplungsreagenzes wie zum Beispiel T3P, Dicyclohexylcarbodiimid, N- (3-Dimethylaminopropyl)-N'-ethylcarbodiimid, N,N'-Cabonyldiimidazol, 2-Chlor-l,3-dimethyl- imidazolium chlorid oder 2-Chlor-l-methylpyridinium iodid (siehe Chemistry of Peptide Synthsis, Ed. Ν. Leo Benoiton, Taylor & Francis, 2006, ISBN- 10: 1-57444-454-9). Polymergebundene Reagenzien wie zum Beispiel polymergebundenes Dicyclohexylcarbodiimid sind auch für diese Kupplungs-reaktion geeignet. Die Reaktion findet bevorzugt in dem Temperaturbereich zwischen 0 °C und 80 °C, in einem adäquaten Lösungsmittel wie zum Beispiel Dichlormethan, Acetonitril, NN-Dimethyl-formamid oder Ethylacetat und in Gegenwart eine Base wie zum Beispiel Triethylamin, N,N-Diisopropylethylamin oder l,8-Diazabicyclo[5.4.0]undec-7-cen statt (siehe Schema 1). Für die T3P Peptidkupplungsbedingungen siehe Organic Process Research & Development 2009, 13, 900-906. Die Amidgruppe und der Rest Q nehmen überwiegend die trans-Konfiguration ein. Das cis-lsomer läßt sich in einigen Fällen in geringen Mengen per NMR detektieren. Amide coupling '-ethylcarbodiimid, N, N' from an acid of general formula (II) with an amine of general formula (III) in the presence of a Amidkupplungsreagenzes such as T3P, dicyclohexylcarbodiimide, N- (3-dimethylaminopropyl) -N -Cabonyldiimidazol, 2-chloro-1,3-dimethylimidazolium chloride or 2-chloro-1-methylpyridinium iodide (see Chemistry of Peptide Synthsis, Ed., Leo Leo Benoiton, Taylor & Francis, 2006, ISBN 10: 1-57444-454 -9). Polymer-bound reagents such as polymer-bound dicyclohexylcarbodiimide are also suitable for this coupling reaction. The reaction preferably takes place in the temperature range between 0 ° C and 80 ° C, in an adequate solvent such as dichloromethane, acetonitrile, N, N-dimethylformamide or ethyl acetate and in the presence of a base such as triethylamine, N, N-diisopropylethylamine or l, 8-diazabicyclo [5.4.0] undec-7-cene (see Scheme 1). For the T3P peptide coupling conditions, see Organic Process Research & Development 2009, 13, 900-906. The amide group and the remainder Q predominantly occupy the trans configuration. The cis isomer can be detected in small amounts by NMR in some cases.
Figure imgf000034_0001
Figure imgf000034_0001
(Ii) (Iii) (la) (Ii) (iii) (la)
Figure imgf000034_0002
Figure imgf000034_0002
Schema 1 Scheme 1
Die Synthese der Säure der allgemeinen Formel (II) lässt sich durch Verseifung der Verbindung der allgemeinen Formel (IV) nach oder analog dem Fachmann bekannten Methoden herstellen. The synthesis of the acid of the general formula (II) can be prepared by saponification of the compound of the general formula (IV) according to or analogously to methods known to those skilled in the art.
Die Verseifung lässt sich in Gegenwart einer Base oder einer Lewis-Säure durchführen. Die Base kann ein Hydroxid-Salz von einem Alkali-Metall (wie zum Beispiel Lithium, Natrium oder Kalium) sein, und die Verseifüngsreaktion findet bevorzugt in dem Temperaturbereich zwischen Raumtemperatur und °C statt. Die Lewis-Säure kann Bortribromid sein, und die Reaktion in einem Temperaturbereich zwischen -20 °C und 100 °C vorzugsweise -5 °C und 50 °C durchgeführt werden. The saponification can be carried out in the presence of a base or a Lewis acid. The base may be a hydroxide salt of an alkali metal (such as lithium, sodium or potassium), and the saponification reaction preferably takes place in the temperature range between room temperature and ° C. The Lewis acid may be boron tribromide, and the reaction may be carried out in a temperature range between -20 ° C and 100 ° C, preferably -5 ° C and 50 ° C.
Figure imgf000035_0001
Figure imgf000035_0001
Mit R' = (Ci-C4)-Alkyl. With R '= (C 1 -C 4 ) -alkyl.
Mit Y = -CH2-. With Y = -CH 2 -.
Schema 2 Die Synthese der Verbindung der allgemeinen Formel (IV) läßt sich durch Reduktion der Verbindung der allgemeinen Formel (V) und anschließender in situ Cyclisierung des enstehenden Amin- Intermediates nach oder analog dem Fachmann bekannten Methoden herstellen (siehe Schema 3). In der Literatur ist die Reduktion von aliphatischen Nitro-Gruppen durch katalytische Hydrogenolyse in Gegenwart von Palladium auf Kohle oder RaneyNickel, Eisen oder Zink im sauren Medium (siehe zum Beispiel Berichte der Deutschen Chemischen Gesellschaft 1904, 37, 3520-3525), und Lithiumalanat beschrieben. Die Reduktion läßt sich auch mit Samarium(II)iodid in Gegenwart einer Protonen-Quelle wie zum Beispiel Methanol (siehe zum Beispiel Tetrahedron Letters 1991, 32 (14), 1699-1702) durchführen. Alternativ läßt sich die Reduktion der aliphatischen Nitro-Gruppe mit Natriumborhydrid in Gegenwart von Nickel(II)acetat oder Nickel(II)chlorid (siehe zum Beispiel Tetrahedron Letters 1985, 26 (52), 6413-6416) durchführen. The synthesis of the compound of the general formula (IV) can be prepared by reduction of the compound of the general formula (V) and subsequent in situ cyclization of the resulting amine intermediate according to or analogously to methods known in the art (see Scheme 3). The literature describes the reduction of aliphatic nitro groups by catalytic hydrogenolysis in the presence of palladium on carbon or Raney nickel, iron or zinc in an acidic medium (see, for example, reports of the Deutsche Chemischen Gesellschaft 1904, 37, 3520-3525), and lithium alanate , The reduction can also be carried out with samarium (II) iodide in the presence of a proton source such as methanol (see, for example, Tetrahedron Letters 1991, 32 (14), 1699-1702). Alternatively, the reduction of the aliphatic nitro group with sodium borohydride in the presence of nickel (II) acetate or nickel (II) chloride (see, for example, Tetrahedron Letters 1985, 26 (52), 6413-6416) perform.
Figure imgf000035_0002
Figure imgf000035_0002
Mit R' = (Ci-C4)-Alkyl.With R '= (C 1 -C 4 ) -alkyl.
Figure imgf000035_0003
Schema 3
Figure imgf000035_0003
Scheme 3
In Schema 4 wird die Synthese der Verbindung der allgemeinen Formel (V) durch Reaktion eines Diesters der allgemeinen Formel (VI) mit einem Nitroalkan der allgemeinen Formel (VII) in Gegenwart einer Base beschrieben. Die Base kann ein Alkanolat-Salz von einem Alkali-Metall (wie zum Beispiel Natriummethylat oder Natriumethylat) sein, in einem adäquaten Lösungsmittel wie zum Beispiel Methanol oder Ethanol. Alternativ kann man die Reaktion mit Basen wie Lithiumhexa-methyldisilazan, Natriumhexamethyldisilazan oder Lithiumdiisopropylamid, in einem adäquaten Lösungsmittel wie zum Beispiel Tetrah drofuran durchführen. In Scheme 4, the synthesis of the compound of general formula (V) by reaction of a diester of general formula (VI) with a nitroalkane of general formula (VII) in the presence a base described. The base may be an alkoxide salt of an alkali metal (such as sodium methylate or sodium ethylate) in an adequate solvent such as methanol or ethanol. Alternatively, the reaction with bases such as lithium hexa-methyldisilazane, sodium hexamethyldisilazane or lithium diisopropylamide, in an adequate solvent such as Tetrah drofuran perform.
Figure imgf000036_0001
Figure imgf000036_0001
(vi) (vii) (V)  (vi) (vii) (V)
Mit R' = : (Ci-C4)-Alkyl. With R '= : (C 1 -C 4 ) -alkyl.
Mit Y =■ -CH2-. Schema 4 With Y = ■ -CH 2 -. Scheme 4
Die Verbindungen der allgemeinen Formel (VI) lassen sich durch Knoevenagel Kondensation eines Aldehydes der allgemeinen Formel (VIII) und Malonestern der allgemeinen Formel (IX) herstellen (siehe Schema 5; G. Jones, Organic Reactions Volume 15, John Wiley and Sons, 1967). The compounds of general formula (VI) can be prepared by Knoevenagel condensation of an aldehyde of general formula (VIII) and malonic esters of general formula (IX) (see Scheme 5, G. Jones, Organic Reactions Volume 15, John Wiley and Sons, 1967 ).
Figure imgf000036_0002
Figure imgf000036_0002
(VIII) (IX) (VI)  (VIII) (IX) (VI)
Mit R' = (Ci-C4)-Alkyl. Schema 5. With R '= (C 1 -C 4 ) -alkyl. Scheme 5.
In Schema 6 wird die Synthese der Verbindung der allgemeinen Formel (V) durch Reaktion eines Malonesters der allgemeinen Formel (IX) mit einem Nitroolefin der allgemeinen Formel (X) in In Scheme 6, the synthesis of the compound of general formula (V) by reaction of a malonic ester of general formula (IX) with a nitroolefin of general formula (X) in
Gegenwart einer Base beschrieben. Die Base kann ein Alkanolat-Salz bzw. Hydroxid von einem Alkali- Metall (wie zum Beispiel Natriummethylat oder Natriumethylat) sein, in einem adäquaten Lösungsmittel wie zum Beispiel Methanol oder Ethanol, oder Basen wie Lithiumhexamethyldisilazan, Presence of a base described. The base may be an alkanolate salt or hydroxide of an alkali metal (such as sodium methylate or sodium ethylate), in an adequate solvent such as methanol or ethanol, or bases such as lithium hexamethyldisilazane,
Natriumhexamethyldisilazan oder Lithiumdiisopropylamid, in einem adäquaten Lösungsmittel wie zum Beispiel Tetrahydrofuran durchführen. Sodium hexamethyldisilazane or lithium diisopropylamide, in an adequate solvent such as tetrahydrofuran perform.
Figure imgf000037_0001
Figure imgf000037_0001
Schema 6. Scheme 6.
Die Verbindungen der allgemeinen Formel (X) lassen sich durch Kondensation eines Aldehydes der allgemeinen Formel (VIII) und Verbindungen der allgemeinen Formel (XI) in Gegenwart einer Base wie zum Beispiel Natriumhydrid, in einem adäquaten Lösungsmittel wie zum Beispiel Tetrahydrofuran herstellen (siehe Schema 7). The compounds of general formula (X) can be prepared by condensation of an aldehyde of general formula (VIII) and compounds of general formula (XI) in the presence of a base such as sodium hydride in an adequate solvent such as tetrahydrofuran (see Scheme 7) ).
Figure imgf000037_0002
Figure imgf000037_0002
(VIII) (XI) (X) (VIII) (XI) (X)
Schema 7.  Scheme 7.
Alternativ lassen sich die Verbindungen der allgemeinen Formel (Ia) durch Reduktion der Verbindung der allgemeinen Formel (XII) und anschließender in situ Cyclisierung des enstehenden Amin- Intermediates nach oder analog dem Fachmann bekannten Methoden herstellen (siehe Schema 8). In der Literatur ist die Reduktion von aliphatischen Nitro-Gruppen durch katalytische Hydrogenolyse in Gegenwart von Palladium auf Kohle oder RaneyNickel beschrieben. Alternativ läßt sich die Reduktion der aliphatischen Nitro-Gruppe mit Natriumborhydrid in Gegenwart von Nickel(II)acetat oder Alternatively, the compounds of the general formula (Ia) can be prepared by reduction of the compound of the general formula (XII) and subsequent in situ cyclization of the resulting amine intermediate according to methods known to those skilled in the art (see Scheme 8). The literature describes the reduction of aliphatic nitro groups by catalytic hydrogenolysis in the presence of palladium on carbon or RaneyNickel. Alternatively, the reduction of the aliphatic nitro group with sodium borohydride in the presence of nickel (II) acetate or
Nickel(II)chlorid durchführen. Nickel (II) chloride.
Figure imgf000037_0003
Mit R' = (Ci-C4)-Alkyl.
Figure imgf000037_0003
With R '= (C 1 -C 4 ) -alkyl.
Mit Y = -CH2-. With Y = -CH 2 -.
Schema 8. Scheme 8.
In Schema 9 wird die Synthese der Verbindung der allgemeinen Formel (XII) durch Reaktion eines Malonesters der allgemeinen Formel (XIII) mit einem Nitroolefin der allgemeinen Formel (X) in Gegenwart einer Base beschrieben. Die Base kann ein Alkanolat-Salz bzw. Hydroxid von einem Alkali- Metall (wie zum Beispiel Natriummethylat oder Natriumethylat) sein, in einem adäquaten Lösungsmittel wie zum Beispiel Methanol oder Ethanol. Alternativ kann man die Reaktion mit Basen wie Scheme 9 describes the synthesis of the compound of general formula (XII) by reaction of a malonic ester of general formula (XIII) with a nitro olefin of general formula (X) in the presence of a base. The base may be an alkanolate salt or hydroxide of an alkali metal (such as sodium methylate or sodium ethylate) in an adequate solvent such as methanol or ethanol. Alternatively, one can use the reaction with bases like
Lithiumhexamethyldisilazan, Natriumhexamethyldisilazan oder Lithiumdiisopropylamid, in einem adäquaten Lösungsmittel wie zum Beispiel Tetrahydrofuran durchfuhren.  Lithiumhexamethyldisilazan, sodium hexamethyldisilazane or lithium diisopropylamide, in an adequate solvent such as tetrahydrofuran durchfuhr.
Figure imgf000038_0001
Figure imgf000038_0001
Mit R' = (Ci-C4)-Alkyl. With R '= (C 1 -C 4 ) -alkyl.
Mit Y = -CH2-. With Y = -CH 2 -.
Schema 9. Scheme 9.
Die Synthese der Verbindung der allgemeinen Formel (XIII) erfolgt durch Reaktion eines The synthesis of the compound of general formula (XIII) is carried out by reaction of a
Monomalonestersäurechlorides der allgemeinen Formel (XIV) mit einem Amin der allgemeinen Formel (XV) in Gegenwart einer Base (siehe Schema 10). Die Base kann Triethylamin oder Monomalonic acid chlorides of the general formula (XIV) with an amine of the general formula (XV) in the presence of a base (see Scheme 10). The base can be triethylamine or
Diisopropylethylamin sein und die Reaktion kann man in einem adäquaten Lösungsmittel wie zum Beispiel Dichlormethan oder Tetrahydrofuran durchführen. Diisopropylethylamine and the reaction can be carried out in an adequate solvent such as dichloromethane or tetrahydrofuran.
(
Figure imgf000038_0002
(
Figure imgf000038_0002
Mit R' = (Ci-C4)-Alkyl. Schema 10. With R '= (C 1 -C 4 ) -alkyl. Scheme 10.
Alternativ lassen sich die Verbindungen der der allgemeinen Formel (I) nach oder analog dem Alternatively, the compounds of the general formula (I) according to or analogous to
Fachmann bekannten Methoden herstellen (siehe WO2015084796, WO2016164201, WO2016196019, WO2016196593, WO2016094117, WO2016164201, WO2016196593, WO2016003997, To those skilled in the art (see WO2015084796, WO2016164201, WO2016196019, WO2016196593, WO2016094117, WO2016164201, WO2016196593, WO2016003997,
WO2016176082, WO2016182780 und IP.com Journal (2015), 15(6B), 1-293)). WO2016176082, WO2016182780 and IP.com Journal (2015), 15 (6B), 1-293)).
Ausgewählte detaillierte Synthesebeispiele für die erfindungsgemäßen Verbindungen der allgemeinen Formel (I) sind im Folgenden aufgeführt. Die angegebenen Beispielnummern entsprechen den in den nachstehenden Tabellen L I bis 1.49 genannten Nummerierungen. Die 'H-NMR-, 13C-NMR- und 19F- NMR-spektroskopischen Daten, die für die in den nachfolgenden Abschnitten beschriebenen chemischen Beispiele angegeben sind, (400 MHz bei 'H-NMR und 150 MHz bei 13C-NMR und 375 MHz bei "F-NMR, Lösungsmittel CDCL, CD3OD oder de-DMSO, interner Standard: Tetramethylsilan δ = 0.00 ppm), wurden mit einem Gerät der Firma Broker erhalten, und die bezeichneten Signale haben die nachfolgend aufgeführten Bedeutungen: br = breit(es); s = Singulett, d = Dublett, t = Triplett, dd = Doppeldublett, ddd = Dublett eines Doppeldubletts, m = Multiplett, q = Quartett, quint = Quintett, sext = Sextett, sept = Septett, dq = Doppelquartett, dt = Doppeltriplett. Bei Diastereomerengemischen werden entweder die jeweils signifikanten Signale beider Diastereomere oder das charakteristische Signal des Hauptdiastereomers angegeben. Die verwendeten Abkürzungen für chemische Gruppen haben beispielsweise die nachfolgenden Bedeutungen: Me = CH3, Et = CH2CH3, t-Hex = C(CH3)2CH(CH3)2, t- Bu = C(CH3)3, n-Bu = unverzweigtes Butyl, n-Pr = unverzweigtes Propyl, i-Pr = verzweigtes Propyl, c- Pr = Cyclopropyl, c-Hex = Cyclohexyl. Selected detailed synthesis examples of the compounds of the general formula (I) according to the invention are listed below. The given example numbers correspond to the numbers listed in tables LI to 1.49 below. The 'H-NMR, 13 C-NMR and 19 F-NMR spectroscopic data given for the chemical examples described in the following sections (400 MHz for' H-NMR and 150 MHz for 13 C-NMR and 375 MHz in "F-NMR, solvent CDCL, CD" 3 " OD or de-DMSO, internal standard: tetramethylsilane δ = 0.00 ppm) were obtained with a Broker instrument and the designated signals have the meanings given below: br = broad (it); s = singlet, d = doublet, t = triplet, dd = double doublet, ddd = doublet of double doublet, m = multiplet, q = quartet, quint = quintet, sext = sextet, sept = septet, dq = Double quartet, dt = double triplet For diastereomeric mixtures, either the respective significant signals of both diastereomers or the characteristic signal of the main diastereomer are given The abbreviations used for chemical groups have the following meanings, for example: Me = CH 3 , Et = CH 2 CH 3 , t- Hex = C (CH 3 ) 2CH (CH 3 ) 2, t -Bu = C (CH 3 ) 3 , n-Bu = unbranched butyl, n-Pr = unbranched propyl, i-Pr = branched propyl, c-Pr = cyclopropyl, c-hex = Cyclohexyl.
Synthesebeispiele: Synthesis Examples:
Synthesebeispiel No. 1.2-1 : Synthesis Example No. 1.2-1:
a) Diethyl-(cyclopropylmethylen)malonat a) diethyl (cyclopropylmethylene) malonate
Figure imgf000039_0001
Figure imgf000039_0001
Cyclopropylcarbaldehyd (5,0 g, 71,34 mmol, 1,0 eq.), Malonsäurediethylester (11,43 g, 71,34 mmol, 1,0 eq.), Piperidin (121 mg, 1,43 mmol, 0,02 eq.) und Essigsäure (86 mg, 1,43 mmol, 0,02 eq.) wurden in Ethanol (50 mL) gelöst und 24 h zum Sieden erhitzt. Nach dem Abkühlen entfernte man das Cyclopropylcarbaldehyde (5.0 g, 71.34 mmol, 1.0 eq.), Diethyl malonate (11.43 g, 71.34 mmol, 1.0 eq.), Piperidine (121 mg, 1.43 mmol, 0, 02 eq.) And acetic acid (86 mg, 1.43 mmol, 0.02 eq.) Were dissolved in ethanol (50 mL) and heated to boiling for 24 h. After cooling, this was removed
Lösungsmittel im Vakuum und reinigte den Rückstand per Chromatographie (Gradient Ethylacetat/n- Heptan), wobei man Diethyl-(cyclopropylmethylen)malonat in Form eines Öls isolierte (13,39 g, 86 % der Theorie). 'H-NMR (400 MHz, CDC13 δ, ppm) 6,36 (d, 1H), 4,32 (q, 2H), 4,23 (q, 2H), 1,96 (m, 1,34 (t, 3H), 1,28 (t, 3H), 1,10-1,06 (m, 2H), 0,77-0,74 (m, 2H). Solvent in vacuo and the residue purified by chromatography (gradient ethyl acetate / n-heptane) to isolate diethyl (cyclopropylmethylene) malonate as an oil (13.39 g, 86%). the theory). 'H-NMR (400 MHz, CDC1 3 δ, ppm) 6.36 (d, 1H), 4.32 (q, 2H), 4.23 (q, 2H), 1.96 (m, 1.34 (t, 3H), 1.28 (t, 3H), 1.10-1.06 (m, 2H), 0.77-0.74 (m, 2H).
b) Diethyl-(1 -cyclopropyl-2-nitroethyl)malonat b) Diethyl (1-cyclopropyl-2-nitroethyl) malonate
Figure imgf000040_0001
Figure imgf000040_0001
Diethyl-(cyclopropylmethylen)malonat (5,0 g, 23,58 mmol, 1,0 eq.), Nitromethan (14,38 g, 235,58 mmol, 10 eq.) und Natriumethylat (21% Lösung in Ethanol, 0,88 mL, 0,1 eq.) wurden in Ethanol (50 mL) gelöst. Die Lösung rührte man 5 h bei Raumtemperatur und entfernte das Lösungsmittel im Diethyl (cyclopropylmethylene) malonate (5.0 g, 23.58 mmol, 1.0 eq.), Nitromethane (14.38 g, 235.58 mmol, 10 eq.) And sodium ethylate (21% solution in ethanol, 0 , 88 mL, 0.1 eq.) Were dissolved in ethanol (50 mL). The solution was stirred for 5 h at room temperature and the solvent was removed in
Vakuum, wobei man Diethyl-(l-cyclopropyl-2-nitroethyl)malonat in Form eines Öls isolierte (6,17 g, 93 % der Theorie). 'H-NMR (400 MHz, CDCI3 δ, ppm) 4,74-4,72 (m, 2H), 4.26-4,18 (m, 4H), 3,71 (d, 1H), 2,11 (m, 1H), 1,31-1,26 (m, 6H), 0,93 (m, 1H), 0,60-0,55 (m, 2H), 0,27-0,25 (m, 2H). Vacuum, isolating diethyl (1-cyclopropyl-2-nitroethyl) malonate as an oil (6.17 g, 93% of theory). 'H NMR (400 MHz, CDCl3 δ, ppm) 4.74-4.72 (m, 2H), 4.26-4.18 (m, 4H), 3.71 (d, 1H), 2.11 ( m, 1H), 1.31-1.26 (m, 6H), 0.93 (m, 1H), 0.60-0.55 (m, 2H), 0.27-0.25 (m, 2H).
c) Ethyl-4-cyclopropyl-2-oxopyrrolidin-3 -carboxylat c) Ethyl 4-cyclopropyl-2-oxopyrrolidine-3-carboxylate
Figure imgf000040_0002
Figure imgf000040_0002
Diethyl-(l-cyclopropyl-2-nitroethyl)malonat (1,73 g, 6,34 mmol, 1 eq.) und Nickel(II)acetat-tetrahydrat (7,89 g, 31,71 mmol, 5 eq.) wurde in Ethanol (70 mL) unter Stickstoffatmosphäre suspediert und mit einem Eisbad auf 0 bis 5 °C gekühlt. Die Suspension versetzte man innerhalb von 30 min portionsweise mit Natriumborhydrid (1,20 g, 31,71 mmol, 5 eq.), wobei eine rasche Schwarzfärbung und Diethyl (1-cyclopropyl-2-nitroethyl) malonate (1.73 g, 6.34 mmol, 1 eq.) And nickel (II) acetate tetrahydrate (7.89 g, 31.71 mmol, 5 eq.). was suspended in ethanol (70 mL) under a nitrogen atmosphere and cooled to 0-5 ° C with an ice bath. The suspension was added portionwise with sodium borohydride (1.20 g, 31.71 mmol, 5 eq.) Over 30 min, giving rapid blackening and
Gasentwicklung stattfand. Das resultierende dickflüssige Reaktionsgemisch wurde bei Raumtemperatur 5 h nachgerührt und danach mit gesättigter Ammoniumchlorid-Lösung (150 mL) und Ethylacetat (150 mL) versetzt (starke Gasentwicklung). Anschließend rührte man 2 h bei Raumtemperatur nach, wobei sich das Reaktionsgemisch dunkelgrün verfärbte. Die Suspension wurde über Bentonit abgesaugt und die Phasen getrennt. Die wässrige Phase extrahierte man zweimal mit Ethylacetat (50 mL). Die vereinigten organischen Phasen wusch man mit gesättigter Ammoniumchlorid-Lösung (50 mL) und danach mit gesättigter Natriumchlorid-Lösung (50 mL), trocknete diese über Magnesiumsulfat. Danach entfernte das Lösungsmittel im Vakuumund isolierte Ethyl-4-cyclopropyl-2-oxopyrrolidin-3-carboxylat in Form eines farblosen Harzes (1,30 g, 98% der Theorie). 'H-NMR (400 MHz, CDCI3 δ, ppm) 5,90 (bs, 1H), 4,24 (q, 2H), 3,57 (t, 1H), 3,22 (d, 1H), 3,18 (dd, 1H), 2,23 (m, 1H), 1,28 (t, 3H), 0,85 8m, 1H), 0,54-0,50 (m, 2H), 0,22-0,20 (m, 2H). c) 4-Cyclopropyl-2-oxopyrrolidin-3-carbonsäure Gas evolution took place. The resulting viscous reaction mixture was stirred at room temperature for 5 h and then treated with saturated ammonium chloride solution (150 mL) and ethyl acetate (150 mL) (strong evolution of gas). The mixture was then stirred for 2 h at room temperature, whereby the reaction mixture turned dark green. The suspension was filtered off with suction through bentonite and the phases were separated. The aqueous phase was extracted twice with ethyl acetate (50 mL). The combined organic phases were washed with saturated ammonium chloride solution (50 ml) and then with saturated sodium chloride solution (50 ml), which was dried over magnesium sulfate. Thereafter, the solvent was removed in vacuo and isolated ethyl 4-cyclopropyl-2-oxopyrrolidine-3-carboxylate as a colorless resin (1.30 g, 98% of theory). 'H NMR (400 MHz, CDCl3 δ, ppm) 5.90 (bs, 1H), 4.24 (q, 2H), 3.57 (t, 1H), 3.22 (d, 1H), 3 , 18 (dd, 1H), 2.23 (m, 1H), 1.28 (t, 3H), 0.85 8m, 1H), 0.54-0.50 (m, 2H), 0.22 -0.20 (m, 2H). c) 4-Cyclopropyl-2-oxopyrrolidine-3-carboxylic acid
Figure imgf000041_0001
Figure imgf000041_0001
Ethyl-4-cyclopropyl-2-oxopyrrolidin-3-carboxylat (1, 20 g, 6,08 mmol, 1 eq.) wurde in einer Mischung aus THF und Wasser (7:2; 45 mL) gelöst und mit Lithiumhydroxidmonohydrat (437 mg, 18,25 mmol, 3 eq.) versetzt. Das Reaktionsgemisch wurde 5 h zum Sieden erhitzt. Nach dem Abkühlen auf Ethyl 4-cyclopropyl-2-oxopyrrolidine-3-carboxylate (1.20 g, 6.08 mmol, 1 eq.) Was dissolved in a mixture of THF and water (7: 2, 45 mL) and treated with lithium hydroxide monohydrate (437 mg, 18.25 mmol, 3 eq.). The reaction mixture was heated to boiling for 5 h. After cooling to
Raumtemperatur versetzt man mit 6 M Salzsäure (10 mL) und extrahiert zweimal mit Ethylacetat (50 mL). Die vereinigten organischen Phasen trocknete diese über Magnesiumsulfat und entfernte das Lösungsmittel im Vakuum. Das gewünschte Produkt 4-Cyclopropyl-2-oxopyrrolidin-3-carbonsäure wurde in Form weißer Kristalle (0,625 g, 60 % der Theorie). 'H-NMR (400 MHz, DMSO δ, ppm) 12,51 (bs, 1H), 7,83 (bs, 1H), 3,35 (m, 1H), 3,08 (d, 1H), 297 (m, 1H), 2,03 (m, 1H), 0,83 (m, 1H), 0,41-0,38 (m, 2H), 0,16 (m, 1H), 0,09 (m, 1H). Room temperature is mixed with 6 M hydrochloric acid (10 mL) and extracted twice with ethyl acetate (50 mL). The combined organic phases were dried over magnesium sulfate and the solvent removed in vacuo. The desired product 4-cyclopropyl-2-oxopyrrolidine-3-carboxylic acid was in the form of white crystals (0.625 g, 60% of theory). 'H NMR (400 MHz, DMSO δ, ppm) 12.51 (bs, 1H), 7.83 (bs, 1H), 3.35 (m, 1H), 3.08 (d, 1H), 297 (m, 1H), 2.03 (m, 1H), 0.83 (m, 1H), 0.41-0.38 (m, 2H), 0.16 (m, 1H), 0.09 ( m, 1H).
d) 4-Cyclopropyl-N-(2-fluorphenyl)-2-oxopyrrolidin-3-carboxamid (Synthesebeispiel No. 1.2-1) d) 4-Cyclopropyl-N- (2-fluorophenyl) -2-oxopyrrolidine-3-carboxamide (Synthesis Example No. 1.2-1)
Figure imgf000041_0002
Figure imgf000041_0002
4-Cyclopropyl-2-oxopyrrolidin-3-carbonsäure (140 mg, 0,83 mmol, 1,0 eq.), 2-Fluoranilin (110 mg, 0.99 mmol, 1,2 eq.) und Diisopropylethylamin (160,4 mg, 1,24 mmol, 1,5 eq.) wurde in Dichlormethan (10 mL) gelöst, mit 1-Hydroxy-lH-benzotriazol (33 mg, 0,25 mmol, 0,3 eq.) und l-(3- (Dimethylamino)propyl-3-ethylcarbodiimide hydrochloride (198,3 mg, 1,03 mmol, 1,25 eq.) versetzt. Das resultierende Reaktionsgemisch wurde über Nacht bei Raumtemperatur gerührt und nach insgesamt 6 h eingeengt. Durch abschließende säulenchromatographische Reinigung (Gradient Essigester/Heptan) des resultierenden Rohproduktes wurde 4-Cyclopropyl-N-(2-fluorphenyl)-2-oxopyrrolidin-3- carboxamid in Form eines farblosen Feststoffs isoliert werden (108 mg, 47 % der Theorie). 'H-NMR (400 MHz, DMSO, δ, ppm): 9,54 (bs, 1H), 8,26 (dt, 1H), 7,12-7,00 (m, 3H), 5,65 (bs, 1H), 3,55 (t, 1H), 3,28 (d, 1H), 3,20 (dd, 1H), 2,52 (m, 1H), 0,98 (m, 1H); 0,61-0,52 (m, 3 H), 0,26 (m, 1H). In Analogie zu den oben angeführten und an entsprechender Stelle rezitierten Herstellungsbeispielen und unter Berücksichtigung der allgemeinen Angaben zur Herstellung von substituierten Pyrrolidinonen erhält man die nachfolgend genannten Verbindungen: 4-Cyclopropyl-2-oxopyrrolidine-3-carboxylic acid (140 mg, 0.83 mmol, 1.0 eq.), 2-fluoroaniline (110 mg, 0.99 mmol, 1.2 eq.) And diisopropylethylamine (160.4 mg , 1.24 mmol, 1.5 eq.) Was dissolved in dichloromethane (10 mL), eluted with 1-hydroxy-1H-benzotriazole (33 mg, 0.25 mmol, 0.3 eq. (Dimethylamino) propyl-3-ethylcarbodiimide hydrochloride (198.3 mg, 1.03 mmol, 1.25 eq.) The resulting reaction mixture was stirred at room temperature overnight and concentrated after a total of 6 h., Followed by final column chromatographic purification (gradient Ethyl acetate / heptane) of the resulting crude product, 4-cyclopropyl-N- (2-fluorophenyl) -2-oxopyrrolidine-3-carboxamide was isolated as a colorless solid (108 mg, 47% of theory). 1 H-NMR (400 MHz, DMSO, δ, ppm): 9.54 (bs, 1H), 8.26 (dt, 1H), 7.12-7.00 (m, 3H), 5.65 (bs, 1H), 3 , 55 (t, 1H), 3.28 (d, 1H), 3.20 (dd, 1H), 2.52 (m, 1H), 0.98 (m, 1H), 0.61-0, 52 (m, 3H), 0.26 (m, 1H). By analogy with the production examples recited above and recited at the appropriate place and taking into account the general information on the preparation of substituted pyrrolidinones, the following compounds are obtained:
Figure imgf000042_0001
Figure imgf000042_0001
Tabelle L I : Bevorzugte Verbindungen der Formel (L I) sind die Verbindungen 1.1-1 bis 1.1-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.1-1 bis 1.1- 40 der Tabelle LI sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Preferred compounds of the formula (L I) are the compounds 1.1-1 to 1.1-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.1-1 to 1.1-40 of Table LI are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Tabelle 1 : Table 1 :
No. Q  No. Q
1 Q-l . l  1 Q-l. l
2 Q-1.2  2 Q-1.2
3 Q-1.3  3 Q-1.3
4 Q-1.4  4 Q-1.4
5 Q-1.5  5 Q-1.5
6 Q-1.6  6 Q-1.6
7 Q-1.7  7 Q-1.7
8 Q-1.8  8 Q-1.8
9 Q-1.9  9 Q-1.9
10 Q-1.10  10 Q-1.10
11 Q-l . l 1  11 Q-l. 1
12 Q-1.12  12 Q-1.12
13 Q-1.13  13 Q-1.13
14 Q-1.14  14 Q-1.14
15 Q-1.15  15 Q-1.15
16 Q-1.16  16 Q-1.16
17 Q-1.17  17 Q-1.17
18 Q-1.18 No. Q 18 Q-1.18 No. Q
19 Q-1.19  19 Q-1.19
20 Q-1.20  20 Q-1.20
21 Q-1.21  21 Q-1.21
22 Q-1.22  22 Q-1.22
23 Q-1.23  23 Q-1.23
24 Q-1.24  24 Q-1.24
25 Q-1.25  25Q-1.25
26 Q-1.26  26 Q-1.26
27 Q-1.27  27 Q-1.27
28 Q-1.28  28 Q-1.28
29 Q-1.29  29 Q-1.29
30 Q-1.30  30 Q-1.30
31 Q-1.31  31 Q-1.31
32 Q-1.32  32 Q-1.32
33 Q-1.33  33 Q-1.33
34 Q-1.34  34 Q-1.34
35 Q-1.35  35 Q-1.35
36 Q-1.36  36 Q-1.36
37 Q-1.37  37 Q-1.37
38 Q-1.38  38 Q-1.38
39 Q-1.39  39 Q-1.39
40 Q-1.40  40 Q-1.40
Figure imgf000043_0001
Tabelle 1.2: Bevorzugte Verbindungen der Formel (1.2) sind die Verbindungen 1.2-1 bis 1.2-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.2-1 bis 1.2- 40 der Tabelle 1.2 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert.
Figure imgf000043_0001
Table 1.2: Preferred compounds of the formula (1.2) are the compounds 1.2-1 to 1.2-40, wherein Q has the meanings given in Table 1 of each Table. The compounds 1.2-1 to 1.2- 40 of Table 1.2 are thus by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000044_0001
Figure imgf000044_0001
Tabelle 1.3: Bevorzugte Verbindungen der Formel (1.3) sind die Verbindungen 1.3-1 bis 1.3-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.3-1 bis 1.3- 40 der Tabelle 1.3 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.3: Preferred compounds of the formula (1.3) are the compounds 1.3-1 to 1.3-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.3-1 to 1.3-40 of Table 1.3 are thus determined by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000044_0002
Figure imgf000044_0002
Tabelle 1.4: Bevorzugte Verbindungen der Formel (1.4) sind die Verbindungen 1.4-1 bis 1.4-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.4-1 bis 1.4- 40 der Tabelle 1.4 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.4: Preferred compounds of the formula (1.4) are the compounds 1.4-1 to 1.4-40, wherein Q has the meanings of Table 1 given in the respective line. The compounds 1.4-1 to 1.4-40 of Table 1.4 are thus by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000044_0003
Tabelle 1.5: Bevorzugte Verbindungen der Formel (1.5) sind die Verbindungen 1.5-1 bis 1.5-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.5-1 bis 1.5- 346 der Tabelle 1.5 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000044_0003
Table 1.5: Preferred compounds of the formula (1.5) are the compounds 1.5-1 to 1.5-40, wherein Q has the meanings indicated in the respective line of Table 1. The compounds 1.5-1 to 1.5-346 of Table 1.5 are thus by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000045_0001
Figure imgf000045_0001
Tabelle 1.6: Bevorzugte Verbindungen der Formel (1.6) sind die Verbindungen 1.6-1 bis 1.6-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.6-1 bis 1.6- 40 der Tabelle 1.6 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.6: Preferred compounds of the formula (1.6) are the compounds 1.6-1 to 1.6-40, in which Q has the meanings indicated in the respective line of Table 1. The compounds 1.6-1 to 1.6-40 of Table 1.6 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000045_0002
Figure imgf000045_0002
Tabelle 1.7: Bevorzugte Verbindungen der Formel (1.7) sind die Verbindungen 1.7-1 bis 1.7-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.7-1 bis 1.7- 40 der Tabelle 1.7 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000046_0001
Table 1.7: Preferred compounds of the formula (1.7) are the compounds 1.7-1 to 1.7-40, wherein Q has the meanings given in Table 1 of each Table. The compounds 1.7-1 to 1.7-40 of Table 1.7 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000046_0001
Tabelle 1.8: Bevorzugte Verbindungen der Formel (1.8) sind die Verbindungen 1.8-1 bis 1.8-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.8-1 bis 1.8- 40 der Tabelle 1.8 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.8: Preferred compounds of the formula (1.8) are the compounds 1.8-1 to 1.8-40, in which Q has the meanings indicated in the respective line of Table 1. The compounds 1.8-1 to 1.8-40 of Table 1.8 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000046_0002
Tabelle 1.9: Bevorzugte Verbindungen der Formel (1.9) sind die Verbindungen 1.9-1 bis 1.9-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.9-1 bis 1.9- 40 der Tabelle 1.9 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000046_0002
Table 1.9: Preferred compounds of the formula (1.9) are the compounds 1.9-1 to 1.9-40, wherein Q has the meanings indicated in the respective line of Table 1. The compounds 1.9-1 to 1.9- 40 of Table 1.9 are thus by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000046_0003
Figure imgf000046_0003
Tabelle 1.10: Bevorzugte Verbindungen der Formel (1.10) sind die Verbindungen 1.10-1 bis 1.10-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.10-1 bis 1.10-40 der Tabelle 1.10 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.10: Preferred compounds of the formula (1.10) are the compounds 1.10-1 to 1.10-40, wherein Q has the meanings given in Table 1 of each Table. The connections 1.10-1 to 1.10-40 of Table 1.10 are therefore distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000047_0001
Figure imgf000047_0001
Tabelle 1.11 : Bevorzugte Verbindungen der Formel (1.11) sind die Verbindungen 1.11 - 1 bis 1.11 -40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen L I 1-1 bis L I 1-40 der Tabelle LI 1 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.11: Preferred compounds of the formula (1.11) are the compounds 1.11-1 to 1.11-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds L I 1-1 to L I 1-40 of the table LI 1 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000047_0002
Figure imgf000047_0002
Tabelle 1.12: Bevorzugte Verbindungen der Formel (1.12) sind die Verbindungen 1.12-1 bis 1.12-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.12-1 bis 1.12-40 der Tabelle 1.12 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.12: Preferred compounds of the formula (1.12) are the compounds 1.12-1 to 1.12-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.12-1 to 1.12-40 of Table 1.12 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000047_0003
Tabelle 1.13: Bevorzugte Verbindungen der Formel (1.13) sind die Verbindungen 1.13-1 bis 1.13-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.13-1 bis 1.13-40 der Tabelle 1.13 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000047_0003
Table 1.13: Preferred compounds of the formula (1.13) are the compounds 1.13-1 to 1.13-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.13-1 to 1.13-40 of Table 1.13 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000048_0001
Figure imgf000048_0001
Tabelle 1.14: Bevorzugte Verbindungen der Formel (1.14) sind die Verbindungen 1.14-1 bis 1.14-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.14-1 bis 1.14-40 der Tabelle 1.14 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.14: Preferred compounds of the formula (1.14) are the compounds 1.14-1 to 1.14-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.14-1 to 1.14-40 of Table 1.14 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000048_0002
Tabelle 1.15: Bevorzugte Verbindungen der Formel (1.15) sind die Verbindungen 1.15-1 bis 1.15-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.15-1 bis 1.15-40 der Tabelle 1.15 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000049_0001
Figure imgf000048_0002
Table 1.15: Preferred compounds of the formula (1.15) are the compounds 1.15-1 to 1.15-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.15-1 to 1.15-40 of Table 1.15 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000049_0001
Tabelle 1.16: Bevorzugte Verbindungen der Formel (1.16) sind die Verbindungen 1.16-1 bis 1.16-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.16-1 bis 1.16-40 der Tabelle 1.16 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.16: Preferred compounds of the formula (1.16) are the compounds 1.16-1 to 1.16-40, wherein Q has the meanings given in Table 1 of each Table. The compounds 1.16-1 to 1.16-40 of Table 1.16 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000049_0002
Tabelle 1.17: Bevorzugte Verbindungen der Formel (1.17) sind die Verbindungen 1.17-1 bis 1.17-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.17-1 bis 1.17-40 der Tabelle 1.17 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000049_0002
Table 1.17: Preferred compounds of the formula (1.17) are the compounds 1.17-1 to 1.17-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.17-1 to 1.17-40 of Table 1.17 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000049_0003
Tabelle 1.18: Bevorzugte Verbindungen der Formel (1.18) sind die Verbindungen 1.18-1 bis 1.18-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.18-1 bis 1.18-40 der Tabelle 1.18 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert.
Figure imgf000049_0003
Table 1.18: Preferred compounds of the formula (1.18) are the compounds 1.18-1 to 1.18-40, in which Q has the meanings of Table 1 given in the respective line. The compounds 1.18-1 to 1.18-40 of Table 1.18 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000050_0001
Figure imgf000050_0001
Tabelle 1.19: Bevorzugte Verbindungen der Formel (1.19) sind die Verbindungen 1.19-1 bis 1.19-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.19-1 bis 1.19-40 der Tabelle 1.19 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.19: Preferred compounds of the formula (1.19) are the compounds 1.19-1 to 1.19-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.19-1 to 1.19-40 of Table 1.19 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000050_0002
Tabelle 1.20: Bevorzugte Verbindungen der Formel (1.20) sind die Verbindungen 1.20-1 bis 1.20-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.20-1 bis 1.20-40 der Tabelle 1.20 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert.
Figure imgf000050_0002
Table 1.20: Preferred compounds of the formula (1.20) are the compounds 1.20-1 to 1.20-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.20-1 to 1.20-40 of Table 1.20 are thus determined by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000051_0001
Figure imgf000051_0001
Tabelle 1.21 : Bevorzugte Verbindungen der Formel (1.21) sind die Verbindungen 1.21-1 bis 1.21-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.21-1 bis 1.21-40 der Tabelle 1.21 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.21: Preferred compounds of the formula (1.21) are the compounds 1.21-1 to 1.21-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.21-1 to 1.21-40 of Table 1.21 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000051_0002
Tabelle 1.22: Bevorzugte Verbindungen der Formel (1.22) sind die Verbindungen 1.22-1 bis 1.22-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.22-1 bis 1.22-40 der Tabelle 1.22 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert.
Figure imgf000051_0002
Table 1.22: Preferred compounds of the formula (1.22) are the compounds 1.22-1 to 1.22-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.22-1 to 1.22-40 of Table 1.22 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000051_0003
Tabelle 1.23: Bevorzugte Verbindungen der Formel (1.23) sind die Verbindungen 1.23-1 bis 1.23-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.23-1 bis 1.23-40 der Tabelle 1.23 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000051_0003
Table 1.23: Preferred compounds of the formula (1.23) are the compounds 1.23-1 to 1.23-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.23-1 to 1.23-40 of Table 1.23 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000052_0001
Figure imgf000052_0001
Tabelle 1.24: Bevorzugte Verbindungen der Formel (1.24) sind die Verbindungen 1.24-1 bis 1.24-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.24-1 bis 1.24-40 der Tabelle 1.24 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.24: Preferred compounds of the formula (1.24) are the compounds 1.24-1 to 1.24-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.24-1 to 1.24-40 of Table 1.24 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000052_0002
Tabelle 1.25: Bevorzugte Verbindungen der Formel (1.25) sind die Verbindungen 1.25-1 bis 1.25-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.25-1 bis 1.25-40 der Tabelle 1.25 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000053_0001
Figure imgf000052_0002
Table 1.25: Preferred compounds of the formula (1.25) are the compounds 1.25-1 to 1.25-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.25-1 to 1.25-40 of Table 1.25 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000053_0001
Tabelle 1.26: Bevorzugte Verbindungen der Formel (1.26) sind die Verbindungen 1.26-1 bis 1.26-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.26-1 bis 1.26-40 der Tabelle 1.26 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.26: Preferred compounds of the formula (1.26) are the compounds 1.26-1 to 1.26-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.26-1 to 1.26-40 of Table 1.26 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000053_0002
Tabelle 1.27: Bevorzugte Verbindungen der Formel (1.27) sind die Verbindungen 1.27-1 bis 1.27-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.27-1 bis 1.27-40 der Tabelle 1.27 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000053_0002
Table 1.27: Preferred compounds of the formula (1.27) are the compounds 1.27-1 to 1.27-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.27-1 to 1.27-40 of Table 1.27 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000053_0003
Figure imgf000053_0003
Tabelle 1.28: Bevorzugte Verbindungen der Formel (1.28) sind die Verbindungen 1.28-1 bis 1.28-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.28-1 bis 1.28-40 der Tabelle 1.28 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.28: Preferred compounds of the formula (1.28) are the compounds 1.28-1 to 1.28-40, in which Q has the meanings of Table 1 indicated in the respective line. The connections 1.28-1 to 1.28-40 of Table 1.28 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000054_0001
Figure imgf000054_0001
Tabelle 1.29: Bevorzugte Verbindungen der Formel (1.29) sind die Verbindungen 1.29-1 bis 1.29-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.29-1 bis 1.29-40 der Tabelle 1.29 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.29: Preferred compounds of the formula (1.29) are the compounds 1.29-1 to 1.29-40, in which Q has the meanings of Table 1 given in the respective line. The compounds 1.29-1 to 1.29-40 of Table 1.29 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000054_0002
Figure imgf000054_0002
Tabelle 1.30: Bevorzugte Verbindungen der Formel (1.30) sind die Verbindungen 1.30-1 bis 1.30-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.30-1 bis 1.30-40 der Tabelle 1.30 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.30: Preferred compounds of the formula (1.30) are the compounds 1.30-1 to 1.30-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.30-1 to 1.30-40 of Table 1.30 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000054_0003
Tabelle 1.31 : Bevorzugte Verbindungen der Formel (1.31) sind die Verbindungen 1.31-1 bis 1.31-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.31-1 bis 1.31-40 der Tabelle 1.31 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000054_0003
Table 1.31: Preferred compounds of the formula (1.31) are the compounds 1.31-1 to 1.31-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.31-1 to 1.31-40 of Table 1.31 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000055_0001
Figure imgf000055_0001
Tabelle 1.32: Bevorzugte Verbindungen der Formel (1.32) sind die Verbindungen 1.32-1 bis 1.32-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.32-1 bis 1.32-40 der Tabelle 1.32 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.32: Preferred compounds of the formula (1.32) are the compounds 1.32-1 to 1.32-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.32-1 to 1.32-40 of Table 1.32 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000055_0002
Figure imgf000055_0002
Tabelle 1.33: Bevorzugte Verbindungen der Formel (1.33) sind die Verbindungen 1.33-1 bis 1.33-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.33-1 bis 1.33-40 der Tabelle 1.33 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.33: Preferred compounds of the formula (1.33) are the compounds 1.33-1 to 1.33-40, in which Q has the meanings given in Table 1 of each Table. The compounds 1.33-1 to 1.33-40 of Table 1.33 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000056_0001
Figure imgf000056_0001
Tabelle 1.34: Bevorzugte Verbindungen der Formel (1.34) sind die Verbindungen 1.34-1 bis 1.34-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.34-1 bis 1.34-40 der Tabelle 1.34 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.34: Preferred compounds of the formula (1.34) are the compounds 1.34-1 to 1.34-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.34-1 to 1.34-40 of Table 1.34 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000056_0002
Tabelle 1.35: Bevorzugte Verbindungen der Formel (1.35) sind die Verbindungen 1.35-1 bis 1.35-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.35-1 bis 1.35-40 der Tabelle 1.35 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000056_0002
Table 1.35: Preferred compounds of the formula (1.35) are the compounds 1.35-1 to 1.35-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.35-1 to 1.35-40 of Table 1.35 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000056_0003
Figure imgf000056_0003
Tabelle 1.36: Bevorzugte Verbindungen der Formel (1.36) sind die Verbindungen 1.36-1 bis 1.36-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.36-1 bis 1.36-40 der Tabelle 1.36 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.36: Preferred compounds of the formula (1.36) are the compounds 1.36-1 to 1.36-40, in which Q has the meanings of Table 1 indicated in the respective line. The connections 1.36-1 to 1.36-40 of Table 1.36 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000057_0001
Figure imgf000057_0001
Tabelle 1.37: Bevorzugte Verbindungen der Formel (1.37) sind die Verbindungen 1.37-1 bis 1.37-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.37-1 bis 1.37-40 der Tabelle 1.37 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.37: Preferred compounds of the formula (1.37) are the compounds 1.37-1 to 1.37-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.37-1 to 1.37-40 of Table 1.37 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000057_0002
Figure imgf000057_0002
Tabelle 1.38: Bevorzugte Verbindungen der Formel (1.38) sind die Verbindungen 1.38-1 bis 1.38-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.38-1 bis 1.38-40 der Tabelle 1.38 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.38: Preferred compounds of the formula (1.38) are the compounds 1.38-1 to 1.38-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.38-1 to 1.38-40 of Table 1.38 are thus affected by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000057_0003
Tabelle 1.39: Bevorzugte Verbindungen der Formel (1.39) sind die Verbindungen 1.39-1 bis 1.39-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.39-1 bis 1.39-40 der Tabelle 1.39 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000057_0003
Table 1.39: Preferred compounds of the formula (1.39) are the compounds 1.39-1 to 1.39-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.39-1 to 1.39-40 of Table 1.39 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000058_0001
Figure imgf000058_0001
Tabelle 1.40: Bevorzugte Verbindungen der Formel (1.40) sind die Verbindungen 1.40-1 bis 1.40-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.40-1 bis 1.40-40 der Tabelle 1.40 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.40: Preferred compounds of the formula (1.40) are the compounds 1.40-1 to 1.40-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.40-1 to 1.40-40 of Table 1.40 are thus distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000058_0002
Figure imgf000058_0002
Tabelle 1.41 : Bevorzugte Verbindungen der Formel (1.41) sind die Verbindungen 1.41-1 bis 1.41-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.41-1 bis 1.41-40 der Tabelle 1.41 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.41: Preferred compounds of the formula (1.41) are the compounds 1.41-1 to 1.41-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.41-1 to 1.41-40 of Table 1.41 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000059_0001
Figure imgf000059_0001
Tabelle 1.42: Bevorzugte Verbindungen der Formel (1.42) sind die Verbindungen 1.42-1 bis 1.42-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.42-1 bis 1.42-40 der Tabelle 1.42 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.42: Preferred compounds of the formula (1.42) are the compounds 1.42-1 to 1.42-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.42-1 to 1.42-40 of Table 1.42 are therefore distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000059_0002
Tabelle 1.43: Bevorzugte Verbindungen der Formel (1.43) sind die Verbindungen 1.43-1 bis 1.43-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.43-1 bis 1.43-40 der Tabelle 1.43 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000059_0002
Table 1.43: Preferred compounds of the formula (1.43) are the compounds 1.43-1 to 1.43-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.43-1 to 1.43-40 of Table 1.43 are thus characterized by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000059_0003
Figure imgf000059_0003
Tabelle 1.44: Bevorzugte Verbindungen der Formel (1.44) sind die Verbindungen 1.44-1 bis 1.44-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.44-1 bis 1.44-40 der Tabelle 1.44 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.44: Preferred compounds of the formula (1.44) are the compounds 1.44-1 to 1.44-40, in which Q has the meanings of Table 1 indicated in the respective line. The connections 1.44-1 to 1.44-40 of Table 1.44 are therefore distinguished by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000060_0001
Figure imgf000060_0001
Tabelle 1.45: Bevorzugte Verbindungen der Formel (1.45) sind die Verbindungen 1.45-1 bis 1.45-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.45-1 bis 1.45-40 der Tabelle 1.45 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.45: Preferred compounds of the formula (1.45) are the compounds 1.45-1 to 1.45-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.45-1 to 1.45-40 of Table 1.45 are thus distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000060_0002
Figure imgf000060_0002
Tabelle 1.46: Bevorzugte Verbindungen der Formel (1.46) sind die Verbindungen 1.46-1 bis 1.46-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.46-1 bis 1.46-40 der Tabelle 1.46 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.46: Preferred compounds of the formula (1.46) are the compounds 1.46-1 to 1.46-40, wherein Q has the meanings given in Table 1 of each Table. The compounds 1.46-1 to 1.46-40 of Table 1.46 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000060_0003
Tabelle 1.47: Bevorzugte Verbindungen der Formel (1.47) sind die Verbindungen 1.47-1 bis 1.47-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.47-1 bis 1.47-40 der Tabelle 1.47 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000060_0003
Table 1.47: Preferred compounds of the formula (1.47) are the compounds 1.47-1 to 1.47-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.47-1 to 1.47-40 of Table 1.47 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000061_0001
Figure imgf000061_0001
Tabelle 1.48: Bevorzugte Verbindungen der Formel (1.48) sind die Verbindungen 1.48-1 bis 1.48-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.48-1 bis 1.48-40 der Tabelle 1.48 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der oben stehenden Tabelle 1 definiert. Table 1.48: Preferred compounds of the formula (1.48) are the compounds 1.48-1 to 1.48-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.48-1 to 1.48-40 of Table 1.48 are thus characterized by the meaning of the respective entries no. 1 to 40 are defined for Q of the above Table 1.
Figure imgf000061_0002
Tabelle 1.49: Bevorzugte Verbindungen der Formel (1.49) sind die Verbindungen 1.49-1 bis 1.49-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.49-1 bis 1.49-40 der Tabelle 1.49 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert.
Figure imgf000062_0001
Figure imgf000061_0002
Table 1.49: Preferred compounds of the formula (1.49) are the compounds 1.49-1 to 1.49-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.49-1 to 1.49-40 of Table 1.49 are therefore distinguished by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Figure imgf000062_0001
Tabelle 1.50: Bevorzugte Verbindungen der Formel (1.50) sind die Verbindungen 1.50-1 bis 1.50-40, worin Q die in der jeweiligen Zeile angegebenen Bedeutungen der Tabelle 1 hat. Die Verbindungen 1.50-1 bis 1.50-40 der Tabelle 1.50 sind somit durch die Bedeutung der jeweiligen Einträge No. 1 bis 40 für Q der Tabelle 1 definiert. Table 1.50: Preferred compounds of the formula (1.50) are the compounds 1.50-1 to 1.50-40, in which Q has the meanings of Table 1 indicated in the respective line. The compounds 1.50-1 to 1.50-40 of Table 1.50 are thus affected by the meaning of the respective entries no. 1 to 40 defined for Q of Table 1.
Spektroskopische Daten ausgewählter Tabellenbeispiele: Spectroscopic data of selected table examples:
Ausgewählte detaillierte Synthesebeispiele für die erfindungsgemäßen Verbindungen der allgemeinen Formeln (I) sind im Folgenden aufgeführt. Die 'H-NMR-, 13C-NMR- und 19F-NMR-spektroskopischen Daten, die für die in den nachfolgenden Abschnitten beschriebenen chemischen Beispiele angegeben sind, (400 MHz bei 'H-NMR und 150 MHz bei 13C-NMR und 375 MHz bei "F-NMR, Lösungsmittel CDCb, CD3OD oder d6-DMSO, interner Standard: Tetramethylsilan δ = 0.00 ppm), wurden mit einem Gerät der Firma Broker erhalten, und die bezeichneten Signale haben die nachfolgend aufgeführten Bedeutungen: br = breit(es); s = Singulett, d = Dublett, t = Triplett, dd = Doppeldublett, ddd = Dublett eines Doppeldubletts, m = Multiplett, q = Quartett, quint = Quintett, sext = Sextett, sept = Septett, dq = Doppelquartett, dt = Doppeltriplett. Bei Diastereomerengemischen werden entweder die jeweils signifikanten Signale beider Diastereomere oder das charakteristische Signal des Hauptdiastereomers angegeben. Die verwendeten Abkürzungen für chemische Gruppen haben beispielsweise die nachfolgenden Bedeutungen: Me = CH3, Et = CH2CH3, t-Hex = C(CH3)2CH(CH3)2, t-Bu = C(CH3)3, n- Bu = unverzweigtes Butyl, n-Pr = unverzweigtes Propyl, i-Pr = verzweigtes Propyl, c-Pr = Cyclopropyl, c-Hex = Cyclohexyl. Selected detailed synthesis examples of the compounds of the general formulas (I) according to the invention are listed below. The 'H-NMR, 13 C-NMR and 19 F-NMR spectroscopic data given for the chemical examples described in the following sections (400 MHz for' H-NMR and 150 MHz for 13 C-NMR and 375 MHz in "F-NMR, solvent CDCb, CD3OD or d6-DMSO, internal standard: tetramethylsilane δ = 0.00 ppm), were obtained with a Broker device and the designated signals have the meanings given below: br = broad (es); s = singlet, d = doublet, t = triplet, dd = double doublet, ddd = doublet of double doublet, m = multiplet, q = quartet, quint = quintet, sext = sextet, sept = septet, dq = double quartet, ., Me = CH 3 Et = CH2CH3, t-Hex = C (CH: dt = double triplet at diastereomers either the respective significant signals of both diastereomers, or the characteristic signal of the major diastereomer are specified, the abbreviations used for chemical groups example, have the following meanings. 3 ) 2CH (CH 3 ) 2, t-Bu = C (CH 3 ) 3 , n-Bu = unbranched butyl, n-Pr = unbranched propyl, i-Pr = branched propyl, c-Pr = cyclopropyl, c-hex = cyclohexyl.
Die nachfolgend aufgeführten spektroskopischen Daten ausgewählter Tabellenbeispiele wurden über klassische 'H-NMR-Interpretation oder über NMR-Peak-Listenverfahren ausgewertet. The spectroscopic data of selected table examples listed below were evaluated by classical 'H-NMR interpretation or by NMR peak list methods.
Klassische 'H-NMR-Interpretation Beispiel No. 1.2 -15: Classical 'H NMR interpretation Example No. 1.2 -15:
'H-NMR (400 MHz, CDC13 δ, ppm) 9,44 (bs, IH), 8,27 (dt, IH), 7,13-7,00 (m, 3H), 5,66 (bs, IH), 3,54 (t, IH), 3,18-3,09 (m, 3H), 2,12 (m, IH), 1,83-1 ,54 (m, 5H), 1,39-1,20 (m, 3H). Beispiel No. 1.2 -23: 'H-NMR (400 MHz, CDC1 3 δ, ppm) 9.44 (bs, IH), 8.27 (dt, IH), 7.13 to 7.00 (m, 3H), 5.66 (bs , IH), 3.54 (t, IH), 3.18-3.09 (m, 3H), 2.12 (m, IH), 1.83-1, 54 (m, 5H), 1, 39-1.20 (m, 3H). Example No. 1.2 -23:
Ή-NMR (400 MHz, CDCI3 δ, ppm) 9,48 (bs, IH), 8,27 (t, IH), 7,10-7,00 (m, 3H), 5,63 (bs, IH), 3,48 (t, IH), 3,23 (m, 2H), 3,00 (m, IH), 1,77-1,53 (m, 5H), 1,27-1,03 (m, 6H).  Ή-NMR (400 MHz, CDCl3 δ, ppm) 9.48 (bs, IH), 8.27 (t, IH), 7.10-7.00 (m, 3H), 5.63 (bs, IH 3.48 (t, IH), 3.23 (m, 2H), 3.00 (m, IH), 1.77-1.53 (m, 5H), 1.27-1.03 ( m, 6H).
Synthesebeispiel No. 1.2-34: Synthesis Example No. 1.2-34:
'H-NMR (400 MHz, CDCI3, δ, ppm): 9,36 (bs, IH), 8,26 (t, IH), 7,13-7,00 (m, 3H), 6,21 (bs, IH), 3,54 (t, IH), 3,18-3,05 (m, 3H), 2,56 (m, IH), 2,09-2,05 (m, 2H), 1,93-1,74 (m, 2H), 1 ,75 (m, IH), 1,28 (m, IH). 'H-NMR (400 MHz, CDCl3, δ, ppm): 9.36 (bs, IH), 8.26 (t, IH), 7.13-7.00 (m, 3H), 6.21 ( bs, IH), 3.54 (t, IH), 3.18-3.05 (m, 3H), 2.56 (m, IH), 2.09-2.05 (m, 2H), 1 , 93-1.74 (m, 2H), 1.75 (m, IH), 1.28 (m, IH).
Beispiel No. 1.5 -1 : Example No. 1.5 -1:
'H-NMR (400 MHz, CDCI3 δ, ppm) 9,67 (bs, IH), 8,02 (m, IH), 7,04 (m, IH), 6,89 (m, IH), 5,65 (bs, IH), 3,55 (t, IH), 3,29 (d, IH), 3,20 (dd, IH), 2,51 (m, IH), 0,96 (m, IH), 0,59-0,55 (m, 3H), 0,28 (m, IH). 'H NMR (400 MHz, CDCl3 δ, ppm) 9.67 (bs, IH), 8.02 (m, IH), 7.04 (m, IH), 6.89 (m, IH), 5 , 65 (bs, IH), 3.55 (t, IH), 3.29 (d, IH), 3.20 (dd, IH), 2.51 (m, IH), 0.96 (m, IH), 0.59-0.55 (m, 3H), 0.28 (m, IH).
Synthesebeispiel No. 1.5-15: Synthesis Example No. 1.5-15:
'H-NMR (400 MHz, CDCI3, δ, ppm): 9,58 (bs, IH), 8,03 (m, IH), 7,02 (m, IH), 6,88 (m, IH), 5,64 (bs, IH), 3,54 (t, IH), 3,19-3,06 (m, 2H), 2,10 (m, IH), 1,81-1,53 (m, 7H), 1,37-1 ,21 (m, 2H). 'H NMR (400 MHz, CDCl3, δ, ppm): 9.58 (bs, IH), 8.03 (m, IH), 7.02 (m, IH), 6.88 (m, IH) , 5.64 (bs, IH), 3.54 (t, IH), 3.19-3.06 (m, 2H), 2.10 (m, IH), 1.81-1.53 (m , 7H), 1.37-1, 21 (m, 2H).
Beispiel No. 1.6-1 : Example No. 1.6-1:
Ή-NMR (400 MHz, CDCb Ö, ppm) 9,61 (bs, IH), 7,95 (m, IH), 6,94 (m, IH), 5,69 (bs, IH), 3,55 (t, IH), 3,28 (d, IH), 3,20 (dd, IH), 2,49 (m, IH), 0,96 (m, IH), 0,59-0,53 (m, 3H), 0,27 (m, IH).  Ή NMR (400 MHz, CDCb,, ppm) 9.61 (bs, IH), 7.95 (m, IH), 6.94 (m, IH), 5.69 (bs, IH), 3, 55 (t, IH), 3.28 (d, IH), 3.20 (dd, IH), 2.49 (m, IH), 0.96 (m, IH), 0.59-0.53 (m, 3H), 0.27 (m, IH).
Beispiel No. 1.6 -15: Example No. 1.6 -15:
'H-NMR (400 MHz, CDCI3 δ, ppm) 9,51 (bs, IH), 7,95 (m, IH), 6,94 (m, IH), 5,77 (bs, IH), 3,54 (t, IH), 3,18-3,06 (m, 3H), 2,14 (m, IH), 1,84-1,52 (m, 5H), 1,38-1,13 (m, 3H).  'H NMR (400 MHz, CDCl3 δ, ppm) 9.51 (bs, IH), 7.95 (m, IH), 6.94 (m, IH), 5.77 (bs, IH), 3 , 54 (t, IH), 3.18-3.06 (m, 3H), 2.14 (m, IH), 1.84-1.52 (m, 5H), 1.38-1.13 (m, 3H).
Synthesebeispiel No. 1.44-1 : Synthesis Example No. 1.44-1:
Ή-NMR (400 MHz, CDCI3, δ, ppm): 9,60 (bs, IH), 8,03 (d, IH), 7,77 (q, IH), 6,66 (m, IH), 6,32 (bs, IH), 3,57 (t, IH), 3,30 (d, IH), 3,22 (dd, IH), 2,50 (m, IH), 0,94 (m, IH), 0,57-0,47 (m, 3H), 0,27 (m, IH). NMR-Peak-Listenverfahren Ή NMR (400 MHz, CDCl3, δ, ppm): 9.60 (bs, IH), 8.03 (d, IH), 7.77 (q, IH), 6.66 (m, IH), 6.32 (bs, IH), 3.57 (t, IH), 3.30 (d, IH), 3.22 (dd, IH), 2.50 (m, IH), 0.94 (m , IH), 0.57-0.47 (m, 3H), 0.27 (m, IH). NMR peak list procedures
Die 1H-NMR-Daten ausgewählter Beispiele werden in Form von 1H-NMR-Peaklisten notiert. Zu jedem Signalpeak wird erst der δ-Wert in ppm und dann die Signalintensität in runden Klammern aufgeführt. Die δ-Wert - Signalintensitäts- Zahlenpaare von verschiedenen Signalpeaks werden durch Semikolons voneinander getrennt aufgelistet. The 1H NMR data of selected examples are noted in terms of 1H NMR peak lists. For each signal peak, first the δ value in ppm and then the signal intensity in round brackets are listed. The δ-value signal intensity number pairs of different signal peaks are listed separated by semicolons.
Die Peakliste eines Beispieles hat daher die Form: δι (Intensität^; 82 (Intensität2); ; δ; (Intensität^; ; δη (Intensitätn) The peak list of an example therefore has the form: δι (intensity ^; 82 (intensity 2);; δ; (intensity ^;; δ η (intensity n )
Die Intensität scharfer Signale korreliert mit der Höhe der Signale in einem gedruckten Beispiel eines NMR-Spektrums in cm und zeigt die wirklichen Verhältnisse der Signalintensitäten. Bei breiten Signalen können mehrere Peaks oder die Mitte des Signals und ihre relative Intensität im Vergleich zum intensivsten Signal im Spektrum gezeigt werden. The intensity of sharp signals correlates with the height of the signals in a printed example of an NMR spectrum in cm and shows the true ratios of the signal intensities. For broad signals, multiple peaks or the center of the signal and their relative intensity can be shown compared to the most intense signal in the spectrum.
Zur Kalibrierung der chemischen Verschiebung von 1H-NMR-Spektren benutzen wir Tetramethylsilan und/oder die chemische Verschiebung des Lösungsmittels, besondern im Falle von Spektren, die in DMSO gemessen werden. Daher kann in NMR-Peaklisten der Tetramethylsilan-Peak vorkommen, muss es aber nicht. To calibrate the chemical shift of 1H NMR spectra we use tetramethylsilane and / or the chemical shift of the solvent, especially in the case of spectra measured in DMSO. Therefore, the tetramethylsilane peak can occur in NMR peaks, but it does not have to.
Die Listen der IH-NMR-Peaks sind ähnlich den klassischen IH-NMR- Ausdrucken und enthalten somit gewöhnlich alle Peaks, die bei einer klassischen NMR-Interpretation aufgeführt werden. The lists of the IH-NMR peaks are similar to the classical IH-NMR prints and thus usually contain all the peaks that are listed in a classical NMR interpretation.
Darüber hinaus können sie wie klassische IH-NMR- Ausdrucke Lösungsmittelsignale, Signale von Stereoisomeren der Zielverbindungen, die ebenfalls Gegenstand der Erfindung sind, und/oder Peaks von Verunreinigungen zeigen. In addition, like classical IH-NMR prints, they can show solvent signals, signals from stereoisomers of the target compounds, which are also the subject of the invention, and / or peaks of impurities.
Bei der Angabe von Verbindungssignalen im Delta-Bereich von Lösungsmitteln und/oder Wasser sind in unseren Listen von IH-NMR-Peaks die gewöhnlichen Lösungsmittelpeaks, zum Beispiel Peaks von DMSO in DMSO-D6 und der Peak von Wasser, gezeigt, die gewöhnlich im Durchschnitt eine hohe Intensität aufweisen. Die Peaks von Stereoisomeren der Targetverbindungen und/oder Peaks von Verunreinigungen haben gewöhnlich im Durchschnitt eine geringere Intensität als die Peaks der Zielverbindungen (zum Beispiel mit einer Reinheit von >90 %). When indicating compound signals in the delta range of solvents and / or water, our lists of IH NMR peaks show the usual solvent peaks, for example, peaks of DMSO in DMSO-D6 and the peak of water, which are usually average have a high intensity. The peaks of stereoisomers of the target compounds and / or peaks of impurities usually have on average a lower intensity than the peaks of the target compounds (for example with a purity of> 90%).
Solche Stereoisomere und/oder Verunreinigungen können typisch für das jeweilige Such stereoisomers and / or impurities may be typical of each
Herstellungsverfahren sein. Ihre Peaks können somit dabei helfen, die Reproduktion unseres Be manufacturing process. Their peaks can thus help the reproduction of our
Herstellungsverfahrens anhand von "Nebenprodukt-Fingerabdrucken" zu erkennen. Einem Experten, der die Peaks der Zielverbindungen mit bekannten Verfahren (MestreC, ACD- Simulation, aber auch mit empirisch ausgewerteten Erwartungswerten) berechnet, kann je nach Bedarf die Peaks der Zielverbindungen isolieren, wobei gegebenenfalls zusätzliche Intensitätsfilter eingesetzt werden. Diese Isolierung wäre ähnlich dem betreffenden Peak-Picking bei der klassischen 1H-NMR- Interpretation. Detect manufacturing process by "by-product fingerprints". An expert calculating the peaks of the target compounds by known methods (MestreC, ACD simulation, but also with empirically evaluated expected values) can isolate the peaks of the target compounds as needed, using additional intensity filters, if necessary. This isolation would be similar to peak picking in classical 1H NMR interpretation.
Weitere Details zu 1H-NMR-Peaklisten können der Research Disclosure Database Number 564025 entnommen werden. Further details on 1H NMR peaks can be found in Research Disclosure Database Number 564025.
1.14-23: Ή-ΝΜΙΙ(400.0 MHz, CDC13): 1.14-23: Ή-ΝΜΙΙ (400.0 MHz, CDC13):
δ= 9.4419 (1.4); 8.1144 (1.6); 8.1094 (1.6); 8.0956 (1.6); 8.0906 (1.6); 7.2609 (56.4); 6.9786 (2.4); 6.9578 (3.1); 6.9518 (2.4); 6.9309 (3.0); 6.8402 (1.0); 6.8385 (1.1); 6.8347 (1.1); 6.8330 (1.1); 6.8280 (1.1); 6.8263 (1.2); 6.8223 (1.2); 6.8205 (1.4); 6.8138 (0.8); 6.8122 (0.8); 6.8070 (0.8); 6.8054 (0.8); 6.8015 (0.7); 6.7999 (0.7); 6.0390 (1.1); 5.2977 (6.2); 3.8314 (2.8); 3.5025 (1.3); 3.5006 (1.3); 3.4782 (3.0); 3.4558 (1.6); 3.4539 (1.6); 3.2317 (3.4); 3.2106 (4.1); 3.1866 (1.6); 3.1685 (2.0); 3.1626 (1.5); 3.1444 (1.7); 3.0167 (0.6); 2.9990 (1.3); 2.9950 (1.1); 2.9772 (1.8); 2.9594 (0.9); 2.9556 (1.0); 2.3299 (0.9); 2.3040 (16.0); 2.3028 (15.9); 2.2629 (0.9); 1.8002 (1.4); 1.7924 (1.5); 1.7804 (1.2); 1.7682 (1.7); 1.7614 (1.8); 1.7062 (2.5); 1.6775 (2.0); 1.6021 (0.6); 1.5934 (0.8); 1.5816 (0.9); 1.5733 (1.0); 1.5644 (0.9); 1.5557 (0.9); 1.5447 (0.7); 1.5352 (0.5); 1.2821 (0.9); 1.2746 (1.4); 1.2696 (1.4); 1.2582 (1.0); 1.2502 (1.2); 1.2425 (1.8); 1.2381 (1.8); 1.2074 (1.6); 1.1818 (0.7); 1.1743 (1.2); 1.1666 (0.8); 1.1510 (0.8); 1.1433 (1.3); 1.1351 (0.6); 1.1193 (1.0); 1.1123 (1.2); 1.0882 (1.0); 1.0814 (1.2); 1.0575 (1.1); 1.0501 (1.2); 1.0270 (0.8); 1.0191 (0.9); 0.8817 (0.5); 0.0080 (0.6); -0.0002 (19.7); -0.0085 (0.6) δ = 9.4419 (1.4); 8.1144 (1.6); 8.1094 (1.6); 8.0956 (1.6); 8.0906 (1.6); 7.2609 (56.4); 6.9786 (2.4); 6.9578 (3.1); 6.9518 (2.4); 6.9309 (3.0); 6.8402 (1.0); 6.8385 (1.1); 6.8347 (1.1); 6.8330 (1.1); 6.8280 (1.1); 6.8263 (1.2); 6.8223 (1.2); 6.8205 (1.4); 6.8138 (0.8); 6.8122 (0.8); 6.8070 (0.8); 6.8054 (0.8); 6.8015 (0.7); 6.7999 (0.7); 6.0390 (1.1); 5.2977 (6.2); 3.8314 (2.8); 3.5025 (1.3); 3.5006 (1.3); 3.4782 (3.0); 3.4558 (1.6); 3.4539 (1.6); 3.2317 (3.4); 3.2106 (4.1); 3.1866 (1.6); 3.1685 (2.0); 3.1626 (1.5); 3.1444 (1.7); 3.0167 (0.6); 2.9990 (1.3); 2.9950 (1.1); 2.9772 (1.8); 2.9594 (0.9); 2.9556 (1.0); 2.3299 (0.9); 2.3040 (16.0); 2.3028 (15.9); 2.2629 (0.9); 1.8002 (1.4); 1.7924 (1.5); 1.7804 (1.2); 1.7682 (1.7); 1.7614 (1.8); 1.7062 (2.5); 1.6775 (2.0); 1.6021 (0.6); 1.5934 (0.8); 1.5816 (0.9); 1.5733 (1.0); 1.5644 (0.9); 1.5557 (0.9); 1.5447 (0.7); 1.5352 (0.5); 1.2821 (0.9); 1.2746 (1.4); 1.2696 (1.4); 1.2582 (1.0); 1.2502 (1.2); 1.2425 (1.8); 1.2381 (1.8); 1.2074 (1.6); 1.1818 (0.7); 1.1743 (1.2); 1.1666 (0.8); 1.1510 (0.8); 1.1433 (1.3); 1.1351 (0.6); 1.1193 (1.0); 1.1123 (1.2); 1.0882 (1.0); 1.0814 (1.2); 1.0575 (1.1); 1.0501 (1.2); 1.0270 (0.8); 1.0191 (0.9); 0.8817 (0.5); 0.0080 (0.6); -0.0002 (19.7); -0.0085 (0.6)
1.16- 23: Ή-ΝΜΙΙ(400.0 MHz, CDC13):  1.16-23: Ή-ΝΜΙΙ (400.0 MHz, CDC13):
δ= 9.5775 (1.7); 7.6968 (2.7); 7.5020 (2.7); 7.2658 (0.6); 7.2650 (0.7); 7.2607 (50.3); 7.1164 (2.9); 5.9655 (1.2); 5.2980 (13.2); 3.7982 (0.6); 3.7495 (1.1); 3.5215 (1.0); 3.4989 (2.4); 3.4766 (1.3); 3.4748 (1.3); 3.2084 (2.8); 3.1928 (1.6); 3.1872 (3.6); 3.1748 (1.7); 3.1691 (1.3); 3.1506 (1.4); 3.0373 (0.5); 3.0193 (1.0); 3.0156 (0.9); 2.9976 (1.5); 2.9793 (0.8); 2.9759 (0.8); 2.3530 (16.0); 1.7782 (1.0); 1.7714 (1.1); 1.7641 (1.2); 1.7024 (1.8); 1.6922 (1.8); 1.6723 (1.6); 1.5887 (0.6); 1.5816 (0.6); 1.5605 (0.6); 1.5524 (0.7); 1.5430 (0.6); 1.5341 (0.7); 1.5252 (0.5); 1.2669 (1.2); 1.2589 (1.2); 1.2427 (0.8); 1.2352 (1.5); 1.2279 (1.4); 1.1987 (1.5); 1.1771 (0.5); 1.1698 (0.9); 1.1622 (0.7); 1.1385 (0.9); 1.1303 (0.8); 1.1060 (0.8); 1.0991 (0.9); 1.0751 (1.0); 1.0685 (0.8); 1.0514 (0.8); 1.0443 (1.0); 1.0212 (0.6); 1.0135 (0.7); -0.0002 (18.8); -0.0085 (0.6) δ = 9.5775 (1.7); 7.6968 (2.7); 7.5020 (2.7); 7.2658 (0.6); 7.2650 (0.7); 7.2607 (50.3); 7.1164 (2.9); 5.9655 (1.2); 5.2980 (13.2); 3.7982 (0.6); 3.7495 (1.1); 3.5215 (1.0); 3.4989 (2.4); 3.4766 (1.3); 3.4748 (1.3); 3.2084 (2.8); 3.1928 (1.6); 3.1872 (3.6); 3.1748 (1.7); 3.1691 (1.3); 3.1506 (1.4); 3.0373 (0.5); 3.0193 (1.0); 3.0156 (0.9); 2.9976 (1.5); 2.9793 (0.8); 2.9759 (0.8); 2.3530 (16.0); 1.7782 (1.0); 1.7714 (1.1); 1.7641 (1.2); 1.7024 (1.8); 1.6922 (1.8); 1.6723 (1.6); 1.5887 (0.6); 1.5816 (0.6); 1.5605 (0.6); 1.5524 (0.7); 1.5430 (0.6); 1.5341 (0.7); 1.5252 (0.5); 1.2669 (1.2); 1.2589 (1.2); 1.2427 (0.8); 1.2352 (1.5); 1.2279 (1.4); 1.1987 (1.5); 1.1771 (0.5); 1.1698 (0.9); 1.1622 (0.7); 1.1385 (0.9); 1.1303 (0.8); 1.1060 (0.8); 1.0991 (0.9); 1.0751 (1.0); 1.0685 (0.8); 1.0514 (0.8); 1.0443 (1.0); 1.0212 (0.6); 1.0135 (0.7); -0.0002 (18.8); -0.0085 (0.6)
1.17- 23: 1H-NMR(400.0 MHz, CDC13): 1.17-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.5466 (5.6); 7.5188 (2.0); 7.3104 (4.4); 7.2599 (285.8); 7.2107 (2.1); 7.1975 (2.3); 7.1850 (9.4); 7.1804 (10.8); 7.1633 (10.7); 7.1580 (9.2); 7.1455 (1.9); 6.9959 (1.6); 6.5583 (2.3); 6.5527 (3.6); 6.5470 (2.1); 6.5361 (4.0); 6.5305 (6.9); 6.5248 (3.6); 6.5139 (2.2); 6.5081 (3.5); 6.5022 (1.8); 5.7490 (4.9); 5.2986 (7.7); 4.1301 (1.2); 4.1128 (1.2); 3.8912 (0.7); 3.8447 (0.5); 3.8191 (0.9); 3.7982 (4.2); 3.7925 (1.9); 3.7759 (0.6); 3.7514 (9.7); 3.7301 (0.7); 3.5786 (0.7); 3.5674 (0.9); 3.5038 (4.5); 3.4806 (9.4); 3.4571 (5.5); 3.4025 (1.4); 3.3867 (1.2); 3.3782 (1.5); 3.3693 (1.7); 3.3482 (1.9); 3.1960 (5.7); 3.1772 (15.8); 3.1553 (16.0); 3.0748 (0.7); 3.0533 (0.6); 3.0124 (2.0); 2.9942 (3.8); 2.9727 (5.5); 2.9542 (3.0); 2.9334 (1.2); 2.3787 (0.5); 2.0436 (5.3); 2.0052 (1.1); 1.7980 (6.7); 1.7740 (7.4); 1.7673 (7.5); 1.7142 (8.2); 1.6899 (10.6); 1.5945 (2.6); 1.5855 (2.6); 1.5644 (4.9); 1.5487 (21.4); 1.5188 (2.3); 1.4486 (0.9); 1.4224 (1.0); 1.3062 (2.7); 1.2750 (7.0); 1.2587 (7.7); 1.2408 (8.8); 1.2080 (8.3); 1.1773 (5.4); 1.1694 (4.0); 1.1463 (4.9); 1.1384 (4.3); 1.1148 (4.5); 1.1079 (4.6); 1.0777 (4.7); 1.0482 (4.6); 1.0267 (3.3); 1.0187 (3.2); 0.9878 (1.6); 0.9351 (1.1); 0.8813 (1.2); 0.8624 (0.6); 0.1459 (0.9); 0.0502 (1.4); -0.0002 (107.3); -δ = 9.5466 (5.6); 7.5188 (2.0); 7.3104 (4.4); 7.2599 (285.8); 7.2107 (2.1); 7.1975 (2.3); 7.1850 (9.4); 7.1804 (10.8); 7.1633 (10.7); 7.1580 (9.2); 7.1455 (1.9); 6.9959 (1.6); 6.5583 (2.3); 6.5527 (3.6); 6.5470 (2.1); 6.5361 (4.0); 6.5305 (6.9); 6.5248 (3.6); 6.5139 (2.2); 6.5081 (3.5); 6.5022 (1.8); 5.7490 (4.9); 5.2986 (7.7); 4.1301 (1.2); 4.1128 (1.2); 3.8912 (0.7); 3.8447 (0.5); 3.8191 (0.9); 3.7982 (4.2); 3.7925 (1.9); 3.7759 (0.6); 3.7514 (9.7); 3.7301 (0.7); 3.5786 (0.7); 3.5674 (0.9); 3.5038 (4.5); 3.4806 (9.4); 3.4571 (5.5); 3.4025 (1.4); 3.3867 (1.2); 3.3782 (1.5); 3.3693 (1.7); 3.3482 (1.9); 3.1960 (5.7); 3.1772 (15.8); 3.1553 (16.0); 3.0748 (0.7); 3.0533 (0.6); 3.0124 (2.0); 2.9942 (3.8); 2.9727 (5.5); 2.9542 (3.0); 2.9334 (1.2); 2.3787 (0.5); 2.0436 (5.3); 2.0052 (1.1); 1.7980 (6.7); 1.7740 (7.4); 1.7673 (7.5); 1.7142 (8.2); 1.6899 (10.6); 1.5945 (2.6); 1.5855 (2.6); 1.5644 (4.9); 1.5487 (21.4); 1.5188 (2.3); 1.4486 (0.9); 1.4224 (1.0); 1.3062 (2.7); 1.2750 (7.0); 1.2587 (7.7); 1.2408 (8.8); 1.2080 (8.3); 1.1773 (5.4); 1.1694 (4.0); 1.1463 (4.9); 1.1384 (4.3); 1.1148 (4.5); 1.1079 (4.6); 1.0777 (4.7); 1.0482 (4.6); 1.0267 (3.3); 1.0187 (3.2); 0.9878 (1.6); 0.9351 (1.1); 0.8813 (1.2); 0.8624 (0.6); 0.1459 (0.9); 0.0502 (1.4); -0.0002 (107.3); -
0.0084 (5.1); -0.0494 (0.7); -0.1503 (0.6) 0.0084 (5.1); -0.0494 (0.7); -0.1503 (0.6)
1.19-23: 1H-NMR(400.0 MHz, CDC13): 1.19-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.2263 (0.6); 8.0800 (0.8); 8.0578 (1.4); 8.0341 (0.6); 7.2607 (32.6); 6.6911 (0.8); 6.6842 (1.2); 6.6603 (1.7); 6.6532 (1.0); 6.6424 (0.7); 6.6396 (0.6); 5.2984 (0.8); 3.7954 (0.6); 3.7902 (0.8); 3.7743 (16.0); 3.7492 (0.8); 3.4750 (1.0); 3.4527 (0.6); 3.2118 (1.2); 3.1909 (1.4); 3.1844 (0.6); 3.1663 (0.7); 3.1603 (0.5); 3.1422 (0.6); 2.9822 (0.6); 1.7657 (0.6); 1.7583 (0.6); 1.7026 (0.8); 1.6951 (0.7); 1.6756 (0.7); 1.2406 (0.6); 1.2347 (0.6); 1.2039 (0.6); -0.0002 (12.0) δ = 9.2263 (0.6); 8.0800 (0.8); 8.0578 (1.4); 8.0341 (0.6); 7.2607 (32.6); 6.6911 (0.8); 6.6842 (1.2); 6.6603 (1.7); 6.6532 (1.0); 6.6424 (0.7); 6.6396 (0.6); 5.2984 (0.8); 3.7954 (0.6); 3.7902 (0.8); 3.7743 (16.0); 3.7492 (0.8); 3.4750 (1.0); 3.4527 (0.6); 3.2118 (1.2); 3.1909 (1.4); 3.1844 (0.6); 3.1663 (0.7); 3.1603 (0.5); 3.1422 (0.6); 2.9822 (0.6); 1.7657 (0.6); 1.7583 (0.6); 1.7026 (0.8); 1.6951 (0.7); 1.6756 (0.7); 1.2406 (0.6); 1.2347 (0.6); 1.2039 (0.6); -0.0002 (12.0)
1.18- 23: 1H-NMR(400.0 MHz, CDC13): 1.18-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.2972 (0.8); 7.5238 (1.1); 7.5174 (1.1); 7.4913 (1.1); 7.4849 (1.2); 7.2618 (24.0); 7.1445 (0.6); 7.1405 (0.7); 7.1383 (0.6); 7.1344 (0.5); 7.1225 (0.7); 7.1185 (0.8); 7.1163 (0.7); 7.1124 (0.6); 6.8810 (1.0); 6.8584 (1.7); 6.8359 (0.8); 5.2984 (3.5); 3.8680 (0.6); 3.8546 (16.0); 3.5061 (0.5); 3.4822 (1.3); 3.4589 (0.6); 3.1779 (0.7); 3.1674 (1.4); 3.1601 (0.9); 3.1539 (0.7); 3.1467 (1.7); 3.1360 (0.7); 3.0060 (0.5); 2.9845 (0.7); 2.0436 (0.7); 1.7828 (0.5); 1.7596 (0.6); 1.7515 (0.6); 1.6992 (0.9); 1.6880 (0.8); 1.6701 (0.9); 1.6023 (0.8); 1.2638 (0.8); 1.2583 (1.1); 1.2404 (0.6); 1.2323 (0.7); 1.2254 (0.7); 1.1967 (0.8); 1.0396 (0.5); -0.0002 (8.4) 1.2-1 : 'H-NMR(400.0 MHz, CDC13): δ = 9.2972 (0.8); 7.5238 (1.1); 7.5174 (1.1); 7.4913 (1.1); 7.4849 (1.2); 7.2618 (24.0); 7.1445 (0.6); 7.1405 (0.7); 7.1383 (0.6); 7.1344 (0.5); 7.1225 (0.7); 7.1185 (0.8); 7.1163 (0.7); 7.1124 (0.6); 6.8810 (1.0); 6.8584 (1.7); 6.8359 (0.8); 5.2984 (3.5); 3.8680 (0.6); 3.8546 (16.0); 3.5061 (0.5); 3.4822 (1.3); 3.4589 (0.6); 3.1779 (0.7); 3.1674 (1.4); 3.1601 (0.9); 3.1539 (0.7); 3.1467 (1.7); 3.1360 (0.7); 3.0060 (0.5); 2.9845 (0.7); 2.0436 (0.7); 1.7828 (0.5); 1.7596 (0.6); 1.7515 (0.6); 1.6992 (0.9); 1.6880 (0.8); 1.6701 (0.9); 1.6023 (0.8); 1.2638 (0.8); 1.2583 (1.1); 1.2404 (0.6); 1.2323 (0.7); 1.2254 (0.7); 1.1967 (0.8); 1.0396 (0.5); -0.0002 (8.4) 1.2-1: 'H-NMR (400.0 MHz, CDC13):
δ= 9.5414 (3.2); 8.2806 (3.4); 8.2772 (2.9); 8.2607 (6.4); 8.2562 (5.5); 8.2406 (3.6); 8.2365 (3.4); 7.5183 (4.3); 7.3181 (0.7); 7.2928 (0.7); 7.2878 (1.8); 7.2855 (1.4); 7.2744 (2.0); 7.2704 (3.0); 7.2688 (3.7); 7.2594 (768.4); 7.2271 (3.5); 7.2095 (2.7); 7.1248 (3.4); 7.1186 (3.3); 7.1134 (5.2); 7.1070 (7.6); 7.0981 (6.8); 7.0945 (7.8); 7.0884 (9.2); 7.0713 (7.4); 7.0660 (7.9); 7.0612 (5.3); 7.0524 (5.4); 7.0482 (7.3); 7.0446 (3.0); 7.0421 (4.0); 7.0347 (3.5); 7.0309 (3.6); 7.0273 (3.4); 7.0229 (1.8); 7.0142 (1.6); 7.0099 (1.4); 6.9954 (4.5); 5.6483 (2.8); 3.5771 (4.6); 3.5749 (4.6); 3.5531 (10.1); 3.5312 (5.8); 3.5291 (5.7); 3.2911 (11.5); 3.2718 (12.3); 3.2171 (5.7); 3.2005 (6.2); 3.1931 (5.4); 3.1766 (5.5); 2.5622 (1.7); 2.5401 (3.7); 2.5228 (4.5); 2.5037 (3.6); 2.4819 (1.8); 1.5362 (112.8); 1.2586 (0.5); 1.0141 (0.7); 0.9900 (1.5); 0.9811 (3.4); 0.9761 (2.2); 0.9657 (2.8); 0.9591 (3.1); 0.9475 (1.8); 0.9427 (2.1); 0.9270 (1.2); 0.6053 (0.7); 0.5876 (3.2); 0.5830 (4.8); 0.5758 (15.1); 0.5695 (12.3); 0.5602 (12.6); 0.5556 (16.0); 0.5517 (10.8); 0.5463 (4.4); 0.5410 (5.3); 0.5216 (1.4); 0.3126 (0.6); 0.2956 (3.4); 0.2836 (5.2); 0.2748 (2.7); 0.2701 (4.6); 0.2578 (2.4); 0.2547 (2.0); 0.1459 (1.0); 0.0282 (0.6); 0.0080 (8.4); -0.0002 (296.8); -0.0086 (11.8);δ = 9.5414 (3.2); 8.2806 (3.4); 8.2772 (2.9); 8.2607 (6.4); 8.2562 (5.5); 8.2406 (3.6); 8.2365 (3.4); 7.5183 (4.3); 7.3181 (0.7); 7.2928 (0.7); 7.2878 (1.8); 7.2855 (1.4); 7.2744 (2.0); 7.2704 (3.0); 7.2688 (3.7); 7.2594 (768.4); 7.2271 (3.5); 7.2095 (2.7); 7.1248 (3.4); 7.1186 (3.3); 7.1134 (5.2); 7.1070 (7.6); 7.0981 (6.8); 7: 945 (7.8); 7.0884 (9.2); 7.0713 (7.4); 7.0660 (7.9); 7.0612 (5.3); 7.0524 (5.4); 7.0482 (7.3); 7.0446 (3.0); 7.0421 (4.0); 7.0347 (3.5); 7.0309 (3.6); 7.0273 (3.4); 7.0229 (1.8); 7.0142 (1.6); 7.0099 (1.4); 6.9954 (4.5); 5.6483 (2.8); 3.5771 (4.6); 3.5749 (4.6); 3.5531 (10.1); 3.5312 (5.8); 3.5291 (5.7); 3.2911 (11.5); 3.2718 (12.3); 3.2171 (5.7); 3.2005 (6.2); 3.1931 (5.4); 3.1766 (5.5); 2.5622 (1.7); 2.5401 (3.7); 2.5228 (4.5); 2.5037 (3.6); 2.4819 (1.8); 1.5362 (112.8); 1.2586 (0.5); 1.0141 (0.7); 0.9900 (1.5); 0.9811 (3.4); 0.9761 (2.2); 0.9657 (2.8); 0.9591 (3.1); 0.9475 (1.8); 0.9427 (2.1); 0.9270 (1.2); 0.6053 (0.7); 0.5876 (3.2); 0.5830 (4.8); 0.5758 (15.1); 0.5695 (12.3); 0.5602 (12.6); 0.5556 (16.0); 0.5517 (10.8); 0.5463 (4.4); 0.5410 (5.3); 0.5216 (1.4); 0.3126 (0.6); 0.2956 (3.4); 0.2836 (5.2); 0.2748 (2.7); 0.2701 (4.6); 0.2578 (2.4); 0.2547 (2.0); 0.1459 (1.0); 0.0282 (0.6); 0.0080 (8.4); -0.0002 (296.8); -0.0086 (11.8);
-0.1497 (1.2) -0.1497 (1.2)
1.2-15: Ή-ΝΜϋ^ΟΟ.Ο MHz, CDC13):  1.2-15: Ή-ΝΜϋ ^ ΟΟ.Ο MHz, CDC13):
δ= 9.4444 (1.6); 8.2908 (1.6); 8.2710 (3.0); 8.2665 (2.5); 8.2508 (1.7); 8.2471 (1.6); 7.5182 (1.9); 7.2594 (341.4); 7.1282 (1.3); 7.1237 (1.6); 7.1165 (1.6); 7.1115 (2.8); 7.1060 (3.3); 7.0960 (2.9); 7.0924 (3.9); 7.0876 (3.9); 7.0693 (3.4); 7.0640 (3.5); 7.0592 (2.2); 7.0503 (2.1); 7.0462 (3.0); 7.0428 (1.3); 7.0403 (1.6); 7.0327 (1.4); 7.0289 (1.5); 7.0254 (1.3); 7.0209 (0.7); 7.0123 (0.6); 7.0079 (0.5); 6.9954 (2.0); 5.6569 (1.5); 5.2984 (16.0); 3.5611 (1.7); 3.5400 (3.8); 3.5186 (1.8); 3.1813 (3.0); 3.1723 (2.3); 3.1629 (5.6); 3.1569 (3.5); 3.1495 (1.2); 3.1392 (3.8); 3.1343 (2.7); 3.1239 (3.2); 3.1057 (1.8); 3.0875 (1.0); 2.2843 (0.8); 2.1408 (0.7); 2.1185 (1.6); 2.0995 (1.7); 2.0771 (1.0); 1.8279 (0.7); 1.8193 (0.9); 1.8094 (1.6); 1.7885 (1.8); 1.7790 (1.8); 1.7652 (1.6); 1.7450 (0.8); 1.7355 (0.8); 1.7291 (0.6); 1.7098 (1.2); 1.7002 (1.7); 1.6885 (1.9); 1.6799 (2.2); 1.6707 (2.0); 1.6582 (2.0); 1.6372 (1.3); 1.6171 (1.4); 1.6092 (1.4); 1.5981 (2.0); 1.5886 (1.5); 1.5800 (2.3); 1.5685 (1.7); 1.5601 (1.6); 1.5500 (1.6); 1.5371 (44.6); 1.5212 (0.6); 1.3882 (0.6); 1.3658 (1.1); 1.3570 (0.8); 1.3440 (1.0); 1.3367 (1.1); 1.3139 (0.9); 1.2958 (0.8); 1.2753 (1.1); 1.2567 (1.9); 1.2443 (1.1); 1.2350 (0.9); 1.2253 (1.1); 1.2034 (0.6); 0.0080 (3.6); -δ = 9.4444 (1.6); 8.2908 (1.6); 8.2710 (3.0); 8.2665 (2.5); 8.2508 (1.7); 8.2471 (1.6); 7.5182 (1.9); 7.2594 (341.4); 7.1282 (1.3); 7.1237 (1.6); 7.1165 (1.6); 7.1115 (2.8); 7.1060 (3.3); 7.0960 (2.9); 7.0924 (3.9); 7.0876 (3.9); 7.0693 (3.4); 7.0640 (3.5); 7.0592 (2.2); 7.0503 (2.1); 7.0462 (3.0); 7.0428 (1.3); 7.0403 (1.6); 7.0327 (1.4); 7.0289 (1.5); 7.0254 (1.3); 7.0209 (0.7); 7.0123 (0.6); 7.0079 (0.5); 6.9954 (2.0); 5.6569 (1.5); 5.2984 (16.0); 3.5611 (1.7); 3.5400 (3.8); 3.5186 (1.8); 3.1813 (3.0); 3.1723 (2.3); 3.1629 (5.6); 3.1569 (3.5); 3.1495 (1.2); 3.1392 (3.8); 3.1343 (2.7); 3.1239 (3.2); 3.1057 (1.8); 3.0875 (1.0); 2.2843 (0.8); 2.1408 (0.7); 2.1185 (1.6); 2.0995 (1.7); 2.0771 (1.0); 1.8279 (0.7); 1.8193 (0.9); 1.8094 (1.6); 1.7885 (1.8); 1.7790 (1.8); 1.7652 (1.6); 1.7450 (0.8); 1.7355 (0.8); 1.7291 (0.6); 1.7098 (1.2); 1.7002 (1.7); 1.6885 (1.9); 1.6799 (2.2); 1.6707 (2.0); 1.6582 (2.0); 1.6372 (1.3); 1.6171 (1.4); 1.6092 (1.4); 1.5981 (2.0); 1.5886 (1.5); 1.5800 (2.3); 1.5685 (1.7); 1.5601 (1.6); 1.5500 (1.6); 1.5371 (44.6); 1.5212 (0.6); 1.3882 (0.6); 1.3658 (1.1); 1.3570 (0.8); 1.3440 (1.0); 1.3367 (1.1); 1.3139 (0.9); 1.2958 (0.8); 1.2753 (1.1); 1.2567 (1.9); 1.2443 (1.1); 1.2350 (0.9); 1.2253 (1.1); 1.2034 (0.6); 0.0080 (3.6); -
0.0002 (126.6); -0.0085 (3.8) 0.0002 (126.6); -0.0085 (3.8)
1.2-2: 1H-NMR(400.0 MHz, CDC13): 1.2-2: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.6947 (3.5); 8.2442 (3.7); 8.2407 (3.0); 8.2320 (0.9); 8.2244 (7.0); 8.2197 (5.8); 8.2044 (3.7); 8.2005 (3.6); 7.5186 (1.2); 7.2597 (202.9); 7.2099 (1.1); 7.1360 (2.7); 7.1303 (4.9); 7.1253 (3.9); 7.1187 (4.1); 7.1139 (8.9); 7.1093 (8.6); 7.1054 (6.8); 7.0959 (7.8); 7.0826 (8.9); 7.0782 (5.9); 7.0762 (6.4); 7.0672 (5.5); 7.0631 (6.7); 7.0569 (4.2); 7.0497 (3.2); 7.0460 (3.7); 7.0422 (3.0); 7.0379 (1.4); 7.0291 (1.4); 7.0249 (1.2); 6.9957 (1.3); 5.8524 (3.0); 5.2982 (10.5); 3.6848 (12.4); 3.6642 (13.3); 3.6504 (3.5); 3.6453 (8.7); 3.6269 (16.0); 3.6036 (9.8); 3.5798 (2.7); 2.9937 (1.9); 2.9736 (2.8); 2.9507 (2.7); 2.9310 (1.6); 2.9203 (1.9); 2.9005 (2.8); 2.8772 (2.7); 2.8577 (1.6); 1.6195 (2.5); 1.2566 (1.2); 1.2090 (0.7); 1.2036 (0.6); 1.1799 (3.2); 1.1736 (4.8); 1.1682 (9.5); 1.1632 (5.2); 1.1587 (4.0); 1.1340 (3.8); 1.1276 (6.2); 1.1206 (10.3); 1.1166 (6.0); 1.1103 (4.0); 1.0905 (3.8); 1.0817 (3.8); 1.0775 (2.4); 1.0699 (1.2); 1.0641 (2.5); 1.0583 (3.6); 1.0537 (4.4); 1.0420 (4.1); 1.0316 (2.5); 1.0281 (2.5); 1.0177 (1.5); 0.9907 (0.5); 0.7269 (2.2); 0.7194 (2.5); 0.7154 (2.6); 0.7085 (2.4); 0.7061 (2.6); 0.6977 (4.0); 0.6924 (4.6); 0.6892 (3.0); 0.6865 (3.0); 0.6752 (1.9); 0.6710 (2.5); 0.6676 (2.6); 0.6570 (0.6); 0.6379 (0.5); 0.0080 (2.3); - 0.0002 (84.0); -0.0085 (2.7) δ = 9.6947 (3.5); 8.2442 (3.7); 8.2407 (3.0); 8.2320 (0.9); 8.2244 (7.0); 8.2197 (5.8); 8.2044 (3.7); 8.2005 (3.6); 7.5186 (1.2); 7.2597 (202.9); 7.2099 (1.1); 7.1360 (2.7); 7.1303 (4.9); 7.1253 (3.9); 7.1187 (4.1); 7.1139 (8.9); 7.1093 (8.6); 7.1054 (6.8); 7.0959 (7.8); 7.0826 (8.9); 7.0.782 (5.9); 7.0762 (6.4); 7.0672 (5.5); 7.0631 (6.7); 7.0569 (4.2); 7.0497 (3.2); 7.0460 (3.7); 7.0422 (3.0); 7.0379 (1.4); 7.0291 (1.4); 7.0249 (1.2); 6.9957 (1.3); 5.8524 (3.0); 5.2982 (10.5); 3.6848 (12.4); 3.6642 (13.3); 3.6504 (3.5); 3.6453 (8.7); 3.6269 (16.0); 3.6036 (9.8); 3.5798 (2.7); 2.9937 (1.9); 2.9736 (2.8); 2.9507 (2.7); 2.9310 (1.6); 2.9203 (1.9); 2.9005 (2.8); 2.8772 (2.7); 2.8577 (1.6); 1.6195 (2.5); 1.2566 (1.2); 1.2090 (0.7); 1.2036 (0.6); 1.1799 (3.2); 1.1736 (4.8); 1.1682 (9.5); 1.1632 (5.2); 1.1587 (4.0); 1.1340 (3.8); 1.1276 (6.2); 1.1206 (10.3); 1.1166 (6.0); 1.1103 (4.0); 1.0905 (3.8); 1.0817 (3.8); 1.0775 (2.4); 1.0699 (1.2); 1.0641 (2.5); 1.0583 (3.6); 1.0537 (4.4); 1.0420 (4.1); 1.0316 (2.5); 1.0281 (2.5); 1.0177 (1.5); 0.9907 (0.5); 0.7269 (2.2); 0.7194 (2.5); 0.7154 (2.6); 0.7085 (2.4); 0.7061 (2.6); 0.6977 (4.0); 0.6924 (4.6); 0.6892 (3.0); 0.6865 (3.0); 0.6752 (1.9); 0.6710 (2.5); 0.6676 (2.6); 0.6570 (0.6); 0.6379 (0.5); 0.0080 (2.3); - 0.0002 (84.0); -0.0085 (2.7)
1.22- 29: 1H-NMR(400.0 MHz, CDC13): 1.22-29: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.4549 (5.2); 7.7549 (7.8); 7.7497 (16.0); 7.7447 (8.7); 7.5181 (8.8); 7.3744 (5.6); 7.3693 (5.5); 7.3487 (7.4); 7.2593 (1696.2); 7.2436 (9.4); 7.2234 (16.7); 7.2032 (8.4); 7.0799 (7.0); 7.0725 (6.9); 7.0599 (5.6); 7.0550 (5.8); 6.9953 (9.1); 5.6122 (4.7); 3.4962 (4.0); 3.4743 (7.7); 3.4510 (3.9); 3.1639 (6.8); 3.1521 (7.6); 3.1443 (15.2); 3.1305 (7.4); 3.1065 (4.3); 3.0937δ = 9.4549 (5.2); 7.7549 (7.8); 7.7497 (16.0); 7.7447 (8.7); 7.5181 (8.8); 7.3744 (5.6); 7.3693 (5.5); 7.3487 (7.4); 7.2593 (1696.2); 7.2436 (9.4); 7.2234 (16.7); 7.2032 (8.4); 7.0799 (7.0); 7.0725 (6.9); 7.0599 (5.6); 7.0550 (5.8); 6.9953 (9.1); 5.6122 (4.7); 3.4962 (4.0); 3.4743 (7.7); 3.4510 (3.9); 3.1639 (6.8); 3.1521 (7.6); 3.1443 (15.2); 3.1305 (7.4); 3.1065 (4.3); 3.0937
(4.2) ; 2.0434 (3.3); 1.8308 (2.9); 1.7348 (11.0); 1.7117 (9.8); 1.6025 (5.0); 1.5323 (351.4); 1.4932 (7.3); 1.4763 (8.0); 1.2839(4.2); 2.0434 (3.3); 1.8308 (2.9); 1.7348 (11.0); 1.7117 (9.8); 1.6025 (5.0); 1.5323 (351.4); 1.4932 (7.3); 1.4763 (8.0); 1.2839
(4.6); 1.2586 (6.8); 0.1461 (3.7); 0.0080 (24.9); -0.0002 (855.4); -0.0085 (26.0); -0.1495 (3.3) (4.6); 1.2586 (6.8); 0.1461 (3.7); 0.0080 (24.9); -0.0002 (855.4); -0.0085 (26.0); -0.1495 (3.3)
1.2-23: 1H-NMR(400.0 MHz, CDC13): 1.2-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.4814 (7.8); 8.2903 (5.4); 8.2706 (9.6); 8.2502 (5.8); 7.5180 (3.2); 7.2610 (488.8); 7.2592 (561.2); 7.2523 (91.1); 7.1046 (11.7); 7.0853 (12.1); 7.0683 (10.2); 7.0488 (8.2); 7.0305 (6.2); 6.9954 (3.8); 5.6263 (7.3); 3.5072 (5.3); 3.4845 (12.3); 3.4613 (7.4); 3.2326 (11.7); 3.2113 (14.6); 3.1969 (7.8); 3.1776 (9.7); 3.1551 (7.0); 3.0393 (2.4); 3.0208 (5.9); 3.0018 (7.8); 2.9817δ = 9.4814 (7.8); 8.2903 (5.4); 8.2706 (9.6); 8.2502 (5.8); 7.5180 (3.2); 7.2610 (488.8); 7.2592 (561.2); 7.2523 (91.1); 7.1046 (11.7); 7.0853 (12.1); 7.0683 (10.2); 7.0488 (8.2); 7.0305 (6.2); 6.9954 (3.8); 5.6263 (7.3); 3.5072 (5.3); 3.4845 (12.3); 3.4613 (7.4); 3.2326 (11.7); 3.2113 (14.6); 3.1969 (7.8); 3.1776 (9.7); 3.1551 (7.0); 3.0393 (2.4); 3.0208 (5.9); 3.0018 (7.8); 2.9817
(5.3) ; 1.7733 (11.0); 1.7127 (16.0); 1.5360 (93.8); 1.5340 (103.7); 1.2670 (13.0); 1.2474 (12.2); 1.2108 (10.6); 1.1795 (6.4); 1.1507 (6.5); 1.1229 (6.8); 1.0907 (7.3); 1.0656 (7.0); 1.0323 (4.9); 0.8825 (7.2); 0.8663 (3.6); 0.1471 (1.3); 0.0017 (182.3); -(5.3); 1.7733 (11.0); 1.7127 (16.0); 1.5360 (93.8); 1.5340 (103.7); 1.2670 (13.0); 1.2474 (12.2); 1.2108 (10.6); 1.1795 (6.4); 1.1507 (6.5); 1.1229 (6.8); 1.0907 (7.3); 1.0656 (7.0); 1.0323 (4.9); 0.8825 (7.2); 0.8663 (3.6); 0.1471 (1.3); 0.0017 (182.3); -
0.0002 (209.9); -0.1492 (1.4) 0.0002 (209.9); -0.1492 (1.4)
1.2-29: 1H-NMR(400.0 MHz, CDC13): 1.2-29: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.5734 (5.4); 8.2954 (4.3); 8.2757 (8.7); 8.2709 (7.1); 8.2555 (4.5); 7.5183 (6.3); 7.3708 (1.1); 7.3589 (1.3); 7.3092 (5.0); 7.2594 (1125.2); 7.2249 (1.9); 7.1212 (4.3); 7.1119 (4.6); 7.1032 (9.8); 7.0964 (8.3); 7.0919 (7.4); 7.0850 (11.8); 7.0693 (9.2); 7.0644 (6.7); 7.0580 (5.2); 7.0493 (5.1); 7.0451 (7.4); 7.0390 (4.2); 7.0277 (4.1); 7.0109 (1.3); 6.9954 (6.2); 5.6107 (5.3); 3.5036 (4.5); 3.4829 (11.9); 3.4613 (5.3); 3.2209 (9.8); 3.2004 (13.9); 3.1720 (5.7); 3.1549 (9.3); 3.1357 (11.0); 3.1255 (5.0); 3.1192 (5.9); 3.1052 (5.5); 3.0876 (2.8); 3.0673 (1.0); 1.8246 (3.4); 1.7354 (14.1); 1.7128 (16.0); 1.5963 (6.8); 1.5328 (228.3); 1.5079 (8.2); 1.4922 (9.8); 1.4752 (11.2); 1.4560 (5.0); 1.3238 (5.1); 1.2982 (5.3); 1.2896 (6.3); 1.2653 (5.8); 1.2403 (2.3); 0.8822 (1.1); 0.1459 (2.7); 0.0498 (2.5); 0.0080 (22.3); 0.0067 (19.9); -0.0002 (634.7); -0.0084 (18.3); -0.0348 (1.2); -0.1498 (3.0) δ = 9.5734 (5.4); 8.2954 (4.3); 8.2757 (8.7); 8.2709 (7.1); 8.2555 (4.5); 7.5183 (6.3); 7.3708 (1.1); 7.3589 (1.3); 7.3092 (5.0); 7.2594 (1125.2); 7.2249 (1.9); 7.1212 (4.3); 7.1119 (4.6); 7.1032 (9.8); 7.0964 (8.3); 7.0919 (7.4); 7.0850 (11.8); 7.0693 (9.2); 7.0644 (6.7); 7.0580 (5.2); 7.0493 (5.1); 7.0451 (7.4); 7.0390 (4.2); 7.0277 (4.1); 7.0109 (1.3); 6.9954 (6.2); 5.6107 (5.3); 3.5036 (4.5); 3.4829 (11.9); 3.4613 (5.3); 3.2209 (9.8); 3.2004 (13.9); 3.1720 (5.7); 3.1549 (9.3); 3.1357 (11.0); 3.1255 (5.0); 3.1192 (5.9); 3.1052 (5.5); 3.0876 (2.8); 3.0673 (1.0); 1.8246 (3.4); 1.7354 (14.1); 1.7128 (16.0); 1.5963 (6.8); 1.5328 (228.3); 1.5079 (8.2); 1.4922 (9.8); 1.4752 (11.2); 1.4560 (5.0); 1.3238 (5.1); 1.2982 (5.3); 1.2896 (6.3); 1.2653 (5.8); 1.2403 (2.3); 0.8822 (1.1); 0.1459 (2.7); 0.0498 (2.5); 0.0080 (22.3); 0.0067 (19.9); -0.0002 (634.7); -0.0084 (18.3); -0.0348 (1.2); -0.1498 (3.0)
1.23- 23: 1H-NMR(400.0 MHz, CDC13): 1.23-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.3524 (3.9); 7.5245 (13.8); 7.5187 (6.1); 7.5078 (7.3); 7.5025 (16.0); 7.4949 (2.4); 7.3103 (2.8); 7.2756 (19.8); 7.2647 (37.6); 7.2595 (276.7); 7.2540 (17.5); 7.2467 (2.8); 7.2246 (0.6); 7.2098 (1.2); 6.9955 (1.6); 5.6763 (3.4); 5.2983 (5.4); 3.4954 (3.0); 3.4727 (6.2); 3.4491 (3.5); 3.1909 (3.8); 3.1736 (10.5); 3.1530 (9.0); 3.0266 (1.4); 3.0093 (2.7); 2.9879 (3.8); 2.9698 (2.0); 2.9482 (0.8); 2.0046 (1.0); 1.7952 (4.5); 1.7717 (5.1); 1.7011 (6.4); 1.5833 (4.9); 1.5635 (3.8); 1.5546 (3.3); 1.4145 (0.7); 1.3005 (1.5); 1.2739 (3.6); 1.2421 (4.6); 1.2066 (4.7); 1.1752 (3.0); 1.1432 (3.2); 1.1111 (3.0); 1.0803 (3.1); 1.0568 (3.0); 1.0501 (3.0); 1.0264 (2.1); 0.9965 (0.9); 0.1461 (0.8); 0.0506 (0.9); 0.0050 (13.4); -0.0002 (104.4); -0.0085 (3.9); -0.0500 (0.6); -0.1500 (0.5) 1.2- 34: 'H-NMR^OO.ö MHz, CDC13): δ = 9.3524 (3.9); 7.5245 (13.8); 7.5187 (6.1); 7.5078 (7.3); 7.5025 (16.0); 7.4949 (2.4); 7.3103 (2.8); 7.2756 (19.8); 7.2647 (37.6); 7.2595 (276.7); 7.2540 (17.5); 7.2467 (2.8); 7.2246 (0.6); 7.2098 (1.2); 6.9955 (1.6); 5.6763 (3.4); 5.2983 (5.4); 3.4954 (3.0); 3.4727 (6.2); 3.4491 (3.5); 3.1909 (3.8); 3.1736 (10.5); 3.1530 (9.0); 3.0266 (1.4); 3.0093 (2.7); 2.9879 (3.8); 2.9698 (2.0); 2.9482 (0.8); 2.0046 (1.0); 1.7952 (4.5); 1.7717 (5.1); 1.7011 (6.4); 1.5833 (4.9); 1.5635 (3.8); 1.5546 (3.3); 1.4145 (0.7); 1.3005 (1.5); 1.2739 (3.6); 1.2421 (4.6); 1.2066 (4.7); 1.1752 (3.0); 1.1432 (3.2); 1.1111 (3.0); 1.0803 (3.1); 1.0568 (3.0); 1.0501 (3.0); 1.0264 (2.1); 0.9965 (0.9); 0.1461 (0.8); 0.0506 (0.9); 0.0050 (13.4); -0.0002 (104.4); -0.0085 (3.9); -0.0500 (0.6); -0.1500 (0.5) 1.2-34: 'H NMR ^ OO.OMEGA, CDC13):
δ= 8.5107 (1.4); 8.3077 (0.8); 8.2947 (1.5); 8.2895 (1.6); 8.2753 (2.6); 8.2553 (1.6); 8.2512 (1.4); 7.5191 (0.9); 7.2607 (173.5); 7.2557 (2.6); 7.2533 (1.3); 7.2524 (1.2); 7.2517 (1.2); 7.2501 (0.9); 7.2484 (0.7); 7.2477 (0.7); 7.2461 (0.6); 7.2381 (0.5); 7.1646 (0.9); 7.1581 (1.5); 7.1511 (1.5); 7.1437 (2.4); 7.1297 (3.1); 7.1228 (3.7); 7.1197 (3.6); 7.1178 (3.6); 7.1139 (2.6); 7.1101 (4.2); 7.1083 (4.4); 7.1060 (4.7); 7.0940 (6.3); 7.0905 (4.8); 7.0793 (2.2); 7.0753 (1.8); 7.0686 (1.8); 7.0640 (1.9); 7.0586 (1.4); 7.0516 (1.4); 7.0476 (1.4); 7.0340 (0.9); 6.9970 (1.1); 5.3002 (16.0); 4.2685 (0.8); 4.2291 (0.7); 3.7638 (0.9); 3.7533 (0.6); 3.7471 (2.2); 3.7410 (0.7); 3.7326 (0.5); 3.7305 (0.9); 3.5961 (3.4); 3.5109 (0.6); 3.3060 (0.6); 3.2447 (1.1); 3.2258 (2.6); 3.2070 (1.3); 3.1012 (0.5); 3.0267 (0.8); 3.0097 (0.6); 2.5381 (0.5); 2.4932 (0.7); 2.4782 (0.6); 2.4704 (0.6); 2.4509 (0.9); 2.4310 (0.7); 2.2718 (0.8); 2.2260 (9.2); 2.2079 (4.1); 2.1890 (1.9); 2.1757 (0.7); 2.1472 (0.8); 2.1410 (0.5); 2.1308 (1.0); 2.1281 (0.8); 2.1210 (1.2); 2.1123 (0.9); 2.1090 (0.9); 2.1006 (1.6); 2.0916 (1.1); 2.0779 (1.0); 2.0721 (1.0); 2.0557 (0.9); 2.0427 (0.8); 2.0276 (0.6); 2.0199 (0.6); 1.9722 (0.6); 1.9649 (0.6); 1.9576 (0.6); 1.9457 (0.6); 1.9369 (0.6); 1.9238 (0.8); 1.9182 (0.9); 1.9131 (0.8); 1.8967 (1.6); 1.8742 (2.1); 1.8703 (2.1); 1.8626 (1.9); 1.8581 (1.6); 1.8536 (3.8); 1.8446 (1.8); 1.8369 (2.0); 1.8236 (1.0); 1.8146 (1.0); 1.8072 (1.2); 1.7959 (0.7); 1.7848 (0.9); 1.7658 (0.9); 1.7592 (1.0); 1.7458 (1.1); 1.7419 (1.2); 1.7148 (1.5); 1.6934 (1.2); 1.6730 (0.5); 1.5529 (51.4); 1.4322 (8.1); 1.3069 (0.7); 1.2890 (0.6); 1.2548 (1.8); 1.1487 (0.5); 0.0079 (3.4); -0.0002 (160.2); -0.0052 (3.2); -0.0060 (2.6); -0.0068 (2.2); -0.0085 (5.4); -0.0108 (1.4); -0.0124 (1.0); -0.0132 (1.0); -0.0139 (0.8); -0.0148 (0.8); -0.0164 (0.6); -0.0172 (0.6); -0.0180 (0.6); -0.0187 (0.6); -δ = 8.5107 (1.4); 8.3077 (0.8); 8.2947 (1.5); 8.2895 (1.6); 8.2753 (2.6); 8.2553 (1.6); 8.2512 (1.4); 7.5191 (0.9); 7.2607 (173.5); 7.2557 (2.6); 7.2533 (1.3); 7.2524 (1.2); 7.2517 (1.2); 7.2501 (0.9); 7.2484 (0.7); 7.2477 (0.7); 7.2461 (0.6); 7.2381 (0.5); 7.1646 (0.9); 7.1581 (1.5); 7.1511 (1.5); 7.1437 (2.4); 7.1297 (3.1); 7.1228 (3.7); 7.1197 (3.6); 7.1178 (3.6); 7.1139 (2.6); 7.1101 (4.2); 7.1083 (4.4); 7.1060 (4.7); 7.0940 (6.3); 7.0905 (4.8); 7.0793 (2.2); 7.0753 (1.8); 7.0686 (1.8); 7.0640 (1.9); 7.0586 (1.4); 7.0516 (1.4); 7.0476 (1.4); 7.0340 (0.9); 6.9970 (1.1); 5.3002 (16.0); 4.2685 (0.8); 4.2291 (0.7); 3.7638 (0.9); 3.7533 (0.6); 3.7471 (2.2); 3.7410 (0.7); 3.7326 (0.5); 3.7305 (0.9); 3.5961 (3.4); 3.5109 (0.6); 3.3060 (0.6); 3.2447 (1.1); 3.2258 (2.6); 3.2070 (1.3); 3.1012 (0.5); 3.0267 (0.8); 3.0097 (0.6); 2.5381 (0.5); 2.4932 (0.7); 2.4782 (0.6); 2.4704 (0.6); 2.4509 (0.9); 2.4310 (0.7); 2.2718 (0.8); 2.2260 (9.2); 2.2079 (4.1); 2.1890 (1.9); 2.1757 (0.7); 2.1472 (0.8); 2.1410 (0.5); 2.1308 (1.0); 2.1281 (0.8); 2.1210 (1.2); 2.1123 (0.9); 2.1090 (0.9); 2.1006 (1.6); 2.0916 (1.1); 2.0779 (1.0); 2.0721 (1.0); 2.0557 (0.9); 2.0427 (0.8); 2.0276 (0.6); 2.0199 (0.6); 1.9722 (0.6); 1.9649 (0.6); 1.9576 (0.6); 1.9457 (0.6); 1.9369 (0.6); 1.9238 (0.8); 1.9182 (0.9); 1.9131 (0.8); 1.8967 (1.6); 1.8742 (2.1); 1.8703 (2.1); 1.8626 (1.9); 1.8581 (1.6); 1.8536 (3.8); 1.8446 (1.8); 1.8369 (2.0); 1.8236 (1.0); 1.8146 (1.0); 1.8072 (1.2); 1.7959 (0.7); 1.7848 (0.9); 1.7658 (0.9); 1.7592 (1.0); 1.7458 (1.1); 1.7419 (1.2); 1.7148 (1.5); 1.6934 (1.2); 1.6730 (0.5); 1.5529 (51.4); 1.4322 (8.1); 1.3069 (0.7); 1.2890 (0.6); 1.2548 (1.8); 1.1487 (0.5); 0.0079 (3.4); -0.0002 (160.2); -0.0052 (3.2); -0.0060 (2.6); -0.0068 (2.2); -0.0085 (5.4); -0.0108 (1.4); -0.0124 (1.0); -0.0132 (1.0); -0.0139 (0.8); -0.0148 (0.8); -0.0164 (0.6); -0.0172 (0.6); -0.0180 (0.6); -0.0187 (0.6); -
0.0196 (0.6); -0.0204 (0.6); -0.0228 (0.6); -0.1494 (0.5) 0.0196 (0.6); -0.0204 (0.6); -0.0228 (0.6); -0.1494 (0.5)
1.26-23: Ή-ΝΜΙΙ(400.0 MHz, CDC13):  1.26-23: Ή-ΝΜΙΙ (400.0 MHz, CDC13):
δ= 9.5148 (3.4); 7.8458 (5.9); 7.8425 (8.8); 7.8390 (6.3); 7.5190 (1.7); 7.3541 (0.8); 7.3349 (27.4); 7.3321 (16.7); 7.3309 (16.8); 7.3089 (0.8); 7.3034 (0.7); 7.2835 (0.5); 7.2827 (0.5); 7.2811 (0.6); 7.2795 (0.7); 7.2787 (0.7); 7.2779 (0.7); 7.2771 (0.8); 7.2764 (0.8); 7.2756 (0.8); 7.2747 (0.8); 7.2740 (0.9); 7.2731 (0.9); 7.2723 (1.2); 7.2716 (1.3); 7.2708 (1.4); 7.2700 (1.6); 7.2692 (1.7); 7.2684 (2.0); 7.2676 (2.3); 7.2668 (2.6); 7.2660 (3.2); 7.2651 (3.9); 7.2643 (5.0); 7.2635 (6.8); 7.2601 (318.3); 7.2538 (2.0); 7.2522 (0.9); 7.2513 (0.8); 7.2505 (0.6); 7.2497 (0.6); 6.9961 (1.7); 5.7751 (2.6); 5.2986 (1.7); 3.7982 (16.0); 3.7508 (1.0); 3.5161 (1.0); 3.5082 (2.4); 3.4954 (1.2); 3.4923 (1.2); 3.4841 (5.9); 3.4763 (1.3); 3.4600 (3.0); 3.2063 (1.3); 3.1950 (3.2); 3.1820 (7.9); 3.1773 (4.3); 3.1710 (3.2); 3.1607 (7.9); 3.1526 (3.4); 3.0965 (0.6); 3.0749 (0.8); 3.0523 (0.6); 3.0130 (1.2); 2.9951 (2.3); 2.9913 (2.0); 2.9733 (3.4); 2.9554 (1.8); 2.9515 (1.8); 2.9336 (0.8); 2.7553 (0.5); 2.0050 (0.7); 1.8039 (2.3); 1.7960 (2.5); 1.7720 (3.0); 1.7651 (3.0); 1.7135 (3.6); 1.6882 (4.6); 1.6013 (0.9); 1.5932 (1.0); 1.5558 (6.4); 1.5265 (1.0); 1.5176 (1.0); 1.3333 (0.5); 1.2991 (0.9); 1.2732 (2.6); 1.2678 (2.5); 1.2573 (2.0); 1.2410 (3.3); 1.2358 (3.5); 1.2054 (4.0); 1.1832 (1.9); 1.1751 (2.5); 1.1674 (1.8); 1.1440 (2.2); 1.1353 (1.8); 1.1028 (2.1); 1.0784 (2.2); 1.0724 (2.0); 1.0464 (2.2); 1.0231 (1.6); 1.0156 (1.7); 0.9938 (0.9); 0.9846 (0.9); 0.0079 (3.5); 0.0063 (1.1); 0.0055 (1.2); 0.0047 (1.4); 0.0039 (1.8); 0.0022 (4.8); -0.0002 (110.9); -0.0027 (5.8); -0.0043 (2.4); -0.0051 (1.8); -0.0060 (1.3); -0.0068 (1.1); -0.0085 (3.2) δ = 9.5148 (3.4); 7.8458 (5.9); 7.8425 (8.8); 7.8390 (6.3); 7.5190 (1.7); 7.3541 (0.8); 7.3349 (27.4); 7.3321 (16.7); 7.3309 (16.8); 7.3089 (0.8); 7.3034 (0.7); 7.2835 (0.5); 7.2827 (0.5); 7.2811 (0.6); 7.2795 (0.7); 7.2787 (0.7); 7.2779 (0.7); 7.2771 (0.8); 7.2764 (0.8); 7.2756 (0.8); 7.2747 (0.8); 7.2740 (0.9); 7.2731 (0.9); 7.2723 (1.2); 7.2716 (1.3); 7.2708 (1.4); 7.2700 (1.6); 7.2692 (1.7); 7.2684 (2.0); 7.2676 (2.3); 7.2668 (2.6); 7.2660 (3.2); 7.2651 (3.9); 7.2643 (5.0); 7.2635 (6.8); 7.2601 (318.3); 7.2538 (2.0); 7.2522 (0.9); 7.2513 (0.8); 7.2505 (0.6); 7.2497 (0.6); 6.9961 (1.7); 5.7751 (2.6); 5.2986 (1.7); 3.7982 (16.0); 3.7508 (1.0); 3.5161 (1.0); 3.5082 (2.4); 3.4954 (1.2); 3.4923 (1.2); 3.4841 (5.9); 3.4763 (1.3); 3.4600 (3.0); 3.2063 (1.3); 3.1950 (3.2); 3.1820 (7.9); 3.1773 (4.3); 3.1710 (3.2); 3.1607 (7.9); 3.1526 (3.4); 3.0965 (0.6); 3.0749 (0.8); 3.0523 (0.6); 3.0130 (1.2); 2.9951 (2.3); 2.9913 (2.0); 2.9733 (3.4); 2.9554 (1.8); 2.9515 (1.8); 2.9336 (0.8); 2.7553 (0.5); 2.0050 (0.7); 1.8039 (2.3); 1.7960 (2.5); 1.7720 (3.0); 1.7651 (3.0); 1.7135 (3.6); 1.6882 (4.6); 1.6013 (0.9); 1.5932 (1.0); 1.5558 (6.4); 1.5265 (1.0); 1.5176 (1.0); 1.3333 (0.5); 1.2991 (0.9); 1.2732 (2.6); 1.2678 (2.5); 1.2573 (2.0); 1.2410 (3.3); 1.2358 (3.5); 1.2054 (4.0); 1.1832 (1.9); 1.1751 (2.5); 1.1674 (1.8); 1.1440 (2.2); 1.1353 (1.8); 1.1028 (2.1); 1.0784 (2.2); 1.0724 (2.0); 1.0464 (2.2); 1.0231 (1.6); 1.0156 (1.7); 0.9938 (0.9); 0.9846 (0.9); 0.0079 (3.5); 0.0063 (1.1); 0.0055 (1.2); 0.0047 (1.4); 0.0039 (1.8); 0.0022 (4.8); -0.0002 (110.9); -0.0027 (5.8); -0.0043 (2.4); -0.0051 (1.8); -0.0060 (1.3); -0.0068 (1.1); -0.0085 (3.2)
1.3- 23: 1H-NMR(400.0 MHz, CDC13): 1.3- 23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.4571 (4.3); 7.5473 (3.4); 7.5418 (5.3); 7.5362 (3.4); 7.5199 (4.1); 7.5143 (5.2); 7.5087 (3.2); 7.2732 (0.5); 7.2725 (0.6); 7.2717 (0.7); 7.2709 (0.7); 7.2701 (0.8); 7.2693 (0.9); 7.2685 (1.0); 7.2677 (1.2); 7.2669 (1.4); 7.2661 (1.7); 7.2653 (2.1); 7.2610 (145.3); 7.2538 (2.9); 7.2378 (2.5); 7.2333 (6.3); 7.2176 (6.1); 7.2130 (4.9); 7.1976 (4.8); 7.1811 (6.0); 7.1781 (7.9); 7.1764 (6.9); 7.1734 (6.7); 7.1608 (3.3); 7.1577 (3.3); 7.1559 (3.6); 7.1530 (2.9); 6.9970 (0.8); 6.7979 (2.4); 6.7953 (2.5); 6.7916 (2.4); 6.7890 (2.3); 6.7773 (4.2); 6.7743 (3.9); 6.7710 (4.3); 6.7683 (3.7); 6.7572 (2.2); 6.7540 (2.3); 6.7507 (2.2); 6.7477 (2.0); 6.0164 (2.8); 5.2980 (16.0); 3.8768 (0.6); 3.8160 (0.5); 3.7977 (2.4); 3.7931 (0.8); 3.7913 (1.3); 3.7497 (9.0); 3.5075 (3.2); 3.5058 (3.2); 3.4831 (7.4); 3.4592 (4.2); 3.3965 (0.6); 3.3705 (1.3); 3.3494 (1.2); 3.1875 (8.3); 3.1828 (4.7); 3.1662 (12.7); 3.1584 (3.9); 3.1402 (4.2); 3.0273 (1.6); 3.0094 (3.2); 3.0057 (2.7); 2.9879 (4.3); 2.9701 (2.1); 2.9664 (2.4); 2.9484 (1.0); 2.2637 (0.6); 2.0436 (1.5); 1.7950 (3.1); 1.7868 (3.4); 1.7632 (4.0); 1.7556 (4.0); 1.7023 (5.3); 1.6946 (5.2); 1.6909 (5.3); 1.6868 (5.3); 1.6056 (1.5); 1.5808 (0.9); 1.5724 (1.0); 1.5628 (1.0); 1.5515 (1.6); 1.5434 (2.0); 1.5340 (1.8); 1.5251 (2.0); 1.5151 (1.5); 1.5052 (1.1); 1.4966 (1.1); 1.2984 (1.2); 1.2912 (1.4); 1.2841 (1.4); 1.2664 (4.8); 1.2584 (5.4); 1.2405 (2.9); 1.2352 (4.6); 1.2284 (4.6); 1.1990 (4.9); 1.1784 (1.9); 1.1710 (3.0); 1.1633 (2.3); 1.1477 (1.3); 1.1396 (2.7); 1.1311 (2.4); 1.1058 (2.4); 1.0997 (2.8); 1.0747 (2.9); 1.0687 (2.4); 1.0511 (2.5); 1.0435 (3.0); 1.0204 (2.0); 1.0126 (2.2); 0.9902 (1.0); 0.9818 (0.9); 0.8989 (1.1); 0.8818 (3.4); 0.8641 (1.3); 0.0080 (1.5); 0.0040 (0.5); 0.0024 (1.7); -0.0002 (52.2); -δ = 9.4571 (4.3); 7.5473 (3.4); 7.5418 (5.3); 7.5362 (3.4); 7.5199 (4.1); 7.5143 (5.2); 7.5087 (3.2); 7.2732 (0.5); 7.2725 (0.6); 7.2717 (0.7); 7.2709 (0.7); 7.2701 (0.8); 7.2693 (0.9); 7.2685 (1.0); 7.2677 (1.2); 7.2669 (1.4); 7.2661 (1.7); 7.2653 (2.1); 7.2610 (145.3); 7.2538 (2.9); 7.2378 (2.5); 7.2333 (6.3); 7.2176 (6.1); 7.2130 (4.9); 7.1976 (4.8); 7.1811 (6.0); 7.1781 (7.9); 7.1764 (6.9); 7.1734 (6.7); 7.1608 (3.3); 7.1577 (3.3); 7.1559 (3.6); 7.1530 (2.9); 6.9970 (0.8); 6.7979 (2.4); 6.7953 (2.5); 6.7916 (2.4); 6.7890 (2.3); 6.7773 (4.2); 6.7743 (3.9); 6.7710 (4.3); 6.7683 (3.7); 6.7572 (2.2); 6.7540 (2.3); 6.7507 (2.2); 6.7477 (2.0); 6.0164 (2.8); 5.2980 (16.0); 3.8768 (0.6); 3.8160 (0.5); 3.7977 (2.4); 3.7931 (0.8); 3.7913 (1.3); 3.7497 (9.0); 3.5075 (3.2); 3.5058 (3.2); 3.4831 (7.4); 3.4592 (4.2); 3.3965 (0.6); 3.3705 (1.3); 3.3494 (1.2); 3.1875 (8.3); 3.1828 (4.7); 3.1662 (12.7); 3.1584 (3.9); 3.1402 (4.2); 3.0273 (1.6); 3.0094 (3.2); 3.0057 (2.7); 2.9879 (4.3); 2.9701 (2.1); 2.9664 (2.4); 2.9484 (1.0); 2.2637 (0.6); 2.0436 (1.5); 1.7950 (3.1); 1.7868 (3.4); 1.7632 (4.0); 1.7556 (4.0); 1.7023 (5.3); 1.6946 (5.2); 1.6909 (5.3); 1.6868 (5.3); 1.6056 (1.5); 1.5808 (0.9); 1.5724 (1.0); 1.5628 (1.0); 1.5515 (1.6); 1.5434 (2.0); 1.5340 (1.8); 1.5251 (2.0); 1.5151 (1.5); 1.5052 (1.1); 1.4966 (1.1); 1.2984 (1.2); 1.2912 (1.4); 1.2841 (1.4); 1.2664 (4.8); 1.2584 (5.4); 1.2405 (2.9); 1.2352 (4.6); 1.2284 (4.6); 1.1990 (4.9); 1.1784 (1.9); 1.1710 (3.0); 1.1633 (2.3); 1.1477 (1.3); 1.1396 (2.7); 1.1311 (2.4); 1.1058 (2.4); 1.0997 (2.8); 1.0747 (2.9); 1.0687 (2.4); 1.0511 (2.5); 1.0435 (3.0); 1.0204 (2.0); 1.0126 (2.2); 0.9902 (1.0); 0.9818 (0.9); 0.8989 (1.1); 0.8818 (3.4); 0.8641 (1.3); 0.0080 (1.5); 0.0040 (0.5); 0.0024 (1.7); -0.0002 (52.2); -
0.0085 (1.5) 0.0085 (1.5)
1.35-29: 1H-NMR(400.0 MHz, CDC13): 1.35-29: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.6736 (7.1); 8.0621 (9.6); 8.0579 (14.7); 7.6787 (6.3); 7.6736 (10.0); 7.6687 (6.4); 7.6599 (6.7); 7.6547 (10.3); 7.6496 (7.2); 7.5191 (2.4); 7.4502 (0.8); 7.4142 (5.0); 7.3950 (15.0); 7.3764 (23.5); 7.3721 (19.1); 7.3683 (12.7); 7.3571 (3.9); 7.3533 (4.8); 7.3492 (2.2); 7.3108 (0.8); 7.2601 (450.8); 7.2105 (1.6); 6.9961 (2.6); 5.7347 (5.8); 4.1485 (0.7); 4.1305 (2.1); 4.1127 (2.1); 4.0951 (0.7); 3.5626 (0.9); 3.5157 (4.6); 3.4922 (10.4); 3.4694 (5.6); 3.1927 (10.3); 3.1842 (6.4); 3.1717 (16.0); 3.1671 (9.6); 3.1605 (4.6); 3.1429 (8.2); 3.1243 (3.8); 3.1106 (3.7); 3.1033 (4.8); 3.0892 (5.0); 3.0719 (2.6); 3.0502 (1.4); 2.0438 (9.8); 1.8603 (1.6); 1.8356 (3.1); 1.8278 (3.0); 1.8206 (3.0); 1.7547 (5.1); 1.7367 (13.5); 1.7095 (11.6); 1.6230 (4.6); 1.6024 (5.6); 1.5494 (47.4); 1.5361 (5.0); 1.5104 (6.8); 1.4966 (8.5); 1.4791 (8.3); 1.3613 (1.0); 1.3199 (4.2); 1.3133 (3.3); 1.3033 (4.0); 1.2947 (5.4); 1.2880 (5.8); 1.2765 (4.7); 1.2701 (4.2); 1.2629 (5.8); 1.2587 (7.7); 1.2408 (3.5); 0.8820 (0.8); 0.1460 (1.0); 0.0080 (7.1); -0.0002 (246.3); -0.0085 (7.5); -0.0497 (1.0); -0.1496 (0.9) 1.38-23: Ή-ΝΜΙΙ(400.0 MHz, CDC13): δ = 9.6736 (7.1); 8.0621 (9.6); 8.0579 (14.7); 7.6787 (6.3); 7.6736 (10.0); 7.6687 (6.4); 7.6599 (6.7); 7.6547 (10.3); 7.6496 (7.2); 7.5191 (2.4); 7.4502 (0.8); 7.4142 (5.0); 7.3950 (15.0); 7.3764 (23.5); 7.3721 (19.1); 7.3683 (12.7); 7.3571 (3.9); 7.3533 (4.8); 7.3492 (2.2); 7.3108 (0.8); 7.2601 (450.8); 7.2105 (1.6); 6.9961 (2.6); 5.7347 (5.8); 4.1485 (0.7); 4.1305 (2.1); 4.1127 (2.1); 4.0951 (0.7); 3.5626 (0.9); 3.5157 (4.6); 3.4922 (10.4); 3.4694 (5.6); 3.1927 (10.3); 3.1842 (6.4); 3.1717 (16.0); 3.1671 (9.6); 3.1605 (4.6); 3.1429 (8.2); 3.1243 (3.8); 3.1106 (3.7); 3.1033 (4.8); 3.0892 (5.0); 3.0719 (2.6); 3.0502 (1.4); 2.0438 (9.8); 1.8603 (1.6); 1.8356 (3.1); 1.8278 (3.0); 1.8206 (3.0); 1.7547 (5.1); 1.7367 (13.5); 1.7095 (11.6); 1.6230 (4.6); 1.6024 (5.6); 1.5494 (47.4); 1.5361 (5.0); 1.5104 (6.8); 1.4966 (8.5); 1.4791 (8.3); 1.3613 (1.0); 1.3199 (4.2); 1.3133 (3.3); 1.3033 (4.0); 1.2947 (5.4); 1.2880 (5.8); 1.2765 (4.7); 1.2701 (4.2); 1.2629 (5.8); 1.2587 (7.7); 1.2408 (3.5); 0.8820 (0.8); 0.1460 (1.0); 0.0080 (7.1); -0.0002 (246.3); -0.0085 (7.5); -0.0497 (1.0); -0.1496 (0.9) 1.38-23: Ή-ΝΜΙΙ (400.0 MHz, CDC13):
δ= 9.6126 (3.4); 7.9312 (6.1); 7.6725 (2.8); 7.6522 (3.2); 7.5198 (0.6); 7.4053 (2.1); 7.3857 (5.0); 7.3657 (3.2); 7.3255 (4.6); 7.3059 (2.6); 7.2608 (116.7); 7.2111 (0.5); 6.9968 (0.6); 5.9929 (2.4); 5.2981 (16.0); 3.7979 (2.8); 3.7915 (0.7); 3.7497 (6.4); 3.5215 (2.2); 3.4988 (5.3); 3.4747 (2.9); 3.3715 (0.9); 3.3505 (1.0); 3.3434 (0.6); 3.2177 (6.0); 3.1969 (9.3); 3.1805 (3.6); 3.1746 (2.7); 3.1563 (3.1); 3.0398 (1.1); 3.0218 (2.3); 3.0181 (2.0); 3.0001 (3.3); 2.9820 (1.6); 2.9786 (1.8); 2.9604 (0.7); 1.7988 (2.2); 1.7906 (2.4); 1.7672 (2.9); 1.7591 (2.8); 1.7060 (4.1); 1.6954 (4.2); 1.6757 (3.8); 1.5942 (0.9); 1.5865 (1.0); 1.5774 (0.9); 1.5662 (1.3); 1.5577 (1.6); 1.5483 (1.4); 1.5394 (1.6); 1.5311 (1.2); 1.5195 (0.9); 1.5109 (0.8); 1.3028 (0.9); 1.2953 (0.9); 1.2702 (2.8); 1.2636 (3.1); 1.2585 (2.5); 1.2460 (2.0); 1.2390 (3.3); 1.2323 (3.3); 1.2027 (3.6); 1.1806 (1.5); 1.1733 (2.2); 1.1656 (1.6); 1.1421 (2.1); 1.1346 (1.9); 1.1105 (1.9); 1.1040 (2.0); 1.0797 (2.2); 1.0736 (1.8); 1.0559 (1.8); 1.0483 (2.2); 1.0253 (1.4); 1.0173 (1.6); 0.9951 (0.6); 0.9869 (0.7); 0.8988 (0.6); 0.8818 (1.6); 0.8641 (0.6); 0.0079 (1.2);δ = 9.6126 (3.4); 7.9312 (6.1); 7.6725 (2.8); 7.6522 (3.2); 7.5198 (0.6); 7.4053 (2.1); 7.3857 (5.0); 7.3657 (3.2); 7.3255 (4.6); 7.3059 (2.6); 7.2608 (116.7); 7.2111 (0.5); 6.9968 (0.6); 5.9929 (2.4); 5.2981 (16.0); 3.7979 (2.8); 3.7915 (0.7); 3.7497 (6.4); 3.5215 (2.2); 3.4988 (5.3); 3.4747 (2.9); 3.3715 (0.9); 3.3505 (1.0); 3.3434 (0.6); 3.2177 (6.0); 3.1969 (9.3); 3.1805 (3.6); 3.1746 (2.7); 3.1563 (3.1); 3.0398 (1.1); 3.0218 (2.3); 3.0181 (2.0); 3,0001 (3.3); 2.9820 (1.6); 2.9786 (1.8); 2.9604 (0.7); 1.7988 (2.2); 1.7906 (2.4); 1.7672 (2.9); 1.7591 (2.8); 1.7060 (4.1); 1.6954 (4.2); 1.6757 (3.8); 1.5942 (0.9); 1.5865 (1.0); 1.5774 (0.9); 1.5662 (1.3); 1.5577 (1.6); 1.5483 (1.4); 1.5394 (1.6); 1.5311 (1.2); 1.5195 (0.9); 1.5109 (0.8); 1.3028 (0.9); 1.2953 (0.9); 1.2702 (2.8); 1.2636 (3.1); 1.2585 (2.5); 1.2460 (2.0); 1.2390 (3.3); 1.2323 (3.3); 1.2027 (3.6); 1.1806 (1.5); 1.1733 (2.2); 1.1656 (1.6); 1.1421 (2.1); 1.1346 (1.9); 1.1105 (1.9); 1.1040 (2.0); 1.0797 (2.2); 1.0736 (1.8); 1.0559 (1.8); 1.0483 (2.2); 1.0253 (1.4); 1.0173 (1.6); 0.9951 (0.6); 0.9869 (0.7); 0.8988 (0.6); 0.8818 (1.6); 0.8641 (0.6); 0.0079 (1.2);
0.0038 (0.7); -0.0002 (41.8); -0.0027 (2.1); -0.0043 (0.9); -0.0052 (0.6); -0.0060 (0.5); -0.0085 (1.2) 0.0038 (0.7); -0.0002 (41.8); -0.0027 (2.1); -0.0043 (0.9); -0.0052 (0.6); -0.0060 (0.5); -0.0085 (1.2)
1.38-29: Ή-ΝΜϋ^ΟΟ.Ο MHz, CDC13):  1.38-29: Ή-ΝΜϋ ^ ΟΟ.Ο MHz, CDC13):
δ= 9.6023 (6.4); 7.9495 (12.8); 7.7013 (6.2); 7.6805 (7.0); 7.5183 (6.9); 7.4397 (5.0); 7.4201 (11.0); 7.4000 (7.1); 7.3532 (9.5); 7.3428 (2.0); 7.3338 (5.9); 7.3104 (1.2); 7.2928 (0.8); 7.2595 (1234.3); 7.2285 (1.0); 7.2099 (2.5); 6.9955 (7.0); 5.6489 (5.6); 3.5054 (5.1); 3.4827 (11.2); 3.4612 (6.4); 3.1915 (9.8); 3.1821 (6.6); 3.1710 (16.0); 3.1651 (10.1); 3.1423 (9.4); 3.1264 (4.3); 3.1191 (5.5); 3.1054 (5.4); 3.0884 (2.6); 3.0671 (1.4); 2.0049 (0.7); 1.8415 (3.3); 1.7411 (13.4); 1.7112 (11.6); 1.6243 (5.0); 1.6080 (6.0); 1.5913 (5.4); 1.5587 (3.3); 1.5355 (210.1); 1.5016 (9.5); 1.4802 (10.6); 1.4606 (5.5); 1.3493 (2.3); 1.3236 (5.4); 1.3155 (4.5); 1.2987 (6.3); 1.2902 (7.6); 1.2652 (13.7); 1.2406 (3.0); 0.8988 (4.5); 0.8819 (15.8); 0.8642 (6.1); 0.1461 (2.4);δ = 9.6023 (6.4); 7.9495 (12.8); 7.7013 (6.2); 7.6805 (7.0); 7.5183 (6.9); 7.4397 (5.0); 7.4201 (11.0); 7.4000 (7.1); 7.3532 (9.5); 7.3428 (2.0); 7.3338 (5.9); 7.3104 (1.2); 7.2928 (0.8); 7.2595 (1234.3); 7.2285 (1.0); 7.2099 (2.5); 6.9955 (7.0); 5.6489 (5.6); 3.5054 (5.1); 3.4827 (11.2); 3.4612 (6.4); 3.1915 (9.8); 3.1821 (6.6); 3.1710 (16.0); 3.1651 (10.1); 3.1423 (9.4); 3.1264 (4.3); 3.1191 (5.5); 3.1054 (5.4); 3.0884 (2.6); 3.0671 (1.4); 2.0049 (0.7); 1.8415 (3.3); 1.7411 (13.4); 1.7112 (11.6); 1.6243 (5.0); 1.6080 (6.0); 1.5913 (5.4); 1.5587 (3.3); 1.5355 (210.1); 1.5016 (9.5); 1.4802 (10.6); 1.4606 (5.5); 1.3493 (2.3); 1.3236 (5.4); 1.3155 (4.5); 1.2987 (6.3); 1.2902 (7.6); 1.2652 (13.7); 1.2406 (3.0); 0.8988 (4.5); 0.8819 (15.8); 0.8642 (6.1); 0.1461 (2.4);
0.0080 (20.0); -0.0002 (712.4); -0.0085 (21.8); -0.0499 (1.4); -0.1496 (2.4) 0.0080 (20.0); -0.0002 (712.4); -0.0085 (21.8); -0.0499 (1.4); -0.1496 (2.4)
1.4-23: 1H-NMR(400.0 MHz, CDC13): 1.4-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.3147 (4.9); 7.5361 (1.1); 7.5273 (11.5); 7.5217 (4.1); 7.5153 (12.0); 7.5100 (7.0); 7.5045 (12.9); 7.4982 (4.2); 7.4925 (12.4); 7.4838 (1.3); 7.2703 (0.8); 7.2612 (163.0); 7.2114 (0.9); 7.0119 (1.3); 7.0032 (12.2); 6.9973 (4.6); 6.9912 (1.7); 6.9860 (4.4); 6.9820 (16.0); 6.9768 (4.4); 6.9716 (1.5); 6.9653 (3.5); 6.9596 (11.0); 6.9508 (1.0); 5.9305 (3.6); 5.2981 (14.2); 4.7837 (15.0); 4.1303 (0.8); 4.1125 (0.9); 3.7976 (3.6); 3.7492 (0.5); 3.5039 (3.6); 3.4815 (8.3); 3.4577 (4.5); 3.1835 (5.2); 3.1776 (9.4); 3.1658 (6.0); 3.1571 (13.2); 3.1417 (4.8); 3.0308 (1.8); 3.0131 (3.6); 3.0092 (3.0); 2.9916 (4.9); 2.9738 (2.4); 2.9702 (2.8); 2.9525 (1.1); 2.0436 (4.0); 2.0039 (1.1); 1.7952 (3.4); 1.7870 (3.7); 1.7634 (4.4); 1.7560 (4.3); 1.7025 (6.3); 1.6945 (5.6); 1.6747 (5.9); 1.5982 (6.7); 1.5800 (1.3); 1.5709 (1.2); 1.5591 (1.8); 1.5508 (2.3); 1.5420 (2.1); 1.5331 (2.3); 1.5245 (1.7); 1.5128 (1.3); 1.5045 (1.2); 1.2990 (1.1); 1.2924 (1.2); 1.2842 (1.0); 1.2761 (3.0); 1.2675 (4.0); 1.2584 (5.9); 1.2404 (3.6); 1.2362 (4.9); 1.2293 (4.8); 1.1998 (5.2); 1.1779 (1.8); 1.1704 (3.2); 1.1626 (2.2); 1.1393 (3.1); 1.1315 (2.8); 1.1078 (2.8); 1.1010 (3.1); 1.0764 (3.2); 1.0701 (2.7); 1.0525 (2.7); 1.0455 (3.3); 1.0220 (2.2); 1.0146 (2.4); 0.9920 (1.0); 0.9834 (0.9); 0.8817 (0.8); 0.0079 (1.6); -0.0002 (56.8); -0.0085 (1.7) δ = 9.3147 (4.9); 7.5361 (1.1); 7.5273 (11.5); 7.5217 (4.1); 7.5153 (12.0); 7.5100 (7.0); 7.5045 (12.9); 7.4982 (4.2); 7.4925 (12.4); 7.4838 (1.3); 7.2703 (0.8); 7.2612 (163.0); 7.2114 (0.9); 7.0119 (1.3); 7.0032 (12.2); 6.9973 (4.6); 6.9912 (1.7); 6.9860 (4.4); 6.9820 (16.0); 6.9768 (4.4); 6.9716 (1.5); 6.9653 (3.5); 6.9596 (11.0); 6.9508 (1.0); 5.9305 (3.6); 5.2981 (14.2); 4.7837 (15.0); 4.1303 (0.8); 4.1125 (0.9); 3.7976 (3.6); 3.7492 (0.5); 3.5039 (3.6); 3.4815 (8.3); 3.4577 (4.5); 3.1835 (5.2); 3.1776 (9.4); 3.1658 (6.0); 3.1571 (13.2); 3.1417 (4.8); 3.0308 (1.8); 3.0131 (3.6); 3.0092 (3.0); 2.9916 (4.9); 2.9738 (2.4); 2.9702 (2.8); 2.9525 (1.1); 2.0436 (4.0); 2.0039 (1.1); 1.7952 (3.4); 1.7870 (3.7); 1.7634 (4.4); 1.7560 (4.3); 1.7025 (6.3); 1.6945 (5.6); 1.6747 (5.9); 1.5982 (6.7); 1.5800 (1.3); 1.5709 (1.2); 1.5591 (1.8); 1.5508 (2.3); 1.5420 (2.1); 1.5331 (2.3); 1.5245 (1.7); 1.5128 (1.3); 1.5045 (1.2); 1.2990 (1.1); 1.2924 (1.2); 1.2842 (1.0); 1.2761 (3.0); 1.2675 (4.0); 1.2584 (5.9); 1.2404 (3.6); 1.2362 (4.9); 1.2293 (4.8); 1.1998 (5.2); 1.1779 (1.8); 1.1704 (3.2); 1.1626 (2.2); 1.1393 (3.1); 1.1315 (2.8); 1.1078 (2.8); 1.1010 (3.1); 1.0764 (3.2); 1.0701 (2.7); 1.0525 (2.7); 1.0455 (3.3); 1.0220 (2.2); 1.0146 (2.4); 0.9920 (1.0); 0.9834 (0.9); 0.8817 (0.8); 0.0079 (1.6); -0.0002 (56.8); -0.0085 (1.7)
1.43- 23: 1H-NMR(400.0 MHz, CDC13): 1.43-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.6049 (5.7); 8.3090 (8.0); 8.3067 (8.7); 8.3042 (8.9); 8.3020 (8.5); 8.2967 (8.4); 8.2945 (9.0); 8.2919 (8.5); 8.2897 (7.6); 8.1886 (0.6); 8.1712 (8.2); 8.1688 (14.9); 8.1665 (8.6); 8.1503 (9.1); 8.1479 (16.0); 8.1455 (8.8); 8.1379 (0.8); 8.1170 (0.8); 8.0969 (0.6); 8.0942 (0.6); 8.0838 (0.9); 8.0812 (0.9); 8.0236 (1.4); 8.0125 (1.4); 8.0104 (1.4); 7.7114 (0.6); 7.7007 (6.4); 7.6959 (6.7); 7.6822 (7.4); 7.6797 (7.5); 7.6776 (8.1); 7.6752 (6.7); 7.6614 (6.0); 7.6566 (5.8); 7.5216 (1.3); 7.4967 (0.8); 7.4921 (0.8); 7.4756 (1.4); 7.4577 (0.9); 7.4532 (1.3); 7.4484 (0.6); 7.4352 (0.6); 7.4323 (0.7); 7.4306 (0.7); 7.4275 (0.8); 7.4144 (0.6); 7.4095 (0.8); 7.2626 (241.6); 7.2120 (1.2); 7.0522 (0.7); 7.0378 (9.6); 7.0352 (9.9); 7.0254 (9.2); 7.0229 (9.9); 7.0194 (9.4); 7.0168 (8.6); 7.0071 (8.8); 7.0045 (8.3); 6.9986 (1.5); 6.6854 (0.7); 6.6830 (0.8); 6.6782 (1.3); 6.6726 (0.8); 6.6702 (0.9); 6.6649 (2.1); 6.6546 (0.8); 6.6522 (0.8); 6.6469 (1.4); 6.5655 (2.0); 6.5635 (2.1); 6.5445 (1.9); 6.5425 (2.0); 6.5066 (0.7); 6.5044 (1.3); 6.4858 (0.7); 6.4835 (1.3); 6.4815 (1.0); 6.4797 (0.9); 6.4588 (0.7); 6.1941 (3.7); 5.4507 (0.6); 5.4418 (0.6); 5.3729 (0.8); 5.3508 (0.5); 5.2987 (5.0); 4.8938 (0.5); 3.8733 (1.8); 3.8395 (1.2); 3.8204 (14.2); 3.8164 (2.1); 3.7945 (3.3); 3.7867 (0.8); 3.7500 (1.1); 3.7232 (1.0); 3.5899 (1.1); 3.5107 (5.1); 3.5090 (5.2); 3.4867 (11.7); 3.4754 (3.3); 3.4627 (6.4); 3.4363 (0.6); 3.3214 (0.7); 3.3158 (1.7); 3.3106 (0.8); 3.3033 (1.7); 3.2251 (12.1); 3.2038 (14.7); 3.1818 (0.5); 3.1652 (6.5); 3.1468 (8.2); 3.1414 (6.1); 3.1229 (7.1); 3.0217 (2.4); 3.0031 (5.2); 3.0003 (4.8); 2.9816 (7.6); 2.9630 (3.9); 2.9601 (4.1); 2.9415 (1.6); 2.0525 (0.6); 2.0396 (0.5); 1.8621 (3.2); 1.7772 (6.1); 1.7681 (6.5); 1.7600 (6.8); 1.7525 (7.1); 1.7490 (7.1); 1.6929 (11.0); 1.6649 (8.7); 1.5641 (0.8); 1.5481 (1.4); 1.5401 (1.8); 1.5311 (1.6); 1.5201 (2.9); 1.5117 (3.7); 1.5020 (2.9); 1.4925 (3.7); 1.4834 (2.9); 1.4725 (1.7); 1.4641 (2.0); 1.4562 (1.1); 1.3334 (0.5); 1.3261 (0.7); 1.3075 (0.8); 1.2899 (2.3); 1.2828 (2.7); 1.2746 (2.2); 1.2650 (4.7); 1.2572 (8.6); 1.2511 (6.0); 1.2435 (3.4); 1.2392 (3.3); 1.2342 (4.7); 1.2266 (8.2); 1.2194 (7.9); 1.1950 (9.5); 1.1738 (3.4); 1.1669 (5.4); 1.1595 (4.0); 1.1424 (2.9); 1.1359 (4.2); 1.1287 (4.4); 1.1211 (3.7); 1.0974 (4.3); 1.0909 (4.7); 1.0702 (4.4); 1.0601 (4.1); 1.0482 (4.5); 1.0401 (5.1); 1.0284 (2.2); 1.0181 (3.8); 1.0102 (3.8); 0.9876 (1.7); 0.9791 (1.7); 0.9494 (0.6); 0.9005 (0.6); 0.8801 (1.0); 0.8618 (0.8); 0.8208 (0.7); 0.0080 (2.8); - 0.0002 (96.9); -0.0085 (3.0); -0.0508 (0.5) δ = 9.6049 (5.7); 8.3090 (8.0); 8.3067 (8.7); 8.3042 (8.9); 8.3020 (8.5); 8.2967 (8.4); 8.2945 (9.0); 8.2919 (8.5); 8.2897 (7.6); 8.1886 (0.6); 8.1712 (8.2); 8.1688 (14.9); 8.1665 (8.6); 8.1503 (9.1); 8.1479 (16.0); 8.1455 (8.8); 8.1379 (0.8); 8.1170 (0.8); 8.0969 (0.6); 8.0942 (0.6); 8.0838 (0.9); 8.0812 (0.9); 8.0236 (1.4); 8.0125 (1.4); 8.0104 (1.4); 7.7114 (0.6); 7.7007 (6.4); 7.6959 (6.7); 7.6822 (7.4); 7.6797 (7.5); 7.6776 (8.1); 7.6752 (6.7); 7.6614 (6.0); 7.6566 (5.8); 7.5216 (1.3); 7.4967 (0.8); 7.4921 (0.8); 7.4756 (1.4); 7.4577 (0.9); 7.4532 (1.3); 7.4484 (0.6); 7.4352 (0.6); 7.4323 (0.7); 7.4306 (0.7); 7.4275 (0.8); 7.4144 (0.6); 7.4095 (0.8); 7.2626 (241.6); 7.2120 (1.2); 7.0522 (0.7); 7.0378 (9.6); 7.0352 (9.9); 7.0254 (9.2); 7.0229 (9.9); 7.0194 (9.4); 7.0168 (8.6); 7.0071 (8.8); 7.0045 (8.3); 6.9986 (1.5); 6.6854 (0.7); 6.6830 (0.8); 6.6782 (1.3); 6.6726 (0.8); 6.6702 (0.9); 6.6649 (2.1); 6.6546 (0.8); 6.6522 (0.8); 6.6469 (1.4); 6.5655 (2.0); 6.5635 (2.1); 6.5445 (1.9); 6.5425 (2.0); 6.5066 (0.7); 6.5044 (1.3); 6.4858 (0.7); 6.4835 (1.3); 6.4815 (1.0); 6.4797 (0.9); 6.4588 (0.7); 6.1941 (3.7); 5.4507 (0.6); 5.4418 (0.6); 5.3729 (0.8); 5.3508 (0.5); 5.2987 (5.0); 4.8938 (0.5); 3.8733 (1.8); 3.8395 (1.2); 3.8204 (14.2); 3.8164 (2.1); 3.7945 (3.3); 3.7867 (0.8); 3.7500 (1.1); 3.7232 (1.0); 3.5899 (1.1); 3.5107 (5.1); 3.5090 (5.2); 3.4867 (11.7); 3.4754 (3.3); 3.4627 (6.4); 3.4363 (0.6); 3.3214 (0.7); 3.3158 (1.7); 3.3106 (0.8); 3.3033 (1.7); 3.2251 (12.1); 3.2038 (14.7); 3.1818 (0.5); 3.1652 (6.5); 3.1468 (8.2); 3.1414 (6.1); 3.1229 (7.1); 3.0217 (2.4); 3.0031 (5.2); 3,0003 (4.8); 2.9816 (7.6); 2.9630 (3.9); 2.9601 (4.1); 2.9415 (1.6); 2.0525 (0.6); 2.0396 (0.5); 1.8621 (3.2); 1.7772 (6.1); 1.7681 (6.5); 1.7600 (6.8); 1.7525 (7.1); 1.7490 (7.1); 1.6929 (11.0); 1.6649 (8.7); 1.5641 (0.8); 1.5481 (1.4); 1.5401 (1.8); 1.5311 (1.6); 1.5201 (2.9); 1.5117 (3.7); 1.5020 (2.9); 1.4925 (3.7); 1.4834 (2.9); 1.4725 (1.7); 1.4641 (2.0); 1.4562 (1.1); 1.3334 (0.5); 1.3261 (0.7); 1.3075 (0.8); 1.2899 (2.3); 1.2828 (2.7); 1.2746 (2.2); 1.2650 (4.7); 1.2572 (8.6); 1.2511 (6.0); 1.2435 (3.4); 1.2392 (3.3); 1.2342 (4.7); 1.2266 (8.2); 1.2194 (7.9); 1.1950 (9.5); 1.1738 (3.4); 1.1669 (5.4); 1.1595 (4.0); 1.1424 (2.9); 1.1359 (4.2); 1.1287 (4.4); 1.1211 (3.7); 1.0974 (4.3); 1.0909 (4.7); 1.0702 (4.4); 1.0601 (4.1); 1.0482 (4.5); 1.0401 (5.1); 1.0284 (2.2); 1.0181 (3.8); 1.0102 (3.8); 0.9876 (1.7); 0.9791 (1.7); 0.9494 (0.6); 0.9005 (0.6); 0.8801 (1.0); 0.8618 (0.8); 0.8208 (0.7); 0.0080 (2.8); - 0.0002 (96.9); -0.0085 (3.0); -0.0508 (0.5)
1.44- 1 : 1H-NMR(400.0 MHz, CDC13): 1.44-1: 1 H NMR (400.0 MHz, CDC13):
δ= 9.5973 (8.1); 8.0995 (0.5); 8.0442 (8.6); 8.0241 (10.3); 7.8014 (4.6); 7.7811 (11.7); 7.7609 (11.3); 7.7410 (4.0); 7.5198 (0.9); 7.4204 (1.2); 7.4027 (1.8); 7.3461 (1.0); 7.3265 (1.9); 7.3079 (1.7); 7.2604 (156.0); 6.9964 (0.9); 6.7313 (0.6); 6.7144 (0.6); 6.6628 (9.3); 6.6570 (9.1); 6.6430 (9.3); 6.6371 (8.6); 6.3249 (5.4); 5.7724 (0.9); 5.7283 (0.9); 5.2581 (1.0); 5.2304 (1.0); 3.5957 (6.1); 3.5729 (11.8); 3.5499 (8.0); 3.4199 (0.6); 3.3121 (12.3); 3.2924 (13.6); 3.2412 (7.4); 3.2236 (8.9); 3.2171 (8.0); 3.1996 (7.2); 2.5401 (1.9); 2.5191 (5.4); 2.4998 (7.8); 2.4803 (5.9); 2.4590 (2.3); 2.1959 (0.7); 2.0448 (0.6); 1.3331 (0.5); 1.2573 (5.1); 0.9908 (0.9); 0.9780 (2.0); 0.9700 (3.1); 0.9577 (5.5); 0.9468 (5.3); 0.9365 (6.0); 0.9257 (4.3); 0.9161 (3.2); 0.9031 (2.1); 0.8805 (1.5); 0.5699 (15.8); 0.5498 (16.0); 0.5205 (4.5); 0.5080 (5.8); 0.4923 (7.1); 0.4818 (6.6); 0.4733 (6.0); 0.2812 (5.7); 0.2673 (6.5); 0.2533 (5.1); 0.1465 (0.7); -0.0002 (60.7); -0.1485 (0.5) 1.5-1 : 'H-NMR(400.0 MHz, CDC13): δ = 9.5973 (8.1); 8.0995 (0.5); 8.0442 (8.6); 8.0241 (10.3); 7.8014 (4.6); 7.7811 (11.7); 7.7609 (11.3); 7.7410 (4.0); 7.5198 (0.9); 7.4204 (1.2); 7.4027 (1.8); 7.3461 (1.0); 7.3265 (1.9); 7.3079 (1.7); 7.2604 (156.0); 6.9964 (0.9); 6.7313 (0.6); 6.7144 (0.6); 6.6628 (9.3); 6.6570 (9.1); 6.6430 (9.3); 6.6371 (8.6); 6.3249 (5.4); 5.7724 (0.9); 5.7283 (0.9); 5.2581 (1.0); 5.2304 (1.0); 3.5957 (6.1); 3.5729 (11.8); 3.5499 (8.0); 3.4199 (0.6); 3.3121 (12.3); 3.2924 (13.6); 3.2412 (7.4); 3.2236 (8.9); 3.2171 (8.0); 3.1996 (7.2); 2.5401 (1.9); 2.5191 (5.4); 2.4998 (7.8); 2.4803 (5.9); 2.4590 (2.3); 2.1959 (0.7); 2.0448 (0.6); 1.3331 (0.5); 1.2573 (5.1); 0.9908 (0.9); 0.9780 (2.0); 0.9700 (3.1); 0.9577 (5.5); 0.9468 (5.3); 0.9365 (6.0); 0.9257 (4.3); 0.9161 (3.2); 0.9031 (2.1); 0.8805 (1.5); 0.5699 (15.8); 0.5498 (16.0); 0.5205 (4.5); 0.5080 (5.8); 0.4923 (7.1); 0.4818 (6.6); 0.4733 (6.0); 0.2812 (5.7); 0.2673 (6.5); 0.2533 (5.1); 0.1465 (0.7); -0.0002 (60.7); -0.1485 (0.5) 1.5-1: 'H-NMR (400.0 MHz, CDC13):
δ= 9.6744 (3.1); 8.0448 (3.5); 8.0287 (5.6); 8.0241 (5.7); 8.0080 (3.6); 7.5182 (8.9); 7.2910 (1.7); 7.2721 (3.6); 7.2705 (4.2); 7.2690 (5.0); 7.2673 (6.9); 7.2665 (8.1); 7.2657 (10.0); 7.2649 (11.8); 7.2594 (1569.2); 7.2552 (47.9); 7.2544 (40.0); 7.2536 (33.9); 7.2528 (29.3); 7.2520 (25.6); 7.2512 (22.5); 7.2487 (14.3); 7.2479 (13.2); 7.2472 (12.9); 7.2455 (11.0); 7.2439 (9.6); 7.2424 (9.1); 7.2376 (7.0); 7.2360 (6.2); 7.2336 (6.3); 7.2289 (5.1); 7.2257 (5.8); 7.0607 (1.8); 7.0457 (4.6); 7.0400 (3.6); 7.0313 (3.6); 7.0250 (4.6); 7.0188 (2.4); 7.0104 (2.4); 7.0050 (2.5); 6.9953 (8.4); 6.9241 (2.9); 6.9201 (2.8); 6.8993 (5.2); 6.8846 (2.7); 6.8808 (4.7); 6.8597 (2.3); 6.8560 (2.1); 5.6454 (2.8); 3.5742 (4.4); 3.5522 (9.4); 3.5280 (5.0); 3.2982 (10.2); 3.2782 (11.1); 3.2203 (5.2); 3.2032 (5.8); 3.1972 (4.9); 3.1789 (5.2); 2.5506 (1.6); 2.5282 (4.1); 2.5109 (4.5); 2.4903 (3.5); 2.4694 (1.6); 1.5326 (228.3); 0.9781 (2.9); 0.9622 (2.8); 0.9554 (2.6); 0.9389 (2.2); 0.5878 (5.0); 0.5811 (16.0); 0.5752 (11.9); 0.5659 (13.8); 0.5610 (14.3); 0.5470 (5.2); 0.2954 (2.9); 0.2823 (4.7); 0.2693 (3.8); 0.1462 (1.7); 0.0080 (15.6); -0.0002 δ = 9.6744 (3.1); 8.0448 (3.5); 8.0287 (5.6); 8.0241 (5.7); 8.0080 (3.6); 7.5182 (8.9); 7.2910 (1.7); 7.2721 (3.6); 7.2705 (4.2); 7.2690 (5.0); 7.2673 (6.9); 7.2665 (8.1); 7.2657 (10.0); 7.2649 (11.8); 7.2594 (1569.2); 7.2552 (47.9); 7.2544 (40.0); 7.2536 (33.9); 7.2528 (29.3); 7.2520 (25.6); 7.2512 (22.5); 7.2487 (14.3); 7.2479 (13.2); 7.2472 (12.9); 7.2455 (11.0); 7.2439 (9.6); 7.2424 (9.1); 7.2376 (7.0); 7.2360 (6.2); 7.2336 (6.3); 7.2289 (5.1); 7.2257 (5.8); 7.0607 (1.8); 7.0457 (4.6); 7.0400 (3.6); 7.0313 (3.6); 7.0250 (4.6); 7.0188 (2.4); 7.0104 (2.4); 7.0050 (2.5); 6.9953 (8.4); 6.9241 (2.9); 6.9201 (2.8); 6.8993 (5.2); 6.8846 (2.7); 6.8808 (4.7); 6.8597 (2.3); 6.8560 (2.1); 5.6454 (2.8); 3.5742 (4.4); 3.5522 (9.4); 3.5280 (5.0); 3.2982 (10.2); 3.2782 (11.1); 3.2203 (5.2); 3.2032 (5.8); 3.1972 (4.9); 3.1789 (5.2); 2.5506 (1.6); 2.5282 (4.1); 2.5109 (4.5); 2.4903 (3.5); 2.4694 (1.6); 1.5326 (228.3); 0.9781 (2.9); 0.9622 (2.8); 0.9554 (2.6); 0.9389 (2.2); 0.5878 (5.0); 0.5811 (16.0); 0.5752 (11.9); 0.5659 (13.8); 0.5610 (14.3); 0.5470 (5.2); 0.2954 (2.9); 0.2823 (4.7); 0.2693 (3.8); 0.1462 (1.7); 0.0080 (15.6); -0.0002
(582.4); -0.0085 (21.4); -0.1500 (1.7)  (582.4); -0.0085 (21.4); -0.1500 (1.7)
1.5-15: Ή-ΝΜϋ^ΟΟ.Ο MHz, CDC13):  1.5-15: Ή-ΝΜϋ ^ ΟΟ.Ο MHz, CDC13):
δ= 9.5773 (4.9); 8.0507 (4.5); 8.0342 (6.8); 8.0301 (7.0); 8.0136 (4.8); 7.5180 (9.8); 7.3590 (1.5); 7.3183 (1.3); 7.2896 (4.4); 7.2591 (1693.3); 7.2255 (10.9); 7.2087 (7.3); 7.1580 (2.0); 7.0647 (2.5); 7.0592 (3.0); 7.0443 (6.0); 7.0385 (5.5); 7.0299 (5.5); 7.0240 (6.2); 7.0171 (3.9); 7.0089 (3.4); 7.0035 (3.2); 6.9951 (10.5); 6.9226 (3.4); 6.9185 (3.6); 6.8974 (6.0); 6.8938 (4.3); 6.8790 (5.7); 6.8757 (5.4); 6.8541 (2.9); 5.6434 (4.6); 4.1306 (1.5); 3.5628 (5.2); 3.5403 (10.7); 3.5186 (6.8); 3.1895 (10.2); 3.1796 (7.0); 3.1709 (16.0); 3.1632 (9.9); 3.1558 (4.9); 3.1403 (9.5); 3.1335 (5.6); 3.1144 (7.4); 3.0942 (5.8); 3.0783 (3.7); 3.0583 (1.6); 2.2867 (1.7); 2.1436 (2.7); 2.1209 (4.8); 2.1025 (5.7); 2.0798 (3.1); 2.0434 (5.8); 1.8206 (2.9); 1.8098 (5.0); 1.7919 (6.4); 1.7798 (6.4); 1.7637 (5.9); 1.7338 (3.4); 1.6910 (6.1); 1.6806 (6.9); 1.6717 (6.4); 1.6616 (6.7); 1.6421 (4.6); 1.6207 (5.2); 1.6008 (6.1); 1.5844 (7.2); 1.5719 (5.8); 1.5637 (5.6); 1.5538 (5.2); 1.5315 (213.6); 1.3651 (3.6); 1.3366 (3.8); 1.3134 (3.0); 1.2946 (2.6); 1.2765 (5.4); 1.2586 (7.7); 1.2258 (3.6); 1.2071 (2.6); 1.1248 (1.6); 0.8818 (1.8); 0.1455 (1.9);δ = 9.5773 (4.9); 8.0507 (4.5); 8.0342 (6.8); 8.0301 (7.0); 8.0136 (4.8); 7.5180 (9.8); 7.3590 (1.5); 7.3183 (1.3); 7.2896 (4.4); 7.2591 (1693.3); 7.2255 (10.9); 7.2087 (7.3); 7.1580 (2.0); 7.0647 (2.5); 7.0592 (3.0); 7.0443 (6.0); 7.0385 (5.5); 7.0299 (5.5); 7.0240 (6.2); 7.0171 (3.9); 7.0089 (3.4); 7.0035 (3.2); 6.9951 (10.5); 6.9226 (3.4); 6.9185 (3.6); 6.8974 (6.0); 6.8938 (4.3); 6.8790 (5.7); 6.8757 (5.4); 6.8541 (2.9); 5.6434 (4.6); 4.1306 (1.5); 3.5628 (5.2); 3.5403 (10.7); 3.5186 (6.8); 3.1895 (10.2); 3.1796 (7.0); 3.1709 (16.0); 3.1632 (9.9); 3.1558 (4.9); 3.1403 (9.5); 3.1335 (5.6); 3.1144 (7.4); 3.0942 (5.8); 3.0783 (3.7); 3.0583 (1.6); 2.2867 (1.7); 2.1436 (2.7); 2.1209 (4.8); 2.1025 (5.7); 2.0798 (3.1); 2.0434 (5.8); 1.8206 (2.9); 1.8098 (5.0); 1.7919 (6.4); 1.7798 (6.4); 1.7637 (5.9); 1.7338 (3.4); 1.6910 (6.1); 1.6806 (6.9); 1.6717 (6.4); 1.6616 (6.7); 1.6421 (4.6); 1.6207 (5.2); 1.6008 (6.1); 1.5844 (7.2); 1.5719 (5.8); 1.5637 (5.6); 1.5538 (5.2); 1.5315 (213.6); 1.3651 (3.6); 1.3366 (3.8); 1.3134 (3.0); 1.2946 (2.6); 1.2765 (5.4); 1.2586 (7.7); 1.2258 (3.6); 1.2071 (2.6); 1.1248 (1.6); 0.8818 (1.8); 0.1455 (1.9);
0.0080 (23.2); -0.0002 (627.3); -0.0084 (30.8); -0.1495 (2.3) 0.0080 (23.2); -0.0002 (627.3); -0.0084 (30.8); -0.1495 (2.3)
1.5-23: 1H-NMR(400.0 MHz, CDC13): 1.5-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.6157 (5.2); 8.0551 (2.8); 8.0511 (5.0); 8.0470 (3.0); 8.0387 (3.0); 8.0345 (7.4); 8.0302 (7.6); 8.0260 (3.2); 8.0177 (2.9); 8.0137 (5.0); 8.0096 (2.7); 7.5188 (2.1); 7.3088 (0.8); 7.2921 (0.6); 7.2889 (0.6); 7.2865 (0.5); 7.2841 (0.5); 7.2817 (0.7); 7.2778 (1.0); 7.2770 (0.9); 7.2754 (1.1); 7.2746 (1.1); 7.2738 (1.1); 7.2730 (1.2); 7.2722 (1.3); 7.2714 (1.5); 7.2706 (1.6); 7.2690 (2.0); 7.2673 (2.7); 7.2599 (395.5); 7.2094 (1.8); 7.0615 (2.4); 7.0560 (2.5); 7.0474 (2.5); 7.0406 (6.1); 7.0349 (5.5); 7.0262 (5.1); 7.0201 (6.2); 7.0138 (3.2); 7.0051 (2.9); 6.9999 (3.0); 6.9960 (2.5); 6.9194 (3.9); 6.9154 (4.0); 6.9009 (4.1); 6.8971 (5.5); 6.8945 (6.5); 6.8908 (4.3); 6.8797 (3.4); 6.8760 (6.3); 6.8726 (5.0); 6.8696 (3.2); 6.8550 (2.8); 6.8511 (2.7); 5.8524 (4.3); 5.2983 (6.2); 4.8925 (0.6); 3.8157 (1.2); 3.5112 (5.1); 3.5091 (5.1); 3.4867 (11.6); 3.4643 (6.4); 3.4623 (6.4); 3.2493 (13.6); 3.2280 (16.0); 3.2021 (6.6); 3.1839 (8.0); 3.1780 (6.0); 3.1597 (6.8); 3.0190 (2.5); 3.0012 (4.9); 2.9971 (4.4); 2.9794 (7.4); 2.9615 (3.7); 2.9576 (3.9); 2.9396 (1.6); 1.8066 (4.8); 1.7990 (5.3); 1.7901 (4.3); 1.7748 (6.0); 1.7678 (6.0); 1.7330 (3.4); 1.7043 (8.9); 1.6820 (6.6); 1.6743 (5.8); 1.6105 (1.0); 1.6025 (1.4); 1.5939 (1.4); 1.5822 (2.5); 1.5739 (3.2); 1.5651 (3.2); 1.5537 (26.8); 1.5360 (1.8); 1.5275 (1.8); 1.5194 (0.9); 1.3090 (1.4); 1.3052 (1.4); 1.2776 (4.7); 1.2738 (4.5); 1.2537 (4.1); 1.2459 (6.3); 1.2420 (6.5); 1.2109 (7.0); 1.1875 (2.3); 1.1798 (4.4); 1.1720 (2.9); 1.1566 (3.0); 1.1485 (5.2); 1.1407 (2.1); 1.1247 (3.6); 1.1175 (4.6); 1.0942 (4.2); 1.0871 (5.1); 1.0641 (4.3); 1.0562 (4.6); 1.0339 (2.9); 1.0259 (3.2);δ = 9.6157 (5.2); 8.0551 (2.8); 8.0511 (5.0); 8.0470 (3.0); 8.0387 (3.0); 8.0345 (7.4); 8.0302 (7.6); 8.0260 (3.2); 8.0177 (2.9); 8.0137 (5.0); 8.0096 (2.7); 7.5188 (2.1); 7.3088 (0.8); 7.2921 (0.6); 7.2889 (0.6); 7.2865 (0.5); 7.2841 (0.5); 7.2817 (0.7); 7.2778 (1.0); 7.2770 (0.9); 7.2754 (1.1); 7.2746 (1.1); 7.2738 (1.1); 7.2730 (1.2); 7.2722 (1.3); 7.2714 (1.5); 7.2706 (1.6); 7.2690 (2.0); 7.2673 (2.7); 7.2599 (395.5); 7.2094 (1.8); 7.0615 (2.4); 7.0560 (2.5); 7.0474 (2.5); 7.0406 (6.1); 7.0349 (5.5); 7.0262 (5.1); 7.0201 (6.2); 7.0138 (3.2); 7.0051 (2.9); 6.9999 (3.0); 6.9960 (2.5); 6.9194 (3.9); 6.9154 (4.0); 6.9009 (4.1); 6.8971 (5.5); 6.8945 (6.5); 6.8908 (4.3); 6.8797 (3.4); 6.8760 (6.3); 6.8726 (5.0); 6.8696 (3.2); 6.8550 (2.8); 6.8511 (2.7); 5.8524 (4.3); 5.2983 (6.2); 4.8925 (0.6); 3.8157 (1.2); 3.5112 (5.1); 3.5091 (5.1); 3.4867 (11.6); 3.4643 (6.4); 3.4623 (6.4); 3.2493 (13.6); 3.2280 (16.0); 3.2021 (6.6); 3.1839 (8.0); 3.1780 (6.0); 3.1597 (6.8); 3.0190 (2.5); 3.0012 (4.9); 2.9971 (4.4); 2.9794 (7.4); 2.9615 (3.7); 2.9576 (3.9); 2.9396 (1.6); 1.8066 (4.8); 1.7990 (5.3); 1.7901 (4.3); 1.7748 (6.0); 1.7678 (6.0); 1.7330 (3.4); 1.7043 (8.9); 1.6820 (6.6); 1.6743 (5.8); 1.6105 (1.0); 1.6025 (1.4); 1.5939 (1.4); 1.5822 (2.5); 1.5739 (3.2); 1.5651 (3.2); 1.5537 (26.8); 1.5360 (1.8); 1.5275 (1.8); 1.5194 (0.9); 1.3090 (1.4); 1.3052 (1.4); 1.2776 (4.7); 1.2738 (4.5); 1.2537 (4.1); 1.2459 (6.3); 1.2420 (6.5); 1.2109 (7.0); 1.1875 (2.3); 1.1798 (4.4); 1.1720 (2.9); 1.1566 (3.0); 1.1485 (5.2); 1.1407 (2.1); 1.1247 (3.6); 1.1175 (4.6); 1.0942 (4.2); 1.0871 (5.1); 1.0641 (4.3); 1.0562 (4.6); 1.0339 (2.9); 1.0259 (3.2);
1.0033 (1.1); 0.9946 (1.2); 0.0080 (4.1); -0.0002 (155.4); -0.0085 (4.5); -0.0507 (0.7) 1.0033 (1.1); 0.9946 (1.2); 0.0080 (4.1); -0.0002 (155.4); -0.0085 (4.5); -0.0507 (0.7)
1.5-29: 1H-NMR(400.0 MHz, CDC13): 1.5-29: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.7020 (5.4); 8.0573 (5.0); 8.0408 (8.0); 8.0364 (7.9); 8.0199 (5.2); 8.0158 (3.4); 7.5185 (5.5); 7.3099 (1.5); 7.2852 (2.2); 7.2757 (2.8); 7.2741 (3.4); 7.2733 (3.4); 7.2709 (4.6); 7.2701 (5.2); 7.2693 (5.1); 7.2685 (6.1); 7.2677 (6.6); 7.2669 (7.4); 7.2661 (8.8); 7.2653 (10.9); 7.2645 (13.4); 7.2596 (991.5); 7.2507 (10.7); 7.2262 (4.2); 7.2096 (3.8); 7.0625 (2.7); 7.0573 (2.8); 7.0484 (2.9); 7.0417 (6.3); 7.0361 (5.8); 7.0272 (5.5); 7.0213 (6.4); 7.0149 (3.8); 7.0058 (3.4); 7.0011 (3.4); 6.9956 (6.1); 6.9208 (4.1); 6.9169 (4.1); 6.9025 (4.6); 6.8986 (5.9); 6.8960 (7.1); 6.8923 (4.5); 6.8811 (3.9); 6.8775 (7.1); 6.8740 (5.7); 6.8565 (3.2); 6.8526 (3.0); 5.7003 (5.5); 3.5084 (5.1); 3.4848 (11.7); 3.4623 (7.3); 3.2334 (12.2); 3.2127 (15.7); 3.1790 (6.4); 3.1614 (9.2); 3.1376 (9.8); 3.1241 (4.5); 3.1106 (4.4); 3.1030 (5.9); 3.0889 (5.5); 3.0715 (3.6); 3.0504 (2.0); 2.0434 (2.5); 1.8278 (3.5); 1.7358 (15.5); 1.7141 (16.0); 1.5985 (7.1); 1.5388 (107.6); 1.5090 (9.2); 1.4939 (10.8); 1.4759 (11.2); 1.3235δ = 9.7020 (5.4); 8.0573 (5.0); 8.0408 (8.0); 8.0364 (7.9); 8.0199 (5.2); 8.0158 (3.4); 7.5185 (5.5); 7.3099 (1.5); 7.2852 (2.2); 7.2757 (2.8); 7.2741 (3.4); 7.2733 (3.4); 7.2709 (4.6); 7.2701 (5.2); 7.2693 (5.1); 7.2685 (6.1); 7.2677 (6.6); 7.2669 (7.4); 7.2661 (8.8); 7.2653 (10.9); 7.2645 (13.4); 7.2596 (991.5); 7.2507 (10.7); 7.2262 (4.2); 7.2096 (3.8); 7.0625 (2.7); 7.0573 (2.8); 7.0484 (2.9); 7.0417 (6.3); 7.0361 (5.8); 7.0272 (5.5); 7.0213 (6.4); 7.0149 (3.8); 7.0058 (3.4); 7.0011 (3.4); 6.9956 (6.1); 6.9208 (4.1); 6.9169 (4.1); 6.9025 (4.6); 6.8986 (5.9); 6.8960 (7.1); 6.8923 (4.5); 6.8811 (3.9); 6.8775 (7.1); 6.8740 (5.7); 6.8565 (3.2); 6.8526 (3.0); 5.7003 (5.5); 3.5084 (5.1); 3.4848 (11.7); 3.4623 (7.3); 3.2334 (12.2); 3.2127 (15.7); 3.1790 (6.4); 3.1614 (9.2); 3.1376 (9.8); 3.1241 (4.5); 3.1106 (4.4); 3.1030 (5.9); 3.0889 (5.5); 3.0715 (3.6); 3.0504 (2.0); 2.0434 (2.5); 1.8278 (3.5); 1.7358 (15.5); 1.7141 (16.0); 1.5985 (7.1); 1.5388 (107.6); 1.5090 (9.2); 1.4939 (10.8); 1.4759 (11.2); 1.3235
(5.1) ; 1.2980 (5.4); 1.2883 (6.4); 1.2636 (6.7); 1.2407 (2.6); 0.8820 (1.5); 0.1460 (1.6); 0.0080 (15.5); -0.0002 (524.2); -0.0085(5.1); 1.2980 (5.4); 1.2883 (6.4); 1.2636 (6.7); 1.2407 (2.6); 0.8820 (1.5); 0.1460 (1.6); 0.0080 (15.5); -0.0002 (524.2); -0.0085
(18.5); -0.1497 (1.7) (18.5); -0.1497 (1.7)
1.5-2: 1H-NMR(400.0 MHz, CDC13): 1.5-2: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.8124 (3.7); 8.0093 (3.8); 7.9929 (5.9); 7.9885 (5.9); 7.9719 (4.3); 7.5183 (16.0); 7.3089 (7.3); 7.2903 (4.5); 7.2594 (2854.0); 7.0695 (2.3); 7.0542 (4.4); 7.0483 (4.1); 7.0396 (3.7); 7.0336 (5.1); 7.0270 (2.7); 7.0136 (2.6); 6.9954 (15.9); 6.9364 (2.9); 6.9155 (4.8); 6.8971 (4.3); 5.6713 (3.3); 3.6950 (11.8); 3.6741 (13.1); 3.6531 (8.6); 3.6337 (8.4); 3.6050 (9.8); 3.5814δ = 9.8124 (3.7); 8.0093 (3.8); 7.9929 (5.9); 7.9885 (5.9); 7.9719 (4.3); 7.5183 (16.0); 7.3089 (7.3); 7.2903 (4.5); 7.2594 (2854.0); 7.0695 (2.3); 7.0542 (4.4); 7.0483 (4.1); 7.0396 (3.7); 7.0336 (5.1); 7.0270 (2.7); 7.0136 (2.6); 6.9954 (15.9); 6.9364 (2.9); 6.9155 (4.8); 6.8971 (4.3); 5.6713 (3.3); 3.6950 (11.8); 3.6741 (13.1); 3.6531 (8.6); 3.6337 (8.4); 3.6050 (9.8); 3.5814
(3.2) ; 2.9725 (2.0); 2.9526 (2.9); 2.9316 (2.7); 2.8994 (2.2); 2.8787 (2.7); 2.8561 (2.7); 1.5305 (432.0); 1.2590 (2.1); 1.1751(3.2); 2.9725 (2.0); 2.9526 (2.9); 2.9316 (2.7); 2.8994 (2.2); 2.8787 (2.7); 2.8561 (2.7); 1.5305 (432.0); 1.2590 (2.1); 1.1751
(9.3) ; 1.1699 (5.3); 1.1405 (3.8); 1.1344 (6.4); 1.1275 (10.2); 1.1171 (3.6); 1.0953 (3.3); 1.0869 (3.0); 1.0673 (2.6); 1.0616 (3.7); 1.0568 (4.8); 1.0449 (3.8); 1.0345 (2.5); 0.8818 (2.5); 0.7288 (2.5); 0.7172 (3.1); 0.6992 (4.2); 0.6941 (4.1); 0.6690 (2.7); 0.1456 (6.6); 0.0491 (3.5); 0.0079 (46.3); -0.0002 (1532.3); -0.0084 (47.4); -0.1495 (6.1) 1.5- 34: Ή-ΝΜϋ^ΟΟ.Ο MHz, CDC13): (9.3); 1.1699 (5.3); 1.1405 (3.8); 1.1344 (6.4); 1.1275 (10.2); 1.1171 (3.6); 1.0953 (3.3); 1.0869 (3.0); 1.0673 (2.6); 1.0616 (3.7); 1.0568 (4.8); 1.0449 (3.8); 1.0345 (2.5); 0.8818 (2.5); 0.7288 (2.5); 0.7172 (3.1); 0.6992 (4.2); 0.6941 (4.1); 0.6690 (2.7); 0.1456 (6.6); 0.0491 (3.5); 0.0079 (46.3); -0.0002 (1532.3); -0.0084 (47.4); -0.1495 (6.1) 1.5-34: Ή-ΝΜϋ ^ ΟΟ.Ο MHz, CDC13):
δ= 8.0498 (1.7); 7.9068 (4.0); 7.9027 (6.4); 7.8860 (10.2); 7.8818 (10.6); 7.8689 (4.5); 7.8648 (7.0); 7.5181 (15.3); 7.3596δ = 8.0498 (1.7); 7.9068 (4.0); 7.9027 (6.4); 7.8860 (10.2); 7.8818 (10.6); 7.8689 (4.5); 7.8648 (7.0); 7.5181 (15.3); 7.3596
(2.5) ; 7.3081 (3.6); 7.2970 (2.8); 7.2908 (4.6); 7.2867 (4.8); 7.2779 (6.6); 7.2592 (2743.9); 7.2287 (10.7); 7.2265 (11.4); 7.2086 (12.5); 7.1543 (2.5); 7.1158 (4.0); 7.1100 (4.0); 7.1013 (4.3); 7.0946 (8.9); 7.0888 (8.0); 7.0803 (7.8); 7.0744 (9.7); 7.0679(2.5); 7.3081 (3.6); 7.2970 (2.8); 7.2908 (4.6); 7.2867 (4.8); 7.2779 (6.6); 7.2592 (2743.9); 7.2287 (10.7); 7.2265 (11.4); 7.2086 (12.5); 7.1543 (2.5); 7.1158 (4.0); 7.1100 (4.0); 7.1013 (4.3); 7.0946 (8.9); 7.0888 (8.0); 7.0803 (7.8); 7.0744 (9.7); 7.0679
(5.2) ; 7.0592 (6.3); 7.0536 (5.9); 7.0378 (2.7); 6.9953 (16.0); 6.9376 (5.8); 6.9337 (6.2); 6.9187 (6.8); 6.9129 (10.9); 6.9092(5.2); 7.0592 (6.3); 7.0536 (5.9); 7.0378 (2.7); 6.9953 (16.0); 6.9376 (5.8); 6.9337 (6.2); 6.9187 (6.8); 6.9129 (10.9); 6.9092
(7.6) ; 6.8939 (10.8); 6.8729 (5.6); 6.8693 (5.5); 6.8125 (7.7); 6.5486 (1.6); 6.5213 (2.6); 6.5056 (2.6); 6.5015 (2.5); 4.4595 (1.6); 4.2605 (3.3); 4.2426 (3.0); 3.9541 (1.6); 3.3134 (2.3); 3.2962 (2.1); 3.1712 (2.3); 3.1548 (1.5); 2.3436 (2.6); 2.3251 (2.6); 2.1305 (4.5); 2.1065 (5.2); 2.0899 (6.0); 2.0063 (5.6); 1.8784 (5.8); 1.8356 (6.3); 1.8171 (6.4); 1.6436 (3.7); 1.5376 (20.3); 1.4319 (10.2); 1.4153 (5.6); 1.4034 (3.3); 1.3417 (5.8); 1.3329 (4.7); 1.3240 (9.9); 1.3060 (5.6); 1.2938 (6.8); 1.2854 (6.7); 1.2812 (7.1); 1.2696 (7.6); 1.2642 (9.5); 1.2546 (15.4); 1.2226 (3.8); 0.9391 (4.0); 0.9204 (4.0); 0.9021 (5.8); 0.8793 (4.1); 0.3312 (3.9); 0.2376 (3.7); 0.1583 (4.7); 0.1459 (3.6); 0.1263 (3.0); 0.0079 (28.2); -0.0002 (1205.6); -0.0085 (53.7); -0.0330(7.6); 6.8939 (10.8); 6.8729 (5.6); 6.8693 (5.5); 6.8125 (7.7); 6.5486 (1.6); 6.5213 (2.6); 6.5056 (2.6); 6.5015 (2.5); 4.4595 (1.6); 4.2605 (3.3); 4.2426 (3.0); 3.9541 (1.6); 3.3134 (2.3); 3.2962 (2.1); 3.1712 (2.3); 3.1548 (1.5); 2.3436 (2.6); 2.3251 (2.6); 2.1305 (4.5); 2.1065 (5.2); 2.0899 (6.0); 2.0063 (5.6); 1.8784 (5.8); 1.8356 (6.3); 1.8171 (6.4); 1.6436 (3.7); 1.5376 (20.3); 1.4319 (10.2); 1.4153 (5.6); 1.4034 (3.3); 1.3417 (5.8); 1.3329 (4.7); 1.3240 (9.9); 1.3060 (5.6); 1.2938 (6.8); 1.2854 (6.7); 1.2812 (7.1); 1.2696 (7.6); 1.2642 (9.5); 1.2546 (15.4); 1.2226 (3.8); 0.9391 (4.0); 0.9204 (4.0); 0.9021 (5.8); 0.8793 (4.1); 0.3312 (3.9); 0.2376 (3.7); 0.1583 (4.7); 0.1459 (3.6); 0.1263 (3.0); 0.0079 (28.2); -0.0002 (1205.6); -0.0085 (53.7); -0.0330
(7.3) ; -0.0508 (7.2); -0.1496 (3.9) (7.3); -0.0508 (7.2); -0.1496 (3.9)
1.6- 1 : Ή-ΝΜϋ^ΟΟ.Ο MHz, CDC13):  1.6- 1: Ή-ΝΜϋ ^ ΟΟ.Ο MHz, CDC13):
δ= 9.6097 (3.7); 7.9771 (2.0); 7.9708 (2.1); 7.9646 (1.9); 7.9575 (3.8); 7.9512 (2.7); 7.9469 (2.7); 7.9341 (4.0); 7.9274 (2.2); 7.9209 (1.8); 7.9140 (1.9); 7.5183 (4.4); 7.2922 (1.8); 7.2595 (777.0); 6.9955 (4.0); 6.9678 (2.0); 6.9618 (2.5); 6.9484 (2.3); 6.9432 (4.8); 6.9379 (4.1); 6.9244 (3.8); 6.9187 (5.0); 6.9140 (2.3); 6.9005 (1.9); 6.8941 (1.9); 5.6856 (3.1); 3.5736 (4.5); 3.5493 (10.2); 3.5251 (5.6); 3.2872 (12.1); 3.2671 (13.0); 3.2201 (6.1); 3.2027 (6.6); 3.1961 (5.8); 3.1784 (5.7); 2.5325 (2.1); 2.5107 (4.5); 2.4902 (4.8); 2.4725 (4.4); 2.4505 (1.8); 2.0437 (1.3); 1.5358 (107.9); 1.2591 (1.8); 0.9850 (1.6); 0.9718 (3.5); 0.9563 (2.8); 0.9496 (3.3); 0.9333 (2.3); 0.9173 (1.2); 0.8818 (1.5); 0.5906 (3.6); 0.5812 (15.4); 0.5740 (11.9); 0.5657 (7.0); 0.5610 (16.0); 0.5556 (9.0); 0.5451 (4.2); 0.5259 (1.1); 0.2919 (3.8); 0.2800 (5.4); 0.2707 (3.0); 0.2663 (4.5); 0.2541 (2.3);δ = 9.6097 (3.7); 7.9771 (2.0); 7.9708 (2.1); 7.9646 (1.9); 7.9575 (3.8); 7.9512 (2.7); 7.9469 (2.7); 7.9341 (4.0); 7.9274 (2.2); 7.9209 (1.8); 7.9140 (1.9); 7.5183 (4.4); 7.2922 (1.8); 7.2595 (777.0); 6.9955 (4.0); 6.9678 (2.0); 6.9618 (2.5); 6.9484 (2.3); 6.9432 (4.8); 6.9379 (4.1); 6.9244 (3.8); 6.9187 (5.0); 6.9140 (2.3); 6.9005 (1.9); 6.8941 (1.9); 5.6856 (3.1); 3.5736 (4.5); 3.5493 (10.2); 3.5251 (5.6); 3.2872 (12.1); 3.2671 (13.0); 3.2201 (6.1); 3.2027 (6.6); 3.1961 (5.8); 3.1784 (5.7); 2.5325 (2.1); 2.5107 (4.5); 2.4902 (4.8); 2.4725 (4.4); 2.4505 (1.8); 2.0437 (1.3); 1.5358 (107.9); 1.2591 (1.8); 0.9850 (1.6); 0.9718 (3.5); 0.9563 (2.8); 0.9496 (3.3); 0.9333 (2.3); 0.9173 (1.2); 0.8818 (1.5); 0.5906 (3.6); 0.5812 (15.4); 0.5740 (11.9); 0.5657 (7.0); 0.5610 (16.0); 0.5556 (9.0); 0.5451 (4.2); 0.5259 (1.1); 0.2919 (3.8); 0.2800 (5.4); 0.2707 (3.0); 0.2663 (4.5); 0.2541 (2.3);
0.1459 (1.1); 0.0079 (8.0); -0.0002 (279.1); -0.0085 (8.4); -0.1497 (1.2) 0.1459 (1.1); 0.0079 (8.0); -0.0002 (279.1); -0.0085 (8.4); -0.1497 (1.2)
1.6-15: 1H-NMR(400.0 MHz, CDC13): 1.6-15: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.5079 (3.6); 7.9806 (1.6); 7.9740 (1.6); 7.9677 (1.7); 7.9610 (3.1); 7.9567 (2.2); 7.9498 (2.2); 7.9437 (2.2); 7.9372 (3.2); 7.9305 (1.6); 7.9242 (1.6); 7.9175 (1.5); 7.5186 (1.8); 7.2927 (0.6); 7.2597 (302.1); 7.2089 (0.8); 6.9957 (1.8); 6.9667 (1.8); 6.9606 (1.9); 6.9471 (2.0); 6.9421 (4.1); 6.9365 (3.4); 6.9230 (3.1); 6.9173 (4.0); 6.9124 (1.9); 6.8990 (1.5); 6.8929 (1.5); 5.7661 (3.0); 5.2984 (1.5); 3.5626 (3.6); 3.5391 (7.5); 3.5166 (4.9); 3.1824 (9.7); 3.1636 (16.0); 3.1564 (3.7); 3.1402 (5.5); 3.1162 (2.4); 3.0961 (4.5); 3.0802 (3.4); 3.0752 (3.5); 3.0602 (2.6); 3.0397 (1.0); 2.2794 (0.9); 2.2467 (0.8); 2.1945 (1.3); 2.1361 (1.5); 2.1161 (3.2); 2.0961 (3.4); 2.0740 (1.9); 2.0544 (0.7); 1.8361 (0.9); 1.8252 (1.1); 1.8170 (1.8); 1.8065 (3.2); 1.7975 (2.5); 1.7878 (3.8); 1.7765 (3.9); 1.7677 (2.7); 1.7579 (3.4); 1.7489 (2.4); 1.7406 (1.4); 1.7293 (2.3); 1.7114 (2.4); 1.7014 (3.2); 1.6891 (3.7); 1.6789 (4.2); 1.6716 (4.0); 1.6612 (4.0); 1.6506 (2.1); 1.6412 (2.8); 1.6318 (1.5); 1.6204 (3.1); 1.6128 (2.8); 1.6021 (3.6); 1.5941 (2.7); 1.5841 (4.3); 1.5709 (3.1); 1.5628 (3.0); 1.5527 (3.2); 1.5445 (19.8); 1.5237 (1.1); 1.3816 (1.1); 1.3591 (2.0); 1.3502 (1.6); 1.3365 (1.9); 1.3298 (2.2); 1.3171 (1.2); 1.3074 (2.1); 1.2901 (1.4); 1.2714 (2.1); 1.2527 (2.8); 1.2403 (2.0); 1.2305 (1.7); 1.2210 (2.2); 1.2082 (1.2); 1.2026 (1.1); 1.1913 (1.1); 1.1499 (0.6); 1.1424 (1.0);δ = 9.5079 (3.6); 7.9806 (1.6); 7.9740 (1.6); 7.9677 (1.7); 7.9610 (3.1); 7.9567 (2.2); 7.9498 (2.2); 7.9437 (2.2); 7.9372 (3.2); 7.9305 (1.6); 7.9242 (1.6); 7.9175 (1.5); 7.5186 (1.8); 7.2927 (0.6); 7.2597 (302.1); 7.2089 (0.8); 6.9957 (1.8); 6.9667 (1.8); 6.9606 (1.9); 6.9471 (2.0); 6.9421 (4.1); 6.9365 (3.4); 6.9230 (3.1); 6.9173 (4.0); 6.9124 (1.9); 6.8990 (1.5); 6.8929 (1.5); 5.7661 (3.0); 5.2984 (1.5); 3.5626 (3.6); 3.5391 (7.5); 3.5166 (4.9); 3.1824 (9.7); 3.1636 (16.0); 3.1564 (3.7); 3.1402 (5.5); 3.1162 (2.4); 3.0961 (4.5); 3.0802 (3.4); 3.0752 (3.5); 3.0602 (2.6); 3.0397 (1.0); 2.2794 (0.9); 2.2467 (0.8); 2.1945 (1.3); 2.1361 (1.5); 2.1161 (3.2); 2.0961 (3.4); 2.0740 (1.9); 2.0544 (0.7); 1.8361 (0.9); 1.8252 (1.1); 1.8170 (1.8); 1.8065 (3.2); 1.7975 (2.5); 1.7878 (3.8); 1.7765 (3.9); 1.7677 (2.7); 1.7579 (3.4); 1.7489 (2.4); 1.7406 (1.4); 1.7293 (2.3); 1.7114 (2.4); 1.7014 (3.2); 1.6891 (3.7); 1.6789 (4.2); 1.6716 (4.0); 1.6612 (4.0); 1.6506 (2.1); 1.6412 (2.8); 1.6318 (1.5); 1.6204 (3.1); 1.6128 (2.8); 1.6021 (3.6); 1.5941 (2.7); 1.5841 (4.3); 1.5709 (3.1); 1.5628 (3.0); 1.5527 (3.2); 1.5445 (19.8); 1.5237 (1.1); 1.3816 (1.1); 1.3591 (2.0); 1.3502 (1.6); 1.3365 (1.9); 1.3298 (2.2); 1.3171 (1.2); 1.3074 (2.1); 1.2901 (1.4); 1.2714 (2.1); 1.2527 (2.8); 1.2403 (2.0); 1.2305 (1.7); 1.2210 (2.2); 1.2082 (1.2); 1.2026 (1.1); 1.1913 (1.1); 1.1499 (0.6); 1.1424 (1.0);
1.1251 (0.9); 0.0080 (3.0); -0.0002 (115.4); -0.0085 (3.8) 1.1251 (0.9); 0.0080 (3.0); -0.0002 (115.4); -0.0085 (3.8)
1.6-2: 1H-NMR(400.0 MHz, CDC13): 1.6-2: 1 H NMR (400.0 MHz, CDC13):
δ= 9.7282 (5.5); 7.9400 (2.4); 7.9336 (2.5); 7.9274 (2.7); 7.9206 (4.8); 7.9162 (3.7); 7.9095 (3.9); 7.9033 (3.6); 7.8969 (5.2); 7.8904 (3.0); 7.8838 (2.4); 7.8776 (2.5); 7.5184 (7.3); 7.3597 (1.4); 7.3074 (2.4); 7.2935 (2.7); 7.2595 (1265.2); 7.2313 (5.6); 7.2089 (6.1); 6.9955 (7.1); 6.9763 (2.6); 6.9704 (2.6); 6.9519 (6.2); 6.9460 (5.2); 6.9328 (4.9); 6.9270 (6.3); 6.9224 (3.2); 6.9086 (2.5); 6.9029 (2.2); 5.7054 (4.4); 3.6877 (15.0); 3.6775 (4.4); 3.6665 (16.0); 3.6535 (10.8); 3.6344 (11.1); 3.6278 (9.8); 3.6039 (12.3); 3.5800 (3.9); 2.9487 (2.2); 2.9280 (3.5); 2.9056 (3.4); 2.8849 (2.2); 2.8757 (2.5); 2.8538 (3.7); 2.8336 (3.4); 2.8117 (1.8); 2.0442 (1.2); 2.0051 (2.2); 1.5334 (118.6); 1.2590 (3.0); 1.1868 (4.0); 1.1794 (6.7); 1.1746 (12.6); 1.1701 (7.0); 1.1645 (5.2); 1.1406 (5.0); 1.1333 (8.3); 1.1270 (13.3); 1.1163 (4.9); 1.0957 (1.9); 1.0860 (3.2); 1.0747 (3.4); 1.0710 (3.1); 1.0577 (3.2); 1.0518 (4.8); 1.0474 (7.0); 1.0352 (4.7); 1.0247 (3.5); 1.0215 (3.4); 1.0110 (2.1); 0.8994 (1.5); 0.8819 (3.8); 0.8641 (1.5); 0.7256 (2.7); 0.7174 (3.4); 0.7139 (3.2); 0.7052 (4.0); 0.6956 (4.5); 0.6909 (5.0); 0.6873 (3.9); 0.6840 (4.4); 0.6689 (3.5); 0.6659 (3.4); 0.1463 (2.6); 0.0339 (1.4); 0.0079 (22.2); -0.0002 (682.7); -0.0085 (26.3); -0.0507 (3.3); -0.1496δ = 9.7282 (5.5); 7.9400 (2.4); 7.9336 (2.5); 7.9274 (2.7); 7.9206 (4.8); 7.9162 (3.7); 7.9095 (3.9); 7.9033 (3.6); 7.8969 (5.2); 7.8904 (3.0); 7.8838 (2.4); 7.8776 (2.5); 7.5184 (7.3); 7.3597 (1.4); 7.3074 (2.4); 7.2935 (2.7); 7.2595 (1265.2); 7.2313 (5.6); 7.2089 (6.1); 6.9955 (7.1); 6.9763 (2.6); 6.9704 (2.6); 6.9519 (6.2); 6.9460 (5.2); 6.9328 (4.9); 6.9270 (6.3); 6.9224 (3.2); 6.9086 (2.5); 6.9029 (2.2); 5.7054 (4.4); 3.6877 (15.0); 3.6775 (4.4); 3.6665 (16.0); 3.6535 (10.8); 3.6344 (11.1); 3.6278 (9.8); 3.6039 (12.3); 3.5800 (3.9); 2.9487 (2.2); 2.9280 (3.5); 2.9056 (3.4); 2.8849 (2.2); 2.8757 (2.5); 2.8538 (3.7); 2.8336 (3.4); 2.8117 (1.8); 2.0442 (1.2); 2.0051 (2.2); 1.5334 (118.6); 1.2590 (3.0); 1.1868 (4.0); 1.1794 (6.7); 1.1746 (12.6); 1.1701 (7.0); 1.1645 (5.2); 1.1406 (5.0); 1.1333 (8.3); 1.1270 (13.3); 1.1163 (4.9); 1.0957 (1.9); 1.0860 (3.2); 1.0747 (3.4); 1.0710 (3.1); 1.0577 (3.2); 1.0518 (4.8); 1.0474 (7.0); 1.0352 (4.7); 1.0247 (3.5); 1.0215 (3.4); 1.0110 (2.1); 0.8994 (1.5); 0.8819 (3.8); 0.8641 (1.5); 0.7256 (2.7); 0.7174 (3.4); 0.7139 (3.2); 0.7052 (4.0); 0.6956 (4.5); 0.6909 (5.0); 0.6873 (3.9); 0.6840 (4.4); 0.6689 (3.5); 0.6659 (3.4); 0.1463 (2.6); 0.0339 (1.4); 0.0079 (22.2); -0.0002 (682.7); -0.0085 (26.3); -0.0507 (3.3); -0.1496
(2.9) (2.9)
1.6-23: 1H-NMR(400.0 MHz, CDC13): 1.6-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.5545 (6.4); 7.9801 (2.4); 7.9734 (2.6); 7.9671 (2.6); 7.9604 (4.9); 7.9562 (3.5); 7.9538 (3.3); 7.9495 (3.5); 7.9432 (3.4); 7.9407 (3.4); 7.9367 (5.0); 7.9300 (2.7); 7.9236 (2.4); 7.9170 (2.4); 7.5204 (1.0); 7.2615 (175.6); 6.9975 (1.0); 6.9627 (2.7); 6.9565 (2.8); 6.9431 (3.1); 6.9381 (6.2); 6.9324 (5.3); 6.9190 (5.0); 6.9133 (6.2); 6.9085 (2.9); 6.8950 (2.4); 6.8889 (2.5); 6.0732 (3.9); 5.2990 (12.2); 3.5122 (5.0); 3.5103 (5.1); 3.4877 (11.7); 3.4652 (6.4); 3.4633 (6.4); 3.4565 (0.8); 3.4501 (0.6); 3.4400 (0.6); 3.2473 (13.7); 3.2259 (16.0); 3.2024 (6.7); 3.1840 (8.0); 3.1782 (6.1); 3.1597 (6.7); 2.9979 (2.4); 2.9799 (4.9); 2.9760 (4.4); 2.9580 (7.5); 2.9400 (3.9); 2.9362 (3.9); 2.9181 (1.7); 2.0056 (2.2); 1.8048 (5.0); 1.7971 (5.5); 1.7867 (4.6); 1.7731 (6.4); 1.7662 (6.3); 1.7108 (7.0); 1.6993 (9.1); 1.6953 (9.0); 1.6733 (5.9); 1.5935 (6.2); 1.5740 (2.9); 1.5656 (3.6); 1.5567 (3.2); 1.5478 (3.5); 1.5375 (2.5); 1.5275 (1.8); 1.5189 (1.8); 1.5111 (1.0); 1.3332 (0.8); 1.3060 (1.8); 1.3022 (1.7); 1.2920 (1.3); 1.2744 (5.4); 1.2709 (5.1); 1.2560 (4.6); 1.2504 (4.6); 1.2428 (6.8); 1.2392 (7.0); 1.2081 (7.7); 1.1845 (2.6); 1.1773 (4.8); 1.1696 (3.2); 1.1461 (4.9); 1.1389 (3.8); 1.1150 (4.3); 1.1092 (4.4); 1.0849 (4.3); 1.0788 (4.4); 1.0584 (4.1); 1.0509 (4.5); 1.0284 (3.0); 1.0207 (3.3); 0.9981 (1.2); 0.9894 (1.2); 0.8800 (0.7); 0.0080 (1.9); -0.0002 (67.3); -0.0085 (1.9) 1.6-29: 'H-NMR(400.0 MHz, CDC13): δ = 9.5545 (6.4); 7.9801 (2.4); 7.9734 (2.6); 7.9671 (2.6); 7.9604 (4.9); 7.9562 (3.5); 7.9538 (3.3); 7.9495 (3.5); 7.9432 (3.4); 7.9407 (3.4); 7.9367 (5.0); 7.9300 (2.7); 7.9236 (2.4); 7.9170 (2.4); 7.5204 (1.0); 7.2615 (175.6); 6.9975 (1.0); 6.9627 (2.7); 6.9565 (2.8); 6.9431 (3.1); 6.9381 (6.2); 6.9324 (5.3); 6.9190 (5.0); 6.9133 (6.2); 6.9085 (2.9); 6.8950 (2.4); 6.8889 (2.5); 6.0732 (3.9); 5.2990 (12.2); 3.5122 (5.0); 3.5103 (5.1); 3.4877 (11.7); 3.4652 (6.4); 3.4633 (6.4); 3.4565 (0.8); 3.4501 (0.6); 3.4400 (0.6); 3.2473 (13.7); 3.2259 (16.0); 3.2024 (6.7); 3.1840 (8.0); 3.1782 (6.1); 3.1597 (6.7); 2.9979 (2.4); 2.9799 (4.9); 2.9760 (4.4); 2.9580 (7.5); 2.9400 (3.9); 2.9362 (3.9); 2.9181 (1.7); 2.0056 (2.2); 1.8048 (5.0); 1.7971 (5.5); 1.7867 (4.6); 1.7731 (6.4); 1.7662 (6.3); 1.7108 (7.0); 1.6993 (9.1); 1.6953 (9.0); 1.6733 (5.9); 1.5935 (6.2); 1.5740 (2.9); 1.5656 (3.6); 1.5567 (3.2); 1.5478 (3.5); 1.5375 (2.5); 1.5275 (1.8); 1.5189 (1.8); 1.5111 (1.0); 1.3332 (0.8); 1.3060 (1.8); 1.3022 (1.7); 1.2920 (1.3); 1.2744 (5.4); 1.2709 (5.1); 1.2560 (4.6); 1.2504 (4.6); 1.2428 (6.8); 1.2392 (7.0); 1.2081 (7.7); 1.1845 (2.6); 1.1773 (4.8); 1.1696 (3.2); 1.1461 (4.9); 1.1389 (3.8); 1.1150 (4.3); 1.1092 (4.4); 1.0849 (4.3); 1.0788 (4.4); 1.0584 (4.1); 1.0509 (4.5); 1.0284 (3.0); 1.0207 (3.3); 0.9981 (1.2); 0.9894 (1.2); 0.8800 (0.7); 0.0080 (1.9); -0.0002 (67.3); -0.0085 (1.9) 1.6-29: 'H-NMR (400.0 MHz, CDC13):
δ= 9.6290 (5.7); 7.9887 (2.4); 7.9820 (2.6); 7.9754 (2.5); 7.9688 (4.7); 7.9649 (3.4); 7.9578 (3.5); 7.9496 (3.3); 7.9452 (5.0); 7.9385 (2.7); 7.9320 (2.4); 7.9254 (2.4); 7.5184 (5.1); 7.3594 (0.7); 7.3091 (4.4); 7.2937 (1.5); 7.2595 (900.9); 7.2277 (1.5); 6.9955 (5.0); 6.9641 (2.6); 6.9578 (2.7); 6.9444 (2.8); 6.9395 (6.2); 6.9339 (5.1); 6.9204 (4.6); 6.9147 (6.2); 6.9099 (2.8); 6.8964 (2.3); 6.8903 (2.4); 5.6730 (5.2); 4.1305 (1.4); 4.1127 (1.4); 3.5064 (5.0); 3.4822 (11.5); 3.4589 (6.6); 3.2222 (12.4); 3.2011 (16.0); 3.1793 (6.3); 3.1616 (8.5); 3.1556 (5.2); 3.1376 (8.1); 3.1068 (3.4); 3.0928 (3.5); 3.0853 (5.1); 3.0711 (5.2); 3.0533 (3.3); 3.0316 (1.4); 2.0436 (6.0); 1.8350 (3.3); 1.8271 (3.0); 1.8206 (3.2); 1.8124 (2.8); 1.7681 (2.0); 1.7517 (5.7); 1.7341 (15.0); 1.7079 (13.7); 1.6183 (5.1); 1.5986 (6.4); 1.5859 (5.6); 1.5553 (3.9); 1.5364 (165.9); 1.5087 (7.7); 1.4928 (9.6); 1.4794 (8.4); 1.4745 (9.2); 1.3605 (1.1); 1.3442 (2.0); 1.3194 (4.2); 1.3097 (3.6); 1.3011 (4.5); 1.2939 (5.0); 1.2845 (5.8); 1.2766 (4.0); 1.2589 (8.4); 1.2408 (2.6); 1.2346 (2.1); 0.8818 (1.2); 0.1460 (1.7); 0.0494 (2.3); 0.0079 (14.5); -0.0002 (486.5); - 0.0084 (14.4); -0.0320 (1.0); -0.1496 (1.8) δ = 9.6290 (5.7); 7.9887 (2.4); 7.9820 (2.6); 7.9754 (2.5); 7.9688 (4.7); 7.9649 (3.4); 7.9578 (3.5); 7.9496 (3.3); 7.9452 (5.0); 7.9385 (2.7); 7.9320 (2.4); 7.9254 (2.4); 7.5184 (5.1); 7.3594 (0.7); 7.3091 (4.4); 7.2937 (1.5); 7.2595 (900.9); 7.2277 (1.5); 6.9955 (5.0); 6.9641 (2.6); 6.9578 (2.7); 6.9444 (2.8); 6.9395 (6.2); 6.9339 (5.1); 6.9204 (4.6); 6.9147 (6.2); 6.9099 (2.8); 6.8964 (2.3); 6.8903 (2.4); 5.6730 (5.2); 4.1305 (1.4); 4.1127 (1.4); 3.5064 (5.0); 3.4822 (11.5); 3.4589 (6.6); 3.2222 (12.4); 3.2011 (16.0); 3.1793 (6.3); 3.1616 (8.5); 3.1556 (5.2); 3.1376 (8.1); 3.1068 (3.4); 3.0928 (3.5); 3.0853 (5.1); 3.0711 (5.2); 3.0533 (3.3); 3.0316 (1.4); 2.0436 (6.0); 1.8350 (3.3); 1.8271 (3.0); 1.8206 (3.2); 1.8124 (2.8); 1.7681 (2.0); 1.7517 (5.7); 1.7341 (15.0); 1.7079 (13.7); 1.6183 (5.1); 1.5986 (6.4); 1.5859 (5.6); 1.5553 (3.9); 1.5364 (165.9); 1.5087 (7.7); 1.4928 (9.6); 1.4794 (8.4); 1.4745 (9.2); 1.3605 (1.1); 1.3442 (2.0); 1.3194 (4.2); 1.3097 (3.6); 1.3011 (4.5); 1.2939 (5.0); 1.2845 (5.8); 1.2766 (4.0); 1.2589 (8.4); 1.2408 (2.6); 1.2346 (2.1); 0.8818 (1.2); 0.1460 (1.7); 0.0494 (2.3); 0.0079 (14.5); -0.0002 (486.5); - 0.0084 (14.4); -0.0320 (1.0); -0.1496 (1.8)
1.6- 34: 'H-NMR^OO.O MHz, CDC13):  1.6-34: 'H NMR ^ OO.O MHz, CDC13):
δ= 8.3923 (7.7); 7.9740 (2.3); 7.9668 (2.8); 7.9610 (2.9); 7.9540 (5.2); 7.9500 (3.8); 7.9430 (4.3); 7.9371 (3.8); 7.9305 (5.2); 7.9237 (3.0); 7.9173 (2.5); 7.9108 (2.4); 7.5182 (7.1); 7.2902 (1.9); 7.2593 (1229.3); 7.2090 (3.1); 7.0155 (2.8); 7.0096 (2.9); 6.9954 (9.7); 6.9911 (7.0); 6.9855 (5.5); 6.9722 (5.2); 6.9665 (6.6); 6.9617 (3.3); 6.9481 (2.5); 6.9424 (2.7); 4.2950 (0.9); 4.2665 (2.0); 4.2269 (1.8); 4.1992 (0.8); 3.2469 (4.8); 3.2280 (10.9); 3.2093 (5.5); 2.5377 (1.1); 2.5225 (1.1); 2.4928 (1.3); 2.4780 (1.3); 2.4695 (1.0); 2.4497 (2.6); 2.4301 (3.6); 2.4112 (3.2); 2.3918 (1.7); 2.2131 (8.5); 2.1942 (16.0); 2.1755 (8.4); 2.1426 (2.2); 2.1304 (3.8); 2.1224 (4.7); 2.1019 (4.9); 2.0794 (2.3); 2.0734 (2.2); 2.0050 (1.6); 1.9365 (1.7); 1.9140 (3.0); 1.8920 (4.8); 1.8811 (2.8); 1.8697 (4.1); 1.8517 (3.7); 1.8289 (2.5); 1.8231 (2.6); 1.8095 (1.6); 1.7612 (2.3); 1.7369 (4.1); 1.7149 (5.0); 1.7098 (5.0); 1.6928 (3.3); 1.6875 (3.8); 1.5345 (70.1); 0.3308 (2.2); 0.2374 (1.9); 0.1575 (2.2); 0.1458 (2.1); 0.1261 (1.4); 0.0080 (15.6); -0.0002 (512.8); -0.0085 (15.9); -0.0508 (1.4); -0.1497 (1.9) δ = 8.3923 (7.7); 7.9740 (2.3); 7.9668 (2.8); 7.9610 (2.9); 7.9540 (5.2); 7.9500 (3.8); 7.9430 (4.3); 7.9371 (3.8); 7.9305 (5.2); 7.9237 (3.0); 7.9173 (2.5); 7.9108 (2.4); 7.5182 (7.1); 7.2902 (1.9); 7.2593 (1229.3); 7.2090 (3.1); 7.0155 (2.8); 7.0096 (2.9); 6.9954 (9.7); 6.9911 (7.0); 6,9855 (5.5); 6.9722 (5.2); 6.9665 (6.6); 6.9617 (3.3); 6.9481 (2.5); 6.9424 (2.7); 4.2950 (0.9); 4.2665 (2.0); 4.2269 (1.8); 4.1992 (0.8); 3.2469 (4.8); 3.2280 (10.9); 3.2093 (5.5); 2.5377 (1.1); 2.5225 (1.1); 2.4928 (1.3); 2.4780 (1.3); 2.4695 (1.0); 2.4497 (2.6); 2.4301 (3.6); 2.4112 (3.2); 2.3918 (1.7); 2.2131 (8.5); 2.1942 (16.0); 2.1755 (8.4); 2.1426 (2.2); 2.1304 (3.8); 2.1224 (4.7); 2.1019 (4.9); 2.0794 (2.3); 2.0734 (2.2); 2.0050 (1.6); 1.9365 (1.7); 1.9140 (3.0); 1.8920 (4.8); 1.8811 (2.8); 1.8697 (4.1); 1.8517 (3.7); 1.8289 (2.5); 1.8231 (2.6); 1.8095 (1.6); 1.7612 (2.3); 1.7369 (4.1); 1.7149 (5.0); 1.7098 (5.0); 1.6928 (3.3); 1.6875 (3.8); 1.5345 (70.1); 0.3308 (2.2); 0.2374 (1.9); 0.1575 (2.2); 0.1458 (2.1); 0.1261 (1.4); 0.0080 (15.6); -0.0002 (512.8); -0.0085 (15.9); -0.0508 (1.4); -0.1497 (1.9)
1.7- 29: 1H-NMR(400.0 MHz, CDC13): 1.7-29: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.4791 (6.8); 7.6898 (3.8); 7.6849 (3.8); 7.6722 (4.3); 7.6662 (4.5); 7.6596 (4.6); 7.6533 (4.5); 7.6418 (4.4); 7.6353 (4.5); 7.5189 (1.6); 7.2601 (281.7); 7.2105 (0.6); 7.1352 (2.1); 7.1254 (2.8); 7.1222 (2.6); 7.1109 (6.5); 7.1054 (8.6); 7.0998 (11.6); 7.0940 (5.2); 7.0806 (7.5); 7.0768 (7.9); 7.0563 (7.6); 7.0339 (3.1); 6.9962 (1.6); 5.7753 (5.6); 5.2985 (8.6); 3.5047 (4.6); 3.4826 (9.5); 3.4591 (5.9); 3.1714 (6.0); 3.1622 (9.0); 3.1541 (9.0); 3.1422 (16.0); 3.1307 (8.5); 3.1172 (4.4); 3.1039 (4.1); 3.0967 (5.0); 3.0826 (5.1); 3.0655 (2.9); 3.0443 (1.2); 2.0435 (0.7); 1.8234 (3.3); 1.8154 (3.3); 1.8090 (3.4); 1.7900 (2.2); 1.7640 (2.2); 1.7296 (14.7); 1.7018 (12.6); 1.6167 (6.0); 1.5964 (7.6); 1.5531 (4.2); 1.5298 (6.1); 1.5221 (5.1); 1.5054 (8.3); 1.4897 (10.1); 1.4720 (9.7); 1.4533 (5.4); 1.3520 (1.2); 1.3346 (2.4); 1.3102 (4.8); 1.2848 (6.6); 1.2798 (6.9); 1.2552 (8.2); 1.2303 (2.2); 0.8804 (1.1); 0.1460 (0.5); 0.0079 (5.5); -0.0002 (142.3); -0.0085 (4.7); -0.1498 (0.5) δ = 9.4791 (6.8); 7.6898 (3.8); 7.6849 (3.8); 7.6722 (4.3); 7.6662 (4.5); 7.6596 (4.6); 7.6533 (4.5); 7.6418 (4.4); 7.6353 (4.5); 7.5189 (1.6); 7.2601 (281.7); 7.2105 (0.6); 7.1352 (2.1); 7.1254 (2.8); 7.1222 (2.6); 7.1109 (6.5); 7.1054 (8.6); 7.0998 (11.6); 7.0940 (5.2); 7.0806 (7.5); 7.0768 (7.9); 7.0563 (7.6); 7.0339 (3.1); 6.9962 (1.6); 5.7753 (5.6); 5.2985 (8.6); 3.5047 (4.6); 3.4826 (9.5); 3.4591 (5.9); 3.1714 (6.0); 3.1622 (9.0); 3.1541 (9.0); 3.1422 (16.0); 3.1307 (8.5); 3.1172 (4.4); 3.1039 (4.1); 3.0967 (5.0); 3.0826 (5.1); 3.0655 (2.9); 3.0443 (1.2); 2.0435 (0.7); 1.8234 (3.3); 1.8154 (3.3); 1.8090 (3.4); 1.7900 (2.2); 1.7640 (2.2); 1.7296 (14.7); 1.7018 (12.6); 1.6167 (6.0); 1.5964 (7.6); 1.5531 (4.2); 1.5298 (6.1); 1.5221 (5.1); 1.5054 (8.3); 1.4897 (10.1); 1.4720 (9.7); 1.4533 (5.4); 1.3520 (1.2); 1.3346 (2.4); 1.3102 (4.8); 1.2848 (6.6); 1.2798 (6.9); 1.2552 (8.2); 1.2303 (2.2); 0.8804 (1.1); 0.1460 (0.5); 0.0079 (5.5); -0.0002 (142.3); -0.0085 (4.7); -0.1498 (0.5)
1.8- 23: 1H-NMR(400.0 MHz, CDC13): 1.8-23: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.4319 (5.5); 8.2295 (4.4); 8.2145 (4.6); 8.2074 (7.1); 8.1925 (7.3); 8.1835 (4.1); 8.1687 (3.6); 7.5202 (1.2); 7.2613 (223.2); 7.2107 (0.5); 6.9973 (1.2); 6.8877 (4.3); 6.8810 (6.5); 6.8714 (2.0); 6.8648 (8.2); 6.8597 (13.4); 6.8538 (6.4); 6.8445 (9.2); 6.8387 (9.4); 6.8329 (6.2); 6.8262 (4.4); 6.8230 (3.8); 6.8189 (1.8); 6.8158 (2.4); 6.7706 (0.5); 6.7517 (0.5); 6.7458 (0.5); 6.0142 (4.7); 5.2985 (16.0); 3.8908 (1.2); 3.8877 (1.0); 3.8314 (9.4); 3.8168 (1.2); 3.8078 (0.7); 3.7947 (2.9); 3.7913 (0.6); 3.7882 (1.5); 3.7487 (6.5); 3.5926 (0.6); 3.5597 (0.6); 3.5054 (4.8); 3.5035 (4.9); 3.4810 (11.1); 3.4586 (6.0); 3.4567 (6.1); 3.3654 (0.9); 3.3572 (0.8); 3.3445 (0.8); 3.3034 (0.9); 3.2978 (0.5); 3.2892 (1.0); 3.2303 (13.2); 3.2091 (15.7); 3.1927 (6.2); 3.1745 (7.5); 3.1687 (5.6); 3.1504 (6.4); 3.0106 (2.3); 2.9927 (4.8); 2.9888 (4.1); 2.9710 (7.0); 2.9532 (3.5); 2.9493 (3.8); 2.9314 (1.6); 1.8018 (4.8); 1.7937 (5.4); 1.7700 (6.2); 1.7631 (6.3); 1.7042 (8.9); 1.7002 (9.0); 1.6789 (7.7); 1.5930 (3.1); 1.5850 (3.7); 1.5733 (3.2); 1.5649 (3.6); 1.5559 (3.3); 1.5472 (3.4); 1.5390 (2.5); 1.5269 (1.9); 1.5181 (1.9); 1.5106 (1.0); 1.3050 (1.5); 1.2736 (4.7); 1.2692 (4.5); 1.2491 (4.1); 1.2419 (6.2); 1.2373 (6.5); 1.2065 (7.3); 1.1832 (2.9); 1.1757 (4.7); 1.1680 (3.3); 1.1445 (4.3); 1.1101 (4.1); 1.0859 (4.0); 1.0793 (4.3); 1.0577 (4.1); 1.0503 (4.4); 1.0283 (3.1); 1.0200 (3.3); 0.9977 (1.3); 0.9890 (1.3); 0.0080 (2.3); 0.0055 (0.7); 0.0047 (0.8); -0.0002 (78.5); -0.0085 (2.3) δ = 9.4319 (5.5); 8.2295 (4.4); 8.2145 (4.6); 8.2074 (7.1); 8.1925 (7.3); 8.1835 (4.1); 8.1687 (3.6); 7.5202 (1.2); 7.2613 (223.2); 7.2107 (0.5); 6.9973 (1.2); 6.8877 (4.3); 6.8810 (6.5); 6.8714 (2.0); 6.8648 (8.2); 6.8597 (13.4); 6.8538 (6.4); 6.8445 (9.2); 6.8387 (9.4); 6.8329 (6.2); 6.8262 (4.4); 6.8230 (3.8); 6.8189 (1.8); 6.8158 (2.4); 6.7706 (0.5); 6.7517 (0.5); 6.7458 (0.5); 6.0142 (4.7); 5.2985 (16.0); 3.8908 (1.2); 3,888 (1.0); 3.8314 (9.4); 3.8168 (1.2); 3.8078 (0.7); 3.7947 (2.9); 3.7913 (0.6); 3.7882 (1.5); 3.7487 (6.5); 3.5926 (0.6); 3.5597 (0.6); 3.5054 (4.8); 3.5035 (4.9); 3.4810 (11.1); 3.4586 (6.0); 3.4567 (6.1); 3.3654 (0.9); 3.3572 (0.8); 3.3445 (0.8); 3.3034 (0.9); 3.2978 (0.5); 3.2892 (1.0); 3.2303 (13.2); 3.2091 (15.7); 3.1927 (6.2); 3.1745 (7.5); 3.1687 (5.6); 3.1504 (6.4); 3.0106 (2.3); 2.9927 (4.8); 2,9888 (4.1); 2.9710 (7.0); 2.9532 (3.5); 2.9493 (3.8); 2.9314 (1.6); 1.8018 (4.8); 1.7937 (5.4); 1.7700 (6.2); 1.7631 (6.3); 1.7042 (8.9); 1.7002 (9.0); 1.6789 (7.7); 1.5930 (3.1); 1.5850 (3.7); 1.5733 (3.2); 1.5649 (3.6); 1.5559 (3.3); 1.5472 (3.4); 1.5390 (2.5); 1.5269 (1.9); 1.5181 (1.9); 1.5106 (1.0); 1.3050 (1.5); 1.2736 (4.7); 1.2692 (4.5); 1.2491 (4.1); 1.2419 (6.2); 1.2373 (6.5); 1.2065 (7.3); 1.1832 (2.9); 1.1757 (4.7); 1.1680 (3.3); 1.1445 (4.3); 1.1101 (4.1); 1.0859 (4.0); 1.0793 (4.3); 1.0577 (4.1); 1.0503 (4.4); 1.0283 (3.1); 1,0200 (3.3); 0.9977 (1.3); 0.9890 (1.3); 0.0080 (2.3); 0.0055 (0.7); 0.0047 (0.8); -0.0002 (78.5); -0.0085 (2.3)
1.9- 29: 1H-NMR(400.0 MHz, CDC13): 1.9-29: 1 H-NMR (400.0 MHz, CDC13):
δ= 9.6949 (5.5); 8.2178 (5.1); 8.2136 (5.4); 8.2004 (5.7); 8.1966 (9.0); 8.1933 (6.2); 8.1804 (5.4); 8.1759 (5.5); 7.5184 (6.5); 7.4091 (0.9); 7.2595 (1165.4); 7.2344 (1.4); 7.2268 (1.7); 7.2094 (3.4); 7.1600 (1.3); 7.1231 (4.1); 7.1188 (4.9); 7.1066 (4.1); 7.1025 (12.2); 7.0985 (8.3); 7.0863 (9.3); 7.0817 (8.5); 7.0611 (8.3); 7.0577 (8.2); 7.0409 (10.5); 7.0373 (11.3); 7.0207 (4.0); 7.0167 (4.4); 6.9955 (6.6); 5.6611 (5.5); 3.5045 (5.2); 3.4825 (11.9); 3.4599 (7.2); 3.2291 (12.1); 3.2083 (16.0); 3.1761 (6.1); 3.1584 (9.1); 3.1528 (4.5); 3.1350 (9.3); 3.1211 (4.0); 3.1075 (3.8); 3.1004 (5.2); 3.0860 (5.3); 3.0686 (3.3); 3.0468 (1.5); 2.0435 (1.9); 1.8321 (3.3); 1.8248 (3.2); 1.8174 (3.3); 1.7350 (15.6); 1.7125 (15.0); 1.6175 (5.0); 1.5989 (6.6); 1.5568 (3.8); 1.5353 (205.3); 1.5073 (8.2); 1.4935 (10.2); 1.4853 (8.8); 1.4799 (9.0); 1.4748 (10.3); 1.4525 (4.9); 1.3630 (1.2); 1.3218 (4.6); 1.3121 (3.8); 1.3033 (4.6); 1.2969 (5.2); 1.2872 (6.1); 1.2623 (6.2); 1.2373 (2.2); 0.8822 (0.8); 0.1460 (2.3); 0.0079 (17.7); - 0.0002 (639.8); -0.0085 (19.6); -0.0501 (1.7); -0.1004 (0.7); -0.1495 (1.8) δ = 9.6949 (5.5); 8.2178 (5.1); 8.2136 (5.4); 8.2004 (5.7); 8.1966 (9.0); 8.1933 (6.2); 8.1804 (5.4); 8.1759 (5.5); 7.5184 (6.5); 7.4091 (0.9); 7.2595 (1165.4); 7.2344 (1.4); 7.2268 (1.7); 7.2094 (3.4); 7.1600 (1.3); 7.1231 (4.1); 7.1188 (4.9); 7.1066 (4.1); 7.1025 (12.2); 7.0985 (8.3); 7.0863 (9.3); 7.0817 (8.5); 7.0611 (8.3); 7.0577 (8.2); 7.0409 (10.5); 7.0373 (11.3); 7.0207 (4.0); 7.0167 (4.4); 6.9955 (6.6); 5.6611 (5.5); 3.5045 (5.2); 3.4825 (11.9); 3.4599 (7.2); 3.2291 (12.1); 3.2083 (16.0); 3.1761 (6.1); 3.1584 (9.1); 3.1528 (4.5); 3.1350 (9.3); 3.1211 (4.0); 3.1075 (3.8); 3.1004 (5.2); 3.0860 (5.3); 3.0686 (3.3); 3.0468 (1.5); 2.0435 (1.9); 1.8321 (3.3); 1.8248 (3.2); 1.8174 (3.3); 1.7350 (15.6); 1.7125 (15.0); 1.6175 (5.0); 1.5989 (6.6); 1.5568 (3.8); 1.5353 (205.3); 1.5073 (8.2); 1.4935 (10.2); 1.4853 (8.8); 1.4799 (9.0); 1.4748 (10.3); 1.4525 (4.9); 1.3630 (1.2); 1.3218 (4.6); 1.3121 (3.8); 1.3033 (4.6); 1.2969 (5.2); 1.2872 (6.1); 1.2623 (6.2); 1.2373 (2.2); 0.8822 (0.8); 0.1460 (2.3); 0.0079 (17.7); - 0.0002 (639.8); -0.0085 (19.6); -0.0501 (1.7); -0.1004 (0.7); -0.1495 (1.8)
Gegenstand der vorliegenden Erfindung ist weiterhin die Verwendung einer oder mehrerer The present invention furthermore relates to the use of one or more
Verbindungen der allgemeinen Formel (I) und/oder deren Salzen, wie oben definiert, vorzugsweise in einer der als bevorzugt bzw. besonders bevorzugt gekennzeichneten Ausgestaltung, insbesondere einer oder mehrerer Verbindungen der Formeln (L I) bis (1.50) und/oder deren Salze, jeweils wie oben definiert, als Herbizid und/oder Pflanzenwachstumsregulator, vorzugsweise in Kulturen von Nutz- und/oder Zierpflanzen. Compounds of the general formula (I) and / or salts thereof, as defined above, preferably in one of the preferred or particularly preferred embodiment, in particular one or more compounds of the formulas (LI) to (1.50) and / or salts thereof, each as defined above, as a herbicide and / or plant growth regulator, preferably in crops of useful and / or ornamental plants.
Gegenstand der vorliegenden Erfindung ist ferner ein Verfahren zur Bekämpfung von Schadpflanzen und/oder zur Wachstumsregulierung von Pflanzen, dadurch gekennzeichnet, dass eine wirksame Menge - einer oder mehrerer Verbindungen der allgemeinen Formel (I) und/oder deren Salzen, wie oben definiert, vorzugsweise in einer der als bevorzugt bzw. besonders bevorzugt gekennzeichneten The present invention furthermore relates to a method for controlling harmful plants and / or for regulating the growth of plants, characterized in that an effective amount of one or more compounds of the general formula (I) and / or their salts, as defined above, is preferably present in one of the marked as preferred or particularly preferred
Ausgestaltung, insbesondere einer oder mehrerer Verbindungen der Formeln (L I) bis (1.50) und/oder deren Salze, jeweils wie oben definiert, oder - eines erfindungsgemäßen Mittels, wie nachstehend definiert, auf die (Schad)Pflanzen, (Schad)Pflanzensamen, den Boden, in dem oder auf dem die (Schad)Pflanzen wachsen, oder die Anbaufläche appliziert wird. Embodiment, in particular one or more compounds of the formulas (LI) to (1.50) and / or salts thereof, each as defined above, or - an agent according to the invention, as defined below, on the (harmful) plants, (harmful) plant seeds, the Soil in which or on which the (harmful) plants grow, or the cultivated area is applied.
Gegenstand der vorliegenden Erfindung ist auch ein Verfahren zur Bekämpfung von unerwünschten Pflanzen, vorzugsweise in Nutzpflanzenkulturen, dadurch gekennzeichnet, dass eine wirksame Menge einer oder mehrerer Verbindungen der allgemeinen Formel (I) und/oder deren Salzen, wie oben definiert, vorzugsweise in einer der als bevorzugt bzw. besonders bevorzugt gekennzeichneten The present invention also provides a process for controlling undesirable plants, preferably in crops, characterized in that an effective amount of one or more compounds of the general formula (I) and / or salts thereof, as defined above, preferably in one of preferred or particularly preferred marked
Ausgestaltung, insbesondere einer oder mehrerer Verbindungen der Formeln (L I) bis (1.50) und/oder deren Salze, jeweils wie oben definiert, oder eines erfindungsgemäßen Mittels, wie nachstehend definiert, auf unerwünschte Pflanzen (z.B. Schadpflanzen wie mono- oder dikotyle Unkräuter oder unerwünschte Kulturpflanzen), das Saatgut der unerwünschten Pflanzen (d.h. Pflanzensamen, z.B. Körner, Samen oder vegetative Vermehrungsorgane wie Knollen oder Sprossteile mit Knospen), den Boden, in dem oder auf dem die unerwünschte Pflanzen wachsen, (z.B. den Boden von Kulturland oder Nicht-Kulturland) oder die Anbaufläche (d.h. Fläche, auf der die unerwünschte Pflanzen wachsen werden) appliziert wird. Gegenstand der vorliegenden Erfindung ist ferner auch Verfahren zur Bekämpfung zur Embodiment, in particular one or more compounds of the formulas (LI) to (1.50) and / or salts thereof, each as defined above, or an agent according to the invention, as defined below, on undesirable plants (eg harmful plants such as mono- or dicotyledonous weeds or unwanted Crops), the seed of the undesirable plants (ie plant seeds, eg grains, seeds or vegetative propagules such as tubers or sprouts with buds), the soil in which or on which the undesirable plants grow (eg the soil of cultivated land or non-cultivated land ) or the area under cultivation (ie area on which the unwanted plants will grow) is applied. The present invention is also a method for controlling
Wachstumsregulierung von Pflanzen, vorzugsweise von Nutzpflanzen, dadurch gekennzeichnet, dass eine wirksame Menge einer oder mehrerer Verbindungen der allgemeinen Formel (I) und/oder deren Salzen, wie oben definiert, vorzugsweise in einer der als bevorzugt bzw. besonders bevorzugt gekennzeichneten Ausgestaltung, insbesondere einer oder mehrerer Verbindungen der allgemeinen Formeln (L I) bis (1.50) und/oder deren Salze, jeweils wie oben definiert, oder eines erfindungsgemäßen Mittels, wie nachstehend definiert, die Pflanze, das Saatgut der Pflanze (d.h. Pflanzensamen, z.B. Körner, Samen oder vegetative Growth regulation of plants, preferably of useful plants, characterized in that an effective amount of one or more compounds of general formula (I) and / or their salts, as defined above, preferably in one of the preferred or particularly preferred Embodiment, in particular one or more compounds of the general formulas (LI) to (1.50) and / or salts thereof, each as defined above, or an agent according to the invention, as defined below, the plant, the seed of the plant (ie plant seeds, eg grains , Seeds or vegetative
Vermehrungsorgane wie Knollen oder Sprossteile mit Knospen), den Boden, in dem oder auf dem die Pflanzen wachsen, (z.B. den Boden von Kulturland oder Nicht-Kulturland) oder die Anbaufläche (d.h. Fläche, auf der die Pflanzen wachsen werden) appliziert wird. Propagating organs such as tubers or sprouts with buds), the soil in which or on which the plants grow (e.g., the soil of cultivated land or non-cultivated land) or the cultivated area (i.e., area on which the plants will grow) is applied.
Dabei können die erfindungsgemäßen Verbindungen bzw. die erfindungsgemäßen Mittel z.B. im Vorsaat- (gegebenenfalls auch durch Einarbeitung in den Boden), Vorauflauf- und/oder The compounds according to the invention or the agents according to the invention may e.g. in Vorsaat- (possibly also by incorporation into the soil), pre-emergence and / or
Nachauflaufverfahren ausgebracht werden. Im einzelnen seien beispielhaft einige Vertreter der mono- und dikotylen Unkrautflora genannt, die durch die die erfindungsgemäßen Verbindungen kontrolliert werden können, ohne dass durch die Nennung eine Beschränkung auf bestimmte Arten erfolgen soll. Postemergence be applied. Specifically, by way of example, some representatives of the monocotyledonous and dicotyledonous weed flora may be mentioned, which can be controlled by the compounds according to the invention, without the intention of being restricted to certain species.
Vorzugsweise werden in einem erfindungsgemäßen Verfahren zur Bekämpfung von Schadpflanzen oder zur Wachstumsregulierung von Pflanzen eine oder mehrere Verbindungen der allgemeinen Formel (I) und/oder deren Salze zur Bekämpfung von Schadpflanzen oder zur Wachstumsregulierung in Kulturen von Nutzpflanzen oder Zierpflanzen eingesetzt, wobei die Nutzpflanzen oder Zierpflanzen in einer bevorzugten Ausgestaltung transgene Pflanzen sind. Preferably, in a method according to the invention for controlling harmful plants or regulating the growth of plants, one or more compounds of the general formula (I) and / or their salts are employed for controlling harmful plants or regulating growth in crops of crops or ornamental plants, the crops or ornamentals in a preferred embodiment are transgenic plants.
Die erfindungsgemäßen Verbindungen der allgemeinen Formel (I) und/oder deren Salze eignen sich zur Bekämpfung der folgenden Gattungen von monokotylen und dikotylen Schadpflanzen: The compounds of the general formula (I) according to the invention and / or salts thereof are suitable for controlling the following genera of monocotyledonous and dicotyledonous harmful plants:
Monokotyle Schadpflanzen der Gattungen: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum. Monocotyledonous weeds of the genera: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata , Ishumum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum.
Dikotyle Schadpflanzen der Gattungen: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium. Werden die erfindungsgemäßen Verbindungen vor dem Keimen der Schadpflanzen (Ungräser und/oder Unkräuter) auf die Erdoberfläche appliziert (Vorauflaufverfahren), so wird entweder das Auflaufen der Ungras- bzw. Unkrautkeimlinge vollständig verhindert oder diese wachsen bis zum Keimblattstadium heran, stellen jedoch dann ihr Wachstum ein und sterben schließlich nach Ablauf von drei bis vier Wochen vollkommen ab. Dicotyledonous weeds of the genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis Galinsoga Galium Hibiscus Ipomoea Kochia Lamium Lepidium Lindernia Matricaria Mentha Mercurialis Mullugo Myosotis Papaver Pharbitis Plantago Polygonum Portulaca Ranunculus Raphanus Rorippa Rotala Rumex , Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium. If the compounds according to the invention are applied to the surface of the earth (weeds and / or weeds) prior to germination (pre-emergence method), either the emergence of the weed seedlings or weed seedlings is completely prevented or they grow up to the cotyledon stage, but then grow and eventually die off after three to four weeks.
Bei Applikation der Wirkstoffe auf die grünen Pflanzenteile im Nachauflaufverfahren tritt nach der Behandlung Wachstumsstop ein und die Schadpflanzen bleiben in dem zum Applikationszeitpunkt vorhandenen Wachstumsstadium stehen oder sterben nach einer gewissen Zeit ganz ab, so dass auf diese Weise eine für die Kulturpflanzen schädliche Unkrautkonkurrenz sehr früh und nachhaltig beseitigt wird. When the active ingredients are applied to the green parts of the plants postemergence, growth stops after the treatment and the harmful plants remain in the growth stage existing at the time of application or die completely after a certain time, so that in this way a weed competition which is harmful to the crop plants takes place very early sustainably eliminated.
Obgleich die erfindungsgemäßen Verbindungen eine ausgezeichnete herbizide Aktivität gegenüber mono- und dikotylen Unkräutern aufweisen, werden Kulturpflanzen wirtschaftlich bedeutender Kulturen z.B. dikotyler Kulturen der Gattungen Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Miscanthus, Nicotiana, Phaseolus, Pisum, Solanum, Vicia, oder monokotyler Kulturen der Gattungen Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Seeale, Sorghum, Triticale, Triticum, Zea, abhängig von der Struktur der jeweiligen erfindungsgemäßen Verbindung und deren Aufwandmenge nur unwesentlich oder gar nicht geschädigt. Die vorliegenden Verbindungen eignen sich aus diesen Gründen sehr gut zur selektiven Bekämpfung von unerwünschtem Pflanzenwuchs in Pflanzenkulturen wie Although the compounds of the invention have excellent herbicidal activity against mono- and dicotyledonous weeds, crops of economically important crops, e.g. dicotyledonous cultures of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Miscanthus, Nicotiana, Phaseolus, Pisum, Solanum, Vicia, or monocotyledonous cultures of the genera Allium, Pineapple , Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Seeale, Sorghum, Triticale, Triticum, Zea, depending on the structure of the respective compound of the invention and their application rate only insignificantly or not at all damaged. For these reasons, the present compounds are very well suited for the selective control of undesired plant growth in crops such as
landwirtschaftlichen Nutzpflanzungen oder Zierpflanzungen. agricultural crops or ornamental plantings.
Darüberhinaus weisen die erfindungsgemäßen Verbindungen (abhängig von ihrer jeweiligen Struktur und der ausgebrachten Aufwandmenge) hervorragende wachstumsregulatorische Eigenschaften beiMoreover, the compounds according to the invention (depending on their respective structure and the applied application rate) have excellent growth-regulatory properties
Kulturpflanzen auf. Sie greifen regulierend in den pflanzeneigenen Stoffwechsel ein und können damit zur gezielten Beeinflussung von Pflanzeninhaltsstoffen und zur Ernteerleichterung wie z.B. durch Auslösen von Desikkation und Wuchsstauchung eingesetzt werden. Desweiteren eignen sie sich auch zur generellen Steuerung und Hemmung von unerwünschtem vegetativem Wachstum, ohne dabei die Pflanzen abzutöten. Eine Hemmung des vegetativen Wachstums spielt bei vielen mono- und dikotylen Kulturen eine große Rolle, da beispielsweise die Lagerbildung hierdurch verringert oder völlig verhindert werden kann. Crops on. They regulate the plant's metabolism and can thus be used to specifically influence plant constituents and facilitate harvesting, such as be used by triggering desiccation and stunted growth. Furthermore, they are also suitable for the general control and inhibition of unwanted vegetative growth, without killing the plants. Inhibition of vegetative growth plays an important role in many monocotyledonous and dicotyledonous crops, since, for example, storage formation can thereby be reduced or completely prevented.
Aufgrund ihrer herbiziden und pflanzenwachstumsregulatorischen Eigenschaften können die Wirkstoffe auch zur Bekämpfung von Schadpflanzen in Kulturen von gentechnisch oder durch konventionelle Mutagenese veränderten Pflanzen eingesetzt werden. Die transgenen Pflanzen zeichnen sich in der Regel durch besondere vorteilhafte Eigenschaften aus, beispielsweise durch Resistenzen gegenüber bestimmten Pestiziden, vor allem bestimmten Herbiziden, Resistenzen gegenüber Pflanzenkrankheiten oder Erregern von Pflanzenkrankheiten wie bestimmten Insekten oder Mikroorganismen wie Pilzen, Bakterien oder Viren. Andere besondere Eigenschaften betreffen z.B. das Erntegut hinsichtlich Menge, Qualität, Lagerfähigkeit, Zusammensetzung und spezieller Inhaltsstoffe. So sind transgene Pflanzen mit erhöhtem Stärkegehalt oder veränderter Qualität der Stärke oder solche mit anderer Because of their herbicidal and plant growth regulatory properties, the active compounds can also be used to control harmful plants in crops of genetically engineered or conventional mutagenized plants. The transgenic plants are usually characterized by particular advantageous properties, for example by resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens of plant diseases such as certain insects or microorganisms such as fungi, bacteria or viruses. Other special properties concern, for example, the crop in terms of quantity, quality, shelf life, composition and special ingredients. So are transgenic plants with increased starch content or altered quality of starch or those with others
Fettsäurezusammensetzung des Ernteguts bekannt. Fatty acid composition of the crop known.
Bevorzugt bezüglich transgener Kulturen ist die Anwendung der erfindungsgemäßen Verbindungen und/oder deren Salze in wirtschaftlich bedeutenden transgenen Kulturen von Nutz und Zierpflanzen, z.B. von Getreide wie Weizen, Gerste, Roggen, Hafer, Hirse, Reis und Mais oder auch Kulturen von Zuckerrübe, Baumwolle, Soja, Raps, Kartoffel, Tomate, Erbse und anderen Gemüsesorten. Preferred for transgenic cultures is the use of the compounds of the invention and / or their salts in economically important transgenic crops of useful and ornamental plants, e.g. of cereals such as wheat, barley, rye, oats, millet, rice and maize or also crops of sugar beet, cotton, soya, rapeseed, potato, tomato, pea and other vegetables.
Vorzugsweise können die erfindungsgemäßen Verbindungen auch als Herbizide in Preferably, the compounds of the invention may also be used as herbicides in
Nutzpflanzenkulturen eingesetzt werden, welche gegenüber den phytotoxischen Wirkungen der Herbizide resistent sind bzw. gentechnisch resistent gemacht worden sind. Crop plants are used, which are resistant to the phytotoxic effects of herbicides or have been made genetically resistant.
Aufgrund ihrer herbiziden und pflanzenwachstumsregulatorischen Eigenschaften können die Wirkstoffe auch zur Bekämpfung von Schadpflanzen in Kulturen von bekannten oder noch zu entwickelnden gentechnisch veränderten Pflanzen eingesetzt werden. Die transgenen Pflanzen zeichnen sich in der Regel durch besondere vorteilhafte Eigenschaften aus, beispielsweise durch Resistenzen gegenüber bestimmten Pestiziden, vor allem bestimmten Herbiziden, Resistenzen gegenüber Pflanzenkrankheiten oder Erregern von Pflanzenkrankheiten wie bestimmten Insekten oder Mikroorganismen wie Pilzen, Bakterien oder Viren. Andere besondere Eigenschaften betreffen z.B. das Erntegut hinsichtlich Menge, Qualität, Lagerfähigkeit, Zusammensetzung und spezieller Inhaltsstoffe. So sind transgene Pflanzen mit erhöhtem Stärkegehalt oder veränderter Qualität der Stärke oder solche mit anderer Due to their herbicidal and plant growth regulatory properties, the active compounds can also be used for controlling harmful plants in crops of known or yet to be developed genetically modified plants. The transgenic plants are usually characterized by particular advantageous properties, for example by resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens of plant diseases such as certain insects or microorganisms such as fungi, bacteria or viruses. Other special properties concern e.g. the crop in terms of quantity, quality, shelf life, composition and special ingredients. So are transgenic plants with increased starch content or altered quality of starch or those with others
Fettsäurezusammensetzung des Ernteguts bekannt. Weitere besondere Eigenschaften können in einer Toleranz oder Resistenz gegen abiotische Stressoren z.B. Hitze, Kälte, Trockenheit, Salz und ultraviolette Strahlung liegen. Fatty acid composition of the crop known. Other particular properties may include tolerance or resistance to abiotic stressors, e.g. Heat, cold, drought, salt and ultraviolet radiation are present.
Bevorzugt ist die Anwendung der erfindungsgemäßen Verbindungen der allgemeinen Formel (I) oder deren Salze in wirtschaftlich bedeutenden transgenen Kulturen von Nutz-und Zierpflanzen, z.B. von Getreide wie Weizen, Gerste, Roggen, Hafer, Triticale, Hirse, Reis, Maniok und Mais oder auch Kulturen von Zuckerrübe, Baumwolle, Soja, Raps, Kartoffel, Tomate, Erbse und anderen Gemüsesorten. Preference is given to the use of the compounds of general formula (I) according to the invention or their salts in economically important transgenic crops of useful and ornamental plants, e.g. of cereals such as wheat, barley, rye, oats, triticale, millet, rice, manioc and maize or also crops of sugar beet, cotton, soya, rapeseed, potato, tomato, pea and other vegetables.
Vorzugsweise können die Verbindungen der allgemeinen Formel (I) als Herbizide in Preferably, the compounds of general formula (I) as herbicides in
Nutzpflanzenkulturen eingesetzt werden, welche gegenüber den phytotoxischen Wirkungen der Herbizide resistent sind bzw. gentechnisch resistent gemacht worden sind. Herkömmliche Wege zur Herstellung neuer Pflanzen, die im Vergleich zu bisher vorkommenden Pflanzen modifizierte Eigenschaften aufweisen, bestehen beispielsweise in klassischen Crop plants are used, which are resistant to the phytotoxic effects of herbicides or have been made genetically resistant. Conventional ways of producing new plants which have modified properties in comparison with previously occurring plants consist, for example, in classical methods
Züchtungsverfahren und der Erzeugung von Mutanten. Alternativ können neue Pflanzen mit veränderten Eigenschaften mit Hilfe gentechnischer Verfahren erzeugt werden. Breeding methods and the generation of mutants. Alternatively, new plants with altered properties can be generated using genetic engineering techniques.
Zahlreiche molekularbiologische Techniken, mit denen neue transgene Pflanzen mit veränderten Eigenschaften hergestellt werden können, sind dem Fachmann bekannt. Für derartige gentechnische Manipulationen können Nucleinsäuremoleküle in Plasmide eingebracht werden, die eine Mutagenese oder eine Sequenzveränderung durch Rekombination von DNA-Sequenzen erlauben. Mit Hilfe von Standardverfahren können z.B. Basenaustausche vorgenommen, Teilsequenzen entfernt oder natürliche oder synthetische Sequenzen hinzugefügt werden. Für die Verbindung der DNA-Fragmente untereinander können an die Fragmente Adaptoren oder Linker angesetzt werden. Numerous molecular biological techniques with which new transgenic plants with altered properties can be prepared are known to the person skilled in the art. For such genetic engineering, nucleic acid molecules can be introduced into plasmids that allow mutagenesis or sequence alteration by recombination of DNA sequences. By means of standard methods, e.g. Base exchanges are made, partial sequences removed or natural or synthetic sequences added. For the connection of the DNA fragments with one another adapters or linkers can be attached to the fragments.
Die Herstellung von Pflanzenzellen mit einer verringerten Aktivität eines Genprodukts kann beispielsweise erzielt werden durch die Expression mindestens einer entsprechenden antisense-RNA, einer sense-RNA zur Erzielung eines Cosuppressionseffektes oder die Expression mindestens eines entsprechend konstruierten Ribozyms, das spezifisch Transkripte des obengenannten Genprodukts spaltet. Hierzu können zum einen DNA-Moleküle verwendet werden, die die gesamte codierende Sequenz eines Genprodukts einschließlich eventuell vorhandener flankierender Sequenzen umfassen, als auch DNA- Moleküle, die nur Teile der codierenden Sequenz umfassen, wobei diese Teile lang genug sein müssen, um in den Zellen einen antisense-Effekt zu bewirken. Möglich ist auch die Verwendung von DNA- Sequenzen, die einen hohen Grad an Homologie zu den codiereden Sequenzen eines Genprodukts aufweisen, aber nicht vollkommen identisch sind. The production of plant cells having a reduced activity of a gene product can be achieved, for example, by the expression of at least one corresponding antisense RNA, a sense RNA to obtain a cosuppression effect, or the expression of at least one appropriately engineered ribozyme which specifically cleaves transcripts of the above gene product. For this purpose, on the one hand DNA molecules can be used which comprise the entire coding sequence of a gene product including any flanking sequences, as well as DNA molecules which comprise only parts of the coding sequence, which parts have to be long enough to be present in the cells to cause an antisense effect. It is also possible to use DNA sequences which have a high degree of homology to the coding sequences of a gene product, but are not completely identical.
Bei der Expression von Nucleinsäuremolekülen in Pflanzen kann das synthetisierte Protein in jedem beliebigen Kompartiment der pflanzlichen Zelle lokalisiert sein. Um aber die Lokalisation in einem bestimmten Kompartiment zu erreichen, kann z.B. die codierende Region mit DNA-Sequenzen verknüpft werden, die die Lokalisierung in einem bestimmten Kompartiment gewährleisten. Derartige Sequenzen sind dem Fachmann bekannt (siehe beispielsweise Braun et al., EMBO J. 11 (1992), 3219- 3227). Die Expression der Nukleinsäuremoleküle kann auch in den Organellen der Pflanzenzellen stattfinden. Die transgenen Pflanzenzellen können nach bekannten Techniken zu ganzen Pflanzen regeneriert werden. Bei den transgenen Pflanzen kann es sich prinzipiell um Pflanzen jeder beliebigen In the expression of nucleic acid molecules in plants, the synthesized protein may be located in any compartment of the plant cell. However, to achieve localization in a particular compartment, e.g. the coding region is linked to DNA sequences which ensure localization in a particular compartment. Such sequences are known to the person skilled in the art (see, for example, Braun et al., EMBO J. 11 (1992), 3219-3227). The expression of the nucleic acid molecules can also take place in the organelles of the plant cells. The transgenic plant cells can be regenerated to whole plants by known techniques. The transgenic plants can in principle be plants of any one
Pflanzenspezies handeln, d.h. sowohl monokotyle als auch dikotyle Pflanzen. So sind transgene Pflanzen erhältlich, die veränderte Eigenschaften durch Überexpression, Suppression oder Inhibierung homologer (= natürlicher) Gene oder Gensequenzen oder Expression heterologer (= fremder) Gene oder Gensequenzen aufweisen. Plant species, ie both monocotyledonous and dicotyledonous plants. Thus, transgenic plants are available which have altered properties by overexpression, suppression or inhibition of homologous (= natural) genes or gene sequences or expression of heterologous (= foreign) genes or gene sequences.
Vorzugsweise können die erfindungsgemäßen Verbindungen (I) in transgenen Kulturen eingesetzt werden, welche gegen Wuchsstoffe, wie z.B. Dicamba oder gegen Herbizide, die essentielle Preferably, the compounds (I) according to the invention can be used in transgenic cultures which are resistant to growth factors, such as e.g. Dicamba or against herbicides, the essential
Pflanzenenzyme, z.B. Acetolactatsynthasen (ALS), EPSP Synthasen, Glutaminsynthasen (GS) oder Hydoxyphenylpyruvat Dioxygenasen (HPPD) hemmen, respektive gegen Herbizide aus der Gruppe der Sulfonylharnstoffe, der Glyphosate, Glufosinate oder Benzoylisoxazole und analogen Wirkstoffe, resistent sind. Plant enzymes, e.g. Acetylactate synthases (ALS), EPSP synthases, glutamine synthases (GS) or hydroxyphenylpyruvate dioxygenases (HPPD), respectively, which are resistant to herbicides from the group of sulfonylureas, glyphosate, glufosinate or benzoylisoxazole and analogues.
Bei der Anwendung der erfindungsgemäßen Wirkstoffe in transgenen Kulturen treten neben den in anderen Kulturen zu beobachtenden Wirkungen gegenüber Schadpflanzen oftmals Wirkungen auf, die für die Applikation in der jeweiligen transgenen Kultur spezifisch sind, beispielsweise ein verändertes oder speziell erweitertes Unkrautspektrum, das bekämpft werden kann, veränderte Aufwandmengen, die für die Applikation eingesetzt werden können, vorzugsweise gute Kombinierbarkeit mit den Herbiziden, gegenüber denen die transgene Kultur resistent ist, sowie Beeinflussung von Wuchs und Ertrag der transgenen Kulturpflanzen. In the application of the active compounds according to the invention in transgenic crops, in addition to the effects observed in other crops on harmful plants, effects which are specific for the application in the respective transgenic crop often occur, for example a modified or specially extended weed spectrum which can be controlled Application rates that can be used for the application, preferably good combinability with the herbicides to which the transgenic culture is resistant, and influencing growth and yield of the transgenic crops.
Gegenstand der Erfindung ist deshalb auch die Verwendung der erfindungsgemäßen Verbindungen der allgemeinen Formel (I) und/oder deren Salze als Herbizide zur Bekämpfung von Schadpflanzen in Kulturen von Nutz- oder Zierpflanzen, gegebenenfalls in transgenen Kulturpflanzen. Bevorzugt ist die Verwendung in Getreide, dabei vorzugsweise Mais, Weizen, Gerste, Roggen, Hafer, Hirse, oder Reis, im Vor- oder Nachauflauf. The invention therefore also relates to the use of the compounds of the general formula (I) according to the invention and / or salts thereof as herbicides for controlling harmful plants in crops of useful or ornamental plants, optionally in transgenic crop plants. Preferred is the use in cereals, preferably corn, wheat, barley, rye, oats, millet, or rice, in the pre- or post-emergence.
Bevorzugt ist auch die Verwendung in Soja im Vor- oder Nachauflauf. Die erfindungsgemäße Verwendung zur Bekämpfung von Schadpflanzen oder zur Preference is also the use in soy in the pre or postemergence. The use according to the invention for controlling harmful plants or for
Wachstumsregulierung von Pflanzen schließt auch den Fall ein, bei dem der Wirkstoff der allgemeinen Formel (I) oder dessen Salz erst nach der Ausbringung auf der Pflanze, in der Pflanze oder im Boden aus einer Vorläufersubstanz ("Prodrug") gebildet wird.  Growth regulation of plants also includes the case where the active ingredient of general formula (I) or its salt is formed from a precursor substance ("prodrug") only after plant, plant or soil application.
Gegenstand der Erfindung ist auch die Verwendung einer oder mehrerer Verbindungen der allgemeinen Formel (I) oder deren Salzen bzw. eines erfindungsgemäßen Mittels (wie nachstehend definiert) (in einem Verfahren) zur Bekämpfung von Schadpflanzen oder zur Wachstumsregulierung von Pflanzen, dadurch gekennzeichnet, dass man eine wirksame Menge einer oder mehreren Verbindungen der allgemeinen Formel (I) oder deren Salzen auf die Pflanzen (Schadpflanzen, gegebenenfalls zusammen mit den Nutzpflanzen) Pflanzensamen, den Boden, in dem oder auf dem die Pflanzen wachsen, oder die Anbaufläche appliziert. Gegenstand der Erfindung ist auch ein herbizides und/oder pflanzenwachstumsregulierendes Mittel, dadurch gekennzeichnet, dass das Mittel The invention also provides the use of one or more compounds of the general formula (I) or salts thereof or an agent according to the invention (as defined below) (in a process) for controlling harmful plants or regulating the growth of plants, characterized in that an effective amount of one or more compounds of the general formula (I) or their salts on the plants (harmful plants, optionally together with the crops) plant seeds, the soil in which or on which the plants grow, or applied to the acreage. The invention also provides a herbicidal and / or plant growth-regulating agent, characterized in that the agent
(a) eine oder mehrere Verbindungen der allgemeinen Formel (I) und/oder deren Salze enthält wie oben definiert, vorzugsweise in einer der als bevorzugt bzw. besonders bevorzugt gekennzeichneten (A) one or more compounds of the general formula (I) and / or salts thereof as defined above, preferably in one of the preferred or particularly preferred
Ausgestaltung, insbesondere eine oder mehrere Verbindungen der Formeln (LI) bis (1.50) und/oder deren Salze, jeweils wie oben definiert, Embodiment, in particular one or more compounds of the formulas (LI) to (1.50) and / or salts thereof, in each case as defined above,
und and
(b) ein oder mehrere weitere Stoffe ausgewählt aus den Gruppen (i) und/oder (ii): (b) one or more further substances selected from groups (i) and / or (ii):
(i) ein oder mehrere weitere agrochemisch wirksame Stoffe, vorzugsweise ausgewählt aus der Gruppe bestehend aus Insektiziden, Akariziden, Nematiziden, weiteren Herbiziden (d.h. solche, die nicht der oben definierten allgemeinen Formel (I) entsprechen), Fungiziden, Safenern, Düngemitteln und/oder weiteren Wachstumsregulatoren, (i) one or more further agrochemically active substances, preferably selected from the group consisting of insecticides, acaricides, nematicides, further herbicides (ie those which do not correspond to the general formula (I) defined above), fungicides, safeners, fertilizers and / or or other growth regulators,
(ii) ein oder mehrere im Pflanzenschutz übliche Formulierungshilfsmittel. (ii) one or more formulation aids customary in crop protection.
Die weiteren agrochemischen wirksamen Stoffe des Bestandteils (i) eines erfindungsgemäßen Mittels sind dabei vorzugsweise ausgewählt aus der Gruppe der Stoffe, die in "The Pesticide Manual", 16th edition, The British Crop Protection Council und the Royal Soc. of Chemistry, 2012 genannt sind. The other agrochemically active substances of constituent (i) of an agent according to the invention are preferably selected from the group of substances described in "The Pesticide Manual", 16th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2012 are mentioned.
Ein erfindungsgemäßes herbizides oder pflanzenwachstumsregulierendes Mittel, umfasst vorzugsweise ein, zwei, drei oder mehr im Pflanzenschutz übliche Formulierungshilfsmittel (ii) ausgewählt aus der Gruppe bestehend aus Tensiden, Emulgatoren, Dispergiermitteln, Filmbildnern, Verdickungsmitteln, anorganischen Salzen, Stäubemitteln, bei 25 °C und 1013 mbar festen Trägerstoffen, vorzugsweise adsorptionsfähigen, granulierten Inertmaterialien, Netzmitteln, Antioxidationsmitteln, Stabilisatoren, Puffersubstanzen, Antischaummitteln, Wasser, organischen Lösungsmitteln, vorzugsweise bei 25 °C und 1013 mbar mit Wasser in jedem beliebigen Verhältnis mischbare organische Lösungsmittel. Die erfindungsgemäßen Verbindungen der allgemeinen Formel (I) können in Form von Spritzpulvern, emulgierbaren Konzentraten, versprühbaren Lösungen, Stäubemitteln oder Granulaten in den üblichen Zubereitungen angewendet werden. Gegenstand der Erfindung sind deshalb auch herbizide und pflanzenwachstumsregulierende Mittel, die Verbindungen der allgemeinen Formel (I) und/oder deren Salze enthalten. A herbicidal or plant growth-regulating agent according to the invention preferably comprises one, two, three or more plant protection formulation auxiliaries (ii) selected from the group consisting of surfactants, emulsifiers, dispersants, film formers, thickeners, inorganic salts, dusts, at 25 ° C and 1013 mbar solid carriers, preferably adsorptive, granulated inert materials, wetting agents, antioxidants, stabilizers, buffer substances, anti-foaming agents, water, organic solvents, preferably at 25 ° C and 1013 mbar with water in any ratio miscible organic solvents. The compounds of the general formula (I) according to the invention can be used in the form of wettable powders, emulsifiable concentrates, sprayable solutions, dusts or granules in the customary formulations. The invention therefore also herbicidal and Plant growth regulating agents containing compounds of general formula (I) and / or their salts.
Die Verbindungen der allgemeinen Formel (I) und/oder deren Salze können auf verschiedene Art formuliert werden, je nachdem welche biologischen und/oder chemisch-physikalischen Parameter vorgegeben sind. Als Formulierungsmöglichkeiten kommen beispielsweise in Frage: Spritzpulver (WP), wasserlösliche Pulver (SP), wasserlösliche Konzentrate, emulgierbare Konzentrate (EC), Emulsionen (EW), wie Öl-in- Wasser- und Wasser-in-Öl-Emulsionen, versprühbare Lösungen, The compounds of the general formula (I) and / or their salts can be formulated in various ways, depending on which biological and / or chemical-physical parameters are predetermined. Possible formulation options are, for example: wettable powder (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as oil-in-water and water-in-oil emulsions, sprayable solutions .
Suspensionskonzentrate (SC), Dispersionen auf Öl- oder Wasserbasis, ölmischbare Lösungen, Suspension concentrates (SC), dispersions based on oil or water, oil-miscible solutions,
Kapselsuspensionen (CS), Stäubemittel (DP), Beizmittel, Granulate für die Streu- und Capsule suspensions (CS), dusts (DP), mordants, granules for the scattering and
Bodenapplikation, Granulate (GR) in Form von Mikro-, Sprüh-, Aufzugs- und Adsorptionsgranulaten, wasserdispergierbare Granulate (WG), wasserlösliche Granulate (SG), ULV-Formulierungen,  Soil application, granules (GR) in the form of micro, spray, elevator and adsorption granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations,
Mikrokapseln und Wachse. Diese einzelnen Formulierungstypen und die Formulierungshilfsmittel wie Inertmaterialien, Tenside, Lösungsmittel und weitere Zusatzstoffe sind dem Fachmann bekannt, und werden beispielsweise beschrieben in: Watkins, "Handbook of Insecticide Dust Diluents and Carriers", 2nd Ed., Darland Books, Caldwell N.J., H.v. Olphen, "Introduction to Clay Colloid Chemistry"; 2nd Ed., J. Wiley & Sons, N.Y.; C. Marsden, "Solvents Guide"; 2nd Ed., Interscience, N.Y. 1963; McCutcheon's "Detergents and Emulsifiers Annual", MC Publ. Corp., Ridgewood N.J.; Sisley and Wood, "Encyclopedia of Surface Active Agents", Chem. Publ. Co. Inc., N.Y. 1964; Schönfeldt, "Grenzflächenaktive Microcapsules and waxes. These individual types of formulation and formulation aids such as inert materials, surfactants, solvents and other additives are known to those skilled in the art and are described, for example, in Watkins, Handbook of Insecticides Dust Diluents and Carriers, 2nd ed., Darland Books, Caldwell N.J., H.v. Olphen, "Introduction to Clay Colloid Chemistry"; 2nd Ed., J. Wiley & Sons, N.Y .; C. Marsden, "Solvents Guide"; 2nd Ed., Interscience, N.Y. 1963; McCutcheon's "Detergents and Emulsifiers Annual", MC Publ. Corp., Ridgewood N.J .; Sisley and Wood, "Encyclopedia of Surface Active Agents", Chem. Publ. Co. Inc., N.Y. 1964; Schönfeldt, "Grenzflächenaktive
Äthylenoxidaddukte", Wiss. Verlagsgesellschaft, Stuttgart 1976; Winnacker-Küchler, "Chemische Technologie", Band 7, C. Hanser Verlag München, 4. Aufl. 1986. Spritzpulver sind in Wasser gleichmäßig dispergierbare Präparate, die neben dem Wirkstoff außer einem Verdünnungs- oder Inertstoff noch Tenside ionischer und/oder nichtionischer Art (Netzmittel, Ethylene oxide adducts ", Wiss. Verlagsgesellschaft, Stuttgart 1976; Winnacker-Kuchler," Chemische Technologie ", Volume 7, C. Hanser Verlag Munich, 4th ed. 1986. Spray powders are preparations which are uniformly dispersible in water and which, in addition to the active substance, have a dilution or inert or ionic and / or nonionic surfactants (wetting agents,
Dispergiermittel), z.B. polyoxyethylierte Alkylphenole, polyoxethylierte Fettalkohole, polyoxethylierte Fettamine, Fettalkoholpolyglykolethersulfate, Alkansulfonate, Alkylbenzolsulfonate, ligninsulfonsaures Natrium, 2,2'-dinaphthylmethan-6,6'-disulfonsaures Natrium, dibutylnaphthalin-sulfonsaures Natrium oder auch oleoylmethyltaurinsaures Natrium enthalten. Zur Herstellung der Spritzpulver werden die herbiziden Wirkstoffe beispielsweise in üblichen Apparaturen wie Hammermühlen, Gebläsemühlen und Luftstrahlmühlen feingemahlen und gleichzeitig oder anschließend mit den Formulierungshilfsmitteln vermischt. Emulgierbare Konzentrate werden durch Auflösen des Wirkstoffes in einem organischen Lösungsmittel z.B. Butanol, Cyclohexanon, Dimethylformamid, Xylol oder auch höhersiedenden Aromaten oder Kohlenwasserstoffen oder Mischungen der organischen Lösungsmittel unter Zusatz von einem oder mehreren Tensiden ionischer und/oder nichtionischer Art (Emulgatoren) hergestellt. Als Emulgatoren können beispielsweise verwendet werden: Alkylarylsulfonsaure Calcium-Salze wie Dispersants), for example polyoxyethylated alkylphenols, polyoxethylated fatty alcohols, polyoxethylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenesulfonates, sodium lignosulfonate, sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, dibutylnaphthalene-sodium sulfonate or sodium oleoylmethyltaurine. To prepare the wettable powders, the herbicidal active compounds are finely ground, for example, in customary apparatus such as hammer mills, blower mills and air-jet mills and mixed simultaneously or subsequently with the formulation auxiliaries. Emulsifiable concentrates are prepared by dissolving the active ingredient in an organic solvent such as butanol, cyclohexanone, dimethylformamide, xylene or higher-boiling aromatics or hydrocarbons or mixtures of organic solvents with the addition of one or several surfactants of ionic and / or nonionic type (emulsifiers). As emulsifiers can be used for example: Alkylarylsulfonsaure calcium salts such as
Ca-dodecylbenzolsulfonat oder nichtionische Emulgatoren wie Fettsäurepolyglykolester, Ca-dodecylbenzenesulfonate or nonionic emulsifiers such as fatty acid polyglycol ester,
Alkylarylpolyglykolether, Fettalkoholpolyglykolether, Propylenoxid-Ethylenoxid- Kondensationsprodukte, Alkylpolyether, Sorbitanester wie z.B. Sorbitanfettsäureester oder Alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers, sorbitan esters such as e.g. Sorbitan fatty acid esters or
Polyoxethylensorbitanester wie z.B. Polyoxyethylensorbitanfettsäureester. Polyoxethylenesorbitanester such. Polyoxyethylene.
Stäubemittel erhält man durch Vermählen des Wirkstoffes mit fein verteilten festen Stoffen, z.B. Dusts are obtained by milling the active ingredient with finely divided solids, e.g.
Talkum, natürlichen Tonen, wie Kaolin, Bentonit und Pyrophyllit, oder Diatomeenerde. Talc, natural clays such as kaolin, bentonite and pyrophyllite, or diatomaceous earth.
Suspensionskonzentrate können auf Wasser- oder Ölbasis sein. Sie können beispielsweise durch Naß-Vermahlung mittels handelsüblicher Perlmühlen und gegebenenfalls Zusatz von Tensiden, wie sie z.B. oben bei den anderen Formulierungstypen bereits aufgeführt sind, hergestellt werden. Emulsionen, z.B. Öl-in- Wasser-Emulsionen (EW), lassen sich beispielsweise mittels Rührern, Suspension concentrates may be water or oil based. They can be prepared, for example, by wet grinding using commercially available bead mills and, if appropriate, addition of surfactants, as described, for example, in US Pat. are already listed above for the other formulation types. Emulsions, e.g. Oil-in-water emulsions (EW), for example, by means of stirrers,
Kolloidmühlen und/oder statischen Mischern unter Verwendung von wäßrigen organischen Colloidal mills and / or static mixers using aqueous organic
Lösungsmitteln und gegebenenfalls Tensiden, wie sie z.B. oben bei den anderen Formulierungstypen bereits aufgeführt sind, herstellen. Granulate können entweder durch Verdüsen des Wirkstoffes auf adsorptionsfähiges, granuliertesSolvents and optionally surfactants, such as e.g. listed above for the other formulation types. Granules can either by spraying the active ingredient on adsorptive, granulated
Inertmaterial hergestellt werden oder durch Aufbringen von Wirkstoffkonzentraten mittels Klebemitteln, z.B. Polyvinylalkohol, polyacrylsaurem Natrium oder auch Mineralölen, auf die Oberfläche von Trägerstoffen wie Sand, Kaolinite oder von granuliertem Inertmaterial. Auch können geeignete Inert material or by applying active substance concentrates by means of adhesives, e.g. Polyvinyl alcohol, polyacrylic acid sodium or mineral oils, on the surface of carriers such as sand, kaolinites or granulated inert material. Also suitable
Wirkstoffe in der für die Herstellung von Düngemittelgranulaten üblichen Weise - gewünschtenfalls in Mischung mit Düngemitteln - granuliert werden. Active ingredients in the usual manner for the production of fertilizer granules - if desired, mixed with fertilizers - granulated.
Wasserdispergierbare Granulate werden in der Regel nach den üblichen Verfahren wie Sprühtrocknung, Wirbelbett-Granulierung, Teller-Granulierung, Mischung mit Hochgeschwindigkeitsmischern und Extrusion ohne festes Inertmaterial hergestellt. Water-dispersible granules are generally prepared by the usual methods such as spray drying, fluidized bed granulation, plate granulation, mixing with high-speed mixers and extrusion without solid inert material.
Zur Herstellung von Teller-, Fließbett-, Extruder- und Sprühgranulaten siehe z.B. Verfahren in "Spray- Drying Handbook" 3rd ed. 1979, G. Goodwin Ltd., London; J.E. Browning, "Agglomeration", Chemical and Engineering 1967, Seiten 147 ff; "Perry's Chemical Engineer's Handbook", 5th Ed., McGraw-Hill, New York 1973, S. 8-57. For the preparation of plate, fluid bed, extruder and spray granules, see e.g. Method in "Spray-Drying Handbook" 3rd ed. 1979, G. Goodwin Ltd., London; J.E. Browning, "Agglomeration", Chemical and Engineering 1967, pages 147 ff; Perry's Chemical Engineer's Handbook, 5th Ed., McGraw-Hill, New York 1973, pp. 8-57.
Für weitere Einzelheiten zur Formulierung von Pflanzenschutzmitteln siehe z.B. G.C. Klingman, "Weed Control as a Science", John Wiley and Sons, Inc., New York, 1961, Seiten 81-96 und J.D. Freyer, S.A. Evans, "Weed Control Handbook", 5th Ed., Blackwell Scientific Publications, Oxford, 1968, Seiten 101-103. For more details on pesticide formulation see, for example, GC Klingman, "Weed Control as a Science", John Wiley and Sons, Inc., New York, 1961, pp. 81-96 and JD Freyer, SA Evans, "Weed Control Handbook", 5th Ed., Blackwell Scientific Publications, Oxford, 1968, pp. 101-103.
Die agrochemischen Zubereitungen, vorzugsweise herbizide oder pflanzenwachstumsregulierende Mittel der vorliegenden Erfindung enthalten vorzugsweise eine Gesamtmenge von 0,1 bis 99 Gew.-%, bevorzugt 0,5 bis 95 Gew.- %, weiter bevorzugt 1 bis 90 Gew.- %, insbesondere bevorzugt 2 bis 80 Gew.-%, an Wirkstoffen der allgemeinen Formel (I) und deren Salzen. The agrochemical preparations, preferably herbicidal or plant growth-regulating agents of the present invention, preferably contain a total amount of from 0.1 to 99% by weight, preferably 0.5 to 95% by weight, more preferably 1 to 90% by weight, more preferably 2 to 80 wt .-%, of active compounds of the general formula (I) and their salts.
In Spritzpulvern beträgt die Wirkstoffkonzentration z.B. etwa 10 bis 90 Gew.-%, der Rest zu 100 Gew.-% besteht aus üblichen Formulierungsbestandteilen. Bei emulgierbaren Konzentraten kann dieIn wettable powders, the drug concentration is e.g. about 10 to 90 wt .-%, the balance to 100 wt .-% consists of conventional formulation ingredients. In the case of emulsifiable concentrates, the
Wirkstoffkonzentration etwa 1 bis 90, vorzugsweise 5 bis 80 Gew.-% betragen. Staubförmige Active ingredient concentration about 1 to 90, preferably 5 to 80 wt .-% amount. Powdery
Formulierungen enthalten 1 bis 30 Gew.-% Wirkstoff, vorzugsweise meistens 5 bis 20 Gew.-% an Formulations contain 1 to 30 wt .-% of active ingredient, preferably usually 5 to 20 wt .-% of
Wirkstoff, versprühbare Lösungen enthalten etwa 0,05 bis 80, vorzugsweise 2 bis 50 Gew.-% Wirkstoff.Active ingredient, sprayable solutions contain about 0.05 to 80, preferably 2 to 50 wt .-% of active ingredient.
Bei wasserdispergierbaren Granulaten hängt der Wirkstoffgehalt zum Teil davon ab, ob die wirksame Verbindung flüssig oder fest vorliegt und welche Granulierhilfsmittel, Füllstoffe usw. verwendet werden. Bei den in Wasser dispergierbaren Granulaten liegt der Gehalt an Wirkstoff beispielsweise zwischen 1 und 95 Gew.-%, vorzugsweise zwischen 10 und 80 Gew.-%. In the case of water-dispersible granules, the active ingredient content depends, in part, on whether the active compound is liquid or solid and which granulating aids, fillers, etc. are used. In the case of the water-dispersible granules, the content of active ingredient is, for example, between 1 and 95% by weight, preferably between 10 and 80% by weight.
Daneben enthalten die genannten Wirkstofformulierungen gegebenenfalls die jeweils üblichen Haft-, Netz-, Dispergier-, Emulgier-, Penetrations-, Konservierungs-, Frostschutz- und Lösungsmittel, Füll-, Träger- und Farbstoffe, Entschäumer, Verdunstungshemmer und den pH- Wert und die Viskosität beeinflussende Mittel. Beispiele für Formulierungshilfsmittel sind unter anderem in "Chemistry and Technology of Agrochemical Formulations", ed. D. A. Knowles, Kluwer Academic Publishers (1998) beschrieben. In addition, the active substance formulations mentioned optionally contain the customary adhesion, wetting, dispersing, emulsifying, penetrating, preserving, antifreezing and solvent, fillers, carriers and dyes, antifoams, evaporation inhibitors and the pH and the Viscosity-influencing agent. Examples of formulation auxiliaries are described inter alia in "Chemistry and Technology of Agrochemical Formulations", ed. D.A. Knowles, Kluwer Academic Publishers (1998).
Die Verbindungen der allgemeinen Formel (I) oder deren Salze können als solche oder in Form ihrer Zubereitungen (Formulierungen) mit anderen pestizid wirksamen Stoffen, wie z.B. Insektiziden, Akariziden, Nematiziden, Herbiziden, Fungiziden, Safenern, Düngemitteln und/oder The compounds of general formula (I) or their salts may be used as such or in the form of their formulations (formulations) with other pesticidally active substances, e.g. Insecticides, acaricides, nematicides, herbicides, fungicides, safeners, fertilizers and / or
Wachstumsregulatoren kombiniert eingesetzt werden, z.B. als Fertigformulierung oder als Growth regulators can be used in combination, e.g. as finished formulation or as
Tankmischungen. Die Kombinationsformulierungen können dabei auf Basis der obengenanntenTank mixes. The combination formulations can be based on the above
Formulierungen hergestellt werden, wobei die physikalischen Eigenschaften und Stabilitäten der zu kombinierenden Wirkstoffe zu berücksichtigen sind. Formulations are prepared, taking into account the physical properties and stabilities of the active ingredients to be combined.
Als Kombinationspartner für die erfindungsgemäßen Verbindungen der allgemeinen Formel (I) in Mischungsformulierungen oder im Tank-Mix sind beispielsweise bekannte Wirkstoffe, die auf einer Inhibition von beispielsweise Acetolactat-Synthase, Acetyl-CoA-Carboxylase, Cellulose-Synthase, Enolpyruvylshikimat-3-phosphat-Synthase, Glutamin-Synthetase, p-Hydroxyphenylpyruvat- Dioxygenase, Phytoendesaturase, Photosystem I, Photosystem II, Protoporphyrinogen-Oxidase beruhen, einsetzbar, wie sie z.B. in Weed Research 26 (1986) 441-445 oder "The Pesticide Manual", 16th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2012 und der dort zitierten Literatur beschrieben sind. Examples of combination partners for the compounds of general formula (I) according to the invention in mixture formulations or in tank mix are known active compounds which are based on inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate-3-phosphate Synthase, glutamine synthetase, p-hydroxyphenylpyruvate Dioxygenase, phytoene desaturase, photosystem I, photosystem II, protoporphyrinogen oxidase, can be used, as described, for example, in Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 16th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2012 and the literature cited therein.
Von besonderem Interesse ist die selektive Bekämpfung von Schadpflanzen in Kulturen von Nutz- und Zierpflanzen. Obgleich die erfindungsgemäßen Verbindungen der allgemeinen Formel (I) bereits in vielen Kulturen sehr gute bis ausreichende Selektivität aufweisen, können prinzipiell in einigen Kulturen und vor allem auch im Falle von Mischungen mit anderen Herbiziden, die weniger selektiv sind, Phytotoxizitäten an den Kulturpflanzen auftreten. Diesbezüglich sind Kombinationen Of particular interest is the selective control of harmful plants in crops of commercial and ornamental plants. Although the compounds of the general formula (I) according to the invention already have very good to sufficient selectivity in many cultures, phytotoxicities on the crop plants can in principle occur in some crops and, above all, in the case of mixtures with other herbicides which are less selective. In this regard, combinations are
erfindungsgemäßer Verbindungen (I) von besonderem Interesse, welche die Verbindungen der allgemeinen Formel (I) bzw. deren Kombinationen mit anderen Herbiziden oder Pestiziden und Safenern enthalten. Die Safener, welche in einem antidotisch wirksamen Gehalt eingesetzt werden, reduzieren die phytotoxischen Nebenwirkungen der eingesetzten Herbizide/Pestizide, z.B. in wirtschaftlich bedeutenden Kulturen wie Getreide (Weizen, Gerste, Roggen, Mais, Reis, Hirse), Zuckerrübe, Zuckerrohr, Raps, Baumwolle und Soja, vorzugsweise Getreide. Compounds (I) of particular interest according to the invention which contain the compounds of general formula (I) or their combinations with other herbicides or pesticides and safeners. The safeners, which are used in an antidote effective content, reduce the phytotoxic side effects of the herbicides / pesticides used, e.g. in economically important crops such as cereals (wheat, barley, rye, corn, rice, millet), sugar beet, sugar cane, oilseed rape, cotton and soybeans, preferably cereals.
Die Gewichtsverhältnisse von Herbizid(mischung) zu Safener hängt im Allgemeinen von der The weight ratios of herbicide (mixture) to safener generally depends on the
Aufwandmenge an Herbizid und der Wirksamkeit des jeweiligen Safeners ab und kann innerhalb weiter Grenzen variieren, beispielsweise im Bereich von 200: 1 bis 1 :200, vorzugsweise 100: 1 bis 1 : 100, insbesondere 20:1 bis 1 :20. Die Safener können analog den Verbindungen der allgemeinen Formel (I) oder deren Mischungen mit weiteren Herbiziden/Pestiziden formuliert werden und als Application rate of herbicide and the effectiveness of each safener and may vary within wide limits, for example in the range of 200: 1 to 1: 200, preferably 100: 1 to 1: 100, especially 20: 1 to 1: 20. The safeners can be formulated analogously to the compounds of the general formula (I) or mixtures thereof with further herbicides / pesticides and as
Fertigformulierung oder Tankmischung mit den Herbiziden bereitgestellt und angewendet werden. Zur Anwendung werden die in handelsüblicher Form vorliegenden Herbizid- oder Herbizid- Safener- Formulierungen gegebenenfalls in üblicher Weise verdünnt z.B. bei Spritzpulvern, emulgierbaren Konzentraten, Dispersionen und wasserdispergierbaren Granulaten mittels Wasser. Staubförmige Zubereitungen, Boden- bzw. Streugranulate sowie versprühbare Lösungen werden vor der Anwendung üblicherweise nicht mehr mit weiteren inerten Stoffen verdünnt. Ready-made formulation or tank mix with the herbicides are provided and used. For use, the herbicidal or herbicidal safener formulations present in commercial form are optionally diluted in a customary manner, e.g. for wettable powders, emulsifiable concentrates, dispersions and water-dispersible granules by means of water. Dust-like preparations, ground or scattered granules and sprayable solutions are usually no longer diluted with other inert substances before use.
Äußere Bedingungen wie Temperatur, Feuchtigkeit etc. beeinflussen zu einem gewissen Teil die Aufwandmenge der Verbindungen der allgemeinen Formel (I) und/oder deren Salze. Die External conditions such as temperature, humidity, etc. influence to a certain extent the application rate of the compounds of general formula (I) and / or their salts. The
Aufwandmenge kann dabei innerhalb weiter Grenzen variieren. Für die Anwendung als Herbizid zur Bekämpfung von Schadpflanzen liegt die Gesamtmenge an Verbindungen der allgemeinen Formel (I) und deren Salze vorzugsweise im Bereich von 0,001 bis 10,0 kg/ha, bevorzugt im Bereich von 0,005 bis 5 kg/ha, weiter bevorzugt im Bereich von 0,01 bis 1,5 kg/ha, insbesondere bevorzugt im Bereich von 0,05 bis 1 kg/ha. Dies gilt sowohl für die Anwendung im Vorauflauf oder im Nachauflauf. Bei der Anwendung von Verbindungen der allgemeinen Formel (I) und/oder deren Salzen als Application rate can vary within wide limits. For use as a herbicide for controlling harmful plants, the total amount of compounds of general formula (I) and their salts is preferably in the range of 0.001 to 10.0 kg / ha, preferably in the range of 0.005 to 5 kg / ha, more preferably in Range of 0.01 to 1.5 kg / ha, particularly preferably in the range of 0.05 to 1 kg / ha. This applies both to pre-emergence or post-emergence applications. In the application of compounds of general formula (I) and / or their salts as
Pflanzenwachstumsregulator, beispielsweise als Halmverkürzer bei Kulturpflanzen, wie sie oben genannt worden sind, vorzugsweise bei Getreidepflanzen wie Weizen, Gerste, Roggen, Triticale, Hirse, Reis oder Mais, liegt die Gesamt- Aufwandmenge vorzugsweise im Bereich von 0,001 bis 2 kg/ha, vorzugsweise im Bereich von 0,005 bis 1 kg/ha, insbesondere im Bereich von 10 bis 500 g/ha, ganz besonders bevorzugt im Bereich von 20 bis 250 g/ha. Dies gilt sowohl für die Anwendung im Plant growth regulator, for example as Halmverkürzer in crops, as mentioned above, preferably in cereal plants such as wheat, barley, rye, triticale, millet, rice or corn, the total application rate is preferably in the range of 0.001 to 2 kg / ha, preferably in the range of 0.005 to 1 kg / ha, in particular in the range of 10 to 500 g / ha, most preferably in the range of 20 to 250 g / ha. This applies to both the application in the
Vorauflauf oder im Nachauflauf. Die Applikation als Halmverkürzer kann in verschiedenen Stadien des Wachstums der Pflanzen erfolgen. Bevorzugt ist beispielsweise die Anwendung nach der Bestückung am Beginn des Pre-emergence or postemergence. The application as Halmverkürzer can be done in various stages of growth of the plants. For example, the application is preferred after placement at the beginning of
Längenwachstums . Length growth.
Alternativ kommt bei der Anwendung als Pflanzenwachstumsregulator auch die Behandlung des Saatguts in Frage, welche die unterschiedlichen Saatgutbeiz- und Beschichtungstechniken einschließt. Die Aufwandmenge hängt dabei von den einzelnen Techniken ab und kann in Vorversuchen ermittelt werden. Alternatively, when used as a plant growth regulator, seed treatment may be considered, including the different seed dressing and coating techniques. The application rate depends on the individual techniques and can be determined in preliminary tests.
Als Kombinationspartner für die erfindungsgemäßen Verbindungen der allgemeinen Formel (I) in erfindungsgemäßen Mitteln (z.B. Mischungsformulierungen oder im Tank-Mix) sind beispielsweise bekannte Wirkstoffe, die auf einer Inhibition von beispielsweise Acetolactat-Synthase, Acetyl-CoA- Carboxylase, Cellulose-Synthase, Enolpyruvylshikimat-3-phosphat-Synthase, Glutamin-Synthetase, p- Hydroxyphenylpyruvat-Dioxygenase, Phytoendesaturase, Photosystem I, Photosystem II oder As combination partners for the compounds of the general formula (I) according to the invention (for example mixture formulations or in the tank mix), known active substances are those which are based on inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvyl shikimate 3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II or
Protoporphyrinogen-Oxidase beruhen, einsetzbar, wie sie z.B. aus Weed Research 26 (1986) 441-445 oder "The Pesticide Manual", 16th edition, The British Crop Protection Council und the Royal Soc. of Chemistry, 2012 und dort zitierter Literatur beschrieben sind. Nachfolgend werden beispielhaft bekannte Herbizide oder Pflanzenwachstumsregulatoren genannt, die mit den erfindungsgemäßen Verbindungen kombiniert werden können, wobei diese Wirkstoffe entweder mit ihrem "common name" in der englischsprachigen Variante gemäß International Organization for Standardization (ISO) oder mit dem chemischen Namen bzw. mit der Codenummer bezeichnet sind. Dabei sind stets sämtliche Protoporphyrinogen oxidase, can be used, as e.g. from Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 16th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2012 and cited therein. The following are examples of known herbicides or plant growth regulators, which can be combined with the compounds of the invention, these agents either with their "common name" in the English version according to International Organization for Standardization (ISO) or with the chemical name or with the code number are designated. There are always all
Anwendungsformen wie beispielsweise Säuren, Salze, Ester sowie auch alle isomeren Formen wie Stereoisomere und optische Isomere umfaßt, auch wenn diese nicht explizit erwähnt sind.  Use forms such as acids, salts, esters as well as all isomeric forms such as stereoisomers and optical isomers, even if they are not explicitly mentioned.
Beispiele für solche herbiziden Mischungspartner sind: Examples of such herbicidal mixture partners are:
Acetochlor, acifluorfen, acifluorfen-sodium, aclonifen, alachlor, allidochlor, alloxydim, alloxydim- sodium, ametryn, amicarbazone, amidochlor, amidosulfuron, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3- methylphenyl)-5-fluoropyridine-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlor- potassium, aminocyclopyrachlor-methyl, aminopyralid, amitrole, ammoniumsulfamate, anilofos, asulam, atrazine, azafenidin, azimsulfuron, beflubutamid, benazolin, benazolin-ethyl, benfluralin, benfuresate, bensulfuron, bensulfuron-methyl, bensulide, bentazone, benzobicyclon, benzofenap, bicyclopyron, bifenox, bilanafos, bilanafos-sodium, bispyribac, bispyribac-sodium, bromacil, bromobutide, bromofenoxim, bromoxynil, bromoxynil-butyrate, -potassium, -heptanoate und -octanoate, busoxinone, butachlor, butafenacil, butamifos, butenachlor, butralin, butroxydim, butylate, cafenstrole, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron, chlorfenac, chlorfenac- sodium, chlorfenprop, chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron, chlorimuron-ethyl, chlorophthalim, chlorotoluron, chlorthal-dimethyl, chlorsulfuron, cinidon, cinidon-ethyl, cinmethylin, cinosulfuron, clacyfos, clethodim, clodinafop, clodinafop-propargyl, clomazone, clomeprop, clopyralid, cloransulam, cloransulam-methyl, cumyluron, cyanamide, cyanazine, cycloate, cyclopyrimorate, cyclosulfamuron, cycloxydim, cyhalofop, cyhalofop-butyl, cyprazine, 2,4-D, 2,4-D-butotyl, -butyl, - dimethylammonium, -diolamin, -ethyl, 2-ethylhexyl, -isobutyl, -isooctyl, -isopropylammonium, - potassium, -triisopropanolammonium und -trolamine, 2,4-DB, 2,4-DB-butyl, -dimethylammonium, isooctyl, -potassium und -sodium, daimuron (dymron), dalapon, dazomet, n-decanol, desmedipham, detosyl-pyrazolate (DTP), dicamba, dichlobenil, 2-(2,4-dichlorobenzyl)-4,4-dimethyl-l,2-oxazolidin-3- one, 2-(2,5-dichlorobenzyl)-4,4-dimethyl-l,2-oxazolidin-3-one, dichlorprop, dichlorprop-P, diclofop, diclofop-methyl, diclofop-P-methyl, diclosulam, difenzoquat, diflufenican, diflufenzopyr, diflufenzopyr- sodium, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, dimetrasulfuron, dinitramine, dinoterb, diphenamid, diquat, diquat-dibromid, dithiopyr, diuron, DNOC, endothal, EPTC, esprocarb, ethalfluralin, ethametsulfuron, ethametsulfuron-methyl, ethiozin, ethofumesate, ethoxyfen, ethoxyfen- ethyl, ethoxysulfuron, etobenzanid, F-9600, F-5231, i.e. N-[2- Chlor-4-fluor-5-[4-(3-fluorpropyl)-4,5-dihydro-5-oxo-lH-tetrazol-l-yl]-phenyl]-ethansulfonamid, F- 7967, i.e. 3-[7-Chlor-5-fluor-2-(trifluormethyl)-lH-benzimidazol-4-yl]-l-methyl-6- (trifluormethyl)pyrimidin-2,4(lH,3H)-dion, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P- ethyl, fenoxasulfone, fenquinotrione, fentrazamide, flamprop, flamprop-M-isopropyl, flamprop-M- methyl, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, Acetochlor, acifluorfen, acifluorfen-sodium, aclonifen, alachlor, allidochlor, alloxydim, alloxydim-sodium, ametryn, amicarbazone, amidochlor, amidosulfuron, 4-amino-3-chloro-6- (4-chloro-2-fluoro-3-methylphenyl ) -5-fluoropyridine-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlor- potassium, aminocyclopyrachloromethyl, aminopyralid, amitrole, ammonium sulfamates, anilofos, asulam, atrazine, azafenidine, azimsulfuron, beflubutamide, benazolin, benazolin-ethyl, benfluralin, benfuresate, bensulfuron, bensulfuron-methyl, bensulide, bentazone, benzobicyclone, benzofenap, bicyclopyrone, bifenox, bilanafos, bilanafos-sodium, bispyribac, bispyribac-sodium, bromacil, bromobutide, bromofenoxime, bromoxynil, bromoxynil-butyrate, -potassium, -heptanoate and -octanoates, busoxinone, butachlor, butafenacil, butamifos, butenachlor, butraline, butroxydim, butylate , cafenstrole, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron, chlorfenac, chlorfenac-sodium, chlorfenprop, chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron, chlorimuron-ethyl, chlorophthalim, chlorotoluron, chlorthal-dimethyl, chlorosulfuron, cinidon, cinidon -ethyl, cinmethylin, cinosulfuron, clacyfos, clethodim, clodinafop, clodinafop-propargyl, clomazone, clomeprop, clopyralid, cloran sulam, cloransulam-methyl, cumyluron, cyanamide, cyanazine, cycloate, cyclopyrimorate, cyclosulfamuron, cycloxydim, cyhalofop, cyhalofop-butyl, cyprazine, 2,4-D, 2,4-D-butotyl, -butyl, - dimethylammonium, -diolamine , -ethyl, 2-ethylhexyl, -isobutyl, -isooctyl, -isopropylammonium, -potassium, -triisopropanolammonium and -trolamine, 2,4-DB, 2,4-DB-butyl, -dimethylammonium, isooctyl, -potassium and -sodium , daimuron (dymron), dalapon, dazomet, n-decanol, desmedipham, detosyl-pyrazolate (DTP), dicamba, dichlobenil, 2- (2,4-dichlorobenzyl) -4,4-dimethyl-1,2-oxazolidine-3 - one, 2- (2,5-dichlorobenzyl) -4,4-dimethyl-l, 2-oxazolidin-3-one, dichlorprop, dichlorprop-P, diclofop, diclofop-methyl, diclofop-P-methyl, diclosulam, difenzoquat , diflufenican, diflufenzopyr, diflufenzopyr-sodium, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, dimetrasulfuron, dinitramine, dinoterb, diphenamid, diquat, diquat-dibromide, dithiopyr, diuron, DNOC, endothal, EPTC, esprocarb, et halfluralin, ethametsulfuron, ethametsulfuron-methyl, ethiozine, ethofumesate, ethoxyfen, ethoxyfen-ethyl, ethoxysulfuron, etobenzanide, F-9600, F-5231, ie N- [2-chloro-4-fluoro-5- [4- (3 fluoropropyl) -4,5-dihydro-5-oxo-1H-tetrazol-1-yl] -phenyl] -ethanesulfonamide, F-7967, ie 3- [7-chloro-5-fluoro-2- (trifluoromethyl) -lH benzimidazol-4-yl] -l-methyl-6- (trifluoromethyl) pyrimidine-2,4 (1H, 3H) -dione, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fenoxasulfone, fenquinotrione, fentrazamide, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-p-butyl,
flucarbazone, flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazin, fluometuron, flurenol, flurenol-butyl, - dimethylammonium und -methyl, fluoroglycofen, fluoroglycofen-ethyl, flupropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone, fluroxypyr, fluroxypyr-meptyl, flurtamone, fluthiacet, fluthiacet-methyl, fomesafen, fomesafen-sodium, foramsulfuron, fosamine, glufosinate, glufosinate-ammonium, glufosinate-P-sodium, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate-ammonium, -isopropylammonium, -diammonium, -dimethylammonium, - potassium, -sodium und -trimesium, H-9201, i.e. 0-(2,4-Dimethyl-6-nitrophenyl)-0-ethyl- isopropylphosphoramidothioat, halauxifen, halauxifen-methyl, halosafen, halosulfuron, halosulfuron- methyl, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, hexazinone, HW-02, i.e. l-(Dimethoxyphosphoryl)-ethyl-(2,4- dichlorphenoxy)acetat, imazamethabenz, Imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin- ammonium, imazethapyr, imazethapyr-immonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl-sodium, ioxynil, ioxynil-octanoate, -potassium und sodium, ipfencarbazone, isoproturon, isouron, isoxaben, isoxaflutole, karbutilate, KUH-043, i.e. 3-({[5-(Difluormethyl)-l - methyl-3-(trifluormethyl)- 1 H-pyrazol-4-yl]methyl} sulfonyl)-5,5-dimethyl-4,5-dihydro- 1 ,2-oxazol, ketospiradox, lactofen, lenacil, linuron, MCPA, MCPA-butotyl, -dimethylammonium, -2-ethylhexyl, - isopropylammonium, -potassium und -sodium, MCPB, MCPB-methyl, -ethyl und -sodium, mecoprop, mecoprop-sodium, und -butotyl, mecoprop-P, mecoprop-P-butotyl, -dimethylammonium, -2-ethylhexyl und -potassium, mefenacet, mefluidide, mesosulfuron, mesosulfuron-methyl, mesotrione, flucarbazone, flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazine, fluometuron, flurenol, flurenol-butyl, - dimethylammonium and -methyl, fluoroglycofen, fluoroglycofen-ethyl, flupropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone, fluroxypyr, fluroxypyr-meptyl, flurtamone, fluthiacet, fluthiacet-methyl, fomesafen, fomesafen-sodium, foramsulfuron, fosamine, glufosinate, glufosinate-ammonium, glufosinate-p-sodium, glufosinate- P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate-ammonium, -isopropylammonium, -diammonium, -dimethylammonium, - potassium, -sodium and -trimesium, H-9201, ie 0- (2,4-dimethyl-6- nitrophenyl) -0-ethyl-isopropylphosphoramidothioate, halo-cy, halo-oxy-silyl, halosulfuron, halosulfuron-methyl, haloxyfop, haloxyfop-P, haloxyfopethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, hexazinone, HW-02, ie 1- (dimethoxyphosphoryl) ethyl (2,4-dichlorophenoxy) acetate, imazamethabenz, imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapicammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquine-ammonium, imazethapyr, imazethapyr-immonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl-sodium, ioxynil, ioxynil-octanoate, -potassium and sodium, ipfencarbazone, isoproturon, isouron, isoxaben, isoxaflutole , karbutilate, KUH-043, ie 3 - ({[5- (difluoromethyl) -1-methyl-3- (trifluoromethyl) -1 H -pyrazol-4-yl] methyl} sulfonyl) -5,5-dimethyl-4 , 5-dihydro-1, 2-oxazole, ketospiradox, lactofen, lenacil, linuron, MCPA, MCPA-butotyl, -dimethylammonium, -2-ethylhexyl, - isopropylammonium, -potassium and -sodium, MCPB, MCPB-methyl, -ethyl and -sodium, mecoprop, mecoprop-sodium, and -butotyl, mecoprop-P, mecoprop-p-butotyl, -dimethylammonium, -2-ethylhexyl and -potassium, mefenacet, mefluidide, mesosulfuron, mesosulfuron methyl, mesotrione,
methabenzthiazuron, metam, metamifop, metamitron, metazachlor, metazosulfuron, methabenzothiazuron, metam, metamifop, metamitron, metazachlor, metazosulfuron,
methabenzthiazuron, methiopyrsulfuron, methiozolin, methyl isothiocyanate, metobromuron, metolachlor, S-metolachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinat, monolinuron, monosulfuron, monosulfuron-ester, MT-5950, i.e. N-[3-chlor-4-(l-methylethyl)- phenyl]-2-methylpentanamid, NGGC-011, napropamide, NC-310, i.e. 4-(2,4-Dichlorbenzoyl)-l-methyl- 5-benzyloxypyrazol, neburon, nicosulfuron, nonanoic acid (Pelargonsäure), norflurazon, oleic acid (fatty acids), orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefon, oxyfluorfen, paraquat, paraquat dichloride, pebulate, pendimethalin, penoxsulam, pentachlorphenol, pentoxazone, pethoxamid, petroleum oils, phenmedipham, picloram, picolinafen, pinoxaden, piperophos, pretilachlor, primisulfuron, primisulfuron-methyl, prodiamine, profoxydim, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen, pyraflufen- ethyl, pyrasulfotole, pyrazolynate (pyrazolate), pyrazosulfuron, pyrazosulfuron- ethyl, pyrazoxyfen, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyribenzoxim, pyributicarb, pyridafol, pyridate, pyriftalid, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyrithiobac-sodium, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, rimsulfuron, saflufenacil, sethoxydim, siduron, simazine, simetryn, SL-261, sulcotrion, sulfentrazone, sulfometuron, sulfometuron-methyl, sulfosulfuron, , SYN-523, SYP-249, i.e. l-Ethoxy-3-methyl-l-oxobut-3-en-2-yl- 5-[2-chlor-4-(trifluormethyl)phenoxy]-2-nitrobenzoat, SYP-300, i.e. l-[7-Fluor-3-oxo-4-(prop-2-in-l- yl)-3,4-dihydro-2H-l,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidin-4,5-dion, 2,3,6-TBA, TCA (Trifluoressigsäure), TCA-sodium, tebuthiuron, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbumeton, terbuthylazin, terbutryn, thenylchlor, thiazopyr, thiencarbazone, thiencarbazone- methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, tiafenacil, tolpyralate, topramezone, tralkoxydim, triafamone, tri-allate, triasulfuron, triaziflam, tribenuron, tribenuron-methyl, triclopyr, trietazine, trifloxysulfuron, trifloxysulfuron-sodium, trifludimoxazin, trifluralin, triflusulfuron, triflusulfüron-methyl, tritosulfuron, urea sulfate, vernolate, XDE-848, ZJ-0862, i.e. 3,4-Dichlor-N- {2- [(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}anilin, sowie die folgenden Verbindungen: methabenzthiazuron, methiopyrsulfuron, methiozoline, methyl isothiocyanate, metobromuron, metolachlor, S-metolachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinate, monolinuron, monosulfuron, monosulfuron ester, MT-5950, ie N- [3-chloro -4- (1-methylethyl) phenyl] -2-methylpentanamide, NGGC-011, napropamide, NC-310, ie 4- (2,4-dichlorobenzoyl) -l-methyl-5-benzyloxypyrazole, neburon, nicosulfuron, nonanoic acid (pelargonic acid), norflurazon, oleic acid (fatty acids), orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefon, oxyfluorfen, paraquat, paraquat dichloride, pebulate, pendimethalin, penoxsulam, pentachlorophenol, pentoxazone, pethoxamide, petroleum oils, phenmedipham, picloram, picolinafen, pinoxaden, piperophos, pretilachlor, primisulfuron, primisulfuron-methyl, prodiamine, profoxydim, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisul furon, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen, pyraflufenethyl, pyrasulfotole, pyrazolynate (pyrazolate), pyrazosulfuron, pyrazosulfuronethyl, pyrazoxyfen, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyribenzoxim, pyributicarb, pyridafol, pyridate, pyriftalid , pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyrithiobac-sodium, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, rimsulfuron, saflufenacil , sethoxydim, siduron, simazine, simetryn, SL-261, sulcotrione, sulfentrazone, sulfometuron, sulfometuron-methyl, sulfosulfuron,, SYN-523, SYP-249, ie, 1-ethoxy-3-methyl-1-oxobut-3-ene -2-yl- 5- [2-chloro-4- (trifluoromethyl) phenoxy] -2-nitrobenzoate, SYP-300, ie 1- [7-fluoro-3-oxo-4- (prop-2-yn-1 - yl) -3,4-dihydro-2H-l, 4-benzoxazin-6-yl] -3-propyl-2-thioxoimidazolidine-4,5-dione, 2,3,6-TBA, TCA (trifluoroacetic acid), TCA-sodium, tebuthiuron, tefuryltrione , tembotrione, tepraloxydim, terbacil, terbucarb, terbumetone, terbuthylazine, terbutryn, thenylchlor, thiazopyr, thiencarbazone, thiencarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, tiafenacil, tolpyralate, topramezone, tralkoxydim, triafamone, tri-allate, triasulfuron, triaziflam , tribenuron, tribenuron-methyl, triclopyr, trietazine, trifloxysulfuron, trifloxysulfuron-sodium, trifludimoxazine, trifluralin, triflusulfuron, triflusulfuron-methyl, tritosulfuron, urea sulfate, vernolate, XDE-848, ZJ-0862, ie 3,4-dichloro-N- {2- [(4,6-dimethoxypyrimidin-2-yl) oxy] benzyl} aniline; the following connections:
Figure imgf000086_0001
Figure imgf000086_0001
Beispiele für Pflanzenwachstumsregulatoren als mögliche Mischungspartner sind: Examples of plant growth regulators as possible mixing partners are:
Acibenzolar, acibenzolar-S-methyl, 5-Aminolävulinsäure, ancymidol, 6-benzylaminopurine,  Acibenzolar, acibenzolar-S-methyl, 5-aminolevulinic acid, ancymidol, 6-benzylaminopurine,
Brassinolid, Catechin, chlormequat chloride, cloprop, cyclanilide, 3-(Cycloprop-l-enyl)propionsäure, daminozide, dazomet, n-decanol, dikegulac, dikegulac-sodium, endothal, endothal- dipotassium, -disodium, und mono(N,N-dimethylalkylammonium), ethephon, flumetralin, flurenol, flurenol-butyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indol-3-acetic acid (IAA), 4- indol-3-ylbutyric acid, isoprothiolane, probenazole, Jasmonsäure, Jasmonsäuremethylester, maleic hydrazide, mepiquat chloride, 1 -methylcyclopropene, 2-(l-naphthyl)acetamide, 1 -naphthylacetic acid, 2- naphthyloxyacetic acid, nitrophenolate-mixture, 4-0x0-4 [(2 -phenylethyl)amino]buttersäure, paclobutrazol, N-phenylphthalamic acid, prohexadione, prohexadione-calcium, prohydrojasmone, Salicylsäure, Strigolacton, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tsitodef, uniconazole, uniconazole-P. Brassinolide, catechin, chloroformate chloride, cloprop, cyclanilide, 3- (cycloprop-1-enyl) propionic acid, daminozide, dazomet, n-decanol, dikegulac, dikegulac-sodium, endothal, endothaldipotassium, -disodium, and mono (N, N-dimethylalkylammonium), ethephon, flumetralin, flurenol, flurenol-butyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid (IAA), 4-indol-3-yl-butyric acid, isoprothiolane, probenazole, jasmonic acid, methyl jasmonate maleic hydrazides, mepiquat chloride, 1-methylcyclopropene, 2- (1-naphthyl) acetamide, 1 -naphthylacetic acid, 2-naphthyloxyacetic acid, nitrophenolate-mixture, 4-0x0-4 [(2-phenylethyl) amino] butyric acid, paclobutrazole , N-phenylphthalamic acid, prohexadione, prohexadione-calcium, prohydrojasmone, salicylic acid, strigolactone, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tsitodef, uniconazole, uniconazole-P.
Ebenfalls als Kombinationspartner für die erfindungsgemäßen Verbindungen der allgemeinen Formel (I) kommen beispielsweise die folgenden Safener in Frage: Sl) Verbindungen aus der Gruppe heterocyclischer Carbonsäurederivate: Also suitable as combination partners for the compounds of the general formula (I) according to the invention are, for example, the following safeners: S1) compounds from the group of heterocyclic carboxylic acid derivatives:
S 1 a) Verbindungen vom Typ der Dichlorphenylpyrazolin-3 -carbonsäure (S 1 a), vorzugsweise S 1 a ) compounds of the type dichlorophenylpyrazoline-3-carboxylic acid (S 1 a ), preferably
Verbindungen wie l-(2,4-Dichlorphenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazolin-3-carbonsäure, 1 -(2,4-Dichlorphenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazolin-3-carbonsäureethylester (S 1 - 1 ) ("Mefenpyr-diethyl"), und verwandte Verbindungen, wie sie in der WO-A-91/07874 beschrieben sind; Slb) Derivate der Dichlorphenylpyrazolcarbonsäure (Slb), vorzugsweise Verbindungen wie Connections like 1- (2,4-dichlorophenyl) -5- (ethoxycarbonyl) -5-methyl-2-pyrazoline-3-carboxylic acid, 1- (2,4-dichlorophenyl) -5- (ethoxycarbonyl) -5-methyl-2- pyrazoline-3-carboxylic acid ethyl ester (S 1 - 1) ("mefenpyr-diethyl") and related compounds as described in WO-A-91/07874; Sl b ) derivatives of Dichlorphenylpyrazolcarbonsäure (Sl b ), preferably compounds such
1 -(2,4-Dichlorphenyl)-5-methylpyrazol-3 -carbonsäureethylester (S 1 -2),  1 - (2,4-dichlorophenyl) -5-methylpyrazole-3-carboxylic acid ethyl ester (S 1 -2),
1 -(2,4-Dichlorphenyl)-5-isopropylpyrazol-3-carbonsäureethylester (S 1 -3),  Ethyl 1 - (2,4-dichlorophenyl) -5-isopropylpyrazole-3-carboxylate (S 1 -3),
1 -(2,4-Dichlorphenyl)-5-(l , 1 -dimethyl-ethyl)pyrazol-3-carbonsäureethylester (S 1 -4) und verwandte Verbindungen, wie sie in EP-A-333131 und EP-A-269806 beschrieben sind; Slc) Derivate der l,5-Diphenylpyrazol-3-carbonsäure (Slc), vorzugsweise Verbindungen wie Ethyl 1 - (2,4-dichlorophenyl) -5- (1,1-dimethyl-ethyl) pyrazole-3-carboxylate (S 1 -4) and related compounds as described in EP-A-333131 and EP-A-269806 are described; Sl c ) derivatives of l, 5-diphenylpyrazole-3-carboxylic acid (Sl c ), preferably compounds such as
l-(2,4-Dichlorphenyl)-5-phenylpyrazol-3-carbonsäureethylester (Sl-5),  Ethyl l- (2,4-dichlorophenyl) -5-phenylpyrazole-3-carboxylate (Sl-5),
l-(2-Chlorphenyl)-5-phenylpyrazol-3-carbonsäuremethylester (Sl-6) und verwandte  1- (2-chlorophenyl) -5-phenylpyrazole-3-carboxylic acid methyl ester (Sl-6) and related
Verbindungen wie sie beispielsweise in der EP-A-268554 beschrieben sind;  Compounds as described, for example, in EP-A-268554;
Sld) Verbindun gen vom Typ der Triazolcarbonsäuren (Sld), vorzugsweise Verbindungen wie Sl d ) Connections gene of the type of triazolecarboxylic acids (Sl d ), preferably compounds such as
Fenchlorazol(-ethylester), d.h. l-(2,4-Dichlorphenyl)-5-trichlormethyl-(lH)-l,2,4-triazol-3- carbonsäureethylester (Sl-7), und verwandte Verbindungen, wie sie in EP-A- 174562 und EP-A-346620 beschrieben sind;  Fenchlorazole (ethyl ester), i. 1- (2,4-dichlorophenyl) -5-trichloromethyl- (1H) -l, 2,4-triazole-3-carboxylic acid ethyl ester (SI-7), and related compounds as described in EP-A-174562 and EP-A- A-346620;
Sle) Verbindungen vom Typ der 5-Benzyl- oder 5-Phenyl-2-isoxazolin-3- carbonsäure, oder der 5,5- Diphenyl-2-isoxazolin-3-carbonsäure(Sle), vorzugsweise Verbindungen wie Sl e ) compounds of the type of 5-benzyl- or 5-phenyl-2-isoxazoline-3-carboxylic acid, or of 5,5-diphenyl-2-isoxazoline-3-carboxylic acid (Sl e ), preferably compounds such as
5-(2,4-Dichlorbenzyl)-2-isoxazolin-3 -carbonsäureethylester (Sl-8) oder  5- (2,4-dichlorobenzyl) -2-isoxazoline-3-carboxylic acid ethyl ester (Sl-8) or
5-Phenyl-2-isoxazolin-3-carbonsäureethylester (Sl-9) und verwandte Verbindungen, wie sie in WO-A-91/08202 beschrieben sind, bzw. 5,5-Diphenyl-2-isoxazolin-carbonsäure (Sl-10) oder 5,5-Diphenyl-2-isoxazolin-3-carbonsäureethylester (Sl-11) ("Isoxadifen-ethyl")  5-phenyl-2-isoxazoline-3-carboxylic acid ethyl ester (Sl-9) and related compounds, as described in WO-A-91/08202, or 5,5-diphenyl-2-isoxazoline-carboxylic acid (Sl-10 ) or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (Sl-11) ("isoxadifen-ethyl")
oder -n-propylester (Sl-12) oder 5-(4-Fluorphenyl)-5-phenyl-2-isoxazolin-3-carbon- säureethylester (Sl-13), wie sie in der Patentanmeldung WO-A-95/07897 beschrieben sind.  or -n-propyl ester (Sl-12) or 5- (4-fluorophenyl) -5-phenyl-2-isoxazoline-3-carboxylic acid ethyl ester (Sl-13), as described in the patent application WO-A-95/07897 are described.
S2) Verbindungen aus der Gruppe der 8-Chinolinoxyderivate (S2): S2) Compounds from the group of 8-quinolinoxy derivatives (S2):
S2a) Verbindungen vom Typ der 8-Chinolinoxyessigsäure (S2a), vorzugsweise S2 a ) compounds of the 8-quinolinoxyacetic acid type (S2 a ), preferably
(5-Chlor-8-chinolinoxy)essigsäure-(l-methylhexyl)-ester ("Cloquintocet-mexyl") (S2-1), (5-Chlor-8-chinolinoxy)essigsäure-(l,3-dimethyl-but-l -yl)-ester (S2-2),  (5-Chloro-8-quinolinoxy) acetic acid (1-methylhexyl) ester ("cloquintocet-mexyl") (S2-1), (5-chloro-8-quinolinoxy) acetic acid (1,3-dimethyl-but -l -yl) ester (S2-2),
(5-Chlor-8-chinolinoxy)essigsäure-4-allyl-oxy-butylester (S2-3),  (5-chloro-8-quinolinoxy) acetic acid 4-allyl oxy-butyl ester (S2-3),
(5-Chlor-8-chinolinoxy)essigsäure-l-allyloxy-prop-2-ylester (S2-4),  (5-chloro-8-quinolinoxy) acetic acid 1-allyloxy-prop-2-yl ester (S2-4),
(5-Chlor-8-chinolinoxy)essigsäureethylester (S2-5),  (5-chloro-8-quinolinoxy) acetic acid ethyl ester (S2-5),
(5-Chlor-8-chinolinoxy)essigsäuremethylester (S2-6), (5-Chlor-8-chinolinoxy)essigsäureallylester (S2-7), (5-chloro-8-quinolinoxy) acetic acid methyl ester (S2-6), Allyl (5-chloro-8-quinolinoxy) acetates (S2-7),
(5-Chlor-8-chinolinoxy)essigsäure-2-(2-propyliden-iminoxy)-l-ethylester (S2-8),  (5-chloro-8-quinolinoxy) acetic acid 2- (2-propylidene-iminoxy) -l-ethyl ester (S2-8),
(5-Chlor-8-chinolinoxy)essigsäure-2-oxo-prop-l -ylester (S2-9) und verwandte Verbindungen, wie sie in EP-A-86750, EP-A-94349 und EP-A-191736 oder EP-A-0 492 366 beschrieben sind, sowie (5-Chlor-8-chinolinoxy)essigsäure (S2-10), deren Hydrate und Salze, beispielsweise deren Lithium-, Natrium- Kalium-, Kalzium-, Magnesium-, Aluminium-, Eisen-, Ammonium-, quartäre Ammonium-, Sulfonium-, oder Phosphoniumsalze wie sie in der WO-A-2002/34048 beschrieben sind; (5-chloro-8-quinolinoxy) acetic acid 2-oxo-prop-1-yl-ester (S2-9) and related compounds as described in EP-A-86750, EP-A-94349 and EP-A-191736 or US Pat EP-A-0 492 366 and (5-chloro-8-quinolinoxy) acetic acid (S2-10), their hydrates and salts, for example their lithium, sodium, potassium, calcium, magnesium and aluminum salts. Iron, ammonium, quaternary ammonium, sulfonium or phosphonium salts as described in WO-A-2002/34048;
Verbindungen vom Typ der (5-Chlor-8-chinolinoxy)malonsäure (S2b), vorzugsweise Compounds of the type of (5-chloro-8-quinolinoxy) malonic acid (S2 b ), preferably
Verbindungen wie (5-Chlor-8-chinolinoxy)malonsäurediethylester, Compounds such as diethyl (5-chloro-8-quinolinoxy) malonate,
(5-Chlor-8-chinolinoxy)malonsäurediallylester, (5-chloro-8-quinolinoxy) malonate,
(5-Chlor-8-chinolinoxy)malonsäure-methyl-ethylester und verwandte Verbindungen, wie sie in EP-A-0 582 198 beschrieben sind.  (5-chloro-8-quinolinoxy) malonic acid methyl ethyl ester and related compounds as described in EP-A-0 582 198.
Wirkstoffe vom Typ der Dichloracetamide (S3), die häufig als Vorauflaufsafener Dichloroacetamide-type drugs (S3), often used as pre-emergence safeners
(bodenwirksame Safener) angewendet werden, wie z. B. (soil-active safeners) are used, such. B.
"Dichlormid" (N,N-Diallyl-2,2-dichloracetamid) (S3-1), "Dichloromid" (N, N-diallyl-2,2-dichloroacetamide) (S3-1),
"R-29148" (3-Dichloracetyl-2,2,5-trimethyl-l,3-oxazolidin) der Firma Stauffer (S3-2), "R-28725" (3-Dichloracetyl-2,2,-dimethyl-l,3-oxazolidin) der Firma Stauffer (S3-3),  "R-29148" (3-dichloroacetyl-2,2,5-trimethyl-1,3-oxazolidine) from Stauffer (S3-2), "R-28725" (3-dichloro-acetyl-2,2-dimethyl) 1, 3-oxazolidine) from Stauffer (S3-3),
"Benoxacor" (4-Dichloracetyl-3,4-dihydro-3-methyl-2H-l,4-benzoxazin) (S3-4), "Benoxacor" (4-dichloroacetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazine) (S3-4),
"PPG-1292" (N-Allyl-N-[(l,3-dioxolan-2-yl)-methyl]-dichloracetamid) der Firma PPG "PPG-1292" (N-allyl-N - [(1,3-dioxolan-2-yl) -methyl] -dichloroacetamide) from PPG
Industries (S3-5), Industries (S3-5),
"DKA-24" (N-Allyl-N-[(allylaminocarbonyl)methyl]-dichloracetamid) der Firma Sagro-Chem (S3-6),  "DKA-24" (N-allyl-N - [(allylaminocarbonyl) methyl] -dichloroacetamide) from Sagro-Chem (S3-6),
"AD-67" oder "MON 4660" (3-Dichloracetyl-l-oxa-3-aza-spiro[4,5]decan) der Firma  "AD-67" or "MON 4660" (3-dichloroacetyl-1-oxa-3-aza-spiro [4,5] decane) from the company
Nitrokemia bzw. Monsanto (S3-7), Nitrokemia and Monsanto (S3-7),
"TI-35" (1-Dichloracetyl-azepan) der Firma TRI-Chemical RT (S3-8),  "TI-35" (1-dichloroacetyl-azepane) from TRI-Chemical RT (S3-8),
"Diclonon" (Dicyclonon) oder "BAS145138" oder "LAB145138" (S3-9) "Diclonone" (dicyclonone) or "BAS145138" or "LAB145138" (S3-9)
((RS)-l-Dichloracetyl-3,3,8a-trimethylperhydropyrrolo[l,2-a]pyrimidin-6-on) der Firma BASF, "Furilazol" oder "MON 13900" ((RS)-3-Dichloracetyl-5-(2-furyl)-2,2-dimethyloxazolidin) (S3-10), sowie dessen (R)-Isomer (S3-11).  ((RS) -1-dichloroacetyl-3,3,8a-trimethylperhydropyrrolo [1,2-a] pyrimidin-6-one) from BASF, "furilazole" or "MON 13900" ((RS) -3-dichloroacetyl) 5- (2-furyl) -2,2-dimethyloxazolidine) (S3-10) and its (R) isomer (S3-11).
Verbindungen aus der Klasse der Acylsulfonamide (S4): Compounds of the class of acylsulfonamides (S4):
N-Acylsulfonamide der Formel (S4a) und deren Salze wie sie in der WO-A-97/45016 beschrieben sind,
Figure imgf000089_0001
worin N-acylsulfonamides of the formula (S4 a ) and salts thereof as described in WO-A-97/45016,
Figure imgf000089_0001
wherein
RA1 (Ci-C6)Alkyl, (C3-C6)Cycloalkyl, wobei die 2 letztgenannten Reste durch VA RA 1 (C 1 -C 6) alkyl, (C 3 -C 6) cycloalkyl, where the 2 last-mentioned radicals are represented by VA
Substituenten aus der Gruppe Halogen, (Ci-C i)Alkoxy, (Ci-Ce)Haloalkoxy und (Ci- C4)Alkylthio und im Falle cyclischer Reste auch durch (Ci-C i)Alkyl und  Substituents from the group halogen, (Ci-C i) alkoxy, (Ci-Ce) haloalkoxy and (Ci-C4) alkylthio and in the case of cyclic radicals by (Ci-C i) alkyl and
(Ci-C4)Haloalkyl substituiert sind;  (C 1 -C 4) haloalkyl are substituted;
RA2 Halogen, (Ci-C4)Alkyl, (Ci-C4)Alkoxy, CF3; mA 1 oder 2; RA 2 halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, CF 3; mA 1 or 2;
VA ist 0, 1 , 2 oder 3 bedeuten; VA is 0, 1, 2 or 3;
Verbindungen vom Typ der 4-(Benzoylsulfamoyl)benzamide der Formel (S4b) und deren Salze, wie sie in der WO-A-99/16744 beschrieben sind, Compounds of the 4- (benzoylsulfamoyl) benzamide of the formula (S4 b) and salts thereof, as described in WO-A-99/16744,
Figure imgf000089_0002
worin RB1, RB2 unabhängig voneinander Wasserstoff, (Ci-C6)Alkyl, (C3-C6)Cycloalkyl, (C3-
Figure imgf000089_0002
in which RB 1 , RB 2 independently of one another are hydrogen, (C 1 -C 6) -alkyl, (C 3 -C 6) -cycloalkyl, (C 3 -C 6) -alkyl,
C6)Alkenyl, (C3-C6)Alkinyl, C 6 ) alkenyl, (C 3 -C 6 ) alkynyl,
RB3 Halogen, (Ci-C4)Alkyl, (Ci-C4)Haloalkyl oder (Ci-C4)Alkoxy und ms 1 oder 2 bedeuten, z.B. solche worin RB1 = Cyclopropyl, RB 2 = Wasserstoff und (RB3) = 2-OMe ist ("Cyprosulfamide", S4-1), RB 3 is halogen, (Ci-C 4 ) alkyl, (Ci-C 4 ) haloalkyl or (Ci-C 4 ) alkoxy and ms is 1 or 2, for example those in which RB 1 = cyclopropyl, R B 2 = hydrogen and (RB 3 ) = 2-OMe ("Cyprosulfamide", S4-1),
RB1 = Cyclopropyl, RB 2 = Wasserstoff und (RB3) = 5-Cl-2-OMe ist (S4-2), RB1 = Ethyl, RB 2 = Wasserstoff und (RB 3) = 2-OMe ist (S4-3), RB 1 = cyclopropyl, R B 2 = hydrogen and (RB 3 ) = 5-Cl-2-OMe (S4-2), RB 1 = ethyl, R B 2 = hydrogen and (R B 3 ) = 2-OMe is (S4-3),
RB1 = Isopropyl, RB 2 = Wasserstoff und (RB3) = 5-Cl-2-OMe ist (S4-4) und RB 1 = isopropyl, R B 2 = hydrogen and (RB 3 ) = 5-Cl-2-OMe is (S4-4) and
RB1 = Isopropyl, RB 2 = Wasserstoff und (RB3) = 2-OMe ist (S4-5); RB 1 = isopropyl, R B 2 = hydrogen and (RB 3 ) = 2-OMe (S4-5);
S4C) Verbindungen aus der Klasse der Benzoylsulfamoylphenylharnstoffe der Formel (S4C), wie sie in der EP-A-365484 beschrieben sind, S4 C ) compounds from the class of the benzoylsulfamoylphenylureas of the formula (S4 C ) as described in EP-A-365484,
Figure imgf000090_0001
wonn
Figure imgf000090_0001
Wonn
Rc1, Rc2 unabhängig voneinander Wasserstoff, (Ci-Cg)Alkyl, (C3-Cg)Cycloalkyl, (C3-Rc 1 , Rc 2 are each independently hydrogen, (Ci-Cg) alkyl, (C3-Cg) cycloalkyl, (C3-
C6)Alkenyl, (C3-C6)Alkinyl, C 6 ) alkenyl, (C 3 -C 6 ) alkynyl,
Rc3 Halogen, (Ci-C4)Alkyl, (Ci-C4)Alkoxy, CF3 und mc 1 oder 2 bedeuten; beispielsweise R c 3 is halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, CF 3 and mc are 1 or 2; for example
1 - [4-(N-2-Methoxybenzoylsulfamoyl)phenyl] -3 -methylharnstoff, 1 - [4- (N-2-methoxybenzoylsulfamoyl) phenyl] -3-methylurea,
1 - [4-(N-2-Methoxybenzoylsulfamoyl)phenyl] -3 ,3 -dimethylharnstoff,  1 - [4- (N-2-methoxybenzoylsulfamoyl) phenyl] -3,3-dimethylurea,
l -[4-(N-4,5-Dimethylbenzoylsulfamoyl)phenyl]-3-methylharnstoff;  1 - [4- (N-4,5-dimethylbenzoylsulfamoyl) phenyl] -3-methylurea;
S4d) Verbindun gen vom Typ der N-Phenylsulfonylterephthalamide der Formel (S4d) und deren Salze, die z.B. bekannt sind aus CN 101838227, S4 d ) compounds of the N-phenylsulfonylterephthalamide type of the formula (S4 d ) and salts thereof which are known, for example, from CN 101838227,
Figure imgf000090_0002
worin
Figure imgf000090_0002
wherein
RD4 Halogen, (Ci-C4)Alkyl, (Ci-C4)Alkoxy, CF3; mD 1 oder 2; RD5 Wasserstoff, (Ci-C6)Alkyl, (C3-C6)Cycloalkyl, (C2-C6)Alkenyl, (C2-C6)Alkinyl, (C5- Ce)Cycloalkenyl bedeutet. RD 4 is halogen, (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkoxy, CF 3; mD 1 or 2; RD 5 is hydrogen, (C 1 -C 6 ) alkyl, (C 3 -C 6 ) cycloalkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 5 -C 6 ) cycloalkenyl.
Wirkstoffe aus der Klasse der Hydroxyaromaten und der aromatisch-aliphatischen Active ingredients from the class of hydroxyaromatics and aromatic-aliphatic
Carbonsäurederivate (S5), z.B.  Carboxylic acid derivatives (S5), e.g.
3,4,5-Triacetoxybenzoesäureethylester, 3,5-Dimethoxy-4-hydroxybenzoesäure, 3,5- Dihydroxybenzoesäure, 4-Hydroxysalicylsäure, 4-Fluorsalicyclsäure, 2-Hydroxyzimtsäure, 2,4- Dichlorzimtsäure, wie sie in der WO-A-2004/084631, WO-A-2005/015994, WO-A- 2005/016001 beschrieben sind.  3,4,5-triacetoxybenzoic acid ethyl ester, 3,5-dimethoxy-4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 4-hydroxysalicylic acid, 4-fluorosalicyclic acid, 2-hydroxycinnamic acid, 2,4-dichlorocinnamic acid, as described in WO-A- 2004/084631, WO-A-2005/015994, WO-A-2005/016001.
Wirkstoffe aus der Klasse der l,2-Dihydrochinoxalin-2-one (S6), z.B. Agents from the class of 1,2-dihydroquinoxaline-2-ones (S6), e.g.
l-Methyl-3-(2-thienyl)-l,2-dihydrochinoxalin-2-on, l-Methyl-3-(2-thienyl)-l,2-dihydro- chinoxalin-2-thion, l-(2-Aminoethyl)-3-(2-thienyl)-l,2-dihydro-chinoxalin-2-on-hydrochlorid, l-(2-Methylsulfonylaminoethyl)-3-(2-thienyl)-l,2-dihydro-chinoxalin-2-on, wie sie in der WO- A-2005/112630 beschrieben sind.  1-methyl-3- (2-thienyl) -1,2-dihydroquinoxalin-2-one, 1-methyl-3- (2-thienyl) -1,2-dihydroquinoxaline-2-thione, 1- (2 -Aminoethyl) -3- (2-thienyl) -1,2-dihydroquinoxaline-2-one hydrochloride, 1- (2-methylsulfonylaminoethyl) -3- (2-thienyl) -1,2-dihydroquinoxaline 2-on, as described in WO-A-2005/112630.
Verbindungen aus der Klasse der Diphenylmethoxyessigsäurederivate (S7), z.B. Compounds from the class of diphenylmethoxyacetic acid derivatives (S7), e.g.
Diphenylmethoxyessigsäuremethylester (CAS-Reg.Nr. 41858-19-9) (S7-1),  Methyl diphenylmethoxyacetate (CAS No. 41858-19-9) (S7-1),
Diphenylmethoxyessigsäureethylester oder Diphenylmethoxyessigsäure wie sie in der WO-A- 98/38856 beschrieben sind.  Diphenylmethoxyessigsäureethylester or Diphenylmethoxyessigsäure as described in WO-A-98/38856.
Verbindungen der Formel (S8), wie sie in der WO-A-98/27049 beschrieben sind, Compounds of the formula (S8) as described in WO-A-98/27049,
Figure imgf000091_0001
Figure imgf000091_0001
worin die Symbole und Indizes folgende Bedeutungen haben: wherein the symbols and indices have the following meanings:
RD1 ist Halogen, (Ci-C4)Alkyl, (Ci-C4)Haloalkyl, (Ci-C4)Alkoxy, (Ci-C4)Haloalkoxy, RD2 ist Wasserstoff oder (Ci-C4)Alkyl, RD 1 is halogen, (Ci-C 4) alkyl, (Ci-C 4) haloalkyl, (Ci-C 4) alkoxy, (Ci-C 4) haloalkoxy, RD 2 is hydrogen or (Ci-C 4) alkyl,
RD3 ist Wasserstoff, (Ci-Cg)Alkyl, (C2-C4)Alkenyl, (C2-C4)Alkinyl, oder Aryl, wobei jeder der vorgenannten C-haltigen Reste unsubstituiert oder durch einen oder mehrere, vorzugsweise bis zu drei gleiche oder verschiedene Reste aus der Gruppe, bestehend aus Halogen und Alkoxy substituiert ist; oder deren Salze, ist eine ganze Zahl von 0 bis 2. RD 3 is hydrogen, (Ci-Cg) alkyl, (C 2 -C 4 ) alkenyl, (C 2 -C 4 ) alkynyl, or aryl, wherein each of the aforementioned C-containing radicals unsubstituted or by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy substituted; or their salts, is an integer from 0 to 2.
Wirkstoffe aus der Klasse der 3-(5-Tetrazolylcarbonyl)-2-chinolone (S9), z.B. Agents from the class of 3- (5-tetrazolylcarbonyl) -2-quinolones (S9), e.g.
1 ,2-Dihydro-4-hydroxy- 1 -ethyl-3-(5-tetrazolylcarbonyl)-2-chinolon (CAS-Reg.Nr. : 219479- 18- 2), l,2-Dihydro-4-hydroxy-l-methyl-3-(5-tetrazolyl-carbonyl)-2-chinolon (CAS-Reg.Nr.  1, 2-dihydro-4-hydroxy-1-ethyl-3- (5-tetrazolylcarbonyl) -2-quinolone (CAS Reg. No. 219479-18-2), 1,2-dihydro-4-hydroxy 1-methyl-3- (5-tetrazolyl-carbonyl) -2-quinolone (CAS Reg.
95855-00-8), wie sie in der WO-A- 1999/000020 beschrieben sind.  95855-00-8), as described in WO-A-1999/000020.
Verbindungen der Formeln (S10a) oder (S10b), wie sie in der WO-A-2007/023719 und WO-A-2007/023764 beschrieben sind, Compounds of the formulas (S10 a ) or (S10 b ), as described in WO-A-2007/023719 and WO-A-2007/023764,
Figure imgf000092_0001
Figure imgf000092_0001
(S10a) (S10b) (S10 a) (S10 b)
worin wherein
Halogen, (Ci-C4)Alkyl, Methoxy, Nitro, Cyano, CF3, OCF: YE, ZE unabhängig voneinander O oder S, eine ganze Zahl von 0 bis 4, Halogen, (C 1 -C 4 ) alkyl, methoxy, nitro, cyano, CF 3 , OCF : Y E , Z E independently of one another are O or S, an integer from 0 to 4,
(Ci-Ci6)Alkyl, (C2-C6)Alkenyl, (C3-C6)Cycloalkyl, Aryl; Benzyl, Halogenbenzyl, Wasserstoff oder (Ci-Ce)Alkyl bedeuten. (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 3 -C 6 ) cycloalkyl, aryl; Benzyl, halobenzyl, hydrogen or (Ci-Ce) alkyl.
Wirkstoffe vom Typ der Oxyimino- Verbindungen (Si l), die als Saatbeizmittel bekannt sind, wie z. B. Active ingredients of the type of oxyimino compounds (Si l), which are known as seed dressings, such as. B.
"Oxabetrinil" ((Z)-l,3-Dioxolan-2-ylmethoxyimino(phenyl)acetonitril) (Sl 1-1), das als Saatbeiz-Safener für Hirse gegen Schäden von Metolachlor bekannt ist,  "Oxabetrinil" ((Z) -l, 3-dioxolan-2-ylmethoxyimino (phenyl) acetonitrile) (Sl 1-1), which is known as a seed dressing safener for millet against damage by metolachlor,
"Fluxofenim" (l-(4-Chlorphenyl)-2,2,2-trifluor-l-ethanon-0-(l,3-dioxolan-2-ylmethyl)-oxim) (Sl 1-2), das als Saatbeiz-Safener für Hirse gegen Schäden von Metolachlor bekannt ist, und "Fluxofenim" (1- (4-chlorophenyl) -2,2,2-trifluoro-1-ethanone-0- (1,3-dioxolan-2-ylmethyl) -oxime) (S1-2) used as seed dressing -Safener for millet is known against damage from metolachlor, and
"Cyometrinil" oder "CGA-43089" ((Z)-Cyanomethoxyimino(phenyl)acetonitril) (Sl l-3), das als Saatbeiz-Safener für Hirse gegen Schäden von Metolachlor bekannt ist. Wirkstoffe aus der Klasse der Isothiochromanone (S 12), wie z.B. Methyl- [(3 -oxo-lH-2- benzothiopyran-4(3H)-yliden)methoxy]acetat (CAS-Reg.Nr. 205121 -04-6) (S 12-1) und verwandte Verbindungen aus WO-A-1998/13361. "Cyometrinil" or "CGA-43089" ((Z) -cyanomethoxyimino (phenyl) acetonitrile) (Sl l-3), which is known as a seed dressing safener for millet against damage from metolachlor. Active substances from the class of the isothiochromanones (S 12), such as, for example, methyl- [(3-oxo-1H-2-benzothiopyran-4 (3H) -ylidene) methoxy] acetate (CAS Reg. No. 205121 -04-6) (S 12-1) and related compounds of WO-A-1998/13361.
Eine oder mehrere Verbindungen aus Gruppe (S13): One or more compounds from group (S13):
"Naphthalic anhydrid" (1 ,8-Naphthalindicarbonsäureanhydrid) (S13-1), das als Saatbeiz-Safener für Mais gegen Schäden von Thiocarbamatherbiziden bekannt ist, "Naphthalene anhydride" (1,8-naphthalenedicarboxylic anhydride) (S13-1), which is known as a seed safener for corn against damage by thiocarbamate herbicides.
"Fenclorim" (4,6-Dichlor-2-phenylpyrimidin) (S13-2), das als Safener für Pretilachlor in gesätem Reis bekannt ist, "Fenclorim" (4,6-dichloro-2-phenylpyrimidine) (S13-2), known as safener for pretilachlor in sown rice,
"Flurazole" (Benzyl-2-chlor-4-trifluormethyl-l ,3-thiazol-5-carboxylat) (S 13-3), das als Saatbeiz-Safener für Hirse gegen Schäden von Alachlor und Metolachlor bekannt ist, "Flurazole" (benzyl-2-chloro-4-trifluoromethyl-1,3-thiazole-5-carboxylate) (S 13-3), which is known as a seeder-safener for millet against damage by alachlor and metolachlor,
"CL 304415" (CAS-Reg.Nr. 31541 -57-8) "CL 304415" (CAS No. 31541 -57-8)
(4-Carboxy-3,4-dihydro-2H-l -benzopyran-4-essigsäure) (S13-4) der Firma American  (4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid) (S13-4) from American
Cyanamid, das als Safener für Mais gegen Schäden von Imidazolinonen bekannt ist, Cyanamide, which is known as safener for maize against damage of imidazolinones,
"MG 191 " (CAS-Reg.Nr. 96420-72-3) (2-Dichlormethyl-2-methyl-l ,3-dioxolan) (S13-5) der Firma Nitrokemia, das als Safener für Mais bekannt ist, "MG 191" (CAS Reg. No. 96420-72-3) (2-dichloromethyl-2-methyl-1,3-dioxolane) (S13-5) from Nitrokemia, which is known as safener for corn,
"MG 838" (CAS-Reg.Nr. 133993-74-5) "MG 838" (CAS Reg. No. 133993-74-5)
(2-propenyl l -oxa-4-azaspiro[4.5]decan-4-carbodithioat) (S13-6) der Firma Nitrokemia "Disulfoton" (0,0-Diethyl S-2-ethylthioethyl phosphordithioat) (S13-7), "Dietholate" (0,0-Diethyl-O-phenylphosphorothioat) (S 13-8), "Mephenate" (4-Chlorphenyl-methylcarbamat) (S 13-9).  (2-propenyl 1 -oxa-4-azaspiro [4.5] decane-4-carbodithioate) (S13-6) from Nitrokemia "Disulfoton" (O-diethyl S-2-ethylthioethyl phosphorodithioate) (S13-7), "Dietholate" (0,0-diethyl-O-phenyl phosphorothioate) (S13-8), "mephenate" (4-chlorophenyl methylcarbamate) (S13-9).
Wirkstoffe, die neben einer herbiziden Wirkung gegen Schadpflanzen auch Safenerwirkung an Kulturpflanzen wie Reis aufweisen, wie z. B. Active substances which, in addition to having a herbicidal action against harmful plants, also have safener action on cultivated plants such as rice, such as, for example, rice. B.
"Dimepiperate" oder "MY-93" (S-\ -Methyl- 1 -phenylethyl-piperidin-l -carbothioat), das als Safener für Reis gegen Schäden des Herbizids Molinate bekannt ist,  "Dimepiperate" or "MY-93" (S-methyl-1-phenylethyl-piperidine-1-carbothioate) known as a safener for rice against damage by the herbicide Molinate,
"Daimuron" oder "SK 23" (l -(l -Methyl-l -phenylethyl)-3-p-tolyl-harnstoff), das als Safener für Reis gegen Schäden des Herbizids Imazosulfuron bekannt ist, "Daimuron" or "SK 23" (1- (1-methyl-1-phenylethyl) -3-p-tolyl-urea) known as a safener for rice against damage by the herbicide imazosulfuron,
"Cumyluron" = "JC-940" (3-(2-Chlorphenylmethyl)-l -(l -methyl-l -phenyl-ethyl)harnstoff, siehe JP-A-60087270), das als Safener für Reis gegen Schäden einiger Herbizide bekannt ist, "Methoxyphenon" oder "NK 049" (3,3'-Dimethyl-4-methoxy-benzophenon), das als Safener für Reis gegen Schäden einiger Herbizide bekannt ist, "Cumyluron" = "JC-940" (3- (2-chlorophenylmethyl) -1- (1-methyl-1-phenyl-ethyl) urea, see JP-A-60087270) which can be used as safener for rice against damage of some herbicides is known "Methoxyphenone" or "NK 049"(3,3'-dimethyl-4-methoxy-benzophenone), which is known as safener for rice against damage of some herbicides,
"CSB" (l -Brom-4-(chlormethylsulfonyl)benzol) von Kumiai, (CAS-Reg.Nr. 54091 -06-4), das als Safener gegen Schäden einiger Herbizide in Reis bekannt ist. Verbindungen der Formel (S 15) oder deren Tautomere, "CSB" (1-Bromo-4- (chloromethylsulfonyl) benzene) from Kumiai, (CAS Registry No. 54091-06-4), which is known as a safener against damage of some herbicides in rice. Compounds of the formula (S 15) or their tautomers,
Figure imgf000094_0001
wie sie in der WO-A-2008/131861 und WO-A-2008/131860 beschrieben sind, worin einen (Ci-C6)Haloalkylrest bedeutet und
Figure imgf000094_0001
as described in WO-A-2008/131861 and WO-A-2008/131860, wherein a (Ci-C6) haloalkyl radical means and
Wasserstoff oder Halogen bedeutet und Is hydrogen or halogen and
RH4 unabhängig voneinander Wasserstoff, (Ci-Ci6)Alkyl, (C2-Ci6)Alkenyl oder RH 4 are independently hydrogen, (Ci-Ci6) alkyl, (C2-Ci6) alkenyl or
(C2-Ci6)Alkinyl, wobei jeder der letztgenannten 3 Reste unsubstituiert oder durch einen oder mehrere Reste aus der Gruppe Halogen, Hydroxy, Cyano, (Ci-C i)Alkoxy, (Ci-C i)Haloalkoxy, (Ci-C4)Alkylthio, (Ci-C4)Alkylamino, Di[(Ci-C4)alkyl]-amino, [(Ci-C4)Alkoxy]- carbonyl, [(Ci-C4)Haloalkoxy]-carbonyl, (C3-C6)Cycloalkyl, das unsubstituiert oder substituiert ist, Phenyl, das unsubstituiert oder substituiert ist, und Heterocyclyl, das unsubstituiert oder substituiert ist, substituiert ist, oder (C3-C6)Cycloalkyl, (C4-C6)Cycloalkenyl, (C3-C6)Cycloalkyl, das an einer Seite des Rings mit einem 4 bis 6-gliedrigen gesättigten oder ungesättigten carbocyclischen Ring kondensiert ist, oder (C4-C6)Cycloalkenyl, das an einer Seite des Rings mit einem 4 bis 6-gliedrigen gesättigten oder ungesättigten carbocyclischen Ring kondensiert ist, wobei jeder der letztgenannten 4 Reste unsubstituiert oder durch einen oder mehrere Reste aus der Gruppe Halogen, Hydroxy, Cyano, (Ci-C4)Alkyl, (Ci-C4)Haloalkyl, (Ci-C4)Alkoxy, (Ci-C4)Haloalkoxy, (Ci-C4)Alkylthio, (Ci-C4)Alkylamino, Di[(Ci- C4)alkyl]-amino, [(Ci-C4)Alkoxy]-carbonyl, [(Ci-C4)Haloalkoxy]-carbonyl, (C 2 -C 6) alkynyl, each of the last-mentioned 3 unsubstituted or by one or more radicals from the group halogen, hydroxy, cyano, (Ci-C i) alkoxy, (Ci-C i) haloalkoxy, (Ci-C 4 ) alkylthio, (C 1 -C 4 ) alkylamino, di [(C 1 -C 4 ) alkyl] amino, [(C 1 -C 4 ) alkoxy] carbonyl, [(C 1 -C 4 ) haloalkoxy] carbonyl, ( C3-C6) cycloalkyl which is unsubstituted or substituted, phenyl which is unsubstituted or substituted, and heterocyclyl which is unsubstituted or substituted, is substituted, or (C3-C6) cycloalkyl, (C 4 -C 6) cycloalkenyl, (C3 -C6) cycloalkyl condensed on one side of the ring with a 4 to 6 membered saturated or unsaturated carbocyclic ring, or (C 4 -C 6) cycloalkenyl attached to one side of the ring with a 4 to 6 membered saturated or is condensed unsaturated carbocyclic ring, wherein each of the last-mentioned 4 unsubstituted or by one or more radicals selected from the group consisting of halogen, hydroxy, cyano, (Ci-C 4 ) alkyl, (C 1 -C 4 ) haloalkyl, (Ci-C 4) alkoxy, (Ci-C 4) haloalkoxy, (Ci-C 4) alkylthio, (Ci-C 4) alkylamino, di [(Ci- C4) alkyl] amino, [(Ci-C 4 ) alkoxy] carbonyl, [(C 1 -C 4 ) haloalkoxy] carbonyl,
(C3-C6)Cycloalkyl, das unsubstituiert oder substituiert ist, Phenyl, das unsubstituiert oder substituiert ist, und Heterocyclyl, das unsubstituiert oder substituiert ist, substituiert ist, bedeutet oder  (C 3 -C 6) cycloalkyl which is unsubstituted or substituted, phenyl which is unsubstituted or substituted, and heterocyclyl which is unsubstituted or substituted, or denotes
RH3 (Ci-C4)-Alkoxy, (C2-C4)Alkenyloxy, (C2-C6)Alkinyloxy oder (C2-C4)Haloalkoxy bedeutet und RH4 Wasserstoff oder (Ci-C4)-Alkyl bedeutet oder RH 3 is (C 1 -C 4 ) -alkoxy, (C 2 -C 4 ) -alkenyloxy, (C 2 -C 6) -alkinyloxy or (C 2 -C 4 ) -haloalkoxy and RH 4 is hydrogen or (C 1 -C 4 ) -alkyl or
RH3 und RH4 zusammen mit dem direkt gebundenen N-Atom einen vier- bis achtgliedrigen RH 3 and RH 4 together with the directly attached N atom form a four- to eight-membered one
heterocyclischen Ring, der neben dem N-Atom auch weitere Heteroringatome, vorzugsweise bis zu zwei weitere Heteroringatome aus der Gruppe N, O und S enthalten kann und der unsubstituiert oder durch einen oder mehrere Reste aus der Gruppe Halogen, Cyano, Nitro, (Ci- C4)Alkyl, (Ci-C4)Haloalkyl, (Ci-C4)Alkoxy, (Ci-C4)Haloalkoxy und (Ci-C4)Alkylthio substituiert ist, bedeutet. heterocyclic ring which, in addition to the N atom, may also contain further hetero ring atoms, preferably up to two further hetero ring atoms from the group consisting of N, O and S, and which may be unsubstituted or substituted by one or more radicals from the group consisting of halogen, cyano, nitro, C 4 ) alkyl, (Ci-C 4 ) haloalkyl, (Ci-C 4 ) alkoxy, (Ci-C 4 ) haloalkoxy and (Ci-C 4 ) alkylthio is substituted, means.
S 16) Wirkstoffe, die vorrangig als Herbizide eingesetzt werden, jedoch auch Safenerwirkung auf Kulturpflanzen aufweisen, z. B. S 16) active substances which are used primarily as herbicides, but also have safener effect on crop plants, eg. B.
(2,4-Dichlorphenoxy)essigsäure (2,4-D), (2,4-dichlorophenoxy) acetic acid (2,4-D),
(4-Chlorphenoxy)essigsäure,  (4-chlorophenoxy) acetic acid,
(R,S)-2-(4-Chlor-o-tolyloxy)propionsäure (Mecoprop),  (R, S) -2- (4-chloro-o-tolyloxy) propionic acid (mecoprop),
4-(2,4-Dichlorphenoxy)buttersäure (2,4-DB),  4- (2,4-dichlorophenoxy) butyric acid (2,4-DB),
(4-Chlor-o-tolyloxy)essigsäure (MCPA),  (4-chloro-o-tolyloxy) acetic acid (MCPA),
4-(4-Chlor-o-tolyloxy)buttersäure,  4- (4-chloro-o-tolyloxy) butyric acid,
4-(4-Chlorphenoxy)buttersäure,  4- (4-chlorophenoxy) butyric acid,
3,6-Dichlor-2-methoxybenzoesäure (Dicamba),  3,6-dichloro-2-methoxybenzoic acid (Dicamba),
l -(Ethoxycarbonyl)ethyl-3,6-dichlor-2-methoxybenzoat (Lactidichlor-ethyl).  L - (ethoxycarbonyl) ethyl 3,6-dichloro-2-methoxybenzoate (lactidichloroethyl).
Bevorzugte Safener in Kombination mit den erfindungsgemäßen Verbindungend der Formel (I) und/oder deren Salze, insbesondere mit den Verbindungen der Formeln (L I) bis (1.50) und/oder deren Salze sind: Cloquintocet-mexyl, Cyprosulfamid, Fenchlorazol-ethylester, Isoxadifen-ethyl, Mefenpyr- diethyl, Fenclorim, Cumyluron, S4-1 und S4-5, und besonders bevorzugte Safener sind: Cloquintocet- mexyl, Cyprosulfamid, Isoxadifen-ethyl und Mefenpyr-diethyl. Biologische Beispiele: Preferred safeners in combination with the compounds of the formula (I) according to the invention and / or their salts, in particular with the compounds of the formulas (LI) to (1.50) and / or salts thereof are: cloquintocet-mexyl, cyprosulfamide, fenchlorazole ethyl ester, isoxadifen and particularly preferred safeners are: cloquintocetmexyl, cyprosulfamide, isoxadifen-ethyl and mefenpyr-diethyl. Biological examples:
Herbizide Wirkung und Kulturverträglichkeit im Nachauflauf (A) Samen von mono- bzw. dikotylen Unkraut- bzw. Kulturpflanzen werden in Kunststoff- oder Holzfasertöpfen in sandigem Lehmboden ausgelegt, mit Erde abgedeckt und im Gewächshaus unter kontrollierten Wachstumsbedingungen angezogen. 2 bis 3 Wochen nach der Aussaat werden die Versuchspflanzen im Einblattstadium behandelt. Die in Form von benetzbaren Pulvern (WP) oder als Emulsionskonzentrate (EC) formulierten erfindungsgemäßen Verbindungen werden dann als wässrige Suspension bzw. Emulsion unter Zusatz von 0,5% Additiv mit einer Wasseraufwandmenge von umgerechnet 600 1/ha auf die grünen Pflanzenteile gesprüht. Nach ca. 3 Wochen Standzeit der Herbicidal action and post-emergence culture compatibility (A) Seeds of monocotyledonous or dicotyledonous weed or crop plants are placed in sandy loam soil in plastic or wood fiber pots, covered with soil and grown in the greenhouse under controlled growth conditions. 2 to 3 weeks after sowing, the test plants are treated in the single leaf stage. The compounds according to the invention formulated as wettable powders (WP) or as emulsion concentrates (EC) are then sprayed onto the green plant parts as an aqueous suspension or emulsion with the addition of 0.5% of additive at a rate of 600 l / ha. After about 3 weeks of service life of
Versuchspflanzen im Gewächshaus, unter optimalen Wachstumsbedingungen, wird die Wirkung der Präparate visuell im Vergleich zu unbehandelten Kontrollen bonitiert. Beispielsweise bedeutet 100% Wirkung = Pflanzen sind abgestorben, 0%> Wirkung = wie Kontrollpflanzen. Test plants in the greenhouse, under optimal growth conditions, the effect of the preparations is scored visually compared to untreated controls. For example, 100% means action = plants are dead, 0%> effect = like control plants.
Die Versuche zeigten, dass erfindungsgemäße Verbindungen bei Behandlung im Nachauflauf eine gute herbizide Wirksamkeit gegen ausgewählte Schadpflanzen wie z.B. Abutilon theophrasti, Alopecurus myosuroides, Amaranthus retroflexus, Avena fatua, Cyperus esculentus, Echinochloa crus-galli, Hordeum murinum, Lolium rigidum, Matricaria inodora, Pharbitis purpurea, Polygonum convolvulus, Setaria viridis, Stellaria media, Veronica persica oder Viola tricolor bei einer Aufwandmenge von 1.28 kg Aktivsubstanz oder weniger pro Hektar aufweisen. The experiments showed that compounds according to the invention have a good herbicidal activity against selected harmful plants, such as e.g. Abutilon theophrasti, Alopecurus myosuroides, Amaranthus retroflexus, Avena fatua, Cyperus esculentus, Echinochloa crus-galli, Hordeum murinum, Lolium rigidum, Matricaria inodora, Pharitis purpurea, Polygonum convolvulus, Setaria viridis, Stellaria media, Veronica persica or Viola tricolor at an application rate of 1.28 kg of active substance or less per hectare.
Daneben zeigten die erfindungsgemäßen Verbindungen teilweise eine hohe Selektivität und eignen sich deshalb im Nachauflaufverfahren zur Bekämpfung von unerwünschtem Pflanzenwuchs in  In addition, some of the compounds according to the invention showed high selectivity and are therefore suitable postemergence for combating undesired plant growth in
landwirtschaftlichen Kulturen. agricultural crops.
(B) Alternativ können die Beprobungen auf Mikrotiterplatten gemäß dem nachfolgend (B) Alternatively, the sampling on microtiter plates according to the following
beschriebenen Protokoll durchgeführt werden. described protocol.
Samen von mono- bzw. dikotylen Unkrautpflanzen werden in 96-well Mikrotiterplatten in Quarzsand ausgelegt und in der Klimakammer unter kontrollierten Wachstumsbedingungen angezogen. 5 bis 7Seeds of monocotyledonous or dicotyledonous weed plants are laid out in 96-well microtiter plates in quartz sand and grown in the climatic chamber under controlled growth conditions. 5 to 7
Tage nach der Aussaat werden die Versuchspflanzen im Keimblattstadium behandelt. Die in Form von Emulsionskonzentraten (EC) formulierten erfindungsgemäßen Verbindungen werden mit einer Wasseraufwandmenge von umgerechnet 2200 Liter pro Hektar appliziert. Nach 9 bis 12 Tagen Standzeit der Versuchspflanzen in der Klimakammer unter optimalen Wachstumsbedingungen, wird die Wirkung der Präparate visuell im Vergleich zu unbehandelten Kontrollen bonitiert. Beispielsweise bedeutet 100%> Wirkung = Pflanzen sind abgestorben, 0%> Wirkung = wie Kontrollpflanzen. In den nachstehenden Tabllen Bl bis B2 sind die Wirkungen ausgewählter Verbindungen der allgemeinen Formel (I) gemäß der Tabellen L I bis 1.50 auf verschiedene Schadpflanzen und einer Aufwandmenge entsprechend 1900 g/ha, die gemäß zuvor genannter Versuchsvorschrift erhalten wurden, dargestellt. Days after sowing, the test plants are treated at the cotyledon stage. The compounds of the invention formulated in the form of emulsion concentrates (EC) are applied at a rate of 2200 liters per hectare. After 9 to 12 days of life of the test plants in the climatic chamber under optimal growth conditions, the effect of the preparations is scored visually in comparison to untreated controls. For example, 100% means> effect = plants are dead, 0%> effect = like control plants. In the following Tables B1 to B2, the effects of selected compounds of the general formula (I) according to Tables LI to 1.50 on various harmful plants and an application rate corresponding to 1900 g / ha, which were obtained according to the aforementioned test protocol are shown.
Tabelle Bl Table Bl
Figure imgf000097_0001
Figure imgf000097_0001
Wie die Ergebnisse zeigen, weisen erfindungsgemäße Verbindungen der Formel (I) bei Behandlung im Nachauflauf eine gute herbizide Wirksamkeit gegen Schadpflanzen auf. Beispielsweise zeigten dabei die in den o.g. Tabellen Bl bis B2 genannten Verbindungen im Nachauflaufverfahren eine sehr gute herbizide Wirkung (80% bis 100% herbizide Wirkung) gegen Schadpflanzen wie Diplotaxis tenuifolia (DIPTE) und Matricaria chamomilla (MATCH) bei einer Aufwandmenge von 1900 g Aktivsubstanz pro Hektar. As the results show, compounds of the formula (I) according to the invention have a good herbicidal activity against harmful plants during postemergence treatment. For example, in the o.g. Tables Bl to B2 compounds postemergence a very good herbicidal action (80% to 100% herbicidal activity) against harmful plants such as Diplotaxis tenuifolia (DIPTE) and Matricaria chamomilla (MATCH) at an application rate of 1900 g of active ingredient per hectare.
Herbizide Wirkung und Kulturverträglichkeit im Vorauflauf Herbicidal action and culture compatibility in pre-emergence
Samen von mono- bzw. dikotylen Unkraut und Kulturpflanzen werden in Kunststoff- oder Seeds of monocotyledonous or dicotyledonous weeds and crops are in plastic or
Holzfasertöpfen ausgelegt und mit Erde abgedeckt. Die in Form von benetzbaren Pulvern (WP) oder als Emulsionskonzentrate (EC) formulierten erfindungsgemäßen Verbindungen werden dann als wässrige Suspension bzw. Emulsion unter Zusatz von 0,5% Additiv mit einer Wasseraufwandmenge von umgerechnet 600 1/ha auf die Oberfläche der Abdeckerde appliziert. Nach der Behandlung werden die Töpfe im Gewächshaus aufgestellt und unter guten Wachstumsbedingungen für die Testpflanzen gehalten. Nach ca. 3 Wochen wird die Wirkung der Präparate visuell im Vergleich zu unbehandelten Kontrollen in Prozentwerten bonitiert. Beispielsweise bedeutet 100% Wirkung = Pflanzen sind abgestorben, 0% Wirkung = wie Kontrollpflanzen. Wood fiber pots designed and covered with soil. The compounds according to the invention formulated in the form of wettable powders (WP) or as emulsion concentrates (EC) are then in the form of an aqueous suspension or emulsion with the addition of 0.5% of an additive with a water application rate of converted 600 1 / ha applied to the surface of the cover soil. After the treatment, the pots are placed in the greenhouse and kept under good growth conditions for the test plants. After about 3 weeks, the effect of the preparations is scored visually in comparison to untreated controls in percentages. For example, 100% means action = plants are dead, 0% effect = like control plants.
Die Versuche zeigten, dass erfindungsgemäße Verbindungen bei Behandlung im Vorauflauf eine gute herbizide Wirksamkeit gegen ausgewählte Schadpflanzen wie z.B. Abutilon theophrasti, Alopecurus myosuroides, Amaranthus retroflexus, Avena fatua, Cyperus esculentus, Echinochloa crus-galli, Hordeum murinum, Lolium rigidum, Matricaria inodora, Pharbitis purpurea, Polygonum convolvulus, Setaria viridis, Stellaria media, Veronica persica oder Viola tricolor bei einer Aufwandmenge von 1.28 kg Aktivsubstanz oder weniger pro Hektar auweisen. The tests showed that compounds according to the invention have a good herbicidal activity against selected harmful plants, such as e.g. Abutilon theophrasti, Alopecurus myosuroides, Amaranthus retroflexus, Avena fatua, Cyperus esculentus, Echinochloa crus-galli, Hordeum murinum, Lolium rigidum, Matricaria inodora, Pharitis purpurea, Polygonum convolvulus, Setaria viridis, Stellaria media, Veronica persica or Viola tricolor at an application rate of 1.28 kg of active substance or less per hectare.
Daneben zeigten die erfindungsgemäßen Verbindungen teilweise eine hohe Selektivität und eignen sich deshalb im Vorauflaufverfahren zur Bekämpfung von unerwünschtem Pflanzenwuchs in  In addition, some of the compounds of the invention showed a high selectivity and are therefore suitable in the pre-emergence process for controlling undesired plant growth in
landwirtschaftlichen Kulturen. agricultural crops.

Claims

Patentansprüche claims
1. Substituierte Cycloalkylpyrrolidinone der allgemeinen Formel (I) oder deren Salze 1. Substituted Cycloalkylpyrrolidinone of the general formula (I) or salts thereof
Figure imgf000099_0001
worin
Figure imgf000099_0001
wherein
für gegebenenfalls substituiertes (C3-Cio)-Cycloalkyl, (C3-Cio)-Halocycloalkyl, (C3-C10)- Cyanocycloalkyl, (Ci-Cio)-Alkyl -(C3-Go)-cycloalkyl, (Ci-Cio)-Alkoxy-(C3-Cio)- cycloalkyl, (Ci-Cio)-Haloalkoxy-(C3-Cio)-cycloalkyl, (Ci-Cio)-Alkylthio-(C3-Cio)- cycloalkyl, Aryl-(C3-Cio)-cycloalkyl, Heteroaryl-(C3-Cio)-cycloalkyl, (C1-C10)- Alkoxycarbonyl -(C3-Cio)-cycloalkyl, Hydroxcarbonyl- (C3-Cio)-cycloalkyl, (C3-C10)- Cycloalkyl-(C3-Cio)-cycloalkyl steht, für die Gruppe
Figure imgf000099_0002
steht, optionally substituted (C3-Cio) -cycloalkyl, (C3-Cio) -halocycloalkyl, (C3-C10) -cyanocycloalkyl, (Ci-Cio) -alkyl - (C3-Go) -cycloalkyl, (Ci-Cio) -alkoxy (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -haloalkoxy- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -alkylthio (C 3 -C 10) -cycloalkyl, aryl- (C 3 -C 10) cycloalkyl, heteroaryl- (C 3 -C 10) -cycloalkyl, (C 1 -C 10) -alkoxycarbonyl- (C 3 -C 10) -cycloalkyl, hydroxcarbonyl- (C 3 -C 10) -cycloalkyl, (C 3 -C 10) -cycloalkyl- (C 3 -C 10) -cycloalkyl Cio) cycloalkyl, for the group
Figure imgf000099_0002
stands,
Y für -C(R7)(R8)-, Sauerstoff, oder NR1 steht, Y is -C (R 7 ) (R 8 ) -, oxygen, or NR 1 ,
W1 und W2 unabhängig voneinander für Sauerstoff oder Schwefel stehen; W 1 and W 2 are independently oxygen or sulfur;
R1 für Wasserstoff, Amino, Hydroxy, Cyano, Formyl, (Ci-Cs)-Alkyl, (Ci-Cs)-Haloalkyl,R 1 is hydrogen, amino, hydroxyl, cyano, formyl, (C 1 -C 5) -alkyl, (C 1 -C 8) -haloalkyl,
(Ci-C8)-Cyanoalkyl, (Ci-C8)-Hydroxyalkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, Aryl-(G-C8)- alkyl, Heteroaryl-(Ci-C8)-alkyl, Heterocyclyl-(Ci-C8)-alkyl, (C3-Cio)-Cycloalkyl, (C3-Cio)-Cycloalkyl-(Ci-C8)-alkyl, (C3-C8)-Halocycloalkyl, (C3-C8)-Halocycloalkyl- (Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, (Ci-C8)-Alkoxycarbonyl, (C2-C8)-Alkenyl, (C2-C8)- Alkynyl, Tris-[(Ci-C8)-alkyl]silyl-(C2-C8)-alkynyl, Tris-[(Ci-C8)-alkyl]silyl steht, für Wasserstoff, Halogen, Hydroxy, (Ci-C8)-Alkyl, (Ci-C8)-Haloalkyl, (Ci-C8)- Hydroxyalkyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl steht, für Wasserstoff, Halogen, Hydroxy, (Ci-C8)-Alkyl, (Ci-C8)-Haloalkyl, (Ci-C8)- Hydroxyalkyl, (Ci-C8)-Alkoxy, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl steht, für ein gegebenenfalls substituiertes Aryl und Heteroaryl steht, wobei jeder Ring oder jedes Ringsystem optional mit bis zu 5 Substituenten aus der Gruppe R6 substituiert sein kann, für Wasserstoff, Hydroxy, Amino, (Ci-C8)-Alkyl, (Ci-C8)-Haloalkyl, (C2-C8)-Alkenyl, (C3-C8)-Alkynyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, (Ci-C8)-Haloalkoxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylthio-(Ci-C8)-alkyl, (Ci-C8)-Alkylsulfmyl-(Ci-C8)-alkyl, (Ci-C8)- Alkylsulfonyl-(Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, (Ci-C8)-Haloalkylcarbonyl, (C3-C8)- Cycloalkylcarbonyl, (Ci-C8)-Alkoxycarbonyl, (C2-C8)- Haloalkoxycarbonyl, (C4-C&)- Cycloalkoxycarbonyl, (C2-C8)-Alkylaminocarbonyl, (C3-Cio)-Dialkylaminocarbonyl, (C3-Cio)-Cycloalkylaminocarbonyl, (Ci-C8)-Alkoxy, (Ci-C8)-Alkylthio, (Ci-Cg)- Haloalkylthio, (C3-C8)-Cycloalkylthio, (Ci-C8)-Alkylsulfmyl, (Ci-C8)-Haloalkylsulfmyl, (C3-C8)-Cycloalkylsulfmyl, (Ci-C8)-Alkylsulfonyl, (Ci-C8)-Haloalkylsulfonyl, (C3-C8)- cycloalkylsulfonyl, (Ci-C8)-Alkylaminosulfonyl, (C2-C8)-Dialkylaminosulfonyl oder (C3-C8)-Trialkylsilyl steht, für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (Ci-Cs)- Alkyl, (C3-C8)-Cycloalkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkynyl, Aryl, Aryl-(Ci-C8)-alkyl, Aryl-(C2-C8)-alkenyl, Aryl-(C2-C8)-alkinyl, Aryl-(Ci-C8)-alkoxy, Heteroaryl, (Ci-C8)- Alkoxy-(Ci-C8)-alkyl, (Ci-C8)-Hydroxyalkyl, (Ci-C8)-Haloalkyl, (C3-C8)-Halocycloalkyl, (Ci-C8)-Alkoxy, (Ci-C8)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C8)-Cycloalkyloxy, Hydroxy, (C3-C8)-Cycloalkyl-(Ci-C8)-alkoxy, (Ci-C8)-Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (Ci-C8)-Alkylaminocarbonyl, (C3-C8)-Cycloalkylaminocarbonyl, (Ci-C8)-Cyanoalkylaminocarbonyl, (C2-C8)-Alkenylaminocarbonyl, (C2-C8)- Alkynylaminocarbonyl, (Ci-C8)-Alkylamino, (Ci-C8)-Alkylthio, (Ci-C8)-Haloalkylthio, Hydrothio, (Ci-C8)-Bisalkylamino, (C3-C8)-Cycloalkylamino, (Ci-Cs)- Alkylcarbonylamino, (C3-C8)-Cycloalkylcarbonylamino, Formylamino, (Ci-Cs)- Haloalkylcarbonylamino, (Ci-C8)-Alkoxycarbonylamino, (Ci-Cs)- Alkylaminocarbonylamino, (Ci-C8)-Dialkyl-aminocarbonylamino, (Ci-Cs)- Alkylsulfonylamino, (C3-C8)-Cycloalkylsulfonylamino, Arylsulfonylamino, (Ci-C 8) cyanoalkyl, (Ci-C8) hydroxyalkyl, (Ci-C 8) alkoxy (Ci-C 8) alkyl, aryl (GC 8) - alkyl, heteroaryl (Ci- C 8) alkyl, heterocyclyl (Ci-C8) alkyl, (C 3 -Cio) cycloalkyl, (C 3 -Cio) cycloalkyl- (Ci-C 8) alkyl, (C 3 -C 8 ) halocycloalkyl, (C 3 -C 8) -Halocycloalkyl- (Ci-C 8) alkyl, (Ci-C 8) alkylcarbonyl, (Ci-C8) alkoxycarbonyl, (C 2 -C 8) alkenyl , (C 2 -C 8) - alkynyl, tris - [(Ci-C 8) alkyl] silyl (C 2 -C 8) alkynyl, tris - [(Ci-C 8) alkyl] silyl, is hydrogen, halogen, hydroxy, (Ci-C 8) -alkyl, (Ci-C 8) haloalkyl, (Ci-C 8) - hydroxyalkyl, (Ci-C 8) alkoxy (Ci-C 8) - alkyl, represents hydrogen, halogen, hydroxy, (Ci-C 8) -alkyl, (Ci-C 8) haloalkyl, (Ci-C 8) - hydroxyalkyl, (Ci-C 8) alkoxy, (Ci-C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, is an optionally substituted aryl and heteroaryl, where each ring or each ring system may optionally be substituted by up to 5 substituents from the group R 6 , for hydrogen, hydroxy, amino, (Ci-C 8) -alkyl, (Ci-C8) -haloalkyl, (C 2 -C 8) -alkenyl, (C 3 -C 8) alkynyl, (Ci-C 8) alkoxy ( C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -haloalkoxy- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylthio (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -Alkylsulfmyl- (Ci-C 8) alkyl, (Ci-C 8) - alkylsulfonyl (Ci-C 8) alkyl, (Ci-C 8) alkylcarbonyl, (Ci-C 8) haloalkylcarbonyl, (C 3 -C 8) - cycloalkylcarbonyl, (Ci-C8) alkoxycarbonyl, (C 2 -C 8) - haloalkoxycarbonyl, (C4-C) - cycloalkoxycarbonyl, (C2-C8) -alkylaminocarbonyl, (C3-Cio ) Dialkylaminocarbonyl, (C 3 -Cio) cycloalkylaminocarbonyl, (Ci-C 8) alkoxy, (Ci-C8) alkylthio, (Ci-Cg) - haloalkylthio, (C 3 -C 8) -cycloalkylthio, ( Ci-C 8 ) -alkylsulfmyl, (Ci-C 8 ) -haloalkylsulfmyl, (C 3 -C 8 ) -cycloalkylsulfmyl, (Ci-C 8 ) -alkylsulfonyl, (Ci-C 8 ) -haloalkylsulfonyl, (C 3 -C 8 ) -cycloalkylsulfonyl, (C 1 -C 8 ) -alkylaminosulfonyl, (C 2 -C 8 ) -dialkylaminosulfonyl or (C 3 -C 8 ) -trialkylsilyl, represents hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen, (C 1 -C 8 ) -alkyl, (C 3 -C 8 ) -cycloalkyl, (C 2 -C 8 ) -alkenyl, (C 2 -C 8 ) -alkynyl, aryl, aryl- (C 1 -C 8 ) -alkyl , aryl (C 2 -C 8) alkenyl, aryl (C 2 -C 8) alkynyl, aryl (Ci-C 8) alkoxy, heteroaryl, (Ci-C8) - alkoxy (Ci C 8) alkyl, (Ci-C8) hydroxyalkyl, (Ci-C8) -haloalkyl, (C 3 -C 8) halocycloalkyl, (Ci-C 8) alkoxy, (Ci-C 8) - haloalkoxy, aryloxy, heteroaryloxy, (C 3 -C 8) cycloalkyloxy, hydroxy, (C 3 -C 8) -cycloalkyl- (Ci-C8) alkoxy, (Ci-C8) alkoxycarbonyl, hydroxycarbonyl, Aminocarbony l, (Ci-C 8) alkylaminocarbonyl, (C 3 -C 8) cycloalkylaminocarbonyl, (Ci-C 8) -Cyanoalkylaminocarbonyl, (C 2 -C 8) -Alkenylaminocarbonyl, (C 2 -C 8) - Alkynylaminocarbonyl, (Ci-C 8) alkylamino, (Ci-C8) alkylthio, (Ci-C8) haloalkylthio, Hydrothio, (Ci-C 8) -Bisalkylamino, (C 3 -C 8) -cycloalkylamino, (C -Cs) - alkylcarbonylamino, (C 3 -C 8) -Cycloalkylcarbonylamino, formylamino, (Ci-Cs) - Haloalkylcarbonylamino, (Ci-C8) alkoxycarbonylamino, (Ci-Cs) - alkylaminocarbonylamino, (Ci-C 8) - Dialkylaminocarbonylamino, (C 1 -C 8 ) -alkylsulfonylamino, (C 3 -C 8 ) -cycloalkylsulfonylamino, arylsulfonylamino,
Heteroarylsulfonylamino, Aminosulfonyl, (Ci-C8)-Aminohaloalkylsulfonyl, (Ci-Cs)- Alkylaminosulfonyl, (Ci-C8)-Bisalkylaminosulfonyl, (C3-C8)-Cycloalkylaminosulfonyl, (Ci-C8)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl-(Ci-C8)-alkylaminosulfonyl, (Ci-C8)-Alkylsulfonyl, (C3-C8)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C8)-Alkylsulfmyl, (C3-C8)-Cycloalkylsulfmyl, Arylsulfmyl, N,S-(Ci-C8)-Dialkylsulfonimidoyl, S-(Ci-C8)- Alkylsulfonimidoyl, (Ci-C8)-Alkylsulfonylaminocarbonyl, (C3-C8)-Cycloalkylsulfonyl- aminocarbonyl, (C3-C8)-Cycloalkylaminosulfonyl, Aryl-(Ci-C8)-alkylcarbonylamino, (C3-C8)-Cycloalkyl-(Ci-C8)-alkylcarbonylamino, Heteroarylcarbonylamino, (Ci-Cs)- Alkoxy-(Ci-C8)-alkylcarbonylamino, (Ci-C8)-Hydroxyalkylcarbonylamino, (Ci-Cs)- Trialkylsilyl steht, Heteroarylsulfonylamino, aminosulfonyl, (Ci-C 8 ) -Aminohaloalkylsulfonyl, (Ci-Cs) - Alkylaminosulfonyl, (C 1 -C 8 ) -bisalkylaminosulfonyl, (C 3 -C 8 ) -cycloalkylaminosulfonyl, (C 1 -C 8 ) -haloalkylaminosulfonyl, arylaminosulfonyl, aryl- (C 1 -C 8 ) -alkylaminosulfonyl, (C 1 -C 8 ) -alkylsulfonyl, (C 3 -C 4) -alkylalkyl C8) cycloalkylsulfonyl, arylsulfonyl, (Ci-C8) -Alkylsulfmyl, (C3-C8) -Cycloalkylsulfmyl, Arylsulfmyl, N, S- (Ci-C8) -Dialkylsulfonimidoyl, S- (Ci-C8) - Alkylsulfonimidoyl , (C 1 -C 8) -alkylsulfonylaminocarbonyl, (C 3 -C 8) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 8) -cycloalkylaminosulfonyl, aryl- (C 1 -C 8) -alkylcarbonylamino, (C 3 -C 8) -cycloalkyl- (C 1 -C 8) alkylcarbonylamino, heteroarylcarbonylamino, (C 1 -C 8) - alkoxy- (C 1 -C 8) -alkylcarbonylamino, (C 1 -C 8) -hydroxyalkylcarbonylamino, (C 1 -C 5) -trialkylsilyl,
R7 und R8 unabhängig voneinander für Wasserstoff, Hydroxy, Halogen, (Ci-C8)-Alkyl, (Ci-Cs)- Haloalkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkynyl, (Ci-C8)-Alkoxy-(Ci-C8)-alkyl, (Ci-C8)- Haloalkoxy-(Ci-C8)-alkyl, (Ci-C8)-Alkylthio-(Ci-C8)-alkyl, (Ci-C8)-Alkylsulfinyl- (Ci-C8)-alkyl, (Ci-C8)-Alkylsulfonyl-(Ci-C8)-alkyl, (Ci-C8)-Alkylcarbonyl, (Ci-C8)- Haloalkylcarbonyl, (C3-C8)-Cycloalkylcarbonyl, (Ci-C8)-Alkoxycarbonyl, (C2-C8)- Haloalkoxycarbonyl, (C3-C8)-Cycloalkoxycarbonyl, (Ci-C8)-Alkylaminocarbonyl, (Ci-Cio)-Dialkylaminocarbonyl, (C3-Cio)-Cycloalkylaminocarbonyl, (Ci-C8)-Alkoxy, (Ci-C8)-Alkylthio, (Ci-C8)-Haloalkylthio, (C3-C8)-Cycloalkylthio stehen. R 7 and R 8 independently of one another represent hydrogen, hydroxyl, halogen, (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -haloalkyl, (C 2 -C 8 ) -alkenyl, (C 2 -C 8 ) -alkynyl, (C 1 -C 8 ) -alkoxy- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -haloalkoxy- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylthio (C 1 -C 8 ) - alkyl, (C 1 -C 8 ) -alkylsulfinyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylsulfonyl- (C 1 -C 8 ) -alkyl, (C 1 -C 8 ) -alkylcarbonyl, (C 1 -C 8 ) -alkyl 8 ) - haloalkylcarbonyl, (C 3 -C 8 ) -cycloalkylcarbonyl, (C 1 -C 8 ) -alkoxycarbonyl, (C 2 -C 8 ) -haloalkoxycarbonyl, (C 3 -C 8 ) -cycloalkoxycarbonyl, (C 1 -C 8 ) -alkylaminocarbonyl, (C 1 -C 8 ) -cycloalkylcarbonyl, Cio) dialkylaminocarbonyl, (C3-Cio) cycloalkylaminocarbonyl, (Ci-C8) alkoxy, (Ci-C8) alkylthio, (Ci-C8) haloalkylthio, (C3-C8) cycloalkylthio stand.
2. Verbindung der allgemeinen Formel (I) nach Anspruch 1 oder deren Salze, worin 2. A compound of general formula (I) according to claim 1 or salts thereof, wherein
Q für gegebenenfalls substituiertes (C3-Cio)-Cycloalkyl, (C3-Cio)-Halocycloalkyl, (C3-C10)- Cyanocycloalkyl, (Ci-Cio)-Alkyl -(C3-Cio)-cycloalkyl, (Ci-Cio)-Alkoxy-(C3-Cio)- cycloalkyl, (Ci-Cio)-Haloalkoxy-(C3-Cio)-cycloalkyl, (Ci-Cio)-Alkylthio-(C3-Cio)- cycloalkyl, Aryl-(C3-Cio)-cycloalkyl, Heteroaryl-(C3-Cio)-cycloalkyl, (C1-C10)- Alkoxycarbonyl -(C3-Cio)-cycloalkyl, Hydroxcarbonyl- (C3-Cio)-cycloalkyl, (C3-C10)- Cycloalkyl-(C3-Cio)-cycloalkyl steht, Q is optionally substituted (C3-Cio) -cycloalkyl, (C3-Cio) -halocycloalkyl, (C3-C10) -cyanocycloalkyl, (Ci-Cio) -alkyl - (C3-Cio) -cycloalkyl, (Ci-Cio) - alkoxy (C3-Cio) - cycloalkyl, (Ci-Cio) haloalkoxy (C 3 -Cio) cycloalkyl, (Ci-Cio) alkylthio (C 3 -Cio) - cycloalkyl, aryl (C3-Cio ) cycloalkyl, heteroaryl (C3-Cio) cycloalkyl, (C 1 -C 1 0) - alkoxycarbonyl - (C3-Cio) cycloalkyl, Hydroxcarbonyl- (C3-Cio) cycloalkyl, (C3-C 1 0) - cycloalkyl- (C3-Cio) -cycloalkyl,
Z für die Gruppe
Figure imgf000101_0001
steht, Z for the group
Figure imgf000101_0001
stands,
Y für -C(R7)(R8)-, Sauerstoff, oder NR1 steht, Y is -C (R 7 ) (R 8 ) -, oxygen, or NR 1 ,
W1 und W2 unabhängig voneinander für Sauerstoff oder Schwefel stehen; für Wasserstoff, Amino, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (Ci-C6)-Hydroxyalkyl, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl, Aryl-(Ci-C6)-alkyl, Heteroaryl-(Ci-C6)-alkyl, W 1 and W 2 are independently oxygen or sulfur; for hydrogen, amino, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, (C 1 -C 6 ) -hydroxyalkyl, (C 1 -C 6 ) -alkoxy- (C 1 -C 6 ) -alkyl, Aryl- (C 1 -C 6 ) -alkyl, heteroaryl- (C 1 -C 6 ) -alkyl,
Heterocyclyl-(Ci-C6)-alkyl, (C3-C6)-Cycloalkyl, (C3-C6)-Cycloalkyl-(Ci-C6)-alkyl, (C3-C6)-Halocycloalkyl, (C3-C6)-Halocycloalkyl-(Ci-C6)-alkyl, (Ci-C6)-Alkylcarbonyl, (Ci-C6)-Alkoxycarbonyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, Tris-[(Ci-C6)-alkyl]silyl- (C2-C6)-alkinyl, Tris-[(Ci-C6)-alkyl]silyl steht, für Wasserstoff, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (Ci-C6)-Hydroxyalkyl, (Ci-C6)- Alkoxy-(Ci-C6)-alkyl steht, für Wasserstoff, Fluor, Chlor, Brom, Iod, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (Ci-C6)- Hydroxyalkyl, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl steht, für ein gegebenenfalls substituiertes Aryl und Heteroaryl steht, wobei jeder Ring oder jedes Ringsystem optional mit bis zu 5 Substituenten aus der Gruppe R6 substituiert sein kann, für Wasserstoff, (Ci-C6)-Alkyl, (Ci-C6)-Haloalkyl, (C2-C6)-Alkenyl, (C3-C6)-Alkynyl, (Ci-C6)-Alkoxy-(Ci-C6)-alkyl, (Ci-C6)-Haloalkoxy-(Ci-C6)-alkyl, (Ci-C6)-Alkylthio- (Ci-C6)-alkyl, (Ci-C6)-Alkylsulfmyl-(Ci-C6)-alkyl, (Ci-C6)-Alkylsulfonyl-(Ci-C6)-alkyl, (C2-C6)-Dialkylaminosulfonyl oder (C3-C8)-Trialkylsilyl steht, für Wasserstoff, Nitro, Amino, Cyano, Thiocyanato, Isothiocyanato, Halogen, (C1-C7)- Alkyl, (C3-C7)-Cycloalkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkynyl, Aryl, Aryl-(Ci-C7)-alkyl, Aryl-(C2-C7)-alkenyl, Aryl-(C2-C7)-alkinyl, Aryl-(Ci-C7)-alkoxy, Heteroaryl, (C1-C7)- Alkoxy-(Ci-C7)-alkyl, (Ci-C7)-Hydroxyalkyl, (Ci-C7)-Haloalkyl, (C3-C7)-Halocycloalkyl, (Ci-C7)-Alkoxy, (Ci-C7)-Haloalkoxy, Aryloxy, Heteroaryloxy, (C3-C7)-Cycloalkyloxy, Hydroxy, (C3-C7)-Cycloalkyl-(Ci-C7)-alkoxy, (Ci-C7)-Alkoxycarbonyl, Hydroxycarbonyl, Aminocarbonyl, (Ci-C7)-Alkylaminocarbonyl, (C3-C7)-Cycloalkylaminocarbonyl, (Ci-C7)-Cyanoalkylaminocarbonyl, (C2-C7)-Alkenylaminocarbonyl, (C2-C7)- Alkynylaminocarbonyl, (Ci-C7)-Alkylamino, (Ci-C7)-Alkylthio, (Ci-C7)-Haloalkylthio, Hydrothio, (Ci-C7)-Bisalkylamino, (C3-C7)-Cycloalkylamino, (C1-C7)- Alkylcarbonylamino, (C3-C7)-Cycloalkylcarbonylamino, Formylamino, (C1-C7)- Haloalkylcarbonylamino, (Ci-C7)-Alkoxycarbonylamino, (C1-C7)- Alkylaminocarbonylamino, (Ci-C7)-Dialkyl-aminocarbonylamino, (C1-C7)- Alkylsulfonylamino, (C3-C7)-Cycloalkylsulfonylamino, Arylsulfonylamino, Hetarylsulfonylamino, Aminosulfonyl, (Ci-C7)-Aminoalkylsulfonyl, (C1-C7)- Alkylaminosulfonyl, (Ci-C7)-Bisalkylaminosulfonyl, (C3-C7)-Cycloalkylaminosulfonyl, (Ci-C7)-Haloalkylaminosulfonyl, Arylaminosulfonyl, Aryl-(Ci-C7)-alkylaminosulfonyl, (Ci-C7)-Alkylsulfonyl, (C3-C7)-Cycloalkylsulfonyl, Arylsulfonyl, (Ci-C7)-Alkylsulfmyl, (C3-C7)-Cycloalkylsulfmyl, Arylsulfmyl, N,S-(Ci-C7)-Dialkylsulfonimidoyl, S-(Ci-C7)- Alkylsulfonimidoyl, (Ci-C7)-Alkylsulfonylaminocarbonyl, (C3-C7)- Cycloalkylsulfonylaminocarbonyl, (C3-C7)-Cycloalkylaminosulfonyl, Aryl-(Ci-C7)- alkylcarbonylamino, (C3-C7)-Cycloalkyl-(Ci-C7)-alkylcarbonylamino, Heterocyclyl (Ci-C 6) alkyl, (C 3 -C 6) -cycloalkyl, (C3-C6) cycloalkyl (Ci-C 6) alkyl, (C 3 -C 6) halocycloalkyl, ( C3-C 6) -Halocycloalkyl- (Ci-C 6) alkyl, (Ci-C 6) alkylcarbonyl, (Ci-C 6) -alkoxycarbonyl, (C 2 -C 6) alkenyl, (C 2 -C 6 ) alkynyl, tris - [(Ci-C 6 ) alkyl] silyl (C 2 -C 6 ) alkynyl, tris - [(Ci-C 6 ) alkyl] silyl, for hydrogen, (C C 6) alkyl, (Ci-C 6) -haloalkyl, (Ci-C 6) hydroxyalkyl, (Ci-C6) - alkoxy- (Ci-C 6) alkyl, represents hydrogen, fluorine, chlorine, bromo, iodo, (Ci-C 6) -alkyl, (Ci-C 6) -haloalkyl, (Ci-C6) - hydroxyalkyl, (Ci-C6) alkoxy (Ci-C 6) -alkyl, is an optionally substituted aryl and heteroaryl, where each ring or each ring system may optionally be substituted with up to 5 substituents from the group R 6 , for hydrogen, (Ci-C 6 ) alkyl, (Ci-C 6 ) haloalkyl , (C 2 -C 6) -alkenyl, (C 3 -C 6) alkynyl, (Ci-C6) alkoxy (Ci-C 6) alkyl, (Ci-C 6) haloalkoxy (C C 6 ) -alkyl, (C 1 -C 6 ) -alkylthio (C 1 -C 6 ) -alkyl, ( Ci-C6) -Alkylsulfmyl- (Ci-C 6) alkyl, (Ci-C 6) alkylsulfonyl (Ci-C 6) alkyl, (C 2 -C 6) dialkylaminosulfonyl, or (C3-C8) -trialkylsilyl is hydrogen, nitro, amino, cyano, thiocyanato, isothiocyanato, halogen, (C 1 -C 7 ) -alkyl, (C 3 -C 7 ) -cycloalkyl, (C 2 -C 7 ) -alkenyl, (C 2 -C 7) alkynyl, aryl, aryl (Ci-C7) alkyl, aryl (C 2 -C 7) alkenyl, aryl (C 2 -C 7) alkynyl, aryl (Ci-C 7) alkoxy, heteroaryl, (C1-C7) - alkoxy (Ci-C7) alkyl, (Ci-C7) hydroxyalkyl, (Ci-C7) haloalkyl, (C 3 -C 7) halocycloalkyl, (C 1 -C 7 ) -alkoxy, (C 1 -C 7 ) -haloalkoxy, aryloxy, heteroaryloxy, (C 3 -C 7 ) -cycloalkyloxy, hydroxyl, (C 3 -C 7 ) -cycloalkyl- (C 1 -C 7 ) -alkoxy , (Ci-C 7) alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, (Ci-C 7) alkylaminocarbonyl, (C3-C 7) cycloalkylaminocarbonyl, (Ci-C 7) -Cyanoalkylaminocarbonyl, (C 2 -C 7) -Alkenylaminocarbonyl , (C 2 -C 7) - Alkynylaminocarbonyl, (Ci-C7) alkylamino, (Ci-C7) -alkylthio, (Ci-C 7) haloalkylthio, Hydrothio, (Ci-C 7) -Bisalkylamino, ( C3-C 7) -Cycloalkylamino, (C 1 -C 7 ) -alkylcarbonylamino, (C 3 -C 7 ) -cycloalkylcarbonylamino, formylamino, (C 1 -C 7 ) -haloalkylcarbonylamino, (C 1 -C 7 ) -alkoxycarbonylamino, (C 1 -C 7 ) -alkylaminocarbonylamino, C 7 ) dialkylaminocarbonylamino, (C 1 -C 7 ) -alkylsulfonylamino, (C 3 -C 7 ) -cycloalkylsulfonylamino, arylsulfonylamino, Hetarylsulfonylamino, aminosulfonyl, (C 1 -C 7) -aminoalkylsulfonyl, (C 1 -C 7) -alkylaminosulfonyl, (C 1 -C 7) -bisalkylaminosulfonyl, (C 3 -C 7) -cycloalkylaminosulfonyl, (C 1 -C 7) -haloalkylaminosulfonyl, arylaminosulfonyl, aryl- (Ci -C 7 ) -alkylaminosulfonyl, (C 1 -C 7 ) -alkylsulfonyl, (C 3 -C 7 ) -cycloalkylsulfonyl, arylsulfonyl, (C 1 -C 7 ) -alkylsulfmyl, (C 3 -C 7 ) -cycloalkylsulfmyl, arylsulfmyl, N, S-- (C 1 -C 7 ) -dialkylsulfonimidoyl, S- (C 1 -C 7 ) -alkylsulfonimidoyl, (C 1 -C 7 ) -alkylsulfonylaminocarbonyl, (C 3 -C 7 ) -cycloalkylsulfonylaminocarbonyl, (C 3 -C 7 ) -cycloalkylaminosulfonyl, aryl- (C 1 -C 7 ) - alkylcarbonylamino, (C3-C7) -cycloalkyl- (Ci-C7) -alkylcarbonylamino,
Heteroarylcarbonylamino, (Ci-C7)-Alkoxy-(Ci-C7)-alkylcarbonylamino, (C1-C7)- Hydroxyalkylcarbonylamino, (Ci-C7)-Trialkylsilyl steht;  Heteroarylcarbonylamino, (C 1 -C 7) alkoxy- (C 1 -C 7) -alkylcarbonylamino, (C 1 -C 7) -hydroxyalkylcarbonylamino, (C 1 -C 7) -trialkylsilyl;
R7 und R8 unabhängig voneinander für Wasserstoff, Hydroxy, Halogen, (Ci-C6)-Alkyl, (CI-CÖ)- Haloalkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkynyl, (Ci-C6)-Alkoxyalkyl, (Ci-C6)- Haloalkoxyalkyl, (Ci-C6)-Alkylthio-(Ci-C6)-alkyl stehen. R 7 and R 8 independently of one another are hydrogen, hydroxyl, halogen, (C 1 -C 6 ) -alkyl, (C 1 -C 6 ) -haloalkyl, (C 2 -C 6 ) -alkenyl, (C 2 -C 6 ) -alkynyl, (C 1 -C 6 ) -alkoxyalkyl, (C 1 -C 6 ) -haloalkoxyalkyl, (C 1 -C 6 ) -alkylthio (C 1 -C 6 ) -alkyl.
3. Verbindung der allgemeinen Formel (I) nach Anspruch 1 oder deren Salze, worin 3. A compound of general formula (I) according to claim 1 or salts thereof, wherein
Q für eine der nachfolgend genannten Gruppen Q-l . l bis Q-1.42 steht Q for one of the following groups Q-l. l to Q-1.42
Figure imgf000103_0001
Figure imgf000104_0001
Figure imgf000103_0001
Figure imgf000104_0001
Z für eine der nachfolgend genannten Gruppen Z-1.1 bis Z-4.3 steht  Z stands for one of the following groups Z-1.1 to Z-4.3
Z-1.1 Z-1.2 Z-1.3 Z-1.4 Z-1.5
Figure imgf000105_0001
Figure imgf000106_0001
Z-1.1 Z-1.2 Z-1.3 Z-1.4 Z-1.5
Figure imgf000105_0001
Figure imgf000106_0001
Y für -CH2- steht, Y is -CH 2 -,
W1 und W2 für Sauerstoff stehen; W 1 and W 2 are oxygen;
R1 für Wasserstoff, Amino, Methyl, Cyclopropyl, Benzyl, p-Methoxy-Benzyl, Allyl, Propargyl steht, R für Wasserstoff, steht, und R 1 is hydrogen, amino, methyl, cyclopropyl, benzyl, p-methoxy-benzyl, allyl, propargyl, R stands for hydrogen, and
R3 für Wasserstoff, Fluor oder Chlor steht. R 3 is hydrogen, fluorine or chlorine.
4. Herbizide Mittel, gekennzeichnet durch einen herbizid wirksamen Gehalt an mindestens einer Verbindung der allgemeinen Formel (I) gemäß einem der Ansprüche 1 bis 3. 4. A herbicidal composition, characterized by a herbicidally active content of at least one compound of the general formula (I) according to one of claims 1 to 3.
5. Herbizide Mittel nach Anspruch 4 in Mischung mit Formulierungshilfsmitteln. 5. A herbicidal composition according to claim 4 in admixture with formulation auxiliaries.
6. Herbizide Mittel nach Anspruch 4 oder 5 enthaltend mindestens einen weiteren pestizid 6. A herbicidal composition according to claim 4 or 5 containing at least one further pesticide
wirksamen Stoff aus der Gruppe Insektizide, Akarizide, Herbizide, Fungizide, Safener und Wachstumsregulatoren.  active substance from the group of insecticides, acaricides, herbicides, fungicides, safeners and growth regulators.
7. Herbizide Mittel nach Anspruch 6 enthaltend einen Safener. 7. A herbicidal composition according to claim 6 containing a safener.
8. Herbizide Mittel nach Anspruch 7 enthaltend cyprosulfamid, cloquintocet-mexyl, mefenpyr- diethyl oder isoxadifen-ethyl. 8. A herbicidal composition according to claim 7 comprising cyprosulfamide, cloquintocet-mexyl, mefenpyr- diethyl or isoxadifen-ethyl.
9. Herbizide Mittel nach einem der Ansprüche 4 bis 8 enthaltend ein weiteres Herbizid. 9. A herbicidal composition according to any one of claims 4 to 8 containing a further herbicide.
10. Verfahren zur Bekämpfung unerwünschter Pflanzen, dadurch gekennzeichnet, daß man eine wirksame Menge mindestens einer Verbindung der allgemeinen Formel (I) gemäß einem der Ansprüche 1 bis 3 oder eines herbiziden Mittels nach einem der Ansprüche 4 bis 9 auf die Pflanzen oder auf den Ort des unerwünschten Pflanzenwachstums appliziert. 10. A method for controlling undesirable plants, characterized in that an effective amount of at least one compound of general formula (I) according to any one of claims 1 to 3 or a herbicidal composition according to any one of claims 4 to 9 on the plants or on the place of undesired plant growth.
11. Verwendung von Verbindungen der allgemeinen Formel (I) gemäß einem der Ansprüche 1 bis 3 oder von herbiziden Mitteln nach einem der Ansprüche 4 bis 9 zur Bekämpfung unerwünschter Pflanzen. 11. Use of compounds of general formula (I) according to any one of claims 1 to 3 or of herbicidal compositions according to any one of claims 4 to 9 for controlling unwanted plants.
12. Verwendung nach Anspruch 11, dadurch gekennzeichnet, daß die Verbindungen der 12. Use according to claim 11, characterized in that the compounds of
allgemeinen Formel (I) zur Bekämpfung unerwünschter Pflanzen in Kulturen von Nutzpflanzen eingesetzt werden.  general formula (I) for controlling undesirable plants in crops of crops.
13. Verwendung nach Anspruch 12, dadurch gekennzeichnet, daß die Nutzpflanzen transgene Nutzpflanzen sind. 13. Use according to claim 12, characterized in that the crops are transgenic crops.
PCT/EP2018/057643 2017-03-30 2018-03-26 4-cyclopropyl-2-oxopyrrolidine-3-carboxamide derivatives and related compounds as herbicidal plant protection agents WO2018178014A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17163805.9 2017-03-30
EP17163805 2017-03-30

Publications (1)

Publication Number Publication Date
WO2018178014A1 true WO2018178014A1 (en) 2018-10-04

Family

ID=58461161

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2018/057643 WO2018178014A1 (en) 2017-03-30 2018-03-26 4-cyclopropyl-2-oxopyrrolidine-3-carboxamide derivatives and related compounds as herbicidal plant protection agents

Country Status (1)

Country Link
WO (1) WO2018178014A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016196593A1 (en) * 2015-06-02 2016-12-08 E I Du Pont De Nemours And Company Substituted cyclic amides and their use as herbicides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016196593A1 (en) * 2015-06-02 2016-12-08 E I Du Pont De Nemours And Company Substituted cyclic amides and their use as herbicides

Similar Documents

Publication Publication Date Title
WO2020002089A1 (en) Substituted 2-heteroaryloxypyridines and salts thereof and their use as herbicidal agents
EP3728235B1 (en) Substituted thiophenyluracils , their salts and use of said compounds as herbicidal agents
WO2021013799A1 (en) Substituted n-phenyl uracils, salts thereof and their use as herbicidal agents
WO2020193474A1 (en) Substituted 2-heteroarylaminobenzenes and the salts thereof and their use as herbicidal agents
EP4003975A1 (en) Substituted n-phenyl-n-aminouarcils and salts thereof and use thereof as herbicidal agents
EP3558976A1 (en) Substituted azolylpyrrolones and azolylhydantoines and salts thereof and use thereof as herbicidal active substances
EP3728237B1 (en) Substituted thiophenyluracils , their salts and use of said compounds as herbicidal agents
WO2019025156A1 (en) Substituted pyrrolidinones, salts thereof and use thereof as herbicidal agents
WO2019081477A1 (en) Substituted pyrazoles, salts thereof and use thereof as herbicidal agents
WO2018177837A1 (en) 4-cyclopentyl- and 4-cyclopropyl-2-oxopyrrolidine-3-carboxamide derivatives and related compounds as herbicidal plant protection agents
EP3655393A1 (en) Substituted 5-(het-)arylpyrazolamides and salts thereof and their use as herbicidal active substances
WO2018177836A1 (en) N-cyclopropyl-2-oxopyrrolidine-3-carboxamide derivatives and related compounds as herbicidal plant protection agents
WO2018178008A1 (en) Substituted isoxazoline-5-ones and salts thereof and use thereof as herbicidal agents
WO2022043205A1 (en) Substituted n-phenyluracils and salts thereof, and use thereof as herbicidal active substances
WO2021151976A1 (en) [(1,4,5-trisubstituted-1h-pyrazol-3-yl)sulfanyl]acetic acid derivatives, salts thereof, and use thereof as herbicidal ingredients
WO2019179928A1 (en) Substituted succinimide-3-carboxamides, salts thereof and the use thereof as herbicidal agents
WO2020002087A1 (en) Substituted 3-heteroaryloxypyridines and salts thereof and their use as herbicidal agents
EP3810588A1 (en) Substituted 4-heteroaryloxypyridines and salts thereof and their use as herbicidal agents
WO2018184890A1 (en) 4-substituted n-amino and n-hydroxy 2-oxo-pyrrolidie-3-carboxamide derivatives, salts thereof and use thereof as herbicidal agents
WO2019121547A1 (en) Substituted thiophenyl uracils, salts thereof and the use thereof as herbicidal agents
WO2019081485A1 (en) Substituted pyrazoles, salts thereof and use thereof as herbicidal agents
WO2018114596A1 (en) Substituted heteroaryl pyrrolones and salts thereof and use thereof as herbicidal active substances
EP3497092A1 (en) Substituted pyrazolinyl derivates, method for the production thereof and use thereof as herbicides and/or plant growth regulators
WO2018178014A1 (en) 4-cyclopropyl-2-oxopyrrolidine-3-carboxamide derivatives and related compounds as herbicidal plant protection agents
WO2018178010A1 (en) N-cyclopropyl-2-oxo-4-phenyl-piperidine-3-carboxamide derivatives and related compounds as herbicidal plant protection agents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18711978

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18711978

Country of ref document: EP

Kind code of ref document: A1